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Curli are thin aggregative fimbriae produced by many Enterobacteriaceae as a structural 
component of biofilms. Curli share many biochemical and biophysical properties with 
amyloid fibers which are often associated with human neurological diseases including 
Alzheimer’s, mad cow, and Parkinson’s. However, curli are the product of a dedicated 
assembly system that consists of a complex gene regulatory network featuring CsgD; a 
secretion system that includes CsgG, CsgE, and CsgF; and the major and minor fiber 
subunits CsgA and CsgB. As a model system, many aspects of curli formation have been 
explored including subunit secretion, regulation, biological function, and 
amyloidgenesis. My work focused on the genetics of curli formation in Escherichia coli, 




 the in vitro amyloidgenesis of CsgA-His. I screened the Keio collection of single gene 
deletions to discover new genes that affect curli production. Over 300 genes modulate 
curli production including the sodium antiporter nhaA, a regulator of the glycine 
cleavage system gcvA, multiple LPS biosynthesis genes, and genes involved in many 
fundamental cellular processes. This analysis suggests that curli production is part of a 
highly regulated and complex developmental pathway. The regulation of glyA by CsgD 
and the curli phenotype of gcvA focused my attention on the amino acid composition of 
CsgA. CsgA is incredibly rich in glycine and serine. As simple amino acids, both are 
inexpensive to synthesize. Consequently, CsgA is relatively cheap to produce on a per 
unit basis. Strikingly, other extracellular proteins including those in Escherichia coli, 
Pseudomonas syringae, Mycobacterium tuberculosis, Saccharomyces cerevisiae, and 
other microbes are also inexpensive relative to intracellular proteins. Since extracellular 
proteins are often lost to the environment, evolution has in turn selected them for 
increased economy to counteract lost resources. Finally, we studied the in vitro amyloid 
formation of CsgA-His. Like disease-associated amyloids, CsgA-His bound Thioflavin T 
upon polymerizing into fibers, reacted with an amyloid specific antibody, self seeded, 
and displayed other aspects of amyloid formation. Collectively, this work sheds new 
light on the biology of the functional amyloid fiber curli and hopefully will beget novel 







Curli are thin aggregative fimbriae produced by many Enterobacteriaceae (Fig. 1.1A) 
(23, 140, 193). As an integral structural component of biofilms (41, 87, 145, 152, 174), 
curli help bacteria persist in the face of environmental insults such as desiccation and 
oxidation (144, 167, 179, 181, 182). Curli have been implicated in pathogenesis and aid 
in adherence, internalization, and persistence (60, 61, 80, 89, 94, 95, 100, 146, 161, 168, 
169, 179). Curli fibers mediate binding to a variety of host factors including fibronectin 
and MHC class I molecules (16, 38, 72, 120-123, 131, 151) and are potent inducers of the 
host inflammatory response (18, 20, 121, 164-166, 179). As a public health and food 
safety issue, curliated bacteria better adhere to plant tissues (10, 11, 26, 79, 88, 99, 163) 
and a variety of inert surfaces used in the food processing industry including glass, 
plastics, and steel (7, 15, 23, 30, 41, 128, 133, 162, 167). 
Curli fibers are the product of a dedicated and highly regulated assembly system 
encoded by curli specific genes1 (12), which are arranged in two divergent operons 
csgDEFG and csgBAC (63, 141). Found primarily in the genomes of Enterobacteriaceae, 
csg genes are also present in different arrangements and combinations in other 
Gammaproteobacteria families including Pseudomonadaceae, Shewanellaceae, and 
Vibrionaceae as well as in a few distantly related bacteria in the Bradyrhizobiaceae, 
Burkholderiaceae, and Flavobacteriaceae families (78, 160) (See Fig 2.11).  
Much of the complex control of curli formation involves regulation of the csgDEFG 
operon (12); CsgD is a transcriptional regulator that is required for transcription of the 
csgBAC operon (63, 142, 192). Transcription of the csgDEFG operon is under the control  
 
1 Originally csg referred to curli subunit genes (6).
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of RpoS (5, 120), Crl (6, 24, 132), MlrA (29), H-NS (5, 56, 120), IHF (56), and a number of 
bacterial two component systems (53, 75, 77, 117, 118, 141, 173, 174). All the curli 
specific genes except CsgD have a Sec secretion signal, which is necessary for their 
translocation across the inner membrane into the periplasmic space (12, 83). The 
accessory proteins CsgE, CsgF, and CsgG are all required for proper curli formation (Fig 
1.2B) (31). CsgG is an outer membrane lipoprotein, that is thought to form a pore by 
which the major and minor curli subunits CsgA and CsgB are secreted (31, 50, 105, 136). 
The functions of CsgE, CsgF, and CsgC are currently not as well characterized (12, 31, 
58). Both CsgE and CsgF interact with CsgG and may aid in its proper function (50, 136). 
CsgF is also important for the association of CsgB with the bacterial outer membrane 
(66, 116) where CsgB nucleates CsgA into the fiber known as curli (19, 64, 66). CsgC is 
dispensable for curli formation (See Fig 1.2B); however, it may influence curli fiber 
morphology (58, 63). See Fig. 1.2A for a schematic model of curli biogenesis. 
Intriguingly, curli fibers have many of the properties of amyloids which are often 
associated with neurological disorders including Alzheimer’s, mad cow, and Parkinson’s 
diseases (31, 66, 177, 178, 180). Curli fibers produced by Escherichia coli K-12 strains 
appear as a mesh like matrix of thin fibers when viewed by transmission electron 
microscopy (TEM) (Fig. 1.1A). When purified the major curli subunit CsgA forms similar 
fiber structures (Fig. 1.1B). These CsgA-His fibers fluoresce when bound to Thioflavin T 
(ThT) (Fig. 1.3A) (85, 93, 101-103), have circular dichroism (CD) spectra indicative of high 
beta sheet content (Fig. 1.3B), and produce a red shift when bound to the amyloid 
specific dye Congo Red (CR) (31, 86, 91, 92, 143, 158, 159, 180). Using ThT fluorescence 
we have shown that CsgA-His polymerizes with a defined lag, growth and stationary 
phase, and that CsgA-His is capable of self seeding with preformed fibers (Fig 1.4) (180). 
Both properties are indicative of nucleation dependent polymerization. Like many 
amyloid fibers, curli are also highly stable (39, 40). Curli fibers resist proteinase K 
digestion, are insoluble in SDS, and require harsh denaturants to separate and mobilize 
into SDS polyacrylamide gels (Fig. 1.5C) (39, 81, 122).  
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Under denaturing conditions, many proteins form amyloids, suggesting that the 
amyloid fold results from backbone interactions and may be an intrinsic property of 
proteins (9, 34, 125). However, in many cases, amyloid formation leads to disease, the 
result of an aberrantly folded protein owing to either destabilizing point mutations or 
defects in the cell’s folding, secretion, or turnover machinery (31, 51, 65, 66, 125, 149, 
177, 178, 180). However, unlike these disease-associated amyloids, curli are not the 
result of an aberrant fold. Instead, curli have evolved to fulfill a functional role and 
require a complex assembly system (see above). As such, curli are part of a growing list 
of functional amyloids which are found in many organisms where they perform cellular 
tasks including regulation, storage, and structural roles (2, 9, 21, 31, 35, 36, 42-44, 49, 
54, 55, 67, 108, 109, 119, 124, 125, 139, 150, 177, 183-185). Many of these functional 
amyloids share little sequence similarity, suggesting the amyloid fold has evolved 
multiple times to fulfill important physiological functions. 
 
Curli as a model system 
 Though often imperfect (25), model systems are useful in biology to generate 
new hypotheses. These hypotheses often regard how components interact with one 
another and function together as a whole. By selecting model systems that are easily 
manipulated and well understood, one can generate concepts that apply to similar 
systems and improve understanding of complex biological processes. The key to a good 
model is the ease of study and the breadth of the science a model allows you to explore.  
In both respects, Curli are an excellent model system, being amenable to study 
and applicable to diverse fields of research. Several properties of curli including the 
amyloid formation of CsgA and the genetic tractability of Escherichia coli allow for the 
use of multitude tools including genetic, in vitro and in silico techniques. Curli have been 
used to explore biofilm formation, pathogenesis, the assembly and secretion of 
fimbriae, and amyloidogenesis. This work focuses on the genetics (Chapter II), molecular 





For any curli defective mutant there are several techniques to discover how curli 
assembly is affected including Congo Red (CR) binding, inter-bacterial complementation, 
Western blotting, biofilm and pellicle formation, TEM, and transcriptional assays. Of 
these techniques CR binding is by far the most important. When curli producing bacteria 
are grown on agar plates supplemented with Congo Red they turn bright red (Fig. 1.5B), 
while strains that lack curli remain white (Fig. 1.2B and 1.5A). The Congo Red phenotype 
can vary from white to dark red and is fairly indicative of the amount of CsgA produced 
by different strains of bacteria (Compare Fig 1.5A and 1.5D). Thus CR allows for 
complementation and genetic screens for accessory factors, greatly facilitating the study 
of curli producing bacteria. 
Utilizing this genetic tool, I screened the Keio collection of single mutants (8) for 
new genes that affect curli biogenesis. More than 300 genes were found to affect curli 
production in E. coli K-12. These genes include transport proteins, lipopolysaccharide 
(LPS) and purine biosynthetic genes, regulatory proteins, and many additional genes 
involved in fundamental cellular processes. Many of these genes affect RpoS levels or 
induce the sigma E stress response which promote and inhibit curli production, 
respectively. Few of the genes identified are involved in motility, underlying that 
motility and biofilm formation are distinct microbial lifestyles. In chapter III, I further 
explore how these results indicate curli production is part of a highly regulated and 
complex developmental pathway in Escherichia coli. 
 
In silico 
 Curli are unique from a bioinformatics perspective due to their unique 
composition and extracellular location. I noticed the connection between these factors 
while pondering the gcvA mutant, which produces less curli (Fig 1.6B). GcvA regulates 
the glycine cleavage system which degrades glycine into ammonia and carbon dioxide 
(57, 69, 82, 154-157, 186-189). CsgD, the master regulator of curli, is known to increase 
glyA levels (32, 33); GlyA is serine hydroxymethyltransferase which interconverts glycine 
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and serine (Fig. 1.6C) (83). The regulation of glyA by CsgD and the gcvA CR phenotype 
indicated these amino acids were import for curli production. Strikingly, CsgA is 
incredibly glycine and serine rich, and the regulation of glyA by CsgD may help balance 
these amino acids for efficient curli production.  
More importantly, as simple amino acids, glycine and serine are relatively 
inexpensive to synthesize (1, 45, 70). Consequently, on a per unit basis CsgA is an 
inexpensive protein to produce. I extended this analysis of protein economy to other 
extracellular proteins. Many extracellular proteins including those in Escherichia coli 
(Fig. 1.7), Pseudomonas syringae, Mycobacterium tuberculosis, Saccharomyces 
cerevisiae, and multiple other microbes were found to contain, on average, less 
expensive amino acids. Furthermore, this effect seems to be independent of the 
abundance (Fig. 1.8), structure, function, or length of extracellular proteins. In Chapter 
III, I explore how economy is a selective pressure on the composition of extracellular 
proteins and discuss possible biological reasons for this selection. 
 
In vitro 
Curli were identified as an amyloid fiber by Matthew Chapman (31). One of the 
original projects in the lab was purifying the major curli subunit CsgA. Following this 
development, Xuan and I studied the in vitro polymerization of CsgA-His through 
Thioflavin T fluorescence, circular dichroism, TEM, and A11 antibody binding. The A11 
antibody recognizes an intermediate in the polymerization of many disease associated 
amyloids (84). These techniques allowed us to study the kinetics, seeding, and factors 
favoring curli fiber formation. In Chapter IV, I describe aspects of the in vitro 
polymerization of CsgA-His and contrast them with disease-associated amyloids. 
 
Economics plays an important role in evolution 
The economic selection on extracellular proteins is part of a broader concept in 
molecular evolution. That is the evolution of proteins is not driven purely by selection 
for increased function. Another factor driving the composition and regulation of 
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proteins is the relative cost of their components. This concept of cost selection grew out 
of the heated debate over neutral evolution. Neutral evolution was originally postulated 
by Kimura (1968) and gained wider recognition following the publication of “Non-
Darwinian Evolution” by King and Jukes in 1969 (90). The theory of neutral evolution 
states that many if not most of mutational changes in organisms do not affect function, 
that is mutations are frequently neutral to natural section and generally reflect genetic 
drift instead of positive selection for a particular trait. An early reply to “Non-Darwinian 
Evolution” by R.C. Richmond (135) stated that many neutral mutations are not 
necessarily so; one quotation of this critique is relevant here as it was elsewhere (1).  
Even if a substituted amino acid were truly neutral in a functional sense, it is 
highly unlikely that factors involved in the synthesis of the protein would render 
the substitution neutral in the broader sense of the organism’s integrated 
functioning. The substituted amino acid must be present within the cell in 
equivalent quantity compared with the original amino acid and, indeed, its 
synthesis or derivation from other molecules and transport into the cell require 
an equivalent amount of energy output. 
  R.C. Richmond “Non-Darwinian Evolution: a critique” Nature 1970 
 
There are now numerous instances where protein composition and regulation 
reflects limited environmental resources. Much of the economical bias present in 
biological molecules appears to reflect global or overall reductions and substitutions of 
rare or expensive components. For example, Akashi and Gojobori (1) showed that many 
abundant proteins have amino acids that cost less for the cell to produce. In ocean 
environments, phytoplankton can overcome phosphorous limitation by substitution 
with sulfur and nitrogen containing lipids (171). Similarly, species of Prochlorococcus 
isolated at deeper depths have more nitrogen and sulfur in their proteomes than 
surface species, reflecting the content of these elements in the water column (106). By 
reducing the use of scarce environmental resources, organisms can decrease the cost of 
their metabolism and replication, thus increasing their relative fitness during times of 
resource limitation. 
Another form of economic selection is more focused and reflects what happens 
during the sudden loss of a needed metabolite. When an organism is suddenly without 
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specific metabolite, it often responds by producing the proteins that transport or 
synthesize this metabolite. However, if proteins that transport or produce a metabolite 
contain a higher composition of the corresponding metabolite, the cell finds itself in a 
classic Catch-22 situation. Such transient starvation should exert a strong and specific 
pressure to reduce the composition of the scarce metabolite in the proteins that 
transport or synthesize it. Organisms that have increased economy of these ‘stress’ 
proteins should be better able to respond to transient starvation and thus be more fit. 
One of the best descriptions this kind of optimization was proposed in the economy of 
amino acid biosynthetic enzymes. Many amino acid biosynthetic proteins have reduced 
contents of the amino acid they ultimately produce (3, 130). Thus when a specific amino 
acid is needed the cell is better able to increase production of the proteins needed for 
an efficient response. Other instances of this form of economy include regulation of 
alternative enzymes during starvation that have less of the limiting resource. 
 
Cost values for cellular components 
Before delving into how economy affects evolution, one must consider the 
different cost values for proteins and other cellular components and their associated 
strengths and weaknesses. The amino acids of proteins have diverse physicochemical 
characteristics which affect protein folding and function. The diversity of amino acid 
chemistry requires different biochemical pathways and chemical precursors. These 
pathways and precursors result in some amino acids being more expensive to synthesize 
than others. The relative cost of amino acid synthesis can be calculated in many ways 
including the ATPs required to make an amino acid, the mass of an amino acid, the 
number of carbons, nitrogens, or sulfurs in an amino acid, or the Gibbs free energy of 
formation (4). 
Craig and Weber (45) first calculated the relative synthetic costs of amino acids 
of E. coli. Using metabolic information, each amino acid cost was calculated by adding 
the ATPs equivalents consumed in synthesis with the energy lost from diverting 
precursor from central metabolism. Akashi and Gojobori (1) updated these values by 
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averaging out the slight differences in cost incurred during growth on different carbon 
sources. This bacterial cost has been extended to other chemoheterotrophic bacteria 
because there is conservation in the central metabolism of many aerobic bacteria (1, 
70). Similar calculations have been done for yeast under both respiratory and 
fermentative conditions (28, 176), resulting in numbers that differ slightly but are highly 
correlated with the bacterial values (Fig. 1.9E). 
Mass has also been proposed as a complementary approach to calculate relative 
costs of amino acid (148). The synthetic cost, mass, and Gibbs free energy (4) of amino 
acids can be used to compare the relative cost of proteins because they convert protein 
components to a common currency. All three cost schemes correlate well with one 
another; however, each emphasizes certain functional groups over others (Fig. 1.9A, 
1.9F, 1.10D). Differences in the atomic composition and chemical nature of amino acid 
precursors result in a slight shuffling in the order of amino acid cost depending on which 
system is used. For example, the acidic and nitrogen rich amino acids tend to more 
massive relative to their synthetic cost (Fig. 1.9A).  
A second type of cost is based on the atomic makeup of the amino acids and 
includes the number of carbons, nitrogens, or sulfurs in each amino acid. Oxygen is 
excluded from economic consideration. Oxygen is usually fixed in amino acids through 
water, and there is little evidence, even in anaerobes, of oxygen limitation affecting 
amino acid composition (175). The remaining elements are often scarce in the 
environment and their economy may be as important if not more so than energy 
concerns. Of these elements, only carbon correlates well with synthetic cost, mass, or 
Gibbs free energy. The vast majority of synthetic cost is due the number of reduced 
carbons diverted from central metabolism (1, 45, 176). 
There are many other costs for proteins and other cellular components. Trace 
metals substitutions in enzymes can be an important cost during metal starvation. The 
amount of DNA an organisms has increases its need for phosphorous, a limiting element 




nitrogen and one less carbon than an AT pair, and GC pairs are more expensive to 
produce (137). Lipids also display compositional biases that reflect environmental 
limitation (171, 172). Unfortunately, there is no single best way to quantify the relative 
cost of cellular components due to the diversity of metabolism and environmental 
conditions (13). Additionally, what is expensive for one organism or group of proteins 
may not necessarily be so for another (3, 48, 70, 130). However, the use of appropriate 
costs in a relevant biological context can elucidate how economy has affected cellular 
composition. 
 
Synthetic cost and carbon 
 Abundant proteins were first shown by Akashi and Gojobori to use less 
expensive amino acids in their synthesis in E. coli and B. subtilis (1). More extensive 
studies in other bacteria found similar results whether using synthetic cost or amino 
acid mass (70, 148). Eukaryotes such as yeast also have less expensive and massive 
amino acids in their abundant proteins (104, 134, 148). Abundant proteins have also 
been shown to have less carbon, nitrogen, and sulfur contents (104). There are notable 
exceptions to this rule for abundant proteins. Ribosomal proteins in particular do not fit 
well (Fig. 1.8), and their removal improves these comparisons; their preference for basic 
amino acids results in high nitrogen contents (104). 
Carbon is intrinsically linked to synthetic cost as much of this cost is due to the 
number of reduced carbons. Therefore, it is not surprising that inexpensive proteins 
have lower carbon contents (See Fig. 3.12). Attempts to separate carbon content and 
synthetic cost have suggested carbon limitation is the driving force in the economy of 
abundant proteins; however, these methods involved removing nitrogen and sulfur 
amino acids including tryptophan which can significantly affect protein cost (104). 
Reductions in carbon content are also present in proteins that assimilate carbon, which 





Nitrogen, sulfur, and phosphorous 
 Nitrogen has been implicated in the economical selection of DNA and proteins. 
Pelagibacter ubique is found near the ocean surface where nitrogen is limited. Despite 
the retention of DNA repair enzymes, the genome of P. ubique is quite AT rich, which 
reduces nitrogen requirements relative to GC rich DNA (59). The limiting nitrogen 
content in the ocean was also suggested to pressure the proteomes of Prochlococcus 
species. Prochlococcus isolates obtained nearer to the ocean surface had lower nitrogen 
and sulfur contents (106). Plants also have less nitrogen in their abundant proteins; 
however, animals do not have a consistent pattern between nitrogen content and 
protein abundance (48) 
 Sulfur limitation in a sulfur assimilation protein was noted prior to the theory of 
neutral evolution (127). Reductions in sulfur content in other sulfur metabolism genes 
were subsequently seen in bacteria and yeast (14), and this depletion is also present in 
abundant proteins (104, 111). During sulfur starvation, sulfur depleted enzymes are 
preferentially expressed in bacteria and yeast (22, 46, 52). However, sulfur reduction 
can also have a strong functional basis which can be conflated with economic selection. 
Both cysteine and methionine are readily oxidized (68, 153, 190); subsequently, 
compartmentalization (138) and reduction of these amino acids occurs to prevent loss 
of protein function (27, 175). 
Phosphorous is primarily used in lipids and nucleotides and is quite limiting in 
the ocean (37, 114). Consequently, the lipids and nucleotides of some ocean microbes 
appear to reflect phosphorous economy. For example, Prochlorococcus and P. ubique 
have greatly reduced genomes (37, 59), which reduces the overall phosphorous 
requirements. P. ubique currently has the smallest genome among free living bacteria, 
and the average intergenic region between its genes is only three bases (59). However, 
despite the genome reduction found in Prochlorococcus strains, nucleotides still account 
for about half the cellular phosphorous (17, 37). Ocean microbes can also overcome 





Ocean microbes also have evolved ways to deal with limiting trace metals 
needed for metabolic enzymes. Many microbes can replace scarce metals such as Zinc 
with Cobalt or Cadmium (97, 114, 115). Several enzymes have been identified that 
explain this exchange of metal cofactors including carbonic anhydrase (96) and 
superoxide mutase (126). Thalassiosira weissflogii expresses an alternative cadmium 
containing carbonic anhydrase when zinc is limiting (96, 98, 191). Similarly, zinc 
limitation increases expression of a zinc independent form of GTP cyclohydrolase, which 
can uses other divalent cations (147). Iron limitation leads to higher manganese content 
in superoxide dimutase (129). Species of Azotobacter express a vanadium containing 
nitrogenase under molybdenum deficiency (47, 62). In several of the instances above 
the limitation of one metal is linked to production of isozymes that uses alternative 
cofactors which helps the cell overcome a metabolic block. Metal limitation can also 
change basic metabolism to reduce the need for a scarce resource. In Euryarchaeon 
halobacterium, low iron changes respiratory pathways and reduces the number of iron 
sulfur clusters (73).  
There are likely many additional examples of economic selection of cellular 
components or regulation of alternative isozymes during starvation. Several such 
examples are listed above along with descriptions of general trends in protein economy. 
Collectively, I believe these examples demonstrate an invaluable biological concept, that 
cost is an important pressure on the composition of life. The exact nature and strength 
of the selection for economy in many of these examples requires further study. Either 
positive selection for increased economy or negative selection of expensive 
substitutions would produce similar results. An early paper suggest protein economy 
result more from the latter; that is selection is against the substitutions of expensive 






Fig. 1.1. TEM of curli fibers produced by Escherichia coli K-12 and purified CsgA-His 
which has polymerized into amyloid fibers. (A) A BW25113 strain of E. coli K-12 
produced curli fibers after being grown on YESCA plates for two days at 26C. 
Magnification is 15,500X. (B) Purified CsgA-His allowed to polymerize at room 
temperature for 7 days. Bar indicates 500nm. Published image (180). A Philips CM12 
Scanning Transmission Electron Microscope was used to visualize the fiber aggregates. 
Samples (10 µl) were placed on formvar coated copper grids (Ernest F. Fullam, Inc.), 
washed with deionized water, and negatively stained with 2% uranyl acetate. 
 
Fig. 1.2. Model of curli biogenesis and in vivo phenotypes of csg single gene deletions. 
(A) Curli is the product of the transcription of two operons csgDEFG and csgBAC. CsgD is 
required for transcription of the csgBAC operon. Phosphorylation of the Asp 59 of CsgD 
reduces its ability to bind to the csgBAC promoter region (192). All the curli specific 
genes except CsgD have a Sec secretion signal resulting in the translocation across the 
inner membrane into the periplasmic space. CsgG is transported by the LOL system to 
the outer membrane where it is thought to form a pore by which the major curli subunit 
CsgA and the minor subunit CsgB are secreted. CsgE aids in the function of CsgG, but 
may have other functions. CsgF helps tether CsgB to the outer membrane where CsgB 
nucleates CsgA transforming it into the majority of the amyloid fiber known as curli. (B) 
Congo red binding and (C) western blots for CsgG and CsgA of WT (BW25113) E. coli K-
12 and single mutant from the Keio collection (8). Strains were grown on YESCA plates 
for two days at 26C. 
 
Fig. 1.3. Fibers formed from CsgA-His display amyloid properties including increased 
ThT fluorescence, CD spectra indicative of high β-sheet content, and a red shift when 
bound by Congo Red. (A) CsgA-his or Bovine Serum Albumin were buffered in 50mM KPi 
pH 7.2. Thioflavin T (ThT) was added to 2 μM. Fluorescence emission was read on a 
Spectramax M2 plate reader (Molecular Devices) with excitation set to 438 nm and the 
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cutoff frequency to 465 nm. Chemical structure of Thioflavin T is inset. (B) Circular 
dichroism (CD) spectra of purified CsgA-His (10 μM in 50mM KPi) incubated at room 
temperature for the times indicated. Spectra were performed in a Jasco J-810 
spectropolarimeter from 190 to 250nm in a quartz cell with 1-mm path length at 25°C. 
(C) Absorbance of Buffer (50mM KPi), polymerized CsgA-His, and Bovine Serum Albumin 
(BSA) with the addition of Congo Red (CR). (D) Difference spectra of BSA and 
polymerized CsgA-His where the absorbance of Buffer + CR was subtracted from the 
respective protein + CR spectra. The maxima of the red shift for CsgA-His with CR was 
544 nm. 
 
Fig. 1.4. CsgA polymerization kinetics and self seeding using ThT fluorescence. (A) 
Thioflavin T time course of CsgA-His polymerization showing the typical lag, log and 
stationary phase (after green arrow) of amyloid fiber growth. CsgA-His was purified as 
described (180) mixed with ThT and allowed to polymerize in a 96 well plate (Costar 
#3605) and be read by a Spectramax M2 plate reader (Molecular Devices) which was set 
to 438 nm excitation 495 nm Emission and 475 nm Cutoff frequencies. The lag time 
(blue arrow) is set as the time between starting the reaction and the point at which the 
two slopes indicated intersect on the X axis (time). The half time (t ½) (black arrow), 
which is affected by both the lag phase and polymerization rate, is the time point half 
way through the growth phase of polymerization. (B) Addition of preformed CsgA-His 
seeds (sonicated) reduces the lag phase of unpolymerized CsgA-His. 
 
Fig. 1.5. Curli fibers bind Congo Red (CR) and are SDS insoluble. (A) Congo Red binding 
phenotypes of different strains of E. coli K-12 from the Keio collection (8). Phenotypes 
range from white to light pink and correlate well with western blots for CsgG and CsgA 
(See Fig. 1.5D). (B) Chemical structure for Congo Red. (C) Curli fibers from a BW25113 
wild type strain of E. coli K-12 are SDS insoluble unless harsh denaturants such as Formic 
Acid (FA) or Hexafluoroisoproponol (HFIP). (D) Western blot of whole cells of the strains 
seen in Fig. 1.5A. Blots in Fig. 1.5C,D were probed antibodies to CsgA and CsgG. 
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Fig. 1.6. Use of Congo Red binding in the Keio collection screen found many mutants 
including gcvA were defective for curli formation leading to an exploration of glycine 
composition in curli specific genes including CsgA. (A) Typical Congo Red (CR) YESCA 
plate from using a plate replicator to transfer Keio collection strains to screen for new 
genes that affect curli production in E. coli K-12. Strains were grown two days at 26C. (B) 
Comparison of CR phenotype of WT (BW25113), csgA, and gcvA strains of E. coli K-12. 
Strains were grown two days at 26C on CR YESCA plates. (C) Diagram of serine and 
glycine interconversion by GlyA and glycine breakdown by the glycine cleavage system. 
(D) Histogram of 4033 proteins in E. coli MG1655 showing their percentage of glycine 
plus serine. The mean % of glycine plus serine is 12.9 %; CsgA is 28.5 % glycine plus 
serine. 
 
Fig. 1.7. Economy of extracellular proteins in Escherichia coli strain MG1655. 
Extracellular proteins contain on average less expensive amino acids than cellular 
proteins. For each protein in E. coli strain MG1655, the average synthetic cost or ASC 
(∑(synthetic cost of amino acid in ATPS)/number of amino acids) was calculated using 
the values for chemoheterotrophic bacteria (1, 70). Using the average synthetic cost and 
the location data from Echobase’s Echolocation website (113) available at 
(HUhttp://www.york.ac.uk/res/thomas/echolocadv.cfm UH) each protein was graphed 
accordingly; within each location the data were spread vertically using protein length 
(0.2×LOG(Length)). The dotted black line represents the mean ASC of all the proteins 
used (23.55 ATPs/aa). The thick solid black line indicates the mean ASC of extracellular 
proteins (20.63 ATP/aa). FliC and CsgA are indicated (black arrows). The difference in 
ASC between extracellular and cellular proteins is significant (Mann Whitney U-test, 
p=1.24×10-10). A few locations were changed based on the literature: FlgM (74), FliK 
(112), and Eno (170) to extracellular, FlgJ to periplasmic (107), and Ag43 was divided 
into its secreted soluble alpha domain and outer membrane beta domain (71) (both α-




Fig. 1.8. Comparison of the effects of location and abundance on protein ASC. 
Abundance does not appear to be a good indication of protein economy in E. coli K-12. 
Proteins from E. coli MG1655 were plotted according to their average synthetic cost 
(ASC) and either their abundance if known (darker blue) (110) or their total length 
(lighter blue). Both Y scales are logarithmic. Extracellular proteins are indicated in green; 
ribosomal proteins (Rpl, Rpm, Rps, and Sra) are indicated in red. The dotted black line 
represents the mean ASC of all the proteins used. See Fig. 1.7 legend for changes to 
location and Table 3.13 in Chapter III for Notes on the merging of Echobase sequences 
(113) with the abundance data of Matsuda et al 2009 (110). 
 
Fig. 1.9. Comparison of the synthetic cost of amino acids in bacteria with their atomic 
mass; number of carbons, nitrogens, or sulfurs; yeast synthetic costs, and Gibbs free 
energy of formation. The synthetic cost of for bacteria is for chemoheterotrophs (1, 70). 
Yeast respiratory and fermentative growth synthetic cost values are from Wagner (176). 
Values for Gibbs free energy of formation of amino acids in sea water (18°C) and 
hydrothermal solutions (100°C) are from Amend and Shock (4). (A) Comparison of 
bacterial synthetic cost and mean amino acid mass. Comparison of bacterial amino acid 
synthetic cost and the numbers of Carbons (B), Nitrogens (C), or Sulfurs (D) per amino 
acid. (E) Comparison of amino acid synthetic cost in bacteria (aerobic growth) with yeast 
in respiratory (green) and fermentative (blue) conditions. (F) Comparison of bacteria 
amino acid synthetic cost with the Gibbs free energy of formation at 18°C in seawater 
(orange) and 100°C in hydrothermal solution (purple). 
 
Fig. 1.10. Comparison of mass of amino acids to their number of carbons, nitrogens, or 
sulfurs and Gibbs free energy of formation. Values for Gibbs free energy of formation 
of amino acids are from Amend and Shock (4). Comparison of amino acid mass with 
their numbers of Carbons (A), Nitrogens (B), or Sulfurs (C). (D) Comparison of amino acid 
mass with their Gibbs free energy of formation at 18°C in seawater (orange) and 100°C 




Figure 1.1.  TEM of curli fibers produced by Escherichia coli K-12 and 















Figure 1.2. Model of Curli biogenesis and in vivo phenotypes of csg single gene deletions.
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Figure 1.3.  Fibers formed from CsgA-His display amyloid properties including increased
ThT fluorescence, CD spectra indicative of high β-sheet content, and a red shift












Figure 1.3 (continued).  Fibers formed from CsgA-His display amyloid properties including
increased ThT fluorescence, CD spectra indicative of high β-sheet content, and a red shift

































































































































Figure 1.6.  Use of Congo Red binding in the Keio collection screen found many
mutants including gcvA were defective for curli formation leading to an
exploration of glycine composition in curli specific genes including CsgA.
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Figure 1.9.  Comparison of the synthetic cost of amino acids in bacteria with
their atomic mass; number of carbons, nitrogens, or sulfurs; 







Figure 1.10  Comparison of mass of amino acids to their number of
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Curli are stable proteinaceous fibers assembled within the extracellular matrix of many 
enteric bacteria including Escherichia coli and Salmonella typhimurium. Curli expression 
and assembly are known to require two fiber subunit genes, three secretion factors, and 
several transcriptional regulators. Using the Keio strain collection of single gene 
deletions, we screened for mutations that affect curli production in E. coli K-12 by 
assessing colony phenotypes on Congo Red indicator plates. We discovered more than 
three hundred genes modulate curli production. Genes affecting many fundamental 
cellular processes including metabolism, environmental sensing, gene regulation, outer 
membrane biosynthesis, molecular transport, and protein turnover had altered curli 
production. For example, deletion of the sodium antiporter NhaA led to loss of curli and 
an increase in motility. Null mutants in several purine, pyrimidine, and inner core 
lipopolysaccharide (LPS) biosynthetic genes also made less curli. The alternative sigma 
RpoS and RpoE appear to have opposing roles in curli production. Mutations such as 
nuoG, clpX, and sdhC that increased RpoS levels produced more curli, while strains with 
lower RpoS including dnaK and dksA made less curli. Mutants predicted to induce RpoE 
expression, such as rseA, inner core LPS and enteric common antigen (ECA) mutants, 
were correlated with a reduction in curli gene expression. Using previously published 
studies, we found only little overlap between genes idenfied as important for curli 
biogenesis with genes affecting swimming and swarming motility. The large number of 
genes identified in this study that affect curli biogenesis, suggest that curli production is 







Curli are thin aggregative fimbriae produced by many Enterobacteriaceae including 
Escherichia coli and Salmonella typhimurium. (18, 23) (See Fig. 2.11). As the major 
protein component of the extracellular matrix, curli are vital for mature biofilms (57). 
Curliated bacteria better adhere to and colonize a variety of surfaces (5, 50, 106, 122, 
126) and are more resistant to environmental damage from desiccation or antimicrobial 
agents (106, 122, 135). Curli fibers have also been implicated in host cell adhesion, 
invasion, and immune system activation (8, 38, 129). 
Curli assembly is a complex process that requires six proteins encoded by the 
divergent operons csgBAC and csgDEFG (18, 41). At the cell surface, the major curli fiber 
subunit CsgA is nucleated into an extracellular amyloid fiber by the minor fiber subunit 
CsgB (9, 18, 42). Secretion of both curli fiber subunits requires the lipoprotein CsgG, 
which forms a putative pore in the outer membrane (18, 30, 69, 98). CsgE and CsgF are 
accessory proteins that assist in subunit secretion and the proper localization of CsgB, 
respectively (18, 79). CsgC is dispensable for curli formation; however, it may influence 
the morphology of curli fibers (36, 41). 
Curli production is affected by a number of additional gene products, most of which 
affect curli through the regulation of the csgDEFG operon (See Table 2.1) (6). Previous 
screens to identify additional accessory factors and regulators have identified only a 
handful of genes such as nagA (7, 40, 41). Therefore, we performed a comprehensive 
screen for genes involved in curli production using the Keio collection (4). The Keio 
collection is a near complete set of single gene knockouts in E. coli K-12. Using Congo 
Red (CR) indicator plates, we found more than 300 strains had reproducible changes in 
curli production. These strains lack genes involved in a variety of cellular processes 
including cell envelope biogenesis, metabolism, transport, and regulation. Therefore, we 
propose curli fiber formation requires significant changes in the physiology and lifestyle 







Results and Discussion 
Screening to identify genes involved in curli production. 
 To better understand curli production and regulation, we screened the Keio 
collection for additional curli associated genes using Congo Red (CR) indicator plates 
(Fig. 2.1A). Curliated bacterial colonies turn red when grown on CR plates, while strains 
that do not produce curli remain white (22). The Keio collection consists of 3985 
nonessential gene mutants comprising more than 90% of the 4,390 open reading frames 
of E. coli K-12 (4). Following growth at 26°C for 48 hours, strains with changes in CR 
phenotypes were isolated and scored according to their color, which varied from the 
lighter pink of csgA to the darker red of rcsF (Fig. 2.1A). Some strains including thyA, 
glnA, ubiE and ubiF (Fig. 2.1A) did not grow well under the conditions tested. 
Strains with an altered phenotype were regrown on CR indicator plates for 
verification and rescored numerically according to color from lightest to darkest (Fig. 
2.1B and Table 2.5). We isolated 318 Keio mutants with reproducible CR phenotypes; 
however, 64 strains had two or more phenotypes upon isolation of single colonies. The 
original gene deletion in the strains with multiple CR phenotypes was verified by PCR, 
and most had the correct Kanr insert for each phenotype (Table 2.6). Many of the strains 
with multiple CR phenotype strains had colonies with WT curli production in addition to 
a mutant CR phenotype. Therefore, we excluded these strains from further study as 
they likely have second site suppressors. However, we included the cmk, fabF, mdoG, 
pgm, trpD, trpE, yiaK, and ymgE strains because the CR phenotypes were always less 
than WT cells. The resulting 265 mutants were 13.7% white, 17.9% light pink, 30.8% 
pink, 19.0% light red, and 18.6% dark red when grown on CR indicator plates (Fig. 2.1D). 
To better quantify curli production in the identified mutants, we measured the 
CsgG and CsgA levels using western blotting (Fig. 2.1C and Table 2.5). The levels of both 
proteins were generally consistent with CR phenotypes (Compare Fig. 2.1B,C). However, 
in some light pink mutants, the putative curli secretion protein CsgG (69, 98) was 






We divided the genes required for WT levels of CR binding into clusters of 
orthologous groups (COGs) (4, 67) and used Echobase (75) to assign a cellular location to 
each gene (Tables 2.3 and 2.5, Fig. 2.5). Collectively, the genes identified in our screen 
are predicted to perform a variety of functional roles in the cell and are primarily 
cytoplasmic. Of the genes outside the csg operon that are known to affect curli, most 
are proposed to affect curli production through transcriptional changes (6); exceptions 
include ycfR, rfaG, lpxM (msbB), and ddhC (Table 2.3). Most of the CR phenotypes of the 
Keio collection were consistent with the literature: exceptions are primarily found in 
cyclic-di-GMP and regulatory proteins some of which are known to have strain 
dependent effects on curli production (Table 2.3) (6). In the following sections, we 
explore genes from several different functional groups and discuss likely roles of their 
gene functions in curli production.  
 
Cell Envelope  
 Genes involved in basic cellular processes like metabolism, regulation, motility 
and envelope biogenesis were identified in our screen (Tables 2.3). Because curli 
assembly occurs on the cell surface, we focused on the cell envelope and outer 
membrane biogenesis COG family group (M). The cell envelope includes the inner 
membrane, the periplasm, the outer membrane and extracellular structures including 
fimbriae and extracellular polysaccharides (EPS) (132). 
Multiple lipopolysaccharide (LPS) biosynthesis gene mutants, many of which are 
involved in assembling the inner core region, were defective for curli production (Fig. 
2.2A,B). Curli associated genes in the inner core region of LPS encode hexose and 
heptose transferases, enzymes that produce the inner core sugar building block ADP-L-
glycero-D-manno-heptose, the LPS kinase rfaP, and the transcriptional antiterminator 
for the rfaQGPSBIJYZK operon rfaH (89, 91, 109). Western blot analysis showed that 
many LPS mutants with CR defects had corresponding decreases in CsgA and CsgG levels 
(Fig. 2.2A,C). Mutants in the inner core sugar transferases rfaC, rfaF, rfaG, and the 






 Several LPS mutant strains had a notably dry and friable texture including galU 
and rfaG and to a lesser degree rfaF (84, 109). GalU produces UDP-D-Glucose and is 
required for growth on galactose and trehalose and the synthesis of trehalose, the LPS 
outer core, colonic acid and periplasmic glucans (11, 32, 56, 133). Since RfaG adds UTD-
D-Glucose to the inner core of LPS, the galU and rfaG mutants should be functionally 
similar. Both strains displayed a light pink phenotype, were visibly drier and crumbled 
when scraped from plates (84), autoagglutinated when resuspended in PBS (109), had 
similarly low levels of CsgG by western blotting, and displayed identical LPS profiles on 
silver stained PAGE gels (32) (Table 2.5, Fig. 2.3A,B). We also tested cell hydrophobicity 
of the inner core sugar transferases using the BATH method (103) and found that strains 
with more developed inner LPS cores had progressively more hydrophilic membranes 
(compare rfaC,F,G in Fig. 2.2B and 2.3C). As expected, both galU and rfaG had similar 
cell hydrophobicity profiles. Surprisingly, a csgA strain was more hydrophobic than the 
wild type curliated strain. Accordingly, the lack of curli in the ycfR strain may explain its 
high hydrophobicity in a previous study (136). 
Both rfaD and gmhB were pinker and had higher Csg protein levels than lpcA, 
rfaE, or rfaC, which were lighter pink and contained very little detectable CsgA and CsgG 
(Fig 2.2A). However, all these gene products are involved in the process of synthesizing 
or transferring the ADP-L-glycero-D-manno-heptose to Lipid A-KDOII (91). Deletion of 
the epimerase rfaD results in accumulation of a mixture of mostly heptose free LPS, 
some LPS with the D-glycero-D-manno-heptose isomer, and a trace amount of LPS with 
the correct L,D heptose isomer (Fig. 2.3A) (21). Strains lacking gmhB accumulate a 
mixture of heptose free and L-glycero-D-manno-heptose core LPS (Fig. 2.3A) (60); 
another haoloacid-dehalogenase-like hydrolase paralog may partially complement 
GmhB function (60, 63). The mixture of LPS in the rfaD and gmhB strains with and 
without core regions may explain their intermediate curli phenotype (See Fig. 2.3A). 
Unlike the rfaG strain and other inner core mutants, both rfaD and gmhB strains have a 






for curli production, it appears even a small amount of Glucose I modified LPS is capable 
of supporting curli secretion and polymerization. 
Previous studies have implicated LPS biosynthesis genes including rfaG, ddhC 
(rfbH) (1), and lpxM (msbB) (58) in curli production. In Salmonella enterica both rfaG and 
ddhC strains produce less curli but more cellulose than wild type (1). Similarly, the rfaG 
strain in K-12 had reduced curli production; however, there was no increase in cellulose 
production, as many K-12 strains including MC4100 do not produce cellulose (70, 139) 
(Fig. 2.6). We also looked at other lipid A modifying enzymes to see if they affected curli 
production. The lpxL, lpxM (msbB), lpxP, pagP, and arnT mutant strains all produced 
curli at WT levels suggesting the modification state of the lipid A core does not 
necessarily affect curli production in K-12 strains of E. coli (Fig. 2.10).  
Other components of the cell envelope include the enteric common antigen 
(ECA) and the periplasmic glucans. Mutants in ECA biosynthesis with altered curli 
production include rfe, rffA, rffC, rffT, and wzxE (Fig. 2.7A). RffA, RffC, and RffT are 
involved in synthesis or addition of the TDP-Fuc4NAc to lipid II (Fig. 2.7B) (92).  Strains 
lacking these proteins accumulate lipid II and have increased degP levels via RpoE and 
CpxR induction (25). Mutants in rfe suppress the degP activation in the rffA, rffH, and 
rffT strains suggesting undecaprenyl-P and lipid II accumulation have opposing roles in 
envelope stress responses and curli production (25). Mutants in the lipid III flipase gene 
wzxE accumulate lipid III, which is toxic to the cell and can be overcome by earlier blocks 
in the ECA synthesis pathway (92, 96). Lipid III also accumulates in the inner membrane 
of wzyE mutants, the ECA chain elongation gene (92), which may be essential (4). These 
results suggest ECA is not required for curli production as only mutants accumulating 
lipids II and III are curli deficient. Conversely, the rfe strain, which accumulates 
undecaprenyl-P, produced more curli than wild type cells (Fig. 2.7). Mutants in the 
osmoregulated periplasmic glucan (OPG) synthesis genes also had changes in curli 
production. Mutants in OPG structural genes mdoG and mdoH resulted in less curli 
whereas the OPG succinyl modification mutants in mdoC produced more curli (Table 






suggesting induction of the Rcs pathway (Table 2.6). Others have reported an mdoH 
mutant induced colonic acid biosynthesis (29).  
The cell envelope is also composed of several extracellular polysaccharides (EPS) 
including colonic acid, poly-β-1,6-GlcNAc (PGA), cellulose, and an unidentified curli 
associated polysaccharide (128, 134); however, only the colonic acid gene galU was 
found to affect curli production. Other mutants in EPS biosynthetic pathways except 
treR (56) all had wild type levels of curli indicating that the galU strain’s curli phenotype 
is likely due to defects in LPS or OPG biosynthesis. Knockouts of genes involved in 
peptidoglycan synthesis or lipid A formation also had normal curli production. However, 
a strain lacking RodZ, which interacts with peptidoglycan and is essential for the rod 
shape in E. coli (112), was defective for curli production. Many of these genes are 
essential and omitted from the Keio collection (4). Collectively, these results suggest the 
minimum cell envelope needed for efficient curli production is partially Glucose I 
substituted LPS and basic OPG structure.  
 
Nucleotide and amino acid biosynthesis 
 Mutants in metabolic genes (COG families C, E-I) constitute nearly forty percent 
of the total strains with altered CR phenotypes (Table 2.1, Fig. 2.5). Deletions in most 
curli associated metabolic genes are defective for curli production, particularly among 
nucleotide and amino acid biosynthesis genes. Nutrient availability may play a 
significant role in the ability of cells to produce curli fibers. We found several pathways 
where nearly every gene in the pathway had defective CR phenotype, including the de 
novo purine and pyrimidine biosynthesis pathways. Accordingly, the cytR strain 
produced less curli likely due to derepression of nucleoside degradation and utilization 
genes (56). 
Relative to pyr strains, mutations in purine biosynthesis genes were more 
defective for curli production suggesting a limitation of purine under our growth 
conditions (Table 2.4). Both pathways had relatively few mutants with wild type levels of 






either a regulatory role or have isozymes that may duplicate their function (56, 78, 104). 
Intriguingly, some mutants in pyrimidine synthetic genes including pyrE, pyrB, and carB 
had increased CR binding when streaked near other strains indicating a diffusible small 
molecule may be able to rescue the defect in curli production (See Fig. 2.12).  
 Mutants in most of the genes for amino acid biosynthesis were absent from our 
screen. However, all five tryptophan biosynthesis genes were defective for curli 
production: trpA, trpB, trpC, trpD, and trpE. Our screen also resulted in multiple 
chorismate biosynthesis gene mutants with considerable curli defects: aroA, aroB, aroC, 
aroD, aroE, aroK, aroH, and aroP (Table 2.5). Chorismate is used in the biosynthetic 
pathways of aromatic amino acids, ubiquinone, menoquinone, THF, and enterobactin 
(4); however, with the exception of aspC and ubiE, curli defectives strains were only 
found in ubiquinone and tryptophan pathways. Mutants in aroF, aroG, and aroL had 
wild type levels of curli; however, their isozymes aroH and aroK were moderately 
defective (Table 2.5) (56).  
 The gcvA, aspA, aspC, asnC, and glnA strains which have defects in serine, 
glycine, asparagine, and glutamine biosynthesis, respectively, were also defective for 
curli production. A possible explanation lies in the high content of these amino acids in 
some curli proteins (Table 3.8). For example, CsgA consists of 28.5% glycine or serine 
(mean 7.13%), the sixth highest such protein in E. coli (Fig. 1.6D). Previously, over 
expression of CsgD has been shown to increase glyA levels (19). GlyA is a serine 
hydroxymethyltransferase (SHMT) which interconverts Ser to Gly (Fig. 1.6C) (56). The 
activation of glyA by CsgD would increase SHMT activity and may allow sufficient pools 
of serine and glycine for efficient translation of curli proteins rich in these amino acids 
such as CsgA. CsgA and the minor curli subunit CsgB also have high levels of Asn and Gln, 
two amino acids often associated with functional amyloids including the yeast prions 
Sup35 and Rnq1 (110, 116) (See Fig. 3.9). CsgA and CsgB have 17.9% and 18.5% 








Inorganic ion transport and metabolism 
 The nhaA mutant did not produce detectable amounts of curli (Fig. 2.4A,B). One 
of three sodium ion antiporters, NhaA uses the proton electrochemical gradient to expel 
sodium ions (56). Curli fibers are maximally produced in low salt conditions at room 
temperature (100). The nhaA mutant was light pink on CR YESCA plates (Fig. 2.4A), 
suggesting the lack of NhaA leads to the accumulation of intracellular sodium ions which 
inhibit curli production. Western blotting for CsgA and CsgG confirmed that the nhaA 
strain had no detectable levels of either curli protein (Fig. 2.4B). After 48 hours, the 
nhaA strains had longer cells, lacked curli fibers, and had considerably more flagellated 
cells than BW25113 and the csgA strain (Fig. 2.4D-F). Western blotting for the flagella 
component FliC confirmed this observation (Fig. 2.4G). The nhaA mutant was also more 
motile in YESCA motility plates than WT (Fig 2.4C). Surprisingly, csgA and csgG showed 
decreased motility relative to WT. It is unclear if the increased hydrophobicity of the 
csgA strain or the induction of a stress response of either csg mutant (Margery Evan 
unpublished data) is related to their reduced motility (Fig. 2.3C).  
 Several mutants for genes in iron acquisition displayed changes in curli 
production including dps, fepB, fepD, and fepG. Low iron conditions have been shown to 
increase curli production at 37°C in Salmonella typhimurium (100). We saw both 
decreased and increased curli production for iron acquisition mutants, and fepE 
displayed both dark and light pink phenotypes. The affects of iron on curli production 
are likely complex and need further study. 
We found several mutants related to sulfate assimilation including cysB, cysC, 
cysE, cysH, cysI, and cysG. CysG is an uroporphyrin III C-methyltransferase necessary for 
the seroheme cofactor used in CysI (130). Most of the proteins had increased curli 
production except the cysH strain that had both pink and wild type colonies (Table 2.6). 
CysE modifies serine to O-acetyl-serine and requires CysM or a complex with CysK to 
fully convert to L-Cys (56). Additionally, the metC strain produced less curli; MetC is one 
of three L-cysteine desulfhydrases and degrades L-Cys. Collectively, these results 






Carbohydrate metabolism and energy production 
Several genes involved in global carbohydrate flux and sugar import were found 
to be defective for curli production: cyaA, crp, fruR (cra), ptsH, ptsI, aceE, fbp, gnd, and 
tpiA. The metabolic flux changes of the Keio cyaA, crp, and fruR strains have been 
examined under different growth conditions; the crp, cyaA and fruR strains had less 
phosphoenolpyruvate (PEP) from oxaloacetate in glucose limiting conditions (77, 86). 
FruR increases PEP production from pyruvate through a combination of pykF repression 
and ppsA activation (107). PEP is used by the phosphotransferase system (PTS) to 
transport and phosphorylate many different sugars. Additionally, the cAMP-CRP 
complex activates ptsHI-crr (138), and cyaA and crp mutants have low levels of glucose 
uptake due to a PTS defect (78). Combined with the curli phenotype for the PTS genes 
ptsH (Enzyme I) and ptsI (HPr), our results suggest a defect in the PTS system results in 
lower curli production. However, many of these gene products have global effects on 
gene transcription:  the cAMP/CRP complex regulates multiple genes including direct 
activation of csgDEFG (138).  
Enzymes for central metabolism, energy production, and their coenzymes also 
play an important role in curli production. TCA cycle mutants with reduced curli 
production included genes encoding enzymes for the complete conversion of α-
ketoglutrate to fumarate: sdhA,B and sucA,B,C,D (Tables 2.5 and 2.6). However, sucC,D 
is typically present during anaerobic growth where curli production is reduced (35, 78, 
99). Why curli defective mutants are restricted to this portion of the TCA cycle is 
unknown and contrasts with the negative regulation of sdhBACD by RpoS and Crl (93, 
97), both positive regulators of curli production (6). Several mutants for quinol 
oxidoreductases gave variable curli phenotypes. SdhA and SdhB, the soluble cytoplasmic 
components of succinate quinone reductase (SQR), are sufficient for succinate oxidation 
(78) and produced less curli than WT. Intriguingly, sdhC and sdhD mutants lacking the 
SQR membrane subunits produced more curli than WT. The nuoA,B,C,E,F,G,J,K,M,N 
strains which are defective for NADH dehydrogenase:quinone reductase I (NDH-I) also 






Conversely, an appC strain lacking the stationary phase (3) induced cytochrome bd-II 
quinol oxidase (CBD-II) (3) produced very little curli. Unlike SQR, both NHD-I and CBD-II 
contribute to the proton gradient needed for membrane transport and ATP production; 
accordingly, mutants in the ATP synthase genes atpA,B,C,E,F,G,H grew more slowly and 
had greatly reduced amounts of curli (Table 2.5).  
The opposing CR phenotypes of quinol oxidase and quinone reductase deficient 
strains suggest quinone has a negative effect on curli production. Previously, a nuoG 
strain had reduced rpoS transcription and a CBD-I mutant cydA had higher levels (111). 
Quinone can affect RpoS levels through the Arc two-component system. Quinones cause 
disulfide bonding in the inner membrane protein ArcB (33, 71). ArcB cross linking limits 
trans-phosphorylation of ArcA and RssB which increases rpoS transcription and RpoS 
stability, respectively (71, 74).  Thus the increased curli production in these quinone 
reductases could be explained by higher levels of RpoS. 
Mutants strains cysG, lipA,B, lpd, pdxH, and ubiE,F,G,H which lack cofactors and 
coenzymes required for some of the proteins described above also produced less curli. 
LipA and LipB are responsible for biosynthesis and transfer of lipoate to Lpd, 
respectively (56). Lpd is utilized by pyruvate dehydrogenase (aceEF), α-ketoglutrate 
dehydrogenase (sucAB), and the glycine cleavage (gcvTHP) multienzyme complexes (56) 
of which the sucA and sucB strains were the most defective (Tables 2.5 and 2.6). The 
ubiquinone biosynthesis mutants produced very little curli and grew slower than 
normal. 
Previously, our lab investigated the affect of nagA mutants on curli production. 
In the Keio collection, we found both nagA and nagC mutants to be defective for curli 
production. For the nagA strain, the decrease in curli production was similar to other K-
12 strains and much less than seen in the C600 strain (7). Intriguingly, we found yhbJ 
and pcnB strains were dark red on CR plates, and produced significantly more curli than 
BW25113. YhbJ has recently been shown to destabilize the RNA glmZ which increases 
the glmS transcript stability (55, 94). Typically this glmS transcript is polyadenylated by 






strain may be due to more than an accumulation of GlcNac-6P. Instead defects in the 
levels of UDP-GlcNac needed for lipid A, ECA, and peptidoglycan biosynthesis may lead 
to a compromised envelope and subsequently to lower curli expression. The curli defect 
of the Keio glmM mutant would seem to confirm this; however, glmM is apparently an 
essential gene (73), and therefore its presence in the Keio collection suggests that the 
glmM strain used in our study has acquired suppressor mutations. We also found 
decreased curli in nanK and nanE. Both are involved in sialic acid biosynthesis which 
ultimately is converted to GlcNAc-6P (56).  
 
Regulatory networks control curli gene expression 
At 754 bases the non-coding region between csgD and csgB is the fifth largest 
intergenic region between divergent operons in E. coli K-12 (Table 2.8, Fig 2.8A) and the 
thirteenth largest overall (Fig 2.8B) (105). The intergenic region between csgD and csgB 
has strong inherent curvature (85) and multiple regulatory proteins binding sites (6, 47, 
56, 82). Most of the proteins previously shown to affect curli production are proposed 
to do so through transcriptional changes at one or both curli operons and include 
several proteins that modify cyclic-di-GMP metabolism (120) (Table 2.2). We found 
strains with defects in transcriptional regulation and signal transduction that were 
defective for curli production. The large number of regulatory mutants affecting curli 
production is consistent with the multiple regulatory binding sites afforded by the large 
csgD_csgB intergenic region.  
CsgD has been shown to regulate a number of genes outside the curli operon 
(14, 15, 19, 20, 37, 39, 65) including some found in this screen:  dps, ompF, and pyrB 
(Table 2.9). Over-expression of CsgD results in down regulation of the iron acquisition 
genes fhuE, fecR, and dps (14). Dps is a nucleoid protein expressed in stationary phase 
that binds and stores iron (56, 137). The down regulation of iron acquisition by CsgD 
conflicts with the stimulatory effects of low iron on curli production in Salmonella 
typhimurium (100), and the increased curli produced by many of the fep strains (Tables 






Several mutants identified in our screen have been shown to be involved in 
directly or indirectly regulating RpoS levels or function including crp, clpP, clpX, dksA, 
dnaK, galU, hns, hfq, nuoG, pgm, and mdoA (mdoGH) (10, 44, 68, 111). Recently, CsgD 
itself has been shown to increase levels of RpoS via activation of iraP (39). IraP stabilizes 
RpoS by preventing RssB mediated ClpXP degradation (13). Like an rpoS mutant, an nlpD 
mutant completely lacks curli, probably due to loss of the major rpoS promoter (64). 
Since DksA affects ppGpp induction of RpoS (16), we decided to test whether altering 
ppGpp production would affect curli production. A relA spoT double mutant in MG1655 
was light pink on CR plates and produced almost no curli proteins (Fig 2.9). In addition to 
rpoS, we found other sigma factors defective for curli production including rpoN and 
rpoZ. 
 The low curli production in the ECA, LPS, and tol pal strains indicates induction 
of the sigma E stress response system has a negative effect on curli production. As 
described above, ECA mutants that induce RpoE make less curli than a WT strain (Fig 
2.7). Defects in LPS biosynthesis also result in RpoE induction and less curli (119).  Inner 
core LPS mutants such as rfaC, rfaD, and galU have drastically altered outer membrane 
protein profiles (84, 109), increased RpoE dependent transcription (51, 59, 76), and little 
curli production. Additionally, mutations in tolA and pal have more RpoE and are 
defective for curli (127). The Cpx two-component system, which negatively regulates 
curli specific genes (27, 53), is also induced in LPS and ECA mutants (25, 59). However, 
the LPS mutant strain rfaC had only increased sigma E dependent transcription (59). 
Finally, the rseA strain, which lacks the anti-sigma factor of RpoE, produces less curli and 
is light pink on CR plates (Fig. 2.7C). Thus RpoE appears to have a role in modulating curli 
production even in cases where RpoS levels are quite high such as  in rfaD and galU 
strains (10, 52). The sigma E stress response may function as a check to prevent curli 
fiber formation during outer membrane stress. In a similar fashion, the sigma E inducing 
strains galU and rfaP produce less flagella and type I pili (32, 61, 84). However, the 
mechanism for the effect of RpoE on curli production is unknown; RpoE is not predicted 






Several genes involved in quorum sensing and virulence were found to affect 
curli production including qseB, qseC, aaeR, lsrF, sdiA, and flgM. QseB and QseC had 
different effects on curli production (Tables 2.5 and 2.6) and were opposite those 
published elsewhere in a uropathogenic strain of E. coli (62). However, our qseB strain 
had both light pink and dark red colonies suggesting suppressor mutations (Table 2.6). 
The Keio flgM strain overproduced flagella and made less curli consistent with the 
antagonistic relationship between these two extracellular appendages (87). However, 
sdiA, which should also overproduce flagella(28), had higher levels of curli production 
(Table 2.5).  
To further explore the intersection of flagella and curli we compared our results 
with other screens involving the Keio collection. Inoue et al (2007) screened the Keio 
collection for defects in swarming motility using Eiken Agar (43, 46) and subsequently 
checked the swarming mutants for reduced swimming motility. Using GeneVenn (88), 
we compared swarming and swimming with curli associated genes (See Fig 2.13). Very 
few genes were found to overlap, especially between swimming motility and curli 
production. More than half the genes that affect swimming motility and curli encode for 
either ATP synthase or LPS biosynthesis genes (Table 2.10). Another screen looked for 
biofilms defective mutants in the Keio collection using crystal violet and 96-well plates; 
biofilms mutants were subsequently tested for the flagella, type I pili, and curli 
production (80). Comparison of flagella, curli, and type I genes in these strains also 
identified little overlap between flagella and curli associated genes. However, there 
were much fewer curli genes identified in their screen, perhaps due to the use of LB  
media in the initial biofilm screen (80). LB media has relatively high salt concentration 
which inhibits curli production (100). Additionally, the CR phenotypes presented here 
are different for several strains (Fig. 2.10, Table 2.7); for example, several inner core LPS 
mutants are listed as WT for CR binding (80). Consequently, we tested our strains using 
similar conditions; only a few are likely due to media, growth, or staining differences 






Curli requires much more than the dedicated Csg proteins encoded in the 
divergent operons csgDEFG and csgBAC (18, 41). In this work, we screened the Keio 
collection for additional factors that affected curli production. More than 300 genes 
were found to be associated with curli production in E. coli K-12, adding greatly to the 
number of known factors. Several factors were shown to increase curli production 
including those that lead to higher RpoS levels. However, mutants that are known to 
induce the sigma E stress response produced less curli. Comparison of genes associated 
with curli and motility indicates little overlap in the metabolism and regulation of these 
two processes. The quantity, diversity, and specificity of function of curli associated 
genes suggest curli formation is a complex and highly regulated developmental pathway 






Materials and Methods 
Bacterial strains and growth. 
 This study used the Keio collection, a systematic collection of nonessential single 
gene knockouts in BW25113 made with the Datsenko and Wanner method (26). The 
collection was shipped grown on Lysis Broth (LB) agar plates. Freezer stocks made with 
LB with 20% glycerol were maintained in 96-well microplates at -80°C. Bacteria were 
grown for 48 h at 26°C on YESCA plates (1 g yeast extract, 10 g Casamino Acids, and 20 g 
agar per liter) for cell hydrophobicity, western blotting, and electron microscopy. Curli 
production was monitored by growing organisms under similar conditions on 20mL 
Congo red (CR) indicator plates (YESCA plates with 50 g/mL CR and 10 g/mL Coomassie 
Brilliant Blue (CBB)). Colonization factor antigen (CFA) agar (1.5g yeast extract, 10g 
Casamino Acids, and 20g agar per liter containing 0.4mM MgS04 and 0.04mM MnCl2 
buffered to pH 7.4) with 100g/mL CR or 50g/mL CR and 10g/mL CBB was tested against 
CR indicator plates (Fig S8). Antibiotics were added when appropriate to the following 
concentrations:  25 µg/mL kanamycin; 25 µg/mL chloramphenicol; or 100 µg/mL 
ampicillin. 
 
Screening of curli associated genes.  
 The Keio collection was shipped as individual colonies grown on LB plates. To 
screen the collection we used sterile toothpicks and plate bolt replicators to copy the 
collection onto CR indicator plates amended with 25 µg/mL kanamycin. Following 
growth for 48 h at 26°C the strains were scored for color. If a colony was pink or darker 
red than the surrounding strains it was restreaked for single colonies. The CR phenotype 
of each strain was verified by comparison to BW25113. To emphasize CR phenotypes, 
levels were uniformly adjusted by setting the gray point to a clear spot on the red agar 








SDS-PAGE and Western blotting.  
Bacteria were scraped off YESCA plates and resuspended in PBS (pH 7.4) before 
normalization by optical density at 600 nm. To allow CsgA solubility, samples were 
briefly treated with formic acid as described (23). Whole cell samples were 
electrophoresed on 13% sodium dodecyl sulfate (SDS)-polyacrylamide and blotted onto 
polyvinylidene difluoride using standard techniques. CsgA and CsgG polyclonal 
antibodies were raised in rabbits with the purified proteins (Proteintech, Chicago, IL) 
and were used at 1:10,000 and 1:100,000 dilutions, respectively. The FliC antibodies 
were kindly provided by Harry Mobley and were used at a 1:5000 dilution. The 
secondary antibodies were anti-rabbit antibodies conjugated to horseradish peroxidase 
(Sigma, St. Louis, MO) and were used at a dilution of 1:10,000 for both CsgA and CsgG 
and a 1:5000 dilution for FliC. Western blots were developed using the Pierce super 
signal detection system. 
 
PCR verification of strains with multiple CR phenotypes. 
Strains with multiple phenotypes were chosen for PCR verification. Primers were 
designed 2-300 bp upstream of each gene and are listed in Table 2.6. Each strain with an 
altered CR phenotype was struck from the Keio collection to make a clean freezer stock. 
At least two independent colonies for each phenotype were resuspended in sterile 
water and subjected to colony PCR. The individual colony mixtures were added to 
master mixes of GoTaq Flexi (Promega). Mixture A contained the appropriate upstream 
primer and primer K1 (4) and was used to verify the location of the Kanamycin insert in 
the genome. Mixture B contained the primers KT and K2 (4) and was used to verify the 
presence of the insert. If each phenotype gave a positive PCR product for both mixtures 
then it was added to Table 2.6. Mutations in energy production, coenzyme metabolism, 
cell envelope biogenesis, and DNA repair genes were more likely to have more than one 









 Cell hydrophobicity was measured as described (103) using Xylene (X5-1; Fisher 
Scientific Co., Pittsburgh, PA), which gave more consistent results than a mixture of 
linear hexanes (136). The assay was performed with 2mL of cells resuspended to OD600 
in PBS pH 7.4 amended with 2M ammonium sulfate (101, 102) which helps distinguish 
between the relatively hydrophilic K-12 strains . Cells were tested in 16x125mm glass 
culture tubes overlaid with increasing amounts of Xylene. Following incubation for 10 
minutes at room temperature, the mixtures were vortexed for 1 minute using a 
Barnstead Thermolyne 16700. Following phase separation for 15 minutes at room 
temperature, a sample from the lower aqueous layer was removed and measured at 
OD600. Each strain was independently tested at least twice. 
 
Silver stained LPS PAGE gels. 
LPS was extracted as described (72) from 10 OD600 of cells grown on YESCA 
plates for 48 h at 26°C. Samples were normalized to 10 ng of KDO per lane using the 
Thiobarbituric Acid Assay and were separated and silver stained in a 14% Tricine SDS 
PAGE gel (72). 
 
Motility assay. 
Cells were grown overnight in YESCA with appropriate antibiotics. Saturated 
cultures were diluted 1/100 in fresh YESCA and grown to mid log phase (OD600 of 0.3-
0.6). Strains were normalized to 0.2 OD600 in YESCA and 2uL was inoculated into 0.2% 
Agar YESCA motility plates. Plates were grown for 8h at 26°C. The strains tested for 
motility were also tested for growth rates in YESCA at 26°C using a Klett meter. No 











 Bacteria were grown on YESCA plates for 48 h at 26°C. Samples were 
resuspended in phosphate buffered saline (PBS) and stained with 2% uranyl acetate as 
previously described (18). Grids were viewed using a Phillips CM10 microscope. 
 
Online databases. 
Intergenic region distance was gathered from Ecogene’s Intergene Regions (105);  







Fig. 2.1. Overview of screen for mutants affecting curli production. (A-B) Congo Red 
(CR) plates grown at 26C for two days. (A) Screen of Keio collection inoculated with bolt 
replicator: JW5581 (ubiE), JW1022 (csgE), JW1024 (csgB), JW1025 (csgA), JW0192 (rcsF), 
and JW0230 (crl). The collection was screened three times by both individual streaking 
and replica plating (B) Associated phenotype scoring:  1 = JW1025 (csgA), 2 = JW4130 
(hfq), 3 = JW0663 (nagA), 4= JW3148 (greA), 5= BW25113 (WT), and 6 = JW3883 (cpxR). 
(C) Whole cell Westerns of strains in Fig. 2.1B. (D) Distribution of CR phenotypes based 
on scoring from white to dark red.  
 
Fig. 2.2. Lipopolysaccharide (LPS) mutants. (A) CR YESCA plates grown at 26C for two 
days: BW25113 (WT), JW1025 (csgA), JW3603 (rfaB ), JW3596 (rfaC), JW3594 (rfaD), 
JW3024 (rfaE), JW3595 (rfaF), JW3606 (rfaG), JW3818 (rfaH), JW3602 (rfaI), JW3601 
(rfaJ), JW3597 (rfaL), JW3605 (rfaP), JW3607 (rfaQ), JW3604 (rfaS), JW3600 (rfaY), 
JW3599 (rfaZ), JW0212 (lpcA), and JW0196 (gmhB). (B) LPS structure. Blue lines 
represent CR defective LPS mutants. Red lines represent LPS genes not in the Keio 
collection. (C) Whole cell Westerns of LPS mutants. All samples were scraped from 
YESCA plates grown at 26C for two days and treated with formic acid.  
 
Fig. 2.3. LPS structure and function. (A) Silver stain of a 14% PAGE Tricine gel of LPS 
mutant and Whole Cell Western blots. (B) BW25113 (WT), JW1025 (csgA), JW1224 
(galU), JW3596 (rfaC), JW3595 (rfaF), and JW3606 (rfaG) grown on CR YESCA for 2 days. 
A sterile loop was scraped through each strain to show friable phenotypes of some LPS 
mutant strains. (C) Cell hydrophobicity of LPS mutant strains in phosphate buffered 
saline (PBS) amended with 2 M ammonium sulfate.  Similar results were obtained in 
indepent replicates (data not shown). 
 
Fig. 2.4. The sodium antiporter gene nhaA is required for curli production. (A) Strains 






with anti-CsgG and anti-CsgA antibodies. (C) YESAC motility plates were inoculated with 
2 µL from a 0.5 OD shaking culture of YESCA cells and then grown for 8 hours at 26C. (D-
F) EM images from cells grown for 26C for two days on YESCA plates, resuspended in 
PBS, and stained with 2% uranyl acetate. Scale bar equals 1µM. (D) WT at 15,500X (E) 
csgA at 15,500X (F) nhaA at 15,500X. (G) Western blot probed with anti-FliC antibodies. 
 
Fig. 2.5. Distribution of the molecular functions of genes affecting curli production. 
Genes affecting curli function were separated according to the molecular function (See 
Table 2.5) using COG families. Genes in bold produce more curli than wild type bacteria. 
 
Fig. 2.6. Congo Red and cellulose phenotypes of different E. coli strains. Strains were 
grown 2 days at 26⁰C on YESCA plates that were amended with (A) Congo Red  or (B) 
Calcuflour. A black light was used to show Calcufluor fluorescence. The UTI89 isolate 
was used as a positive control for cellulose production. 
 
Fig. 2.7. Congo red phenotypes of Enteric Common Antigen (ECA) and rseA gene 
deletions. (A) Curli deficient strains:  rffA, rffC, rffT, wxzE. Strains with increased curli 
production: rfe. (B) Diagram of Enteric Common Antigen biosynthetic pathway. (C) A 
rseA deletion strain was defective for Congo Red binding. 
 
Fig. 2.8. Comparison of the length of intergenic regions in Escherichia coli K-12. (A) 
Histogram of the length of divergent intergenic regions. (B) Histogram of the length of 
all intergenic regions including divergent, convergent, and codirectional. Intergenic 
regions were downloaded from Ecogene (105) and can be found at 
http://www.ecogene.org/InterGeneTable.php. 
 
Fig. 2.9. Low ppGpp strains and dksA mutants produce less curli. Congo red binding 
and Western blots of strains deficient for producing ppGpp. Background is BW25113 (4) 






which the Kanamyacin cassette has been excised using pCP20 which encodes Flp 
recombinase (26). The ∆spoT207::cat was moved into the BW25113 relA’ strain by P1 
transduction; however, the relA’ strain is more defective than the relA::kan strain. 
Duplicate strains of relA’ and relA’ ∆spoT207::cat  were independent isolates. Strains 
relA’, relA’ ∆spoT207::cat, MG1655 ∆relA251::kan, and MG1655 ∆relA251::kan 
∆spoT207::cat were from Janine Maddock. Strains were grown on YESCA plates for two 
days at 26C. 
 
Fig. 2.10. Differences in Congo Red phenotypes of Keio collection strains on YESCA and 
CFA plates and CFA plates without Coommassie Brilliant Blue counterstain. Niba et al 
2007 (80) performed a screen of the Keio collection for biofilm defective mutants. The 
biofilm mutants were subsequently tested for their motility, Type I pili formation, and 
curli production. For curli production they grew strains on CFA agar with twice the usual 
amount of Congo Red and no Coommassie Brilliant Blue (CBB) counterstain. Some of 
their CR phenotypes which were scored as +, -, or ± were different than ours. We tested 
these strains on YESCA and CFA plates with CR and CBB and on CFA plates without CBB 
and twice the CR as in Niba et al 2007 (80). Sets (A) (B) and (C) were scored based on 
their CR phenotypes from 1-6 at 24, 48, and 72 hours at 26C (See Table 2.7). Shown here 
is 48 hours growth. Some of the phenotypic differences are due to plating differences. 
CBB aids in detecting subtle differences between strains. 
 
Fig. 2.11. Distribution of Curli Specific Genes in other organism according to String. 
Found primarily in the genomes of Enterobacteriaceae, csg genes are also present in 
different arrangements and combinations in other Gammaproteobacteria families 
including Pseudomonadaceae, Shewanellaceae, and Vibrionaceae as well as in a few 
distantly related bacteria in the Bradyrhizobiaceae, Burkholderiaceae, and 
Flavobacteriaceae families (49, 118). Darker colors indicated higher similarity to the Csg 







Fig. 2.12. Rescue of Congo Red binding in some pyr mutants when struck near other 
strains. When struck near other strains several pyrimidine biosynthesis mutants from 
the Keio collection displayed increased Congo Red binding. This was seen for pyrB, pyrD, 
pyrE, pyrF, and carB. In many cases the ‘donating’ strain did not matter; rpoS, BW25113, 
and various pur mutants were able to rescue pyrE. Exceptions include the effects of the 
lack of donation from purD to pyrB and carB, and the fact that other pyr mutants were 
unable to donate the missing compound; however, pyrE was able to donate to carB. 
 
Fig. 2.13. Venn diagrams demonstrating few genes associated with curli affect 
swarming or swimming. Comparison of genes found to affect curli with swimming and 
swarming associated genes. (A) Excludes and (B) includes the less defective swarming 
mutants found in Table S2 of Inoue et al (46).  Sections of Venn diagrams: a (orange) 
curli associated genes that do not affect swarming or swimming motility; b (dark green) 
curli associated genes that affect swarming motility; c (dark blue) curli associated genes 
that affect swimming motility; d (light blue) swimming defective genes that do not affect 
curli; e (light green) swarming defective genes that do not affect curli.  Venn diagram is 
































Figure 2.1.  Overview of screen for mutants affecting curli production. 
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Figure 2.1 (continued).  Overview of screen for mutants affecting curli production. 
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Figure 2.3.  Phenotypes of deletions in inner core LPS biosynthetic genes.

















Figure 2.4.  The sodium antiporter gene nhaA is required for curli production. 
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 sdhC, sdhD, sucA, sucC












   cysC
       cysI
           ddpD
             dps, fepB 
                 fepD, fepG
                       nhaA
                          yoeE
ccmA, clpA, clpP, clpX
dnaK, iT, lon, sspA
    surA, yjjW, yncG
iI, tolA, tolB, tolC, tolQ, tolR
                 csgA, csgB
csgE, csgF, csgG, cusB
galU, gmhB, hlpA, lpcA, lpp
 mdoC, mdoG, mdoH, mltA, nlpD, ompC
 ompF, pal, rfaC, rfaD, rfaE, rfaF 














                         aaeR, asnC
                       csgD, cysB, cytR
                     gM, fruR, gcvA, greA
                    hdfR, hns, mlrA, mtlR
                nusB, perR, purR, puuR, rfaH
                rpoN, rpoS, rpoZ, rstA, sdiA
              srlR, torI, treR, xapR, ydcI




  rimM, rplA
   rpsF rpsT 
        rsgA 
      rumA
      srmB
Translation, ribosome structure, & biogenesis
Transcription
DNA replication, recombination, and repair
Cell envelope biogenesis, outer membrane
Cell motility & secretion
Posttranslational modication, protein turnover, chaperones
Inorganic ion transport & metabolism
Signal transduction mechanisms
Energy production & conversion
Amino Acid transport & metabolism
Nucleotide transport & metabolism
Carbohydrate transport & metabolism
Coenzyme metabolism
Lipid metabolism














































C55-PP-GlcNAc   Lipid I
C55-PP-GlcNAc-ManNAc  Lipid II













Transfer of ECA chains to phospholipids


















*    Curli levels down
**  Curli levels up  






Figure 2.7.  Congo red phenotypes of Enteric Common Antigen (ECA) and rseA














Figure 2.8.  Comparison of the length of intergenic regions in Escherichia coli K-12.
MG1655                BW25113           MG1655               MG1655
                                     ∆csgA::kan    ∆relA251::kan        ∆relA251::kan
                             ∆spoT207::cat      
CsgG
CsgA













BW25113 dksA::kan relA’ relA’
∆spoT207::cat
rpoS::kan relA::kan relA’ relA’










Figure 2.9.  Low ppGpp and dksA mutants produce less curli.
WT              csgA          hC lt       hC WT     iG lt
iG WT          iI                iT            btuC lt        btuC WT
btuB              csgA              csgB          csgC           csgD
csgE                csgF           csgG           surA         dnaK
  fruR                gcvA          greA         csgA          WT
WT              csgA          hC lt       hC WT     iG lt
iG WT          iI                iT            btuC lt        btuC WT
btuB              csgA              csgB          csgC           csgD
csgE             csgF           csgG           surA         dnaK
  fruR            gcvA          greA         csgA          WT
WT              csgA          hC lt       hC WT     iG lt
iG WT          iI                iT            btuC lt        btuC WT
btuB              csgA              csgB          csgC           csgD
csgE                csgF           csgG           surA         dnaK











Figure 2.10.  Differences in Congo Red phenotypes of Keio collection strains on YESCA
and CFA plates and CFA plates without Coommassie Brilliant Blue counterstain. 
WT              csgA          lpcA        gmhB         rfaC
rfaD              rfaE               rfaF         rfaG           rfaH
rfaP            galU          hfq           hsrA/yieO    yieP
lon                mdoH        mlrA    nagA        nifU/iscU
                         pink
  ompR    rpoS          nlpD           csgA          WT
WT              csgA          lpcA        gmhB           rfaC
rfaD              rfaE               rfaF         rfaG           rfaH
rfaP            galU          hfq           hsrA/yieO    yieP
lon                mdoH        mlrA       nagA        nifU/iscU
                         pink
  ompR        rpoS          nlpD           csgA            WT
WT              csgA          lpcA        gmhB            rfaC
rfaD              rfaE               rfaF         rfaG           rfaH
rfaP            galU             hfq           hsrA/yieO    yieP
lon                mdoH        mlrA       nagA        nifU/iscU
                         pink











Figure 2.10 (continued).  Differences in Congo Red phenotypes of Keio collection strains
on YESCA and CFA plates and CFA plates without Coommassie Brilliant Blue counterstain. 
WT              csgA          crp           cyaA          sdhC
  ptsI              ihfB           mdoH          csgA            WT
             mucoid
tolA           tolB               tolR             ycfM        yciB
yciC          yciM              ydaM           ynjC        ynjD
lpxL            lpxM          lpxP        crcA/pagP   arnT
WT              csgA          crp           cyaA          sdhC
  ptsI              ihfB          mdoH        csgA            WT
            mucoid
tolA               tolB             tolR             ycfM        yciB
yciC          yciM              ydaM           ynjC        ynjD
  lpxL             lpxM          lpxP       crcA/pagP   arnT
WT              csgA          crp           cyaA          sdhC
  ptsI              ihfB           mdoH          csgA            WT
             mucoid
tolA           tolB               tolR             ycfM        yciB
yciC          yciM              ydaM           ynjC        ynjD
lpxL            lpxM          lpxP        crcA/pagP   arnT
C
76
Figure 2.10 (continued).  Differences in Congo Red phenotypes of Keio collection strains










Figure 2.11.  Distribution of Curli Specific Genes in other organism according to String.
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Figure 2.11.  Distribution of Curli Specific Genes in other organism according to String.
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Figure 2.12.  Rescue of Congo Red binding in some pyr mutants












Figure 2.13.  Venn diagrams demonstrating few genes 








Table 2.1. Genes required for or known to affect curli production  
 
Gene   Effect on Curli production Source         Color in screen 
cpxA,R    -   (27, 53)   WT, dark red  
crl    +   (12, 90)   WT 
csgA,B    Fiber subunits  (18, 41)   white 
csgC    Fiber morphology b (36)   WT 
csgD    csgBAC transcription (41)   white 
csgE,Fa,G   Secretion, chaperone (18)   white 
ddhC (rfbH)   + d   (1)   N/A e 
dksA    + o   (40)   pink 
envZ    +   (34, 53)   white 
hns    variable j  (2, 34, 83)  WT 
ihfA,B    +   (34)   light pink 
fis    - f   (108)   WT 
flhC,D    -   (87)   WTl 
fliZ    -   (87)   WT 
lon    +   (125)   mucoid white 
lpp    + f   (123)   light red 
lpxM (msbB)   + f    (58)   WT 
mlrA    +   (17)   white 
nagA o,C    +   (7, 40)   pink 
ompR    + o   (34, 40, 53)  white 
pal    + c   (125)   light pink 
rcsA,B,C    -   (31, 53, 125)  WTm 
rfaG    + d   (1)   light pink 
rpoS    +   (2, 12, 83)  white 
rssB    + o   (40)   pink & WT n 
rstA,B    -   (81)   light red, WT 
qseB,C    none, +   (62)   variable, dark red 
sdiA    -   (66)   dark red 
tolA,B,Q,R   +   (125)   light pink 
ycfR    +   (136)   white & WT g 
 
Cyclic-di-GMP (GGDEF or EAL) 
adrA (yaiC)   + i   (54)   WT i 
ycgF    - (via Rcs)  (115, 121)  WT 
yciR (gmr,STM1703)   -   (113, 115, 131)  pinkh 
ydaM    +   (115, 131)  white  
yeaP    +   (115)   WT 
yedQ    Cellulose onlyk  (24, 115, 131)  dark red  
yegE (STM2123)   +   (54, 87, 115)  WT 
yhdA    +   (115)   WT 
yhjH (STM3611)   -   (54, 87, 113, 115)  WT 
yjcC (STM4264)   -   (113)   WT 
STM3388   +   (54)   N/Ae 
STM1827   -   (113)   N/Ae 










Table 2.1 (continued). Genes required for or known to affect curli production 
 
Notes:  Genes in bold differed from results found in the literature when applicable.  
a Some curli production occurs but is not cell associated (79). b Larger, more stable fibers 
(36) . c Inferred from (125). d In Salmonella enterica serovar Typhimurium (DT104 Rv or 
LT2) (1). Abequose is not used for E. coli O-antigens (117). e No homolog in BW25113 (4, 
56). f In Eschrelichia coli O157:H57 EHEC strain 4304. g Mostly white colonies with few 
red suppressors. h Pink on CR plates but WT levels of CsgG and CsgA. i AdrA is also 
regulated by CsgD (139); positive feedback on CsgD was seen in S. Typhimurium MAE52 
but not UMR1(54). j  (-) in E. coli K-12 (+) in S. typhimurium. k No effect when tested in E. 
coli W3110, a BW25113 relative (4, 48, 115). l flhC had mostly pinkish/light red colonies 
with a few WT colonies. m rcsF is dark red. n Mostly pink colonies with few red 
suppressors. o Found in screens for additional genes affecting curli production (40). 














Cytoplasmic 193 (75.6) aaeR, aceE, aegA, argC, aroA, aroB, aroC, aroD, aroE, aroK, asnC, 
aspA, aspC, atpA, atpC, atpG, atpH, carA, carB, ccmA, clpA, clpP, 
clpX, cmk, cpxR, crp, csgD, cyaA, cysB, cysC, cysG, cysI, cytR, dam, 
ddpD, dksA, dnaG, dnaK, dnaT, dps, efp, fabF, fabH, fbp, fhlA, 
flgM, fliI, fliT, fruR, galM, galU, gcvA, glmM, glnA, glxK, gmhB, 
gmr, gnd, greA, guaB, hdfR, hfq, hns, hybD, ihfA, ihfB, ilvG, lipA, 
lipB, lon, lpcA, lpd, lsrF, metC, miaA, mlrA, mtlR, nagA, nanK, ndk, 
nudC, nudH, nuoB, nuoC, nuoE, nuoF, nuoG, nusB, ompR, pdxH, 
pepT, perR, pgm, php, poxA, priA, ptsH, ptsI, purA, purC, purD, 
purE, purF, purH, purK, purL, purM, purR, putA, puuR, pyrB, pyrC, 
pyrD, pyrE, pyrF, racC, rbfA, rfaC, rfaD, rfaE, rfaF, rfaG, rfaH, rfaP, 
rffC, rimK, rimM, rnhA, rplA, rpoN, rpoS, rpoZ, rpsF, rpsT, rsgA, 
rstA, rumA, sdhA, sdhB, sdiA, speB, srlR, srmB, sspA, sucA, sucC, 
sucD, thyA, torI, tpiA, treR, trpA, trpB, trpC, trpD, trpE, ubiE, ubiF, 
ubiG, ubiH, uspE, xapR, ybaJ, ybaM, ybeZ, ybgC, ycgV, ydaF, 
ydaM, ydaT, ydcI, ydeJ, ydiT, yeaB, yecH, yeeN, yeiL, yfcX, ygfZ, 
ygiF, yhbG, yhbJ, yheV, yiaK, yicC, yieP, yiiS, yjjW, ynaK, yncG, 
ynjD, yoeE, yqaB 
Periplasmic 11 (4.3) cpxP, csgE, csgF, fepB, hlpA, mdoG, surA, tolB, yciM, yfeW, yfgC 
Integral Membrane 
Proteins 
32 (12.5) appC, atpB, atpE, cmr, cpxA, eamA, envZ, essQ, fepD, fepG, kdpD, 
mdoC, mdoH, narQ, nhaA, nuoA, nuoJ, nuoK, nuoM, nuoN, proW, 
qseC, rseA, sdhC, sdhD, tolQ, wzxE, ybcI, yciC, yedQ, ykgH, ymgE 
Membrane Anchored 7 (2.7) atpF, cusB, glvG, tolA, tolR, yedV, yfgA 
Outer membrane  
Lipoproteins 
7 (2.7) csgG, lpp, mltA, nlpD, pal, slp, ycfM 
 
Outer Membrane  
ß-barrel proteins 
3 (1.2) ompC, ompF, tolC  















Information storage     
Translation, ribosome 
structure, & biogenesis 
J 13 (5.0) efp, miaA, pcnB, poxA, rbfA, rimK, rimM, rplA, rpsF, 
rpsT, rsgA, rumA, srmB 
Transcription K 30 (11.5) aaeR, asnC, csgD, cysB, cytR, flgM, fruR, gcvA, greA, 
hdfR, hns, mlrA, mtlR, nusB, perR, purR, puuR, rfaH, 
rpoN, rpoS, rpoZ, rstA, sdiA, srlR, torI, treR, xapR, 
ydcI, yieP, ynaK  
DNA replication, 
recombination, and repair 
L 8 (3.1) dam, dnaG, dnaT, ihfA, ihfB, priA, rnhA, yeaB 
    
Cellular processes    
Cell envelope biogenesis, 
outer membrane 
M 34 (12.2) csgA, csgB, csgE, csgF, csgG, cusB, galU, gmhB, hlpA, 
lpcA, lpp, mdoC, mdoG, mdoH, mltA, nlpD, ompC, 
ompF, pal, rfaC, rfaD, rfaE, rfaF, rfaG, rfaP, rfe, rffA, 
rffC, rffT, slp, wzxE, ycgV, yfeW, yhbG 




O 11 (4.2) ccmA, clpA, clpP, clpX, dnaK, fliT, lon, sspA, surA, 
yjjW, yncG 
Inorganic ion transport & 
metabolism 




T 18 (6.9) cpxA, cpxP, cpxR, crp, dksA, envZ, gmr, kdpD, narQ, 
ompR, qseC, rseA, uspE, ybeZ, ydaM, yedQ, yedV, 
yeiL 
    
Metabolism    
Energy production & 
conversion 
C 33 (12.6) aceE, aegA, appC, atpA, atpB, atpC, atpE, atpF, 
atpG, atpH, hybD, lpd, nuoA, nuoB, nuoC, nuoE, 
nuoF, nuoG, nuoJ, nuoK, nuoM, nuoN, putA, racC, 
sdhA, sdhB, sdhC, sdhD, sucA, sucC, sucD, ydiT, yiaK 
Amino Acid transport & 
metabolism 
E 24 (9.2) argC, aroA, aroB, aroC, aroD, aroE,aroH, aroK, aroP, 
aspA, aspC, carA, carB, eamA, glnA, metC, pepT, 
proW, speB, trpA, trpB, trpC, trpD, trpE 
Nucleotide transport & 
metabolism 
F 20 (7.7) cmk, cyaA, guaB, ndk, nudC, purA, purC, purD, purE, 
purF, purH, purK, purL, purM, pyrB, pyrC, pyrD, pyrE, 
pyrF, thyA 
Carbohydrate transport & 
metabolism 
G 15 (5.7)  fbp, glmM, glvG, glxK, gnd, lsrF, nagA, nagC, nanE, 
nanK, pgm, ptsH, ptsI, tpiA, yciM 
Coenzyme metabolism H 8 (3.1) cysG, lipA, lipB, pdxH, ubiE, ubiF, ubiG, ubiH 
Lipid metabolism I 3 (1.1) fabF, fabH, yfcX 
    
Poorly characterized    
General function prediction 
only 
R 15 (5.7) essQ, hfq, ilvG, nudH, php, ybcI, ybgC, ycfM, ydeJ, 
yeiR, yfgC, ygfZ, yhbJ, ynjD, yqaB 
Unknown/Other S,U,V 13 (5.0) ybaJ, ybaM, yciC, ydaF, ydaT, yecH, yeeN, yfgA, 
yheV, yicC, yiiS, ykgH, ymgE 







 Table 2.4. Phenotypes of mutants in genes for purine and pyrimidine biosynthesis. 
 
Gene  CR phenotype  __CgG Levels___CsgA Levels 
BW25113 red    ++++  ++++ 
 
purA  white    +/-  - 
purB  essentiala   ND  ND 
purC  white    +/-  - 
purD  white    -  - 
purE  light pink   -  - 
purF  white    -  - 
purH  white    +/-  - 
purK  light pink   +/-  - 
purL  white    -  - 
purM  light pink   -  - 
purN  light pink and red b  ND  ND 
purR d  dark red   ++++  +++++ 
purT  red    ++++  ++++ 
purU c  red    ND  ND 
guaA  red    ++++  ++++ 
guaB  white    -  - 
 
pyrB  light pink   +/-  - 
pyrC  pink to light red  +++  ++ 
pyrD  light red   +++  ++ 
pyrE  light pink   +  + 
pyrF  pink    +++  + 
pyrG,H  essentiala   ND  ND 
pyrI  red    ND  ND 
pyrL d  red    ND  ND 
carA  pink    +++  + 
carB  light pink   +  +/- 
 
a Not in Keio collection, essential (4) b See Table S2 c In formylTHF biosynthesis I pathway 



























aaeR K cytoplasmic dark red 4 3 ++++ +++++ 
aceE C cytoplasmic light red 4 3 +++ +++ 




Protein white to lt pink 1 4 +/- +/- 
argC E cytoplasmic light red 3 4 + +/- 
aroA E cytoplasmic white to lt pink 2-3,2 2,3 ++,++ +/-,+/- 
aroB E cytoplasmic white to lt pink 2-3,4 3,2 +/-,+ -,+/- 
aroC E cytoplasmic pink to orange 4,3 2,3 +,++ +/-,++ 
aroD E cytoplasmic white to lt pink 1,2 2-3,3 +,+/- +/-,- 
aroE E cytoplasmic white to lt pink 2-3,2 2,3 ++,++ +/-,+ 
aroH 
   
3 4 +++ ++ 
aroK E cytoplasmic pink to orange 4,3 4,4 +++,+++ ++++,++ 
aroP 
   
4 4 ++ +++ 
asnC K cytoplasmic dark red 4,4 4,4 +++++,++ +++++,+++ 
aspA E cytoplasmic pink to orange 3(SG) 4(SG) ++ + 
aspC E cytoplasmic pink to orange 4 2-3 +++ +++ 




Protein slow growth/other 2,3(SG) 1,1(SG) ++,+ -,+++ 




Protein slow growth/other 3,3(SG) 2,2(SG) ++,+++ ++,+++ 
atpF C 
Membrane 
Anchored slow growth/other 3,3(SG) 2,2(SG) ++,+++ +,++ 
atpG C cytoplasmic slow growth/other 3,3(SG) 2,2(SG) +++,+++ ++++,++++ 
atpH C cytoplasmic slow growth/other 3,3(SG) 1,1(SG) +,+ +/-,+++ 
carA E cytoplasmic light red 3 4 +++ + 

























ccmA O cytoplasmic dark red 5 4 ++ +++++ 
clpA O cytoplasmic red 3 4 ++++ +++ 
clpP O cytoplasmic red 3 4 +++ +++ 
clpX O cytoplasmic dark red 6 4 +++++ +++++ 
cmk F cytoplasmic pink to orange 1 dry 4 - - 
cmk ' ' pink to orange 2 4 +/- +/- 
cmr P 
Integral Membrane 
Protein dark red 4 4 ++ ++ 
cpxA T 
Integral Membrane 
Protein pink 3 4 ++++ ++++ 
cpxP T periplasmic* light red 4 4 +++ ++++ 
cpxR T cytoplasmic dark red 6 4 +++++ ++++ 
crp T cytoplasmic light red 5-6,5-6 4,3-4 +++++,++ +++++,++++ 
csgA M Extracellular white to lt pink 1 4-5 +++++ - 
csgB M Extracellular white to lt pink 1 4 +++++ - 
csgD K cytoplasmic white to lt pink 1 4 ++++ - 
csgE M periplasmic white to lt pink 1 4 + - 
csgF M periplasmic white to lt pink 2-3 4 ++ + 
csgG M 
Outer membrane 
Lipoprotein white to lt pink 1 4 - - 
cusB M Membrane anchored dark red 5-6 4 +++++ ++++ 
cyaA F cytoplasmic white to lt pink 1 3 +/- - 
cysB K cytoplasmic dark red 6 3-4 +++++ ++++ 
cysC P cytoplasmic dark red 6,5 4,4 ++++ +++++ 
cysE 
  
dark red 5-6 3 ++++ +++++ 
cysG H cytoplasmic dark red 6 4 +++++ +++++ 
cysI P cytoplasmic dark red 6,5 4,3 ++++ +++++ 

























dam L cytoplasmic pink to orange 4,4 4,4 ++++,+++ ++++,+++ 
ddpD P cytoplasmic pink to orange 3 4 ++ ++ 
dksA T cytoplasmic light red 3 3 ++++ ++ 
dnaG L cytoplasmic pink to orange 4 4 ++++ +++ 
dnaK O cytoplasmic white to lt pink 2 6 +/- - 
dnaT L cytoplasmic pink to orange 4 5 +/- +/- 
dps P cytoplasmic dark red 6 4 ++++ +++++ 
eamA E* 
Integral Membrane 
Protein pink to orange 4 4 +++ ++++ 
efp J cytoplasmic pink to orange 3 4 ++ + 
envZ T 
Integral Membrane 
Protein white to lt pink 2 4-5 +/- +/- 
essQ R* 
Integral Membrane 
Protein pink to orange 3 4 ++++ + 
fabF I cytoplasmic pink to orange 2 4 +/- - 
fabF ' ' pink to orange 3 4 ++ + 
fabH I cytoplasmic pink to orange 3 4 ++ +++ 
fadJ I cytoplasmic pink to orange 3 3 ++++ ++++ 
fbp G cytoplasmic pink to orange 4,2 4,4 +++,++ +,++ 
fepB P periplasmic light red 4 3 ++ +++++ 
fepD P 
Integral Membrane 
Protein white to lt pink 3 3 ++ ++++ 
fepG P 
Integral Membrane 
Protein red 6 3 +++++ ++++ 
fhlA K cytoplasmic light red 3 4 + + 
flgM K* cytoplasmic light red 3-4 4 ++++ ++ 
fliI N cytoplasmic dark red 6,6,4 4,4,4 +++++,+++++,++++ ++++,+,++++ 
fliT O* cytoplasmic pink to orange 3,3 4,4 +++ +++ 
fruR K cytoplasmic white to lt pink 3 4 +++ +/- 
























gcvA K cytoplasmic white to lt pink 3 4 ++ +++ 
glmM G cytoplasmic light red 4,3-4 4,4 ++,+++ ++++,+++ 






SG) NA,NA,- NA,NA,- 
glvG G 
Membrane 
anchored red 4,4 4,4 +++,+++ ++++,++++ 
glxK G cytoplasmic light red 4 4 +++ +++ 
gmhB M* cytoplasmic white to lt pink 1,2-3,2-3 4,ND,ND ++,+,+ +,-,+ 
gmr T cytoplasmic red 3 4 ++++ ++++ 
gnd G cytoplasmic pink to orange 3 4 + ++ 
greA K* cytoplasmic pink to orange 4,3-4 4,4 +++++,+++ +++++,+++ 
guaB F cytoplasmic 
slow 
growth/other 1(SG) 5(SG) - - 
hdfR K cytoplasmic light red 3-4 4 +++ ++ 
hfq R cytoplasmic white to lt pink 2,1-2 5-6,5 +/- -,- 
hybD C cytoplasmic light red 3 4 + + 
ihfA L cytoplasmic white to lt pink 1 4 - - 
ihfB L cytoplasmic white to lt pink 1 4 - - 




Protein pink to orange 2 4-5 ++ ++ 
lipA H cytoplasmic 
slow 
growth/other 1,2,2(VSG) 1,2,1(VSG) +/-,++,+/- NA,+/-,+/- 
lipB H cytoplasmic 
slow 
growth/other 2(SG),2(VSG) 1(SG),1(VSG) ND,+/- ND,+++ 
lon O cytoplasmic 
slow 
growth/other 1(mucoid) 4 - - 
lpcA M* cytoplasmic white to lt pink 2,1,2,2 5,5,ND,ND ++,++,+,+/- -,-,-,- 
lpd C cytoplasmic 
slow 




Lipoprotein light red 4, 4 5, 4 ++++, ++++ +, ++++ 
































Protein red 6,6 4,4 +++++, +++++ ++++,++++ 
mdoG M* periplasmic light red 3 4 ++ +++ 
mdoG ' ' light red 1 mucoid 4 - - 
mdoH M 
Integral Membrane 
Protein light red 3 4 ++ +++ 
metC E cytoplasmic pink to orange 3-4 4 ++ +++ 
miaA J cytoplasmic light red 4 4 ++++ +++ 
mlrA K cytoplasmic white to lt pink 1 3 - - 
mltA M 
Outer membrane 
Lipoprotein red 4 4 +++ +++++ 
mtlR K cytoplasmic light red 4 4 ++++ ++ 
nagA G cytoplasmic pink to orange 3 4 ++ ++ 
nagC G cytoplasmic pink 
    
nanE 
   
3-4 ND +++ ++ 
nanK G cytoplasmic light red 4,3-4 4,ND ++,+++ ++++,++ 
narQ T 
Integral Membrane 
Protein light red 3 4 ++ + 
ndk F cytoplasmic dark red 5 4 ++++ ++ 
nhaA P 
Integral Membrane 
Protein white to lt pink 1,1 5,5 -,- -,- 
nlpD M 
Outer membrane 
Lipoprotein white to lt pink 1 4 +/- - 
nudC F* cytoplasmic red 5-6 4 ++++ +++++ 
nudH R cytoplasmic pink to orange 3 3 + + 
nudL R* cytoplasmic light red 3 4 ++ ++++ 
nuoA C* 
Integral Membrane 
Protein dark red 6 3 +++++ ++++ 
nuoB C cytoplasmic red 6 3 +++++ ++++ 
nuoC C cytoplasmic dark red 6 3 ++++ +++++ 
nuoE C cytoplasmic red 6 3 +++++ ++++ 

























nuoG C* cytoplasmic red 6 3 +++++ +++++ 
nuoJ C 
Integral Membrane 
Protein dark red 6 3 ++++ ++++ 
nuoK C 
Integral Membrane 
Protein dark red 6 3 ++++ ++++ 
nuoM C 
Integral Membrane 
Protein red 6 3 +++++ ++++ 
nuoN C 
Integral Membrane 
Protein dark red 6 3 ++++ ++++ 
nusB K cytoplasmic white to lt pink 2, 3 5-6, 6 +/-, - -, - 
ompC M 
Outer Membrane ß-
barrel protein  light red 3,3 3,3 ++++,++ ++,+++ 
ompF M 
Outer Membrane ß-
barrel protein  light red 4 3 ++++ ++++ 
ompR T cytoplasmic white to lt pink 2 5 - - 
pal M 
Outer membrane 
Lipoprotein white to lt pink 1 5 + - 
pcnB 
   
6 ND +++ +++++ 
pdxH H cytoplasmic pink to orange 2 3 + + 
pepT O* cytoplasmic white to lt pink 1 4 +/- +/- 
perR K cytoplasmic dark red 5-6 4 +++++ ++++ 
pgm G cytoplasmic white to lt pink 1 mucoid 5 - - 
pgm ' ' white to lt pink 2 mucoid 5 +/- +/- 
php R cytoplasmic white to lt pink 1,2 4,4 - - 
poxA J cytoplasmic pink to orange 3 4 + ++ 
priA L cytoplasmic pink to orange 4-5 3 +++ +++ 
proW E 
Integral Membrane 
Protein dark red 6,6 4,4 ++++,+++++ ++++,+++++ 
ptsH G cytoplasmic light red 3,3-4,2-3 3,3,4 ++,++,++ ++,++,+++ 
ptsI G cytoplasmic white to lt pink 2,3,2 2,3,1 +,+/-,+/- +,+/-,+ 
purA F cytoplasmic pink to orange 1(SG),3 4(SG),3 +/-,- -,ND 
purC F cytoplasmic pink to orange 1(SG) 5 +/- - 

























purE F cytoplasmic white to lt pink 2(SG) 2(SG) - - 
purF F cytoplasmic white to lt pink 1,3 5(SG),3 -,- -,ND 
purH F cytoplasmic pink to orange 1(SG) 5 +/- - 
purK F cytoplasmic white to lt pink 2 4 +/- - 
purL F cytoplasmic white to lt pink 1(SG),2 4(SG),1 -,- -,ND 
purM F cytoplasmic white to lt pink 2,3 5-6,3 -.- -,ND 
purR K cytoplasmic dark red 5, 6 5, 4 ++++, ++++ +++++, ++++ 
putA C cytoplasmic dark red 6,5 4,4 +++,+++++ +++++ 
puuR K cytoplasmic light red 2 4 + + 
pyrB F cytoplasmic white to lt pink 2 4 +/- - 
pyrC F cytoplasmic light red 3(SG) 4(SG) +++ ++ 
pyrD F cytoplasmic light red 4 2 +++ ++ 
pyrE F cytoplasmic white to lt pink 4-5(SG),5,2(SG) 3,2,3(SG) +++,+/-,+ +,ND,+ 




Protein dark red 6 3-4 +++++ ++ 
racC C cytoplasmic pink to orange 3 4 - ++++ 




    
rcsF 
  
dark red 6 
 
+++++ +++++ 
rfaC M cytoplasmic white to lt pink 2,2,2,2 5,5,ND,ND ++,++,+,+ NA,-,-,- 
rfaD M cytoplasmic white to lt pink 2-3,2-3,2-3,2-3 4-5,4,ND,ND ++,++,++ -,+/-,+/- 
rfaE M cytoplasmic white to lt pink 2,2,2-3,2 5,5,ND,ND ++,+,+,+ NA,-,-,- 
rfaF M cytoplasmic white to lt pink 1,1,1-2,2 4-5,4,ND,ND +/-,+/-,+/-,+/- -,-,-,- 
rfaG M cytoplasmic white to lt pink 1,2,2 4-5,ND,ND +/-,+/-,+/- -.-,- 

























rfaP M cytoplasmic pink to orange 4,3-4,3,3 4,4,ND,ND +++,+++,+++,+++ +,++,+/-,++ 
rfe M 
  
6 ND +++ +++++ 
rffA M 
  
3-4 ND +++ +++ 
rffC M cytoplasmic light red 3,3,4,3 4,4,4,ND ++,++++,+++,+++ +++++,++,+++,++ 
rffT M 
  
3 ND +++ +++++ 
rimK J* cytoplasmic dark red 5,4 4,4 ++++,++ +++++,++ 
rimM J* cytoplasmic white to lt pink 2 5 +/- - 
rnhA L cytoplasmic pink to orange 4 4 ++++ +++ 
rodZ M* 
Membrane 
anchored white to lt pink 2-3,2, 4 4,4-5, 4 ++,++ NA,+++ 
rplA J cytoplasmic pink to orange 4 4 ++ +++ 
rpoN K cytoplasmic light red 3-4 3 ++ ++ 
rpoS K cytoplasmic white to lt pink 1 3 - - 
rpoZ K cytoplasmic pink to orange 3 4 ++++ ++++ 
rpsF J cytoplasmic white to lt pink 2 4 - - 




Protein light red 3 6 +++++ +++++ 
rsgA J* cytoplasmic pink to orange 3 4 ++ + 
rstA K cytoplasmic light red 3 4 ++ + 
rstB 
       
rumA J cytoplasmic dark red 5 4 +++++ +++ 
sdhA C cytoplasmic pink to orange 3 3 +++ ++ 








Protein pink to orange 6,6 4,3 +++,++++ +++++,+++ 























skp M periplasmic dark red 5 4 ++++ +++ 
slp M* 
Outer membrane 
Lipoprotein light red 3-4 4 +++ ++++ 
speB E cytoplasmic light red 2-3 4 ++ ++ 
srlR K* cytoplasmic white to lt pink 4 4 ++ ++ 
srmB J cytoplasmic light red 3 4 ++++ ++++ 
sspA O cytoplasmic pink to orange 4 5 ++ ++ 
sucA C cytoplasmic light red 2(SG) 3(SG) +/- ++ 
sucC C cytoplasmic light red 3 3 + + 
sucD C cytoplasmic dark red 4 1-2 ++ +++ 
surA O periplasmic light red 3-4 5 +++ ++++ 
thyA F cytoplasmic slow growth/other 1(VVSG) 1(VVSG) slow growth slow growth 
tolA N* 
Membrane 
anchored pink to orange 5,4 4,ND +++++,+++++ ++++,+++ 
tolB N periplasmic white to lt pink 2,2 5,2 +,+/- NA,- 
tolC N 
Outer Membrane ß-
barrel protein  red 3,3 4,4 ++++,+++ ++++,++ 
tolQ N 
Integral Membrane 
Protein white to lt pink 2,2 5,5-6 +,+/- -,- 
tolR N 
Membrane 
anchored white to lt pink 2-3 5 + - 
tomB T* cytoplasmic light red 3 3 + ++ 
torI K* cytoplasmic* pink to orange 3 4 ++ +/- 
tpiA G cytoplasmic red 4 3 +++++ ++++ 
treR K cytoplasmic dark red 5,6 4,4 ++++,+++++ ++++,+++++ 
trpA E cytoplasmic white to lt pink 2,1 3,3 +,+/- +/-.+/- 
trpB E cytoplasmic white to lt pink 2 3 + +/- 
trpC E cytoplasmic white to lt pink 2,3,2 3,3,4 NA,+/-,+/- ++++,-,- 
trpD E cytoplasmic white to lt pink 2,2 3,4 +,+ ++,+/- 
























trpE E cytoplasmic white to lt pink 2,2 4 ++,+/- ++,+/- 
trpE ' ' white to lt pink 3,3 4 +++,++ ++++,++ 
ubiE H cytoplasmic slow growth/other 1,2,1(SG) 2,1,2(SG) -,+,- -,-,- 
ubiF H cytoplasmic slow growth/other 2,2(SG) 2,2(SG) +,+/- +/-,- 
ubiG H cytoplasmic slow growth/other 1(SG),1(SG) 1(SG),1(SG) ND,- ND,- 
ubiH H cytoplasmic slow growth/other 1,1(SG) 1,1(SG) - - 
uspE T cytoplasmic dark red 3 4 +++ + 
wzxE M* 
Integral 
Membrane Protein pink to orange 3,3 4,ND +++,++ ++,++ 
xapR K cytoplasmic light red 5, 6 4, 4 +++, ++ ++++, ++++ 
ybaM S* cytoplasmic light red 6 4 +++++ +++++ 
ybcI R 
Integral 
Membrane Protein light red 2 3-4 ++ ++ 
ybeZ T cytoplasmic dark red 6 4 +++++ +++++ 
ybgC R cytoplasmic light red 3 4-5 +++ +++ 
ycfM R 
Outer membrane 
Lipoprotein pink to orange 4 4 ++++ +++++ 
ycgV M cytoplasmic light red 3 4 ++++ ++++ 
yciC S* 
Integral 
Membrane Protein light red 3, 4 4, 4 ++++, +++ ++, ++ 
yciM G periplasmic light red 2,3,2 5,4,ND +, ++,++ ++++, ++,+/- 
ydaF S* cytoplasmic light red 2-3,2-3 4,4 ++,++ NA,++++ 
ydaM T cytoplasmic white to lt pink 1 4 + - 
ydaT S* cytoplasmic pink to orange 3,2-3 4-5,4-5 ++++, ++ +++,+++ 
ydcI K cytoplasmic white to lt pink 1 4 + - 
ydeJ R cytoplasmic dark red 6 4 +++++ +++++ 
ydiT C cytoplasmic light red 4 3 +++ ++ 
yecH S* cytoplasmic pink to orange 3 4 ++++ ++++ 
yedQ T 
Integral 























yedV T Membrane anchored light red 3 4 ++ + 
yeeN S cytoplasmic dark red 6 4-5 +++++ ++ 
yeiL T* cytoplasmic pink to orange 3 4 + +/- 
yeiR 
   
6 ND +++++ ++++ 
yfeW M periplasmic dark red 6,5-6 3,4 ++++,++++ +++++,+++++ 
yfgC R periplasmic dark red 5-6 4 +++++ +++++ 
ygfZ R cytoplasmic slow growth/other 3 3 +++ +++ 
yhbJ R cytoplasmic dark red 6 4 +++ +++++ 
yheV S* cytoplasmic dark red 4 4 +++++ +++ 
yiaK C cytoplasmic light red 2,2 4,4 +/- - 
yiaK ' ' light red 3-4,3-4 4,4 ++++ +++ 
yicC S cytoplasmic light red 2 4 ++ ++++ 
yieP K* cytoplasmic white to lt pink 1 4 +/- - 
yiiS S cytoplasmic red 4 3 ++++ +++ 
yjjW O cytoplasmic light red 4 4 +++ +++ 
ykgH S 
Integral Membrane 
Protein light red 4 4 ++++ ++ 
ymgE S 
Integral Membrane 
Protein pink to orange 3 4 ++ ++ 
ymgE ' ' pink to orange 3-4 4 + + 
ynaK K cytoplasmic light red 3 4 ++++ ++++ 
yncG O cytoplasmic pink to orange 3 4 +++ ++ 
ynjD R cytoplasmic light red 4 4 +++ +++++ 
yoeE P cytoplasmic dark red 5-6,5 4,3 ++++,+++++ +++++,+++++ 
yqaB R cytoplasmic light red 4-5 3 ++ +++ 
Notes 
* Best pick 
or changed 
* Changed from 
Echobase or best 
idea 






Table 2.5 (continued). Congo Red and Western blot data for Keio strains. 
Keio strains that were tested by Western blot or retested for CR and shown to be WT 
Name Original Color Color @ 26C Color @ 37C Wester CsgG Level Western CsgA Level 
alaS pink to orange 5 4 ++++ ++++ 
appB red 5-6,5 3-4,4 ++++,++++ ++++,++++ 
arcA 
 
5 ND ++++ ++++ 
aroF 
 
5 4 ++++ ++++ 
aroG 
 
5-6 4 ++++ +++++ 
aroL 
 
5 4 +++++ +++++ 
argI 
 
5 ND ++++ ++++ 
argF pink 6,4-5(dry),5 4,4,ND,ND ++++,+++++,+++++ ++++,+++++,++++ 
arnT 
 
5 ND ++++ ++++ 
atpD pink 4-5 5 ++++ ++++ 
bioH red 4-5 4 ++++ ++++ 
btuD dark red 5,5-6 4,4 ++++,++++ ++++,++++ 
cbpA red 5,4,4 4,4,4 ++++,++++,++++ ++++,++++,++++ 
crl red 4,5 4,4 ++++ ++++ 
csgC red 5, 5 4, 3 ++++ ++++ 
cspC pink to orange 5 4 ++++ ++++ 
cusR light red 5 4 ++++ ++++ 
cusS red 4, 5 4, 4 ++++ ++++ 
emtA red 4-5 4 ++++ ++++ 
fadH light red 5,4 4,4 ++++ ++++ 
fecC dark red 4 4 ++++ ++++ 
fepC dark red 5 2 ++++ ++++ 
fes light red 5 2 ++++ ++++ 
fre red 5 2 ++++ ++++ 
fucO light red 5 4 ++++ ++++ 
gltA dark red 5 4 ++++ ++++ 
guaA red 4,4,5-6 4,4,4 ++++,++++,++++ NA,++++,++++ 
hisG light red 4 4 ++++ ++++ 
lpxL 
 
5 ND ++++ bad 
lpxM 
 
5 ND ++++ ++++ 
lpxP 
 
5 ND bad +++ 
ilvB red 5 4 ++++ ++++ 
mltB  red 4-5 4 ++++ ++++ 
nanA 
 
5 ND ++++ ++++ 
paaF dark red 5 5 ++++ ++++ 
paaI pink to orange 4-5 4 ++++ ++++ 
pagP 
 
5 ND bad 
 pdxJ pink 5 3-4 ++++ ++++ 
phoP red 5 4 ++++ ++++ 
phoQ red 5 4 ++++ ++++ 
purT dark red 5,5 4,4 ++++,++++ ++++,++++ 







Table 2.5 (continued). Congo Red and Western blot data for Keio strains. 
 
Keio strains that were tested by Western blot or retested for CR and shown to be WT 
Name Original Color Color @ 26C Color @ 37C Wester CsgG Level Western CsgA Level 
rfaI red 5,4-5,4-5,4-5 4,4,ND,ND ++++,++++,++++,++++ +++,++++,+++++,++++ 
rfaJ red 4-5,5,5,5 4,4,ND,ND ++++,++++,++++,++++ ++++,++++,+++++,+++++ 
rfaL red 4-5,4-5,5,5 4,4,ND,ND ++++,++++,++++,++++ ++++,++++,NA,++++ 
rfaQ red 4-5,5,5 4,ND,ND ++++,++++,+++++ ++++,++++,+++++ 
rfaS red 5,5,5,5 4,4,ND,ND ++++,++++,++++,++++ ++++,+++++,+++++,++++ 
rfaY red 5,5,5,5 4,4,ND,ND ++++,++++,++++,++++ ++++,+++++,++++,++++ 
rfaZ red 5,5,5 4,ND,ND ++++,++++,++++ ++++,++++,++++ 
rph red 4 4 ++++ ++++ 
rpmE red 4 4 ++++ ++++ 
rstB dark red 5-6 4 ++++ ++++ 
sbmC dark red 5 4 ++++ ++++ 
tktA red 4 4 ++++ ++++ 
tktB red 5 4 ++++ ++++ 
tpr dark red 4 4 ++++ ++++ 
treC red 4 4 ++++ ++++ 
truB red 4-5 4 +++++ ++++ 
ubiC 
 
4 4 ++++ +++++ 
uidC dark red 5 4 ++++ ++++ 
ybaP dark red 6 4 ++++ ++++ 
ycbR red 5-6 4 ++++ ++++ 
yceP light red 4 4 ++++ ++++ 
ycjU dark red 5,5,5 4,4,4 ++++,?,++++ ++,?,++++ 
ydbH light red 4 4 ++++ ++++ 
ydiZ dark red 4 4 ++++ ++++ 
yfcL dark red 5-6 4 ++++ ++++ 
yhaK pink 5 4 ++++ ++++ 
yjbB light red 5 4 ++++ ++++ 
yjiK red 4 4 ++++ ++++ 
ylcG red 4-5 4 ++++ ++++ 
ymjB dark red 4 4 ++++ ++++ 
yniD light red 4-5 4 ++++ ++++ 
yoaE light red 4-5 4 ++++ ++++ 
ypfG light red 4-5,4-5 4,4 ++++ ++++ 
yqeC dark red 5-6 4 ++++ ++++ 
yqiK dark red 5 4 ++++ ++++ 
zraR dark red 5 4 ++++ ++++ 
ygiF dark red 5,5 4,4 +++++,++++ +++++,+++ 
hns red 5, 5 4, 3 +++++ ++ 
galM pink to orange 5,5 4,4 ++++,++++ ++++,+++++ 
 
Notes:   Commas separate individual experiments.  






Table 2.6. Results from PCR for strains with multiple CR phenotypes. 
 
Gene Color PCR Results Upstream Primer COG Notes 
btuC 3,5 both correct CGC TTA CAA AAG CTG AAA TGT C H 
 cysH 3,5 both correct CGA AAC ATG GTG TCA GCG H 
 dcuC 3,5 both correct CGA GAT ACA ACA ATC ATC TTA ACG C 
 dnaQ 1,2,3,4 all correct GCA TCA AGA CGT TGC CAG L 
 fepE 2,6 both correct CTG TTT GTT GCT GAA CGC P,M entertobactin and O antigen length 
flhC 3,5 both correct GTG AAA CCG CAT AAA AAT AAA GTT GG K* 
 fliG 2,5 both correct GCT CAA TGT CGT TAA CTC G N 
 glcD 3,4 both correct GCG TAC TGA ACA GAT GGA TC C 
 gshB 4,5 both correct GCG TTA AAC TGG ATA GTG AAC G H 
 hepA 3,4 both correct CGA TGA AGA AAA CCA AAA GCG K 
 hycI 3,5 both correct GAA AAG GTG GTG TTC AGT CAA C C hydrogenase maturation 
hypE 3,5 both correct CGA TTG CCG ATG TGT TCT G O hydrogenase maturation 
kbl 3,5 both correct CTA TCT GGG GAG AGG AAA ATG G H 
 manY 3,5 both correct CAC ACG TAG TTG ATG TTG C G 
 mfd 3,5 both correct GCT GAA TGT GAT TGG CTC C L* 
 mppA 2,5 both correct CGG CAT TCT CAT TAT TTA TAG ATA GG E 
 mutL 2,3,5 all correct GTC TGA CCC CTA TTT AAG CC L 
 nuoH 5,6,1 all correct CAA ATT CCA GGA CGA AGT GG C 
 nuoI 2,5,6 all correct CCG CAA TTC TTT GGT TTT ATT ACC C 
 nuoL 2,5,6 all correct GCC AAT CAG TGC TAA AGC C 
 pdxB 1 mucoid,5 both correct CGC CAG ATT ATG CTC AGC H* Mucoid white -> 5. Can't isolate only mucoid 
purN 2,5 both correct GGT AAG CCA TTA GCC GAT C F 
 qseB 2,6 both correct GCA TCT TTG AAC ACG TAG AGA TC K quorum sensing regulates flhDC 
rbsK 2,4 both correct GCG CAG AAT GAT GAA ATG G G 
 rbsR 2,5 both correct CCA TCA AAA TAA GAC TAT CGT TGC K regulates rbsDABCK 
rdgC 3,5 both correct GTC TTT ATC GAA TGG CTG ACC L pillin variation in Neisseria gonorrhoeae  
rnk 2,5 both correct GCA GTT AAG CTA ACG TGC K 
 rssB 3,5 NONE GAA TGG TGA TTC TCT GCC G T No correct inserts - Wrong primer/Strain? 
rsxC 2,5 both correct GAA GCC ATC AGC TGT AAC G C 
 sbcD 3,5 both correct GGT GTT TGA TGA ACT GGA TAC C L 
 sfcA 2,5 both correct CGG CAA CCT AAT TTA GGG G C 
 ssnA 2,5 both correct GTA ACT ACG TTT GCA GCA AG R* 
 sucB 2,6 both correct GTA GTG ATG TGT TCT GGT AAG G C 
 tonB 2,5 both correct CCC TGG ATC GTT ACT GTC M 
 uup 3,4-5 both correct GCA ACC TGC GTC TGA ATG R 
 wcaD 3,5 both correct GGC GAC AAA ATT GAA CTG C M* 
 ybaB 2,5 both correct GCT ACC AAA ACT GGT CGA AC S 
 rlmF 3,6 both correct CAG GTT ACT CAT CGG TTG C J* was ybiN 
ybjN 3,5 both correct GAT TTT CGT TCC AAT TTG CAT CG R* 3' to rimK 
ycbL 3,5 both correct GGC TAT ATT CAG GAA GAA TTG GC R 
 ycbQ 3,5 both correct GAG AAG GAA AGC GAG GAC U pillin ATPase 
bhsA 1,5 both correct GAG AAG TCG CTT CAT AAC CG M* was ycfR 
yciU 2,5 both correct CGA TGA TTT ACT TCA TGC GAT TTG S* 
 ydeP 3,5 both correct CAG GAA ACA AGG TTT CAG C C 
 ydfD 3,5 both correct CGG TAT CAG TTT TAC TCC GTG S* 
 ydiY 3,5 both correct GGA TAA ATT TGC GGG GTA ATT G M 








Table 2.6 (continued). 
 
Gene Color PCR Results Upstream Primer COG Notes 
yebY 3,5 both correct CGA TTC ACC TGA TTT GTG C S* 
 yehE 3,6 both correct GGT GGT GCA GAG AAA CTG S* 
 yfjW 3,5 both correct CAT CCA CGG AGA TCA TAA CG R* 
 yjbI 3,5 both correct CTA AGA ATA TCC ATT ATC TCA ATG CC S 
 gsiA 2,5 both correct GCG GAA TGA CCA ATA AAT TAC C H* was yliA,was E* 
ynfH 5,6 both correct GCA ATG CAT AAG CGT GAA G C* 
 Still used 
  cmk 1,2 both correct GCG CTA TCA ATG CTA AAT ACT CC F 
 fabF 2,3 both correct CGA AAA CCA TCG CGA AAG C Q 
 mdoG 3, 1 mucoid both correct GGT TCA TAT ATG GTT AAC TAA TCT CGG M* 
 pgm 1 mucoid,2 mucoid both correct GCC GGT CAA AAC GAT TAA AGA C G 
 trpD 2,3 both correct CCA AAG TTG ACC GTT ATT CC E 
 trpE 2,3 both correct CGT GAA ATT TCC TCT CTT GC E 
 yiaK 2,3 both correct GCA ATA AGC GAT GGA CGG C 
 ymgE 3,3-4 both correct CGA TGT TGT CTT CGG CTT G S 
 Only one correct 
   fhlA 3,5 only 3's GGT TGT GGT ATT GAA CTT TCA G K 
 sdhC 2,6 only 6 GCA TTA TAT GCT TTT CCT GGT AAT G C 
 sdhD 3,6(SG) only 6(SG) CAT GTG GGC GTT ATT CAT GAT AAG C 
  
 
Distribution of function of strains with multiple CR phenotypes 
COG Number Total # COG Category % of Suppressors % COG Category 
C 12 281 19.67 4.27 
E 3 390 4.92 0.77 
F 2 83 
  G 4 355 6.56 1.13 
H 6 144 9.84 4.17 
J 1 170 
  K 5 288 8.2 1.74 
L 5 237 8.2 2.11 
M 5 219 8.2 2.28 
N 1 151 
  O 1 133 
  P 1 253 
  Q 1 95 
  R 5 448 8.2 1.12 
S 7 447 11.48 1.57 
T 1 187 






Table 2.7. Congo Red phenotypes of Keio strains on YESCA and CFA plates or CFA plates without Coommassie Brilliant Blue. 
 
Set A Niba Results  24H   48H   72H  Different 
Name 
 
YESCA CR CFA CR CFA 2XCR YESCA CR CFA CR CFA 2XCR YESCA CR CFA CR CFA 2XCR  
flhC lt + 3 3 3 3 3 3 3 3 3 Yes 
flhC WT + 4-5 5 5 4 5 5 4-5 4-5 5 no 
fliG lt + 2 2 2 3 2 2 3 3 2-3 Yes 
fliG WT + 4-5 4-5 4-5 4-5 5 5 5 5 5 no 
fliI + 6 6 6 6 6 6 6 6 6 Yes*** 
fliT + 3 3-4 3 3 3-4 3 2-3 3 3 Yes 
btuC lt Not Tested 2 2 2 2 2 2 2 2 2  
btuC WT Not Tested 4-5 4-5 4-5 4 4-5 5 4-5 4 4  
btuB variable 4-5 4-5 4-5 6 5 6 4-5 5 5 unclear 
csgA - 1 1 1 1 1 1 1 1 1 no 
csgB - 1 1 1 1 1 1 1 1 1 no 
csgC Not Tested 4-5 4-5 4-5 5 5 5 6 6 6  
csgD - 1 1 1 1 1 1 1 1 1 no 
csgE - 1 1 1 1 1 1 1 1 1 no 
csgF * + 1 1 1 1 1 1 1 1 1 Yes* 
csgG - 1 1 1 1 1 1 1 1 1 no 
surA + 2-3 3 3 3-4 3-4 4-5 4 4 4 Yes**** 
dnaK + 1 1-2 2 2 2 2 2-3 2 3 Yes 
fruR + 2 1-2 2 2 2 2 3 2 2 Yes 
gcvA +/- 2 2 2 2-3 2-3 2 3 3 2 no 
greA + 2-3 2-3 2-3 3 3 3 4 4 3 Yes 
 
 
Notes * csgF has red fibers underneath the colonies in the agar and can appear pinkish 
 




*** Niba et al did not test for higher curli expression 
 






Table 2.7 (continued). Congo Red phenotypes of Keio strains on YESCA and CFA plates or CFA plates without CBB. 
 
Set B Niba Results  24H   48H   72H  Different 
Name 
 
YESCA CR CFA CR CFA 2XCR YESCA CR CFA CR CFA 2XCR YESCA CR CFA CR CFA 2XCR 
 lpcA + 1-2 1 1 1-2 1 1-2 2 1 1-2 Yes 
gmhB + 2 2 1 2 1 1 2 1 1 Yes 
rfaC Not tested 2 2 1 2 1 2 2 1 2 
 rfaD + 2 2 2 2-3 2 3 2-3 1-2 2 Yes 
rfaE + 1-2 1 1 2 1 1-2 2 1 1-2 Yes 
rfaF + 1 1 1 1 1 1 1 1 1 Yes 
rfaG +/- 1 1 1 1 1 1 1 1 1 no 
rfaH + 2-3 3 3 3 3 3 3 3-4 4-5 Yes**** 
rfaP + 2-3 3 3 3 4 3 3 4 3 Yes 
galU + 1 1 1 1 1 1 1 1 1 Yes 
hfq +/- 1 1 1 1-2 2 2 2-3 3 3 no 
hsrA/yieO - 3-4 4-5 4 5 5 3-4 4 4 4 Yes**** 
yieP Not tested 1 1 1 1** 1** 1** 1** 1** 1** 
 lon - 1 mucoid 1 mucoid 1 mucoid 1 mucoid 1 mucoid 1 mucoid 1 mucoid 1 mucoid 1 mucoid no 
mdoH pink + 3 4-5 4 3-4 4 3-4 3 5 4 Yes**** 
mlrA - 1 1 1 1 1 1 1 1 1 no 
nagA + 2 3 3 2-3 2-3 2 2 3 3 Yes 
nifU/iscU +/- 3 3 3 3-4 4 3 3-4 4 4 no 
ompR - 1 1 1 2 2 2 2 2 2 no 
rpoS - 1 1 1 1 1 1 1-2 1-2 1-2 no 
nlpD - 1 1 1 1 2 1-2 1 2 2 no 
 
Notes * csgF has red fibers underneath the colonies in the agar and can appear pinkish 
 




*** Niba et al did not test for higher curli expression 
 






Table 2.7 (continued). Congo Red phenotypes of Keio strains on YESCA and CFA plates or CFA plates without CBB. 
 












CR CFA CR 
CFA 
2XCR  
crp +/- 6 6 6 6 5-6 5 4-5 4-5 4-5 Yes***   **** 
cyaA - 1-2 slow 1 slow 1 slow 1 slow 1 slow 1 slow 1 slow 1 slow 1 slow no 
sdhC + 6 5 6 5-6 5 5 5-6 5 5 Yes*** 
tolA + 3-4 4 4 4 4 4-5 4 5 5 Yes**** 
tolB +/- 2 2 2 2 2 2 2 2 3 no 
tolR +/- 2 2 2 2 2 2 2 2 3 no 
ycfM + 2-3 3 3 3 3 3 3 3 3 Yes 
yciB + 3 4 4 5 5 5 4 4 4-5 no 
yciC Not tested 3 3-4 3-4 4 5 4 4 4 4  
yciM +/- 2 2 2 2-3 2 2-3 2-3 2-3 3 no 
ydaM +/- 1 1 1 1 1 1 1 1 1 no 
ynjC + 3 3-4 3 3 4 3-4 3 4 4-5 Yes**** 
ynjD Not tested 6 6 6 6 6 6 6 6 6  
ptsI + 1-2 2 2 1 1-2 1-2 1 1 1 Yes 
ihfB - 1 1 1 1-2 1-2 2 2 2 2 no 
mdoH mucoid + 2** 2-3** 2-3** 2** 2-3** 2-3** 2-3 3 3 Yes 
lpxL Not tested 3-4 3-4 4 5 5 5 4-5 5 5  
lpxM Not tested 3-4 3-4 4 5 5 5 5 5 5  
lpxP Not tested 4-5 3-4 5 5 5 5 5 5 5  
crcA/pagP Not tested 4-5 3-4 5 5 5-6 5 5 5 5  
arnT Not tested 3-4 3-4 4 4-5 4-5 5 5 5 4-5  
 
Notes * csgF has red fibers underneath the colonies in the agar and can appear pinkish 
 




*** Niba et al did not test for higher curli expression 
 





Table 2.8.  Two hundred longest intergenic regions in E. coli K-12. 
 
Rank Name Length Orientation L_END R_END Cs 
1 nanC_fimB 1455 Divergent 4537525 4538979 97.8 
2 ygcE_ygcF 1372 Convergent 2901397 2902768 62.53 
3 iap_ygbF 950 Convergent 2875641 2876590 61.98 
4 lrhA_yfbQ 919 Divergent 2404664 2405582 51.83 
5 dppA_proK 910 Codirectional- 3705729 3706638 79.87 
6 betT_yahA 874 Codirectional+ 330721 331594 7.13 
7 yiiD_yiiE 858 Codirectional+ 4076462 4077319 87.86 
8 mngB_cydA 846 Codirectional+ 769835 770680 16.59 
9 hdeD_gadE 798 Codirectional+ 3655591 3656388 78.79 
10 araF_ftnB 796 Divergent 1984153 1984948 42.76 
11 matA_ykgL 775 Divergent 310561 311335 6.69 
12 ycgV_ychF 768 Codirectional- 1255176 1255943 27.05 
13 csgD_csgB 754 Divergent 1102420 1103173 23.76 
14 essQ_cspB 753 Codirectional- 1638610 1639362 35.32 
15 ydfJ'_ydfK 753 Divergent 1630310 1631062 35.14 
16 ypjC'_ileY 750 Codirectional- 2783034 2783783 59.98 
17 yncH_rhsE' 749 Codirectional+ 1525177 1525925 32.87 
18 ychE_oppA 737 Codirectional+ 1298469 1299205 27.99 
19 ycdU_serX 735 Convergent 1096053 1096787 23.62 
20 eco_mqo 714 Convergent 2302416 2303129 49.62 
21 gltA_sdhC 708 Divergent 753692 754399 16.24 
22 ynaE_ttcC' 700 Codirectional- 1432282 1432981 30.87 
23 iraM_ycgX 699 Codirectional- 1211227 1211925 26.11 
24 dinQ_arsR 694 Divergent 3645857 3646550 78.58 
25 yfcV_sixA 680 Codirectional- 2453669 2454348 52.88 
26 yjiC_iraD 672 Divergent 4554344 4555015 98.16 
27 yobF_yebO 669 Codirectional- 1905616 1906284 41.07 
28 stpA_ygaW 668 Divergent 2796518 2797185 60.27 
29 leuL_leuO 659 Divergent 83709 84367 1.8 
30 wza_yegH 658 Divergent 2135268 2135925 46.02 
31 yjdN_yjdM 657 Codirectional- 4323765 4324421 93.19 
32 gltP_yjcO 641 Convergent 4293818 4294458 92.55 
33 nuoA_lrhA 630 Codirectional- 2403095 2403724 51.79 
34 arsC_yhiS' 628 Codirectional+ 3648686 3649313 78.64 
35 yjjP_yjjQ 618 Divergent 4600882 4601499 99.16 
36 atpI_rsmG 616 Codirectional- 3920464 3921079 84.5 
37 yaiS_tauA 615 Divergent 383841 384455 8.27 
38 purH_rrsE 614 Divergent 4205556 4206169 90.64 
39 yhaC_rnpB 613 Convergent 3267625 3268237 70.43 
40 malP_malT 611 Divergent 3550496 3551106 76.52 
41 nth_tppB 610 Codirectional+ 1710183 1710792 36.86 
42 dnaA_rpmH 606 Divergent 3881753 3882358 83.66 
43 hns_tdk 604 Divergent 1292146 1292749 27.85 
44 ompF_asnS 602 Codirectional- 986206 986807 21.26 




Table 2.8 (continued).  Two hundred longest intergenic regions in E. coli K-12.  
 
Rank Name Length Orientation L_END R_END Cs 
46 ppc_argE 597 Codirectional- 4151122 4151718 89.47 
47 yedS'_hchA 591 Codirectional+ 2033268 2033858 43.82 
48 dcuC_pagP 588 Divergent 655192 655779 14.12 
49 pgaA_ycdT 586 Divergent 1091513 1092098 23.53 
50 yjhR'_yjhS 582 Convergent 4534055 4534636 97.72 
51 yhcC_gltB 581 Divergent 3352073 3352653 72.25 
52 mhpE_mhpT 577 Codirectional+ 374106 374682 8.06 
53 glnS_ybfM 576 Codirectional+ 706981 707556 15.24 
54 nmpC'_essD 572 Divergent 576049 576620 12.42 
55 dcuB_dcuR 570 Codirectional- 4346768 4347337 93.69 
56 yodB_serU 569 Convergent 2040923 2041491 43.99 
57 gltD_gltF 559 Codirectional+ 3358639 3359197 72.39 
58 ileY_ygaQ' 559 Divergent 2783860 2784418 60 
59 ygdH_sdaC 556 Codirectional+ 2925695 2926250 63.06 
60 yjhV'_fecE 556 Convergent 4508157 4508712 97.17 
61 ydhZ_pykF 556 Divergent 1753166 1753721 37.79 
62 ykgP'_eaeH' 551 Divergent 313030 313580 6.75 
63 fucA_fucP 546 Divergent 2931711 2932256 63.19 
64 tomB_acrB 545 Codirectional- 479933 480477 10.34 
65 tfaX'_appY 545 Codirectional+ 582359 582903 12.55 
66 yiaW_aldB 544 Codirectional- 3752452 3752995 80.88 
67 trxB_lrp 544 Divergent 931274 931817 20.07 
68 putP_efeU' 542 Codirectional+ 1080037 1080578 23.28 
69 IS4_yjhB 542 Divergent 4501539 4502080 97.02 
70 aroP_pdhR 540 Divergent 121552 122091 2.62 
71 narI_rttR 539 Convergent 1285750 1286288 27.71 
72 yibI_mtlA 536 Divergent 3769768 3770303 81.25 
73 yneO'_lsrK 530 Codirectional- 1596111 1596640 34.4 
74 ykgD_ykgE 526 Codirectional+ 320306 320831 6.9 
75 lysC_pgi 524 Divergent 4231257 4231780 91.2 
76 yfjW_ypjI' 523 Codirectional+ 2773044 2773566 59.77 
77 hemB_yaiT' 523 Divergent 388952 389474 8.38 
78 pntA_ydgH 523 Divergent 1675928 1676450 36.12 
79 thrS_arpB' 523 Divergent 1800595 1801117 38.81 
80 minC_ycgJ 519 Divergent 1225304 1225822 26.41 
81 yhjB_yhjC 519 Divergent 3669918 3670436 79.1 
82 narK_narG 515 Codirectional+ 1278572 1279086 27.56 
83 sseA_ryfA 515 Codirectional+ 2651362 2651876 57.15 
84 frc_yfdX 512 Codirectional- 2491277 2491788 53.7 
85 tyrB_yjbS 501 Convergent 4266331 4266831 91.95 
86 yjgZ_IS4 500 Convergent 4499613 4500112 96.98 
87 pgi_yjbE 498 Codirectional+ 4233431 4233928 91.24 
88 yjiS_yjiT' 498 Codirectional+ 4569939 4570436 98.5 
89 ybjE_aqpZ 494 Codirectional- 914081 914574 19.7 




Table 2.8 (continued).  Two hundred longest intergenic regions in E. coli K-12.  
 
Rank Name Length Orientation L_END R_END Cs 
91 zupT_ribB 489 Convergent 3181346 3181834 68.57 
92 yghJ_glcA 484 Codirectional- 3117135 3117618 67.18 
93 sokC_nhaA 482 Codirectional+ 17007 17488 0.37 
94 IS1H_uspC 482 Divergent 1977295 1977776 42.62 
95 fimE_fimA 481 Codirectional+ 4540657 4541137 97.87 
96 yieP_rrsC 480 Divergent 3939351 3939830 84.91 
97 mdtM_yjiP' 478 Divergent 4566543 4567020 98.42 
98 ydaN_dbpA 477 Codirectional+ 1407058 1407534 30.33 
99 fimB_fimE 477 Codirectional+ 4539583 4540059 97.84 
100 adhE_ychE 476 Divergent 1297345 1297820 27.96 
101 ygeV_ygeW 475 Divergent 3003809 3004283 64.74 
102 yffP_yffQ 474 Codirectional+ 2561140 2561613 55.2 
103 ykgR_ykgP' 473 Codirectional- 312467 312939 6.73 
104 rrsD_yrdA 473 Divergent 3426785 3427257 73.86 
105 caiT_fixA 471 Divergent 41932 42402 0.9 
106 folD_sfmA 470 Divergent 556965 557434 12 
107 yffL_yffM 469 Codirectional+ 2558921 2559389 55.15 
108 yjgX'_yjgZ 468 Divergent 4498815 4499282 96.96 
109 ybcK_ybcL 464 Codirectional+ 569652 570115 12.28 
110 xisE_ymfI 464 Divergent 1200256 1200719 25.87 
111 ddlA_iraP 462 Divergent 400148 400609 8.62 
112 yoaE_manX 462 Divergent 1899610 1900071 40.94 
113 cyaY_yifL 462 Divergent 3992083 3992544 86.04 
114 cyoA_ampG 459 Codirectional- 450835 451293 9.72 
115 yqeG_yqeH 459 Codirectional+ 2985099 2985557 64.34 
116 yhbX_leuU 458 Codirectional- 3319636 3320093 71.55 
117 uvrY_yecF 458 Divergent 1993384 1993841 42.96 
118 ymfE_lit 457 Divergent 1197461 1197917 25.81 
119 yhgF_feoA 456 Codirectional+ 3537729 3538184 76.25 
120 dapB_carA 455 Codirectional+ 29196 29650 0.63 
121 ydhY_ydhZ 454 Codirectional- 1752502 1752955 37.77 
122 ygeR_xdhA 453 Divergent 2997914 2998366 64.61 
123 yeeN_asnW 452 Convergent 2055599 2056050 44.3 
124 ybdK_hokE 452 Divergent 606607 607058 13.07 
125 iscR_trmJ 451 Codirectional- 2660154 2660604 57.33 
126 rhaD_rhaA 450 Codirectional- 4092296 4092745 88.2 
127 gcvT_visC 447 Codirectional- 3048690 3049136 65.71 
128 astC_xthA 445 Divergent 1830007 1830451 39.44 
129 rrsG_clpB 442 Codirectional- 2729180 2729621 58.82 
130 yeeW'_yoeD' 441 Convergent 2076132 2076572 44.75 
131 kilR_sieB 441 Divergent 1416254 1416694 30.52 
132 rfaQ_waaA 441 Divergent 3806122 3806562 82.03 
133 prpB_prpC 439 Codirectional+ 348797 349235 7.52 
134 flxA_intK' 436 Convergent 1644762 1645197 35.45 




Table 2.8 (continued).  Two hundred longest intergenic regions in E. coli K-12. 
 
Rank Name Length Orientation L_END R_END Cs 
136 ygfT_ygfU 435 Divergent 3028954 3029388 65.28 
137 gudP_yqcA 434 Codirectional- 2920123 2920556 62.94 
138 mdh_argR 434 Divergent 3382291 3382724 72.9 
139 yiaF_yiaG 433 Divergent 3717068 3717500 80.11 
140 lysQ_nadA 432 Codirectional+ 780876 781307 16.83 
141 ybbP_rhsD 430 Codirectional+ 522055 522484 11.25 
142 yhdV_yhdW' 430 Codirectional+ 3416634 3417063 73.64 
143 tldD_yhdP 429 Codirectional- 3390051 3390479 73.07 
144 yjcB_yjcC 429 Divergent 4273065 4273493 92.1 
145 yobD_yebN 428 Codirectional+ 1903284 1903711 41.02 
146 serT_hyaA 426 Divergent 1030936 1031361 22.22 
147 ygjK_fadH 425 Codirectional+ 3229262 3229686 69.6 
148 aqpZ_ybjD 425 Divergent 915271 915695 19.73 
149 yfaL_ypaB 424 Codirectional- 2342192 2342615 50.48 
150 aslA_glmZ 424 Divergent 3984031 3984454 85.87 
151 glpF_zapB 424 Divergent 4116114 4116537 88.72 
152 ynfM_asr 423 Codirectional+ 1668977 1669399 35.97 
153 metK_galP 423 Codirectional+ 3085883 3086305 66.51 
154 ompT_pauD' 423 Divergent 584857 585279 12.61 
155 livK_yhhK 423 Divergent 3595584 3596006 77.5 
156 psuK_fruA 422 Codirectional- 2257319 2257740 48.65 
157 putA_putP 422 Divergent 1078106 1078527 23.24 
158 yahG_yahI 421 Codirectional+ 338968 339388 7.31 
159 yoaB_yoaC 421 Codirectional+ 1891736 1892156 40.77 
160 cspF_quuQ 421 Convergent 1640092 1640512 35.35 
161 yjjV_yjjW 419 Convergent 4612284 4612702 99.41 
162 yabP'_rluA 417 Convergent 59270 59686 1.28 
163 IS1D_cspH 417 Convergent 1049769 1050185 22.63 
164 yagT_yagU 417 Divergent 301798 302214 6.5 
165 aer_patA 417 Divergent 3217099 3217515 69.34 
166 emrK_evgA 415 Divergent 2481362 2481776 53.48 
167 casA_ygcB 414 Codirectional- 2882161 2882574 62.12 
168 yahL_yahM 412 Codirectional+ 344216 344627 7.42 
169 rplA_rplJ 412 Codirectional+ 4177607 4178018 90.04 
170 ryjA_yjcD 412 Divergent 4276090 4276501 92.16 
171 lpxT_spr 411 Codirectional+ 2267590 2268000 48.87 
172 mdtJ_tqsA 411 Divergent 1671526 1671936 36.03 
173 yhjD_yhjE 410 Codirectional+ 3672399 3672808 79.15 
174 yjbM_dusA 407 Codirectional+ 4259330 4259736 91.8 
175 rpoE_nadB 407 Divergent 2708035 2708441 58.37 
176 phoR_brnQ 406 Codirectional+ 418409 418814 9.02 
177 fdnI_yddM 406 Convergent 1550016 1550421 33.41 
178 focA_ycaO 405 Codirectional- 953690 954094 20.56 
179 yegR_yegS 405 Divergent 2166331 2166735 46.69 




Table 2.8 (continued).  Two hundred longest intergenic regions in E. coli K-12. 
 
Rank Name Length Orientation L_END R_END Cs 
181 glnH_dps 403 Codirectional- 847228 847630 18.26 
182 yhjA_treF 403 Divergent 3667212 3667614 79.04 
183 ydeN_ydeO 401 Codirectional- 1580549 1580949 34.07 
184 yjbS_aphA 401 Divergent 4267036 4267436 91.97 
185 aroK_hofQ 400 Codirectional- 3517087 3517486 75.8 
186 agaI_yraH 400 Codirectional+ 3285048 3285447 70.8 
187 yjdM_yjdA 400 Divergent 4324758 4325157 93.21 
188 ycfP_ndh 399 Codirectional+ 1164909 1165307 25.11 
189 ymgF_ycgH' 399 Codirectional+ 1218425 1218823 26.26 
190 yjjY_yjtD 399 Codirectional+ 4638566 4638964 99.98 
191 ugpB_livF 398 Codirectional- 3590349 3590746 77.38 
192 sgcX_yjhY' 398 Codirectional- 4529675 4530072 97.63 
193 alx_sstT 398 Codirectional+ 3237568 3237965 69.78 
194 envR_acrE 398 Divergent 3411488 3411885 73.53 
195 speC_yqgA 397 Divergent 3107178 3107574 66.97 
196 asnB_nagD 396 Codirectional- 698401 698796 15.05 
197 yicT'_setC 396 Codirectional+ 3834580 3834975 82.65 
198 ybhK_moaA 396 Divergent 815871 816266 17.58 
199 sspA_rpsI 394 Codirectional- 3375443 3375836 72.75 



















Table 2.9.  CsgD regulon excluding csgBAC. 
 
CsgD overexpression decreased levels of cpsA, cpsB, cpsG, fecR, fhuE, gatA, gatC, GatY, 
GatZ, glnS, infA, metA, ompF, ompT, pyrB, pyrI, pepD, thyA, TnaA, and yagS (14, 15). 
 
CsgD overexpression increased levels of adrA (yaiC), Dps, glyA, GadA, gsk, hmd, iraP, 
OmpW, osmB, PflB, recT, WrbA, yaiB,ydjC (chbG), yhiE, yjbR, yjgW, ymdA, yoaD, and ytfI, 
levels (14, 15, 19, 20, 39).  
 
CsgD also regulates bapA, a large membrane protein required for biofilm formation in 
Salmonella enterica serovar Enteritidis (65). Finally CsgD differentially regulates the 
divergent yihVW and yihU-PyshA operons, which are involved in O-antigen production in 





Table 2.10. Comparison of curli associated genes with swimming and swarming 
motility associated genes (See Figure 2.13 for diagram). 
 
Numbers in parenthesis indicate gene count for respective section of Venn diagram. 
 
Without Table 2 (more defective swarming mutants (46)): 
a (192): aaeR, aceE, aegA, appC, argC, aroA, aroB, aroC, aroD, aroH, aroK, aroP, 
asnC, aspA, aspC, carA, carB, ccmA, clpA, clpP, clpX, cmr, cpxP, cpxR, csgA, csgB, 
csgD, csgE, csgF, csgG, cusB, cyaA, cysC, cysE, cysG, cysI, cytR, dam, ddpD, dksA, 
dnaG, eamA, envZ, essQ, fabF, fadJ, fbp, fhlA, flgM, fliT, fruR, gcvA, glmM, glvG, glxK, 
gnd, greA, hdfR, hfq, hybD, ihfA, ihfB, ilvG, kdpD, lipB, lon, lpp, lsrF, mdoG, mdoH, 
metC, miaA, mlrA, mltA, mtlR, nagA, nanE, nanK, narQ, nhaA, nlpD, nudC, nudH, nudL, 
nuoA, nuoB, nuoC, nuoE, nuoG, nuoJ, nuoK, nuoM, nuoN, nusB, ompC, ompF, pcnB, 
pdxH, pepT, perR, php, poxA, proW, purA, purD, purE, purF, purH, purL, purM, purR, 
putA, puuR, pyrB, pyrC, pyrD, pyrE, qseC, racC, rbfA, rcsB, rcsF, rimK, rimM, rnhA, 
rpoN, rpoS, rpoZ, rpsF, rpsT, rseA, rstA, rstB, rumA, sdhD, sdiA, slp, speB, srlR, srmB, 
sspA, sucC, surA, thyA, tolA, tomB, torI, tpiA, treR, trpA, trpB, trpC, trpD, trpE, ubiG, 
uspE, xapR, ybaM, ybcI, ybeZ, ybgC, ycfM, ycgV, yciC, yciM, ydaF, ydaM, ydcI, ydeJ, 
ydiT, yecH, yedQ, yedV, yeeN, yeiL, yeiR, yfeW, yfgC, yhbJ, yheV, yiaK, yicC, yieP, yiiS, 
yjjW, ykgH, ymgE, ynaK, yncG, ynjD, yoeE, yqaB 
 
b(47): aroE, cpxA, crp, cysB, dnaT, dps, efp, fepB, fepD, fepG, glnA, gmhB, gmr, guaB, 
lipA, lpd, mdoC, nagC, ndk, nuoF, ompR, pal, ptsH, ptsI, purC, purK, pyrF, rfaF, rfaG, 
rfaP, rfe, rffA, rffC, rffT, sdhA, sdhB, sdhC, skp, sucA, sucD, tolC, tolQ, ubiE, ubiF, 
wzxE, ydaT, ygfZ 
 
c(26): atpA, atpB, atpC, atpE, atpF, atpG, atpH, cmk, dnaK, fabH, fliI, galU, lpcA, lptB, 
pgm, priA, rfaC, rfaD, rfaE, rfaH, rodZ, rplA, rsgA, tolB, tolR, ubiH 
 
In order above: 
COGs of b:  E, T, T, k, l, P, j, P, P, P, E, M, T, F, H, C, M, G, F, C, T, M, G, G, F, F, F, 
M, M, M, M, M, M, M, C, C, C, M, C, C, N, N, H, H, M, S, R 






Table 2.10. Comparison of curli associated genes with swimming and swarming 
motility associated genes (See Figure 2.13 for diagram). 
 
Without Table 2 (continued): 
d(52): atpD, cheA, cheB, cheR, cheW, cheY, cheZ, dsbA, fis, flgA, flgB, flgC, flgD, flgE, 
flgF, flgG, flgI, flgJ, flgK, flgL, flgN, flhA, flhB, flhC, fliA, fliC, fliD, fliF, fliG, fliJ, fliK, 
fliM, fliN, fliO, fliP, fliQ, fliS, folB, folP, hflD, motA, motB, mtn, rcsC, rho, rluD, rrmJ, 
sufC, tap, ubiX, ycjW, yhcA  
 
e(169): ackA, acnA, ahpF, aldA, argG, argP, argR, arnF, arpB, asmA, asnB, atoS, bamB, 
barA, chaC, csdA, cusR, cvpA, cvrA, cydD, cyoA, dapF, deaD, dgkA, dsbB, entB, entE, 
entF, envC, envR, etk, eutS, evgS, fadK, fadL, fdrA, fdx, feoA, feoB, fepA, fes, fimA, fimB, 
fimC, fimD, fimF, fimH, fliR, fucU, galE, galM, gapC, gatY, gpmI, grxB, hemE, hflC, 
hipB, hscA, hspQ, htpG, htpX, hyaA, hyaB, idaB, iscS, iscU, lplT, macA, marA, mdtH, 
metL, mglB, mgsA, mpaA, mrcB, murR, narH, ninE, nlpI, ogt, ompA, oppC, osmB, osmC, 
pabC, pdxJ, pdxY, pgi, pldB, ppdC, ppiB, ppiD, ppk, prmB, prpD, puuC, rep, rfaB, rfaI, 
rfaJ, rfaQ, rfaS, rfaY, rfaZ, rffD, rffE, rffH, rffM, rof, rpiA, rssB, rsxG, sapF, sucB, sulA, 
tpx, treA, trkA, trmE, trpL, truA, trxB, tsx, ubiC, uxuR, wcaE, wcaH, xerC, xerD, yaiW, 
ybaK, ybdH, ybdO, ybeD, ybiA, yccK, ycdY, yciG, ycjZ, ydbA, ydcX, ydcZ, ydeE, ydfT, 
ydgA, yeeF, yehP, yeiA, yfeH, yfeR, yfgJ, yfjN, yfjP, ygfH, yhcH, yheL, yheM, yheN, yigG, 
ymfA, yncH, yncN, yneE, ynfG, yqaA, yqaD, yrbE, zwf 
 
With Table  2 (includes less defective swarming mutants (46)):  
a(241): aaeR, aceE, aegA, appC, argC, aroA, aroB, aroC, aroD, aroH, aroK, aroP, 
asnC, aspA, aspC, bhsA, btuC, carA, carB, ccmA, clpA, clpP, clpX, cmr, cpxP, cpxR, 
csgA, csgB, csgD, csgE, csgF, csgG, cusB, cyaA, cysC, cysE, cysG, cysH, cysI, cytR, 
dam, dcuC, ddpD, dksA, dnaG, dnaQ, eamA, envZ, essQ, fabF, fadJ, fbp, fepE, fhlA, 
flgM, fliT, fruR, gcvA, glcD, glmM, glvG, glxK, gnd, greA, gshB, gsiA, hdfR, hepA, hfq, 
hybD, hycI, hypE, ihfA, ihfB, ilvG, kbl, kdpD, lipB, lon, lpp, lsrF, manY, mdoG, mdoH, 
metC, mfd, miaA, mlrA, mltA, mppA, mtlR, mutL, nagA, nanE, nanK, narQ, nhaA, nlpD, 
nudC, nudH, nudL, nuoA, nuoB, nuoC, nuoE, nuoG, nuoH, nuoI, nuoJ, nuoK, nuoL, 
nuoM, nuoN, nusB, ompC, ompF, pcnB, pdxB, pdxH, pepT, perR, php, poxA, proW, purA, 
purD, purE, purF, purH, purL, purM, purN, purR, putA, puuR, pyrB, pyrC, pyrD, pyrE, 
qseB, qseC, racC, rbfA, rbsK, rbsR, rcsB, rcsF, rdgC, rimK, rimM, rlmF, rnhA, rnk, 
rpoN, rpoS, rpoZ, rpsF, rpsT, rseA, rstA, rstB, rsxC, rumA, sbcD, sdhD, sdiA, sfcA, slp, 
speB, srlR, srmB, ssnA, sspA, sucC, surA, thyA, tolA, tomB, tonB, torI, tpiA, treR, trpA, 
trpB, trpC, trpD, trpE, ubiG, uspE, uup, wcaD, xapR, ybaB, ybaM, ybcI, ybeZ, ybgC, 
ybjN, ycbL, ycbQ, ycfM, ycgV, yciC, yciM, yciU, ydaF, ydaM, ydcI, ydeJ, ydeP, ydfD, 
ydiT, ydiY, ydjI, yebY, yecH, yedQ, yedV, yeeN, yehE, yeiL, yeiR, yfeW, yfgC, yfjW, yhbJ, 
yheV, yiaK, yicC, yieP, yiiS, yjbI, yjjW, ykgH, ymgE, ynaK, yncG, ynfH, ynjD, yoeE, yqaB 
 
b(48):  aroE, cpxA, crp, cysB, dnaT, dps, efp, fepB, fepD, fepG, glnA, gmhB, gmr, guaB, 
lipA, lpd, mdoC, nagC, ndk, nuoF, ompR, pal, ptsH, ptsI, purC, purK, pyrF, rfaF, rfaG, 
rfaP, rfe, rffA, rffC, rffT, sdhA, sdhB, sdhC, skp, sucA, sucB, sucD, tolC, tolQ, ubiE, ubiF, 





Table 2.10. Comparison of curli associated genes with swimming and swarming 
motility associated genes (See Figure 2.13 for diagram). 
 
With Table 2 (continued): 
c(28): atpA, atpB, atpC, atpE, atpF, atpG, atpH, cmk, dnaK, fabH, flhC, fliG, fliI, galU, 
lpcA, lptB, pgm, priA, rfaC, rfaD, rfaE, rfaH, rodZ, rplA, rsgA, tolB, tolR, ubiH 
 
d(50):  atpD, cheA, cheB, cheR, cheW, cheY, cheZ, dsbA, fis, flgA, flgB, flgC, flgD, flgE, 
flgF, flgG, flgI, flgJ, flgK, flgL, flgN, flhA, flhB, fliA, fliC, fliD, fliF, fliJ, fliK, fliM, fliN, 
fliO, fliP, fliQ, fliS, folB, folP, hflD, motA, motB, mtn, rcsC, rho, rluD, rrmJ, sufC, tap, 
ubiX, ycjW, yhcA 
 
e(168): ackA, acnA, ahpF, aldA, argG, argP, argR, arnF, arpB, asmA, asnB, atoS, bamB, 
barA, chaC, csdA, cusR, cvpA, cvrA, cydD, cyoA, dapF, deaD, dgkA, dsbB, entB, entE, 
entF, envC, envR, etk, eutS, evgS, fadK, fadL, fdrA, fdx, feoA, feoB, fepA, fes, fimA, fimB, 
fimC, fimD, fimF, fimH, fliR, fucU, galE, galM, gapC, gatY, gpmI, grxB, hemE, hflC, 
hipB, hscA, hspQ, htpG, htpX, hyaA, hyaB, idaB, iscS, iscU, lplT, macA, marA, mdtH, 
metL, mglB, mgsA, mpaA, mrcB, murR, narH, ninE, nlpI, ogt, ompA, oppC, osmB, osmC, 
pabC, pdxJ, pdxY, pgi, pldB, ppdC, ppiB, ppiD, ppk, prmB, prpD, puuC, rep, rfaB, rfaI, 
rfaJ, rfaQ, rfaS, rfaY, rfaZ, rffD, rffE, rffH, rffM, rof, rpiA, rssB, rsxG, sapF, sulA, tpx, 
treA, trkA, trmE, trpL, truA, trxB, tsx, ubiC, uxuR, wcaE, wcaH, xerC, xerD, yaiW, ybaK, 
ybdH, ybdO, ybeD, ybiA, yccK, ycdY, yciG, ycjZ, ydbA, ydcX, ydcZ, ydeE, ydfT, ydgA, 
yeeF, yehP, yeiA, yfeH, yfeR, yfgJ, yfjN, yfjP, ygfH, yhcH, yheL, yheM, yheN, yigG, ymfA, 
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Economical Evolution:  Microbes Optimize the Synthetic Cost of Extracellular Proteins 
 
Abstract 
Protein evolution is not simply a race towards improved function. Because organisms 
compete for limited resources, fitness is also affected by the relative economy of an 
organism’s proteome. Indeed, many abundant proteins contain relatively high 
percentages of amino acids that are metabolically less taxing for the cell to make, thus 
reducing cellular cost. However, not all abundant proteins are economical and many 
economical proteins are not particularly abundant. Here we examined protein 
composition and found that the relative synthetic cost of amino acids constrains the 
composition of microbial extracellular proteins. In Escherichia coli extracellular proteins 
contain, on average, fewer energetically-expensive amino acids independent of their 
abundance, length, function, or structure. Economic pressures have strategically shaped 
the amino acid composition of multi-component surface appendages, such as flagella, 
curli, Type I pili; and extracellular enzymes including Type III effector proteins and 
secreted serine proteases. Furthermore, in silico analysis of Pseudomonas syringae, 
Mycobacterium tuberculosis, Saccharomyces cerevisiae, and over 25 other microbes 
spanning a wide range of GC-content revealed a broad bias towards more economical 
amino acids in extracellular proteins. The synthesis of any protein, especially those rich 
in expensive aromatic amino acids, represents a significant investment. Because 
extracellular proteins are lost to the environment and not recycled like other cellular 
proteins, they present a greater burden on the cell as their amino acids cannot be re-
utilized during translation. Out analysis indicates that evolution has optimized 





Microbes secrete proteins to perform essential interactions with their 
environment such as motility, pathogenesis, biofilm formation and resource acquisition. 
However, because microbes generally lack protein import systems, secretion is often a 
one way street. Consequently, secreted proteins are less likely to be recycled by the cell 
due to environmental loss. We demonstrate evolution has in turn selected these 
extracellular proteins for increased economy at the level of their amino acid 
composition. Compared to their cellular counterparts, extracellular proteins have fewer 
synthetically expensive amino acids and more inexpensive amino acids. The resulting 
bias lessens the loss of cellular resources due to secretion. Furthermore, this economical 
bias was observed regardless of the abundance, length, structure, or function of 
extracellular proteins. Thus, it appears economy may account for the compositional bias 




By enveloping cellular life, membranes separate proteomes into two distinct 
groups: cellular and extracellular. While free living bacteria secrete extracellular 
proteins through several dedicated pathways, there are no known systems by which 
extracellular proteins are imported (121, 125, 129, 130). Consequently, extracellular 
proteins are less likely to be recycled by the cell or passed down during cell division. 
Many extracellular proteins contribute to pathogenesis and have been noted for their 
unique compositional biases (48, 100, 159), which are significant enough to be 
predictive (27, 39, 51, 52, 90, 100, 120, 132, 136, 168). However, identifying and 
exploiting these biases has received more attention than determining which pressures 
led to them (9, 109). 
Evolution selects for phenotypic changes that increase organismal fitness. At the 
molecular level, amino acid substitutions that enhance, diversify, or maintain beneficial 




affect protein folding or function (75, 148). Nonetheless such neutral substitutions, 
particularly in abundant proteins, can affect the metabolic load on an organism, and 
thus be subject to natural selection (24, 123). Accordingly, microbes that thrive in 
nutrient restrictive environments have proteins with fewer sulfurs, carbons, or nitrogens 
(16, 44, 81, 86, 91). Similarly, transient nutrient starvation results in expression of 
proteins with less of a limiting element (23, 46). Furthermore, many amino acid 
biosynthetic enzymes contain less of the amino acid they produce (7, 113). 
Protein composition is also shaped by the energy required to synthesize 
individual amino acids (3, 63, 81, 119, 135, 149). The total synthetic cost of an amino 
acid includes both the ATPs/GTPs used in biosynthesis and the energy lost to central 
metabolism from the consumption of precursors (3, 35, 63, 160). The synthetic costs of 
amino acids vary over six fold in Escherichia coli: Gly costs 11.7 high energy phosphate 
bonds (~P) or ATPs, whereas, Trp costs 74.3 (Table 3.1, 3.2) (3). Numerous studies have 
found that abundant proteins are often composed of amino acids that require fewer 
ATPs to produce (3, 63, 81, 119, 135). Here, we demonstrate that protein composition 
and economy is more tightly coupled to location. Compared to cytoplasmic, periplasmic, 
or membrane proteins, extracellular proteins contain a significantly higher amount of 
economic amino acids. 
 
Results and Discussion 
Protein location and cost in Escherichia coli 
We calculated the average synthetic cost (ASC) of each protein in E. coli K-12 
(Fig. 3.1A, Table 3.3A) using the amino acid synthetic cost of chemoheterotrophic 
bacteria (3, 63). Strikingly, 11 of the 100 most economical proteins (lowest ASCs) were 
extracellular, even though extracellular proteins comprise only 0.37% of total proteins – 
a 30 fold enrichment (Fig. 3.1B, Table 3.4). Extracellular proteins required 2.9 fewer 
ATPs per residue than an average protein (Table 3.5A: U-test, P=1.96×10-9). Thus for a 




for location in E. coli: not a single extracellular protein had an ASC above the global 
average. 
Periplasmic and outer membrane proteins were enriched three and five fold 
respectively amongst economical proteins; inner membrane proteins were more likely 
to contain expensive residues. Surprisingly, outer membrane proteins were significantly 
more economical than inner membrane proteins due to an increased number of 
expensive amino acids in integral membrane proteins (Tables 3.6, 3.7, Fig. 3.6: 1.8 ATPs 
per aa, U-test, P=4.21×10-31). ASCs of outer membrane β-barrel and membrane 
anchored proteins were similar to cytoplasmic proteins; however, outer membrane 
lipoproteins, many of which have soluble periplasmic domains, had significantly lower 
ASCs than cytoplasmic proteins (Fig. 3.6, Tables 3.6, 3.7).  
Inner membrane lipoproteins also had significantly lower ASCs than cytoplasmic 
proteins (Fig 3.6, Table 3.6). Many inner and outer membrane lipoporteins have 
domains that are localized within the periplasmic space, and expectedly both types of 
lipoproteins have a mean ASC similar to periplasmic proteins (Fig 3.6, Table 3.7). 
However, the inner membrane lipoproteins are slightly cheaper than their outer 
membrane counterparts (Table 3.7). Besides a slightly lower hydrophobic content than 
outer membrane lipoproteins (Table 3.7), one possible reason for the lower cost of 
inner membrane lipoproteins may lie in amino aicd biases proximal to the N-terminal 
cysteine by which lipoproteins are attached to phospholipids (154). Inner membrane 
lipoproteins, have biases in positions proximal to this cysteine which defines their 
retention from Lol system transport to the outer membrane; less expensive amino acids 
are typically preferred in position 3, while several of the more expensive amino acids are 
not (154). Consequently, I compared the ASC along the length of the ten most 
economical inner membrane liporproteins to similar costing outer membrane 
lipoproteins. The average cost of the first 25 and 50 amino acids of inner membrane 
lipoproteins were 4.3 and 4.0% less, respectively than in outer membrane lipoproteins 
with similar ASCs. These biases in inner membrane liporprotines may reflect that 




Protein economics of extracellular appendages 
One of the most abundant extracellular proteins in E. coli is the major subunit of the 
curli fiber CsgA (13) (Fig. 3.8B). Similar to some curli-specific gene products, CsgA is rich 
in Gly and Ser. CsgA is composed of 19.2% Gly (global mean 7.2%) and 28.5% Gly+Ser 
(Fig. 3.1C, 3.7 and Table 3.8: global mean 12.8%), the 6th highest amount of any E. coli 
protein. Intriguingly, the curli regulator CsgD increases expression of a gene for the 
biosynthetic enzyme GlyA which interconverts Gly and Ser (30). CsgD may increase GlyA 
to balance Gly and Ser pools resulting in efficient curli production. More appropriately, 
as ancient (66), relatively simple amino acids, Gly and Ser are two of the least expensive 
to produce (3, 35, 160) (Table 3.1). Consequently, CsgA has the 9th lowest ASC in E. coli, 
utilizing 4.17 fewer ATPs per residue than average (Table 3.9). The major subunits of 
flagella and Type 1 pili have the 6th and 11th lowest ASCs, respectively (See Fig. 3.8; Table 
3.9). 
The relative economy of extracellular proteins is not due to enrichment of the same 
amino acids. Collectively, extracellular proteins in E. coli contain more of the inexpensive 
amino acids Ala, Asn, Gln, Ser, and Thr and fewer of the expensive residues Arg, His, 
Met, Phe, and Trp (Table 3.7). When examining amino acid usage in CsgA, FimA, and 
FliC, we found all three contain fewer aromatic residues. However, each major fiber 
subunit had a unique combination of inexpensive amino acids (Table 3.10). Enrichment 
of Gly and Asn is responsible for 65.8% of CsgA’s energy savings (Table 3.8 and Fig 3.9); 
whereas, 54.9% of FimA’s savings is due to enrichment of Ala and Thr. In contrast, FliC is 
not particularly rich in any one amino acid: 31.7% of its savings is due to enrichment of 
Asn and Thr. Instead, FliC contains reduced amounts of aromatic amino acids relative 
even to CsgA or FimA. Thus extracellular proteins are not simply rich in a specific subset 
of economical amino acids. Rather they contain many combinations of inexpensive 
amino acids and typically lack expensive ring-structured amino acids. 
The bacterial flagellum is one of most complex and well-studied cellular 
structures in bacteria (87). With multiple proteins in every cellular compartment, the 




ASC within a single organelle. Indeed, the cost of flagellar proteins decreases the farther 
they are from the cytoplasm (darker reds in Fig. 3.2). Extracellular flagellar proteins have 
significantly lower ASCs than cytoplasmic flagellar proteins (Table 3.11, Fig. 3.10A: 2.6 
ATPs per aa, T-test, P=2.62×10-6). Furthermore, Curli and Type I pili proteins show 
economic trends similar to flagellar proteins (Table 3.9, Fig. 3.11). Because ASC might be 
influenced by protein length, abundance, or function (3, 135), we tried to correlate the 
ASC of flagellar proteins with these criteria. However, we did not find a significant trend 
when comparing the ASCs of flagellar proteins with their length or abundance (87) 
(Table 3.12, Fig. 3.10: Spearman rs=-0.189,-0.255; P=0.232, 0.209). Additionally, the 
function of extracellular flagellar proteins includes structural, assembly, and regulatory 
roles; thus function does not appear to affect their relative economy. The cytoplasmic 
regulatory proteins of flagella are relatively expensive (Table 3.9). Intriguingly, FlgM 
which is a secreted anti-sigma factor (68) is quite economical. Among regulatory 
proteins in K-12 (Uniprot GO:65007), FlgM is by far the most economical, requiring 3.91 
fewer ATPs per residue than an average regulatory protein. 
In a more encompassing analysis, we reexamined the correlation between ASC 
and length, abundance, or function in the E. coli proteome. Although cytoplasmic and 
periplasmic proteins had significant negative correlations between abundance and cost, 
outer membrane β-barrel and integral membrane proteins did not (Table 3.13). 
Additionally, while protein length and cost were weakly correlated overall (rs=-0.05, 
P=0.0009), there was no significant correlation in outer membrane, periplasmic, or 
extracellular proteins (Table 3.14). Finally, many extracellular proteins are fibrous in E. 
coli; therefore, we examined the ASC of several different fibrous protein polymers. As 
expected, extracellular protein polymers contained fewer expensive amino acids than 
their intracellular counterparts (Table 3.15: 1.7 ATPs per aa, T-test, P=4.3×10-4). 
Collectively, these results suggest location has a more significant role on the amino acid 
composition of proteins than previously appreciated. 
How significant are the energy savings garnered by FliC and FimA? Previous 




subject to negative selection (24, 81). Indeed, one Gly to Trp substitution in FliC would 
increase the total cellular ATP requirement of E. coli by 0.031%. We compared the ASC 
of FliC and FimA to an average cellular protein to calculate how much energy E. coli 
saves by making these proteins with less expensive amino acids (See Table 3.16). The 
biases in FliC save the cell 4.4x107 ATPs per flagellum. If converted to H+ these savings 
correspond to the energy required to run the flagellum at 100Hz for 24 minutes. In a 
typical E. coli cell, FliC or FimA savings (2.2x108 ATPs for 5 flagella or 300 fimbriae) 
represents a 1.10% reduction in overall cellular cost. Accordingly, flagellar mutants 
rapidly overtake WT strains due to lower metabolic loads (106), constitutive flagellar 
mutants (flgM and fliD) grow slower due to excess FliC production (78), and flgG 
mutants but not motAB mutants outcompete WT bacteria on plates (43). 
 
Alternative costs 
The association between amino acid costs and protein abundance has been 
explored using different parameters including amino acid mass and atomic composition 
(16, 23, 24, 35, 63, 81, 135, 160). A composite of atomic content, mass has been 
proposed as a complementary approach to calculate relative costs (135). The synthetic 
cost and mass of amino acids are highly correlated (Fig. 3.3A, Table 3.2: R=0.803, 
P=2.02×10-5). Predictably, we found extracellular proteins have smaller amino acids than 
cytoplasmic proteins (Fig. 3.3B, Table 3.17A: 6.7 Daltons per aa, U-test, P=3.4x10-9). 
Subsequently, we looked at their carbon and nitrogen content. Diversion of carbon 
precursors from central metabolism is the largest component of the synthetic cost of 
amino acids (3, 35, 160). While the carbon content of amino acids significantly 
correlates with their synthetic costs, nitrogen content does not (Table 3.2). However, 
extracellular proteins have significantly lower contents of both carbon and nitrogen 
compared to cytoplasmic proteins (Fig. 3.12, Table 3.17A: 8.5%, 6.4% less per aa, U-test, 
P=3.0×10-9, 5.0×10-8). Amino acids in extracellular proteins also have on average lower 
sulfur content and Gibbs free energy (8) (Fig. 3.12, Table 3.17A: 46.4%, 8.3% less per aa, 




in extracellular proteins are, on average, more economical than those in cellular 
proteins. 
Surpisingly, inner membrane proteins have less nitrogen content and mass than 
cytoplasmic proteins. These results conflict with the higher ASC and carbon content of 
inner membrane proteins and may reflect functional constraints. Inner membrane 
proteins and integral membrane proteins, in particular, have less charged residues 
including Arg, Lys, Asp, and Glu likely due to the hydrophobic nature of phospholipids 
(Table 3.7). Arg and Lys are nitrogen rich amino acids. The reduced content of Arg and 
Lys along with slight reductions in Asn and Gln residues results in a lower mean nitrogen 
content of inner membrane proteins. The mass difference in inner membrane proteins 
is likely due to the increased content of Asn, Asp, Glu, Gln, and Arg and slightly 
increased contents of Ala and Gly in inner membrane proteins. In Fig 3.3A these amino 
acids are further away from the linear fit of amino acid mass to synthetic costs. 
Consequently, these amino acids are respectively more and less massive relative to their 
synthetic cost in comparison to other amino acids. The composition of these residues in 
inner membrane proteins results in their contradictory lower mean amino acid mass. 
 
Protein function and structure 
The extracellular environment represents a unique folding environment which is 
relatively devoid of cellular chaperones and thus may affect amino acid preferences in 
extracellular proteins. To explore this possibility we looked at ASCs in Type III secretion 
effectors which many pathogenic bacteria secrete directly into eukaryotic cells (34). 
Although Type III effectors are extracellular proteins, they function within the host in an 
environment that is similar to the bacterial cytoplasm. Despite their potential functional 
constraints, the Type III effectors of Pseudomonas syringae (called HOPs) had 
significantly lower ASCs than cytoplasmic proteins (Fig. 3.4A, Tables 3.18A, 3.19, 3.20: 
1.48 ATPs per aa, U-test, P=6.22×10-15). Type III effectors of other animal and plant 
pathogens also had significantly lower ASCs (Fig. 3.13, Tables 3.18B, 3.19: 1.27 ATPs per 




To further investigate if localized protein economy is independent of function, 
we inspected bacterial serine proteases. On average, extracellular serine proteases cost 
0.72 ATPs less per residue than cellular serine proteases (Table 3.21: U-test, P=2.7×10-9). 
In Escherichia and Bacillus species, savings were 1.15 and 1.18 ATPs per residue, 
respectively (T-test, P=1.6×10-8, 4.6×10-5). 
Additionally, we examined Type V secretion proteins, or autotransporters, to 
explore the effects of localized protein economy at the domain level. Autotransporters 
are bacterial proteins that contain a β-domain which integrates into the outer 
membrane and assists the translocation of an α-domain to the cell surface where it is 
often cleaved autolytically or by other proteases (65). While β-domains have high 
similarity, α-domains are quite diverse and function as enzymes (protease, esterase, 
lipase) or assist cell aggregation, actin polymerization, or other virulent activities (65). I 
compared the cost of cleaved α-domains to their respective β-domains in 
autotransproters with defined α-domains in Uniprot from Henderson et al 2004 (65). 
While most β-domains had average ASCs, all the α-domains except IgA1 protease had 
lower ASCs (See Ag43 in Fig. 1.7). On average, the α-domains examined had an 8.7% 
lower ASC than their respective β-domain (Table 3.18C).  Autotransporters thus 
demonstrate that extracellular protein economy is also refected on the domain level 
with secreted and cleaved domains having lower cost than retained transport domains. 
Oxidation and proteolysis are more likely in the harsh environment where 
extracellular proteins function. Protein oxidation levels are influenced by both the 
structure and amino acid composition of proteins as well as the particular oxidant to 
which they are exposed (H2O2, HOCl, NO) (25, 62, 142, 166). Commonly oxidized 
residues include Met, Cys, and the aromatic amino acids. With the exception of Tyr, 
there are fewer of these amino acids in extracellular proteins; however, the majority of 
the cost savings in extracellular proteins is not due to these biases (Tables 3.7, 3.10, 
3.20). Further exploration of how protein inactivation may have shaped extracellular 
proteins will require more knowledge of which amino acids are surface exposed or 




extracellular proteins are also exposed to extracellular peptidases. Within the GI tract, 
the extracellular proteins of E. coli encounter trypsin, chymotrypsin, and elastase which 
cleave after basic, aromatic, and simple amino acids (31). However, the effects these 
peptidases would have on ASC are contradictory; avoidance of cleavage would 
theoretically select for more or less expensive amino aicds depending on the protease.  
Therefore, selection to prevent proteolysis is unlikely to be the primary cause of 
compositional economy in extracellular proteins. 
The unique folding environment of the extracellular space may also constrain 
protein structure. Consequently, we examined the predicted secondary structure and 
intrinsic disorder of non-membrane proteins in E. coli and P. syringae. Extracellular 
proteins in E. coli had significantly less helical structure and significantly more strand 
content than cytoplasmic proteins (See Table 3.22A). However, there was no correlation 
between the ASC of E. coli proteins and their helix, strand, or coil content (Table 3.22). 
Furthermore, strands are by far the most expensive secondary structure (Table 3.22). 
Such analysis led us to examine which structures had the most savings relative to 
cytoplasmic proteins. While all three secondary structures were less expensive in 
extracellular proteins, coiled regions had the most economical substitutions (Table 
3.22). Finally, extracellular proteins had greater amounts of disordered regions 
compared to cytoplasmic proteins; however these differences are not significant in E. 
coli (Table 3.23: T-test, P=0.324). Disordered regions also are a small percentage of the 
overall structure of extracellular proteins and thus do not significantly alter the relative 
economy of these proteins (Table 3.23). We found similar results in P. syringae, except 
for Type III effectors which had higher contents of disordered regions and lower strand 
contents than other extracellular proteins (Tables 3.22B, 3.23). Disordered regions in 
Type III effectors may assist their function within eukaryotes where such structural 
disorder is more common and is often associated with protein-protein interactions (41, 
138). Collectively, these results suggest structural differences are not responsible for the 
economy of many extracellular proteins and that more economical substitutions occur 




Ubiquity of extracellular protein economy 
A wide variety of other extracellular proteins also contain, on average, fewer 
expensive amino acids. For example the elastases and exotoxins of Pseudomonas 
aeruginosa, the S-layer and holdfast proteins of Caulobacter cresentus, and the major 
capsule protein Caf1p of Yersinia pestis are among the most economical proteins in 
those organisms (Table 3.18D). More distantly related organisms, such as the Gram-
positive pathogen Mycobacterium tuberculosis and the budding yeast Saccharomyces 
cerevisiae, showed similar patterns. Both cell wall and extracellular proteins of M. 
tuberculosis have significantly lower ASCs, partially due to the many cell surface 
antigens in the PE_GRS protein family (Fig. 3.4B, Tables 3.3C, 3.17C). Likewise, the cell 
wall and extracellular proteins of yeast have significantly lower ASCs under both 
respiratory (Fig. 3.4C, 3.14 and Table 3.3B) and fermentative growth conditions (Fig. 
3.4D, Table 3.17B). 
 To see just how broadly protein location affected ASC, we initially examined the 
ASCs of the extracellular proteins in all 717 Gram-negative organisms in PSORTDB. To 
our knowledge, this is the most extensive examination of protein synthetic cost in 
bacteria. Overall, the amino acids in extracellular proteins cost 1.3 ATPs less per residue 
than cytoplasmic proteins (U-test, Z=64.1, P<<1×10-325). However, typical savings may be 
much greater. Combining these proteomes over represents certain species such as E. 
coli, includes obligate anaerobes and amino acid auxotrophs, excludes known 
extracellular proteins (See Methods), and overlooks the effects of GC-content on carbon 
content and amino acid composition (15, 32, 139). 
Currently, the relative cost of proteins in organisms lacking one or more amino 
acid synthesis pathways is difficult to assess. Abundant proteins in two different 
Chlamydia species have been shown to contain either more or less of the amino acids 
for which they are auxotrophic, perhaps due to metabolic or nutritional differences (63). 
When comparing the cost of extracellular proteins in Gammaproteobacteria, we found 
several insect endosymbionts had relatively expensive extracellular flagellar proteins 




their metabolism or nutrition (127, 165, 169). For example, Buchnera aphidicola has 
more His, Ile, and Lys and less Gly, Thr, and Val in its extracellular flagellar proteins 
despite its capacity to synthesize these amino acids. Other factors including transport 
efficiency, host metabolic interdependency, or GC-skew may be more relevant (1, 32). 
More knowledge of how these factors affect amino acid composition is needed to 
properly study protein economy in auxotrophic organisms. 
Protein composition is also affected by an organism’s GC-content (139). GC-rich 
codons tend to code for less expensive amino acids (135) (Table 3.2). Accordingly, 
proteins produced by GC-rich organisms are, on average, less expensive to synthesize 
than proteins produced by organisms with lower GC-contents (Fig. 3.5A). For example, 
the mean cost of M. tuberculosis proteins is less than in E. coli due to high GC-content 
affecting amino acid preferences (Compare Mtu and Eco in Fig. 3.5A) (33). To overcome 
these limitations we looked, individually, at a diverse collection of 25 Gram-negative 
aerobes representing a wide range of genomic GC-content. Each has retained the ability 
to synthesize the standard 20 amino acids (See Table 3.25). In all of these organisms, 
extracellular proteins had significantly lower ASCs and mean amino acid mass when 
compared to other cellular proteins (Fig. 3.5B, 3.15 and Table 3.26). Given the trends in 
Fig. 3.5B, a typical Gram-negative organism with 50% GC-content would save 2.05 ATPs 
per amino acid in its extracellular proteins, an 8.7% reduction in synthetic cost (Table 
3.16). Assuming 5x105 copies per cell, amino acid biases in extracellular proteins would 
reduce total cellular cost by 1.54%. Theoretically, in a direct competition, strains without 
these savings would be outnumbered nearly 15 fold within 250 generations. 
 
Conclusion 
Previous studies have explored the connection between amino acid cost and a 
variety of attributes (3, 23, 35, 36, 63, 81, 119, 135, 149, 160, 161). However, as 
evidenced in the flagella system of E. coli, cellular location can have a stronger influence 
on average cost of amino acids. We found the synthetic costs of extracellular proteins 




other organisms. Furthermore, this economic bias is observed despite the abundance, 
length, function, or structure of extracellular proteins. Understanding these 
compositional biases in extracellular proteins may improve current prediction methods. 
In Fig 3.5B, 92.3% of extracellular proteins have an ASC below the organism’s mean ASC. 
Additionally, comprehending the economic selection of amino acids in extracellular 
proteins may elucidate new pressures upon and constraints of their evolution, 
particularly in horizontally-acquired genomic islands where disparate codon usage and 
GC-content gradually adapt to the host (57, 79, 80) 
Microbes interact with their environment directly through external structures, 
leading to possible loss of surface proteins. Besides secretion, extracellular proteins are 
lost during fiber-shedding, outer membrane blebbing, and cell wall damage. This egress 
of extracellular protein is likely irreparable (121, 125, 129, 130); consequently, they are 
less likely to be recycled by the cell’s chaperone and protease systems. Such loss 
increases the relative cost of extracellular proteins to the cell. Accordingly, excessive 
production of extracellular proteins results in decreased growth rate and competitive 
fitness (43, 78, 106, 114). Therefore, we propose that there is a strong selection for less 







Calculating Average Synthetic Cost (ASC) and other cost values. 
To calculate protein cost including ASC (ATPs/aa), mean amino acid mass, mean 
Gibbs free energy (∆G r), and average atoms (Carbon, Nitrogen, Sulfur) per amino acid 
we used the following equation 
Protein Cost = (∑Ci × Fi) / L 
where Ci is the appropriate cost of the amino acid i, Fi is the frequency of ith amino acid, 
and L is total protein length.  
The different cost values for amino acids used include the amino acid synthetic 
cost in ATPs, the amino acid mass in Daltons, the ∆G r for an amino acid, or the number 
of carbons, nitrogens, or sulfurs in a given amino acid. For ASC, different synthetic costs 
were used depending on the organisms. For E. coli K-12, P. syringae pv. tomato str 
DC3000, M. tuberculosis H37Rv, and other bacteria the synthetic cost values for amino 
acids in chemoheterotrophic bacteria were used (3); for S. cerevisiae the respiratory and 
fermentative synthetic costs of amino acids in yeast were used (160).  
For more information about cost values see Table 3.1, 3.2, and associated notes. 
Similar economic trends were seen using costs values other than synthetic cost including 
atomic composition, Gibbs free energy (8), and mean mass of amino acids (135) (See Fig. 
3.3, 3.4, 3.12, Table 3.17). Statistical comparisons of cost values between locations were 
primarily Mann Whitney U-test; data for many groups failed normality test (detailed 




Protein sequence and locations for E. coli K-12 are from Echobase Echolocation 
(http://www.york.ac.uk/res/thomas/index.cfm); YdbA (EB1284) lacked sequence data. 
The location of FlgM (68) and FliK (95) were reassigned to extracellular and FlgJ to 
periplasmic (87). S. cerevisiae protein location and sequence were downloaded from the 




muenchen.de/genre/proj/yeast/). Protein sequence and locations for M. tuberculosis, P. 
syringae, and other bacteria were from PSORTDB (http://db.psort.org/). For M. 
tuberculosis Fmt, TrmD, Hns, HupB, and ribosomal proteins (33) were changed to 
cytoplasmic. All bacterial proteins with the GO term “secreted” (keyword 0964 in 
UniProt) were reassigned to extracellular, except the cell wall proteins of M. 
tuberculosis. Other changes are listed in below; modified locations in E. coli and M. 
tuberculosis are bold in Tables 3.3A,C. 
 
Changes to Protein Location Annotations 
Bacteria sequences and locations (exceptions E. coli – Echobase; S. glossinidius, 
B. aphidicola Sg, and H. cicadicola Dsem - NCBI) were from PSORTdb. The location of 
several proteins in PSORTdb were either annotated as ‘Unknown’ or given the wrong 
location altogether. To improve the location data, all ribosomal proteins were changed 
to cytoplasmic. We also searched the literature for known extracellular proteins and 
reannotated their locations. Those changes are as follows:  CsgA,B and FimH for S. 
typhimurium LT2; MshA,B,O for C. psychrerythraea 34H (155); MshA,B,O and CsgA,B for 
S. oneidensis MR-1; CiaB for W. succinogenes DSM 1740 (12); AcuG, ComC, and ComP 
for Acinetobacter sp. ADP1 (BD413) (54, 82, 116); AprX and PopB for P. aeruginosa PAO1 
(42, 61); TcpA, HylA (6), MshA,B (155), Hcp, and VgrG (22) for V. cholera El Tor; and HfaA 
for C. cresentus CB15 (152) were all changed to extracellular. In Gram-negative bacteria, 
PilA, FlgD,E,K,L (87), FlgM (68), FliK (95), and flagellins were changed to extracellular. For 
F. johnsoniae UW101, SprB (72) and homologs of the curli subunits CsgA,B were 
changed to extracellular. For C. hutchinsonii ATCC 33406, SprB was identified by blasting 
with FjoH_0979 of F. johnsoniae UW101. CHU_2225 (Uniprot Q11SX6_CYTH3) was 








Graphing of Protein Average Synthetic Cost (ASC) 
To vertically spread the cost data within a location, protein length was used. The 
value 0.2×LOG10 (Length) was added to a specific integer of each location. For example 
cytoplasmic proteins were 1+0.2×LOG10 (Length), and inner membranes were 
2+0.2×LOG10 (Length). These numbers were graphed vs. proteins costs to generate the 
graphs in Fig. 3.1A, 3.3B, 3.4, 3.6, 3.8, 3.12, 3.13.  
 
Electron Microscopy 
For flagella, Type 1 pili, and curli TEMs, BW25113 was grown to late log in 
Lysogeny broth (LB: 10g Tryptone, 5g Yeast extract, 10g NaCl per liter) shaking at 250 
rpm, stationary in LB at 37°C for 16 h, or on YESCA plates (10g Casamino acids, 1g Yeast 
extract, 20g Agar per liter) for 48h at 26°C respectively. All samples were resuspended in 
PBS, incubated with formvar-coated copper grids (Ernest F Fullam, Inc), briefly washed 
with H20, and stained 2 minutes in 2% uranyl acetate. Grids were viewed using a Phillips 
CM10 microscope. 
 
Calculating Percent Savings for a Specific Amino Acid Bias in a Given Protein 
Total ATPs saved in a protein: 
Protein chain length × (Organism’s mean ASC – Protein ASC)  
ATPs saved per amino acid: 
(Number of a specific amino acid in a protein – (Organism’s mean % of 
specific amino acid × Protein chain length)) × (Average cost of all amino 
acids – Cost of a specific amino acid) 
Percent Savings of a specific amino acid: 
(ATPs saved per amino acid / Total ATPs saved) × 100 
 
Type III Effectors 
Type III effectors were culled from a recent survey of plant and animal 




Type III effectors (also called Hops – Hrp outer protein) we used the Hop database, the 
T3SS helper database, and the Discontinued Hops database at the “P. syringae Hop 
Identification and Nomenclature Home Page” (http://pseudomonas-
syringae.org/pst_func_gen2.htm). We included the following proteins:  PSPTO_4101 
(hopAK1), PSPTO_1022 (hopAM1-1), and PSPTO_5061 (hopAN1) which have plant 
phenotypes (56, 71, 131); PSPTO_1378 (hrpH) which was shown to be a T3SS substrate 
(111), and PSPTO_3292,3293,0907 which are translocated into plant cells (131). 
Confirmed Hop proteins were considered to be extracellular in later analysis. Only one 
copy of Hcp (P. aeruginosa PAO1) and HopAM1 (P. syringae tomato) were used in data 
analysis. See Table 3.18A for a complete table of P. syringae Hops and Hop helpers. Fig. 




Extracellular serine proteases were those annotated as “secreted” in Uniprot 
(http://www.uniprot.org). Cellular serine proteases were serine proteases not 
annotated as “secreted.” 5,784 bacterial serine proteases were downloaded from 
Uniprot using the keywords ”taxonomy:2 keyword:720” on August 18, 2009. Bacterial 
extracellular serine proteases (191 total) were downloaded using “taxonomy:2 
keyword:720 keyword:964”. Taxonomy 2 = “Bacteria”; keyword 720 = “Serine 
protease”; and keyword 964 = “Secreted”. 
 
Autotransporters 
The autotransporters used were those described in Table 1 of Henderson et al 
2004 (65). Uniprot (http://www.uniprot.org) was used to select autotransporters which 
had defined secreted α-domains. The ASC of both the α-domain and their respective β-






Protein Abundance Values 
Abundance values from Masuda et al (89) and Ishihama et al (70). Protein 
sequences and location were from Echobase; abundance values were merged with 
Echobase data using ECK and Uniprot numbers respectively. 
 
Prediction of Secondary Structure and Intrinsic Disorder 
 The secondary structure of cytoplasmic, periplasmic, and extracellular proteins 
from E. coli K-12 and P. syringae were predicted using PSIPRED version 2.61 (92). 
Intrinsically disordered regions were predicted with DISOPRED2 version 2.4 (163) using a 
2% false positive rate. Both programs were downloaded from 
(http://bioinfadmin.cs.ucl.ac.uk/downloads/). 
 
Comparison of Amino Acid Composition of Flagellar Subunits 
Extracellular assembly or structural components of E. coli flagella were 
individually blasted against 216 Gammaproteobacteria. Many flagella genes have similar 
regions, so sequences with E values below 10-10 were removed except for FlgG (<10-20) 
and FliK (<10-5) which have high identity to FlgG (83) and low ortholog identity 
respectively (164). Sequences whose lengths were 50% (+/-) their respective E. coli 






Fig. 3.1. Protein location in E. coli is indicative of synthetic cost. (A) Each protein in E. 
coli is plotted based upon its average synthetic cost (ASC) and cellular location. Dotted 
line = mean ASC of all proteins in E. coli. Black bars = mean ASC of proteins in that 
location. U-tests were used to compare the protein ASCs of each location against 
cytoplasmic proteins. (B) Location of all proteins, the 100 most economical, and the 100 
least economical proteins in E. coli as ranked by ASC. (C) Histogram of the %Gly+Ser for 
all proteins in E. coli. CsgA, the major component of of extracellular curli fibers, is 
indicated (green arrow); 28.5% of the amino acids in CsgA or either glycine or serine. 
 
Fig. 3.2. Protein abundance and cost of flagellar proteins. Flagellum diagram showing 
colored economic percentiles of each protein. Proteins with lower ASCs (more 
economical) have higher percentiles and are dark red. ASC increases in order: dark red 
to pink, light to dark blue, gray. * Contain Sec secretion sequences. Number of proteins 
per flagella is given if known (87). 
 
Fig. 3.3. Molecular mass of amino acids correlates with their synthetic cost; 
extracellular proteins have simpler amino acids. (A) The synthetic cost of amino acids 
positively correlates with their mass. Letter codes are used to indicate individual amino 
acids. (B) Mass has been used as an alternative cost for amino acids (135). Using mass, 
extracellular proteins of E. coli are significantly more economical; their amino acids are 
simpler and have less mass than average. Dotted line = mean average mass of amino 
acids of all proteins in E. coli. Black bars = mean average mass of amino acids of proteins 
in that location. U-tests were used to compare mass based costs. 
 
Fig. 3.4. Relationship between protein location and cost extends to diverse organisms. 
(A) Cost and location of extracellular proteins and Type III Effectors – called HOPs for 
Hrp outer proteins (green) and HOP helpers (blue) from P. syringae. Smaller blue and 




M. tuberculosis proteins. PE_GRS (red), PPE (orange), and PE (green) family proteins are 
indicated. (C,D) Cost and location of S. cerevisiae proteins under respiratory and 
fermentative growth. Dotted lines = each organism’s mean ASC. Black bars = the mean 
ASC of proteins in that location. U-tests were used to compare the protein ASCs of each 
location against an organism’s cytoplasmic proteins. 
 
Fig. 3.5. Per residue, proteins in GC-rich organism cost less to synthesize; however, 
extracellular proteins are still economical. (A) Chromosomal GC-content and mean ASC 
of chromosomally encoded proteins in 70 Gram-negative (red) and 30 Gram-positive 
(blue) bacteria. White + = thermophile, white center = psychophile, black center = host-
associated organisms, black outline = chromosomal DNA < 1.3 MB of P. ubique the 
smallest genome of free living organisms (53). Slope=15.1, R=0.930. (B) Comparison of 
the mean ASC of extracellular proteins to total proteins in 25 Gram-negative bacteria. 
Each is capable of aerobic growth and synthesis of all 20 amino acids (See Table 3.25). 
Slope=-11.0,-17.0; R=0.696, 0.960 respectively. Eco-Escherichia coli, Cru-Carsonella 
ruddii, Smu-Sulcia muelleri, Wgl-Wigglesworthia glossinidia, Bap-Buchnera aphidicola, 
Abu-Arcobacter butzleri, Plu-Photorhabdus luminescens, Aae-Aquifex aeolicus, Th-
Thermotoga maritime/petrophila, Hci-Hodgkinia cicadicola, Mtu-M. tuberculosis, Dra-
Deinococcus radiodurans, Sco-Streptomyces coelicolor, Rsp-Rhodobacter sphaeroides, 
Pae-Pseudomonas aeruginosa, Psy-Pseudomonas syringae pv. tomato, Fjo-
Flavobacterium johnsoniae. 
 
Fig. 3.6. Cost and sublocations of E. coli proteins in inner and outer membranes. Each 
protein in E. coli is plotted based upon its average synthetic cost (ASC) and cellular 
location. Dotted line = overall mean average synthetic cost. Black bars = mean ASC of 
location. Mann Whitney U-tests were used to compare ASCs of proteins with integral 






Fig. 3.7. Glycine and Serine composition of E. coli proteins with an emphasis on curli 
specific gene proteins. Histograms of percent of amino acids including (A) Glycine (B) 
Serine (C) Glycine plus Serine. Green arrows indicate curli proteins above the 95th 
percentile of respective percent amino acid composition. (D) Schematic of Glycine 
metabolism including GlyA and the glycine cleavage system. 
 
Fig. 3.8. Protein abundance and cost of extracellular fibers. (A-C) Negative stained TEM 
micrographs of BW25113 cells showing flagella, curli, and Type 1 fimbriae, respectively. 
Bars equal to 500 nm. (D) Each protein in E. coli is plotted based upon its average 
synthetic cost (ASC) and cellular location. Dotted line = mean ASC of all proteins in E. 
coli. Black bars = mean ASC of proteins in that location. 
 
Fig. 3.9. Amino acid compositions of E. coli K-12 proteins with an emphasis on curli 
specific gene proteins. Histograms of percent of amino acids including (A) Asparagine 
(B) Glutamine (C) Asparagine and Glutamine (D) A combination of Gly, Ser, Asn, and Gln. 
Green arrows indicate curli proteins above the 95th percentile of respective percent 
amino acid composition. 
 
Fig. 3.10. The average synthetic cost (ASC) of flagellar proteins correlates with location 
but not abundance. (A) Comparison of flagellar protein ASC and location. Dotted line = 
overall mean ASC of flagellar proteins. Black bars = mean ASC of flagellar proteins in that 
location. P values from Student T-test (See Table 3.11). (B,C) Comparisons of ASC and 
abundance using known stoichiometry (87) (B) Log scale of abundance used to show FliC 
(20,000 per flagellum). (C) Linear scale of abundance; does not include FliC. Slope of 







Fig. 3.11. Protein economy of curli and Type 1 pili proteins. Colored diagram of the 
economic percentiles of each protein. Proteins with lower ASCs (more economical) 
have higher percentiles and are dark red. ASC increases in order: dark red to pink, light 
to dark blue, white. Proteins without a known function are marked with a “?”.  
 
Fig. 3.12. Extracellular proteins contain less carbon, nitrogen, or ∆G r per amino acid 
than other locations. (A) Correlation of synthetic cost and number of carbons per amino 
acid. (B) Extracellular proteins in E. coli have less carbons per amino acid relative to 
other locations. (C) The synthetic cost and number of nitrogens do not correlate. (D) 
Extracellular proteins in E. coli have less nitrogens per amino acid relative to other 
locations. (E) Correlation of synthetic cost and Gibbs free energy (∆Gr) of amino acids in 
seawater at 18°C. (F) Extracellular proteins in E. coli have amino acids with lower ∆G r 
relative to other locations. Dotted lines = overall mean number of carbons, nitrogens, or 
∆Gr per amino acid in E. coli proteins. Black bars = mean value of that location. Mann 
Whitney U-tests were used to compare values between locations. 
 
Fig. 3.13. Type III effectors from multiple pathogens are economical. Average synthetic 
cost (ASC) of Type III effectors from animal (blue) and plant (green) pathogens from (10) 
versus cost and location of E. coli proteins. Species are listed in Table 3.18B. Dotted line 
= overall mean ASC of E. coli. Black bars = mean ASC of protein in that location. Smaller 
blue and green bars = mean ASC of animal and plant Type III effectors respectively. 
Mann Whitney U-tests were used to compare the Type III effector ASC values with those 
of cytoplasmic proteins of E. coli. 
 
Fig. 3.14. Cost and location of S. cerevisiae proteins. Location and sequences from 
CYGD (55). Dotted line represent overall mean average synthetic cost (ASC). Black bars 






Fig. 3.15. Although proteins in GC-rich organisms have reduced mass per residue, 
extracellular proteins have simpler amino acids. More massive amino acids are 
generally more expensive to produce (See Tables 3.1, 3.2), and thus mass has been 
proposed as an complementary approach to calculating their cost (135) . (A) Organism 
GC-content and the average of mean amino acid mass of chromosomally encoded 
proteins in 70 Gram-negative (red) and 30 Gram-positive organisms (blue). White + = 
thermophile, white center = psychophile, black center = host-associated organisms, 
black outline = chromosomal DNA < 1.3 MB of P. ubique the smallest genome of free 
living organisms (53). Slope = -6.54, R = 0.938 (B) Mean average synthetic cost (ASC) vs 
average of mean amino acid mass of chromosomally encoded proteins in 100 bacteria . 
Slope = -2.23,R = 0.978. (C) Comparison of the average mean amino acid mass of 
extracellular proteins and total proteins of 25 Gram-negative bacteria. Each is capable of 
aerobic growth and synthesis of all 20 amino acids (See Table 3.25). Slope = -5.49, -6.56; 
R = 0.813, 0.956 respectively. Abu-Arcobacter butzleri, Fjo-Flavobacterium johnsoniae, 
Plu-Photorhabdus luminescens, Eco-Escherichia coli, Psy-Pseudomonas syringae pv. 
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Figure 3.1.  Protein location in E. coli is indicative of synthetic cost.
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Figure 3.3.  Molecular mass of amino acids correlates with their 
synthetic cost; extracellular proteins have simpler  amino acids.
150
Figure 3.4.  Relationship between protein location and cost 
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Figure 3.4 (continued).  Relationship between protein location and
cost extends to diverse organisms.
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Figure 3.5.  Per residue, proteins in GC-rich organism cost less to














B.   Integral Membrane
C.   Membrane Anchored
D.   Periplasmic with N-terminal Anchor
E.    Inner Membrane Lipoprotein*
F.    Membrane Associated
G.   Periplasmic
H.   Outer Membrane β-barrel
I.     Outer Membrane Lipoprotein*
J.    Extracellular**
*   Difficulty determining which membrane for seven
     “Membrane Lipoproteins” (VisC,YfbK,YiaF,YifL,
     YihN,YjbH, and YraM).  These proteins included 
     in “Inner Membrane” for Figures 3.1A, 3.3B, 3.6, 3.8, 
     3.12, 3.13 and Table 3.3-6.
**  Subdivided into “Secreted and released”
      and “Cell surface appendage”
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Figure 3.6.  Cost and sublocations of E. coli  proteins in inner and outer membranes.
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Figure 3.7.  Glycine and Serine composition of E. coli proteins
with an emphasis on curli specific gene proteins.
% Gly Rank Gly % Ser Rank Ser %SG Rank SG
CsgA 19.2 4 9.3 228 28.5 6
CsgB 9.9 483 8.6 361 18.5 169
CsgC 3.6 4003 14.6 12 18.2 206
CsgD 4.2 3854 8.3 414 12.5 2402
CsgE 4.7 3665 5.4 2350 10.1 3663
CsgF 8.7 1068 8.0 537 16.7 426
CsgG 6.9 2304 7.2 855 14.0 1411
Mean 7.13 5.84 12.98
Median 7.07 5.62 12.85
STDEVP 2.45 2.06 3.06
Bold 95th Percentile
CsgA CsgC
Average of Ser 5.84%
Median of Ser 5.62%
STDEVP of Ser 2.06%



















Average of Gly 7.13%
Median of Gly 7.07%




Average of S + G 12.98%
Median of S + G 12.85%
STDEVP of S + G 3.06%











Rank % Gly # Gly # AA Name
1 27.66 26 94 YmgG
2 19.51 16 82 YeaQ
3 19.23 15 78 YciG
4 19.21 29 151 CsgA
5 19.05 16 84 YmgE
6 18.84 13 69 YedS_2
7 18.06 13 72 OsmB
8 18.06 26 144 RplO
9 17.65 33 187 YfaZ
10 16.77 26 155 SlyB
11 16.29 29 178 Ssb
12 15.76 26 165 YahC
13 15.55 206 1325 YdeK
14 15.29 13 85 RpmA
15 15.20 26 171 YedS_1
16 15.15 35 231 AqpZ
17 15.12 13 86 YoeE
18 15.07 63 418 YdhQ
19 14.80 29 196 SlyD













Figure 3.8.  Protein abundance and cost of extracellular fibers.
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Figure 3.9.  Amino acid compositions of E. coli K-12 proteins 












Average of Asn 3.89%
Median of Asn 3.73%
STDEVP of Asn 1.77%
Average of Gln 4.40%
Median of Gln 4.20%






Average of N + Q 8.29%
Median of N + Q 8.15%
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Figure 3.10.  The average synthetic cost (ASC) of flagellar 





























99.7 99 98 909597 85 80 <80
More Economical Less Economical
158


















































Average Carbons per Amino Acid in E. coli proteins



























































































Figure 3.12.  Extracellular proteins contain less carbon, 
nitrogen, or ∆Gr per amino acid than other locations.
Mean ATPs per Amino Acid (ASC) Comparing E. coli 
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*  Duplicates removed
** Duplicates and Cytoplasmic/Nuclear Removed
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Figure 3.15.  Per residue, proteins in GC-rich organisms have reduced 


















Table 3.1:  Synthetic cost of amino acids.  
       Gibbs Free Energy (∆Gr) 
   Enzymes 
in E. coli 
Codons Molecular Hydrothermal Seawater 
   # %GC Mass Carbons Nitrogens (kJ mol
-1) 100⁰C (kJ mol-1) 18⁰C 
Alanine Ala A 1 4 83.33 71.079 3 1 -12.12 113.66 
Arginine Arg R 10 6 72.22 156.188 6 4 197.52 409.46 
Asparagine Asn N 1 2 16.67 114.104 4 2 83.53 201.56 
Aspartic Acid Asp D 1 2 50 115.089 4 1 32.78 146.74 
Cysteine Cys C 9 2 50 103.145 3 1 60.24 224.67 
Glutamic Acid Glu E 1 2 50 129.116 5 1 -1.43 172.13 
Glutamine Gln Q 2 2 50 128.131 5 2 44.03 223.36 
Glycine Gly G 4 4 83.33 57.052 2 1 14.89 80.49 
Histidine His H 1 2 50 137.141 5 3 154.48 350.52 
Isoleucine Ile I 11 3 11.11 113.16 6 1 -96.4 213.93 
Leucine Leu L 7 6 38.89 113.16 6 1 -105.53 205.03 
Lysine Lys K 10 2 16.67 128.17 6 2 -28.33 258.56 
Methionine Met M 9 1 33.33 131.199 5 1 -174.71 113.22 
Phenylalanine Phe F 9 2 16.67 147.177 9 1 -114.54 303.64 
Proline Pro P 4 4 83.33 97.117 5 1 -38.75 192.83 
Serine Ser S 3 6 50 87.078 3 1 69.47 173.73 
Threonine Thr T 6 4 50 101.105 4 1 53.51 216.5 
Tryptophan Trp W 12 1 66.67 186.213 11 2 -38.99 431.17 
Tyrosine Tyr Y 9 2 16.67 163.176 9 1 -59.53 334.2 
Valine Val V 4 4 50 99.133 5 1 -70.12 178 
           
Average aa   5.7 3.05  118.887 5.3 1.45 -1.5 227.17 














Table 3.1:  Synthetic cost of amino acids (continued). 
 Bacteria Yeast 
 Chemoheterophs Photoautotrophs* Li et al* Craig&Weber* Respiratory Fermentative 
 Cost (~P) Savings (~P) Cost (~P) Cost (~P) Cost (ATPs) Cost (~P) Cost (~P) 
Alanine 11.7 15.66 11.7 11.7 12.5 14.5 2 
Arginine 27.3 0.06 27.3 38.3 18.5 20.5 13 
Asparagine 14.7 12.66 14.7 12.7 4 18.5 6 
Aspartic Acid 12.7 14.66 12.7 14.7 1 15.5 3 
Cysteine 24.7 2.66 24.7 24.7 24.5 26.5 13 
Glutamic Acid 15.3 12.06 15.3 34.3 8.5 9.5 2 
Glutamine 16.3 11.06 16.3 15.3 9.5 10.5 3 
Glycine 11.7 15.66 11.7 11.7 14.5 14.5 1 
Histidine 38.3 -10.94 40.3 32.3 33 29 5 
Isoleucine 32.3 -4.94 32.3 30.3 20 38 14 
Leucine 27.3 0.06 27.3 27.3 33 37 4 
Lysine 30.3 -2.94 30.3 27.3 18.5 36 12 
Methionine 34.3 -6.94 34.3 20.3 18.5 36.5 24 
Phenylalanine 52 -24.64 54 52 63 61 10 
Proline 20.3 7.06 20.3 16.3 12.5 14.5 7 
Serine 11.7 15.66 11.7 11.7 15 14.5 1 
Threonine 18.7 8.66 18.7 18.7 6 21.5 9 
Tryptophan 74.3 -46.94 76.3 74.3 78.5 75.5 14 
Tyrosine 50 -22.64 52 50 56.5 59 8 
Valine 23.3 4.06 23.3 23.3 25 29 4 
        
Average aa 27.36  27.76 27.36 23.625 29.075 7.75 
Source (3, 63)  
(63) (81) (35) (160) (160) 
 
*  Numbers in BOLD differ from chemoheterotrophic bacteria. 
  
Notes:  Values in Akashi and Gojobori (3) are based on the average of overall synthetic cost under growth 
on three substrates: glucose, acetate, and malate. Cost varied slightly with different carbon sources but 
were highly correlated (glucose vs acetate r2=0.968, glucose vs malate r2=0.998)(3). Bragg and Wagner 
(23) use 16 ~P (respiratory) and 1 ~P (fermentative) for Lys instead of 36 ~P and 12~P from Wagner (160); 
Lys production in yeast uses α-ketoglutarate instead of oxaloacetate(23). Average cost (equal amino acids) 
for respiratory and fermentative growth using these numbers would be 28.075 and 7.2 respectively.  
 
Li et al(81) has the same values for eukaryotes as Wagner (160) and sources Heizer et al (63) values for 
prokaryotes. However the values listed in their supplementary section do not match with Heizer et al (63):  
Arg is listed 38.3 not 27.3, Asp and Asn values were mixed up, Glu is listed 34.3 not 15.3, Gln is listed 15.3 
not 16.3, His is listed 32.3 not 38.3, Ile is listed 30.3 not 32.3, Lys is listed 27.3 not 30.3, Met is listed 20.3 




Table 3.2:  Correlation between different amino acid synthetic costs. 
 
 
Spearman Kendall   Linear Correlation (Pearson)  
vs Chemoheterotrophic R p value Tau p value Gamma                             R p value 
Number of Enyzmes E. coli 0.6974 6.31E-04 0.5736 4.06E-04 0.6145 0.692 7.24E-04 
Number of Codons -0.4565 0.0431 -0.3427 0.0346 -0.4058 -0.4309 0.0579 
Number of Carbons 0.8429 3.08E-06 0.7176 9.71E-06 0.7875 0.9125 2.07E-08 
Number of Nitrogens 0.2536 0.2806 0.193 0.2341 0.2826 0.1871 0.4295 
Average Codon %GC -0.4438 0.05 -0.3536 0.0293 -0.4 -0.2855 0.2223 
Average Codon %GC Weighted* -0.4211 0.0645 -0.2979 0.0663 -0.3011 -0.3026 0.1947 
Molecular Mass 0.7502 1.39E-04 0.6027 2.03E-04 0.6108 0.803 2.02E-05 
Surface Seawater ∆G(kJ mol-1) 18⁰C 0.7149 3.97E-04 0.5639 5.09E-04 0.5699 0.748 1.49E-04 





    0.9996 →0, t=156 
Yeast respiratory 0.8737 4.87E-07 0.7147 1.05E-05 0.7363 0.954 7.37E-11 
Yeast fermentative 0.7724 6.59E-05 0.6183 1.38E-04 0.6354 0.5414 0.0137 
Yeast respiratory Bragg 0.8427 3.12E-06 0.672 3.43E-05 0.6923 0.936 1.35E-09 
Yeast fermentative Bragg 0.6788 0.001 0.546 7.64E-04 0.5642 0.5155 0.02 
Li et al Prokaryotic 0.8615 1.06E-06 0.7566 3.10E-06 0.773 0.9256 5.08E-09 





    
 
  




    
 
  
Number of Enyzmes E. coli 0.7223 3.23E-04 0.5525 6.60E-04 0.5976 0.7328 2.38E-04 
Number of Codons -0.3207 0.168 -0.2575 0.1124 -0.3088 -0.3748 0.1035 
Number of Carbons 0.7103 4.49E-04 0.5913 2.67E-04 0.6561 0.8809 2.96E-07 
Number of Nitrogens 0.0417 0.8616 0.0292 0.8569 0.0435 -0.0059 0.9805 
Average Codon %GC -0.5558 0.0109 -0.4436 0.0063 -0.5067 -0.4183 0.0664 
Molecular Mass 0.5272 0.0169 0.3871 0.017 0.3956 0.6895 7.71E-04 
Surface Seawater ∆G(kJ mol-1) 18⁰C 0.5459 0.0128 0.4129 0.0109 0.4208 0.6131 0.004 
Hydrothermal Sol. ∆G (kJ mol-1) 100⁰C -0.5595 0.0103 -0.3164 0.0511 -0.3224 -0.4797 0.0323 
Photoautotrophic 0.8737 4.87E-07 0.7147 1.05E-05 0.7363 0.9523 1.02E-10 
Yeast fermentative 0.7106 4.46E-04 0.5203 0.0013 0.5393 0.514 0.0204 
Yeast respiratory Bragg 0.9682 2.85E-12 0.9 2.89E-08 0.9344 0.9702 1.56E-12 
Yeast fermentative Bragg 0.6167 0.0038 0.4469 0.0059 0.4659 0.4693 0.0368 
Li et al Prokaryotic 0.6778 1.02E-03 0.5547 6.28E-04 0.5714 0.859 1.24E-06 





    
 
  




    
 
  
Number of Enyzmes E. coli 0.3811 0.0973 0.3068 0.0586 0.3254 0.5097 0.0217 
Number of Codons -0.6168 0.0038 -0.5225 0.0013 -0.6115 -0.4507 0.0461 
Number of Carbons 0.7633 9.03E-05 0.6364 8.74E-05 0.6914 0.8669 7.59E-07 
Number of Nitrogens 0.5111 0.0213 0.4265 0.0086 0.6129 0.474 0.0347 
Average Codon %GC -0.3603 0.1187 -0.2823 0.0819 -0.3158 -0.3606 0.1184 
Average Codon %GC Weighted* -0.4438 0.05 -0.3325 0.0404 -0.3333 -0.3769 0.1014 
Surface Seawater ∆G(kJ mol-1) 18⁰C 0.6702 0.0012 0.533 0.001 0.5344 0.8352 4.60E-06 
Hydrothermal Sol. ∆G (kJ mol-1) 100⁰C -0.1121 0.6381 -0.0792 0.6256 -0.0794 -0.0357 0.8813 
Photoautotrophic 0.7502 1.39E-04 0.6027 2.03E-04 0.6108 0.8024 2.08E-05 
Yeast fermentative 0.53 0.0162 0.3807 0.0189 0.388 0.4854 0.03 
Yeast respiratory Bragg 0.503 0.0238 0.3656 0.0242 0.3736 0.6667 0.0013 
Yeast fermentative Bragg 0.4664 0.0382 0.3289 0.0426 0.337 0.4488 0.0472 
Li et al Prokaryotic 0.806 1.79E-05 0.6774 2.97E-05 0.6865 0.8434 3.00E-06 
Craig&Weber E. coli 0.4414 0.0514 0.3102 0.0559 0.3152 0.6568 0.0017 
 




Table 3.2:  Correlation between different amino acid synthetic costs (continued). 
 
 
Spearman Kendall   Linear Correlation (Pearson)  
vs Average Codon %GC R p value Tau p value Gamma                             R p value 
Number of Enyzmes E. coli -0.2779 0.2355 -0.2526 0.1195 -0.3043 -0.3195 0.1698 
Number of Codons 0.3559 0.1236 0.2104 0.1947 0.2846 0.3803 0.0981 
Average Codon %GC Weighted* 0.9375 1.11E-09 0.8504 1.58E-07 0.9477 0.984 6.18E-15 
Number of Carbons -0.4215 0.0642 -0.3365 0.0381 -0.4179 -0.3484 0.1323 





    
 
  




    
 
  
Number of Enyzmes E. coli -0.1029 0.666 -0.0601 0.7109 -0.0758 -0.0982 0.6805 
 
 




Table 3.3: Location and ASC of proteins in (A) E. coli (B) S. cerevisiae (C) M tuberculosis. 




























Cytoplasmic 2859 65.96 36 95 167 19 38 68 0.546 0.288 
IM 972 22.43 12 34 43 78 156 223 0.535 3.477 
Periplasmic 337 7.80 24 37 50 2 3 4 3.077 0.256 
OM 149 3.44 17 22 28 1 3 5 4.944 0.291 
Extracellular 16 0.37 11 12 12 0 0 0 29.789 0 
Total 4333 65.96 100 200 300 100 200 300 
   




Table 3.5A:  Statistics comparing ASCs of proteins in different locations of E. coli. 
 
 
Mann Whitney U Kolmogorov–Smirnov 
vs Cytoplasm Z p value Max Dif p value 
IM 23.196 4.98E-119 -0.418 9.82E-112 
Periplasm 6.029 1.65E-09 0.156 6.71E-07 
OM 3.713 2.05E-04 0.144 4.82E-03 
Extracellular 5.983 2.19E-09 0.674 3.57E-07 
 
    
 
  
vs All     
 
  
Cytoplasm 6.223 4.89E-10 0.084 5.46E-11 
IM 19.529 6.17E-85 -0.336 5.73E-79 
Periplasm 8.242 1.69E-16 0.225 2.26E-14 
OM 5.149 2.62E-07 0.174 2.66E-04 
Extracellular 6.001 1.96E-09 0.663 5.70E-07 
 
    
 
  
vs IM     
 
  
Periplasm 17.023 5.56E-65 0.549 6.61E-67 
OM 11.598 4.21E-31 0.489 7.70E-28 
Extracellular 6.447 1.14E-10 0.776 2.74E-09 
 
    
 
  
vs OM     
 
  
Periplasm 0.146 0.8839 0.107 0.1803 
Extracellular 4.868 1.13E-06 -0.567 8.89E-05 
       
       
 
Student T Test* 
 
vs Cytoplasm T value 95% CI 99.9% CI 
Deg 
Free p value 
 IM 22.178 1.962 3.298 1314 7.87E-93 
 Periplasm 6.378 1.966 3.314 414 4.79E-10 
 OM 3.818 1.975 1.975 159 1.93E-04 
 Extracellular 8.461 2.131 4.073 15 4.29E-07 
 
       
 
* Assumes unequal variance. Confidence intervals are 2 tailed 
 
Mann Whitney U test results used instead of student t test 
 
 






Table 3.5B:  Statistics comparing ASCs of proteins in different locations of S. cerevisiae. 
 
  Mann Whitney U Kolmogorov–Smirnov 
vs Cytoplasm Z p value Max Dif p value 
Extracellular 3.08 0.0021 -0.271 6.09E-04 
Cell Wall 5.78 7.46E-09 -0.432 9.93E-08 
Cytoskeleton 5.654 1.56E-08 -0.196 7.05E-07 
Bud 3.345 0.0008 -0.211 4.66E-06 
Nucleus 3.609 0.0003 -0.056 9.77E-04 
PM 9.011 2.04E-19 0.41 1.92E-26 
ER 13.623 2.94E-42 0.311 1.33E-39 
Golgi 7.736 1.02E-14 0.281 6.95E-11 
ER or Golgi Unique** 11.7 1.28E-31 0.338 1.08E-29 
Integral/Endo Membranes 16.56 1.35E-61 0.648 7.49E-61 
Cell Periphery 2.78 0.0054 0.216 1.07E-08 
Trans Vesicles 5.295 1.19E-07 0.241 2.21E-07 
Mitochondria 11.708 1.16E-31 0.175 5.03E-21 
Peroxisome 5.031 4.88E-07 0.378 5.19E-07 
Endosome 0.857 0.3912 0.125 0.315 
Vacoule 9.486 2.41E-21 0.329 3.85E-25 
Microsome 2.113 0.0346 0.732 4.09E-03 
Lipid Particles 4.712 2.45E-06 0.504 1.15E-06 
Punctate Comp. 2.261 0.0237 0.128 0.0221 
Ambigious 3.368 0.0008 0.145 1.73E-04 
ER or Golgi Only*** 13.398 6.25E-41 0.513 1.42E-34 
Extracellular or Cell Wall 4.08 4.51E-05 -0.286 1.93E-05 
Cyto & Nuc* 1.127 0.2598 -0.017 0.741 
All* 14.862 5.85E-50 0.159 8.70E-45 
 
*      Duplicates removed or none present  
**    Duplicates, Cytoplasmic, Nuclear removed  




Table 3.5B: Statistics comparing ASCs of proteins in different locations of S. cerevisiae 
(continued). 
 
  Mann Whitney U Kolmogorov–Smirnov 






Extracellular 4.846 1.26E-06 -0.294 0.0001 
Cell Wall 6.898 5.27E-12 -0.47 3.57E-09 
Cytoskeleton 9.542 1.41E-21 -0.299 4.40E-16 
Bud 6.606 3.94E-11 -0.279 1.36E-10 
Cytoplasm 14.862 5.85E-50 -0.159 8.70E-45 
Nucleus 16.904 4.19E-64 -0.183 6.98E-48 
PM 4.39 1.13E-05 0.255 7.21E-11 
ER 6.641 3.11E-11 0.156 2.18E-11 
Golgi 3.324 0.0009 0.144 0.003 
ER or Golgi Unique** 5.95 2.68E-09 0.182 1.82E-09 
Integral/Endo Membranes 12.337 5.71E-35 0.493 1.66E-36 
Cell Periphery 1.701 0.0889 -0.126 0.0023 
Trans Vesicles 1.031 0.3024 0.104 0.092486 
Mitochondria 1.17 0.242 0.084 4.60E-06 
Peroxisome 2.031 0.0423 0.264 0.0011 
Endosome 1.529 0.1262 -0.093 0.6795 
Vacoule 3.988 6.66E-05 0.181 2.84E-08 
Microsome 1.059 0.2897 0.584 0.0387 
Lipid Particles 2.566 0.0103 0.363 0.0011 
Punctate Comp. 1.559 0.1191 -0.084 0.2713 
Ambigious 1.628 0.1035 -0.061 0.343 
ER or Golgi Only*** 9.218 3.02E-20 0.357 1.77E-17 
Extracellular or Cell Wall 6.026 1.68E-09 -0.32 8.49E-07 
Cyto & Nuc* 17.351 1.93E-67 -0.159 1.70E-53 
 
*      Duplicates removed or none present  
**    Duplicates, Cytoplasmic, Nuclear removed  








Mann Whitney U Kolmogorov–Smirnov 
vs Cyto & Nuc* Z p value Max Dif p value 
Extracellular 2.9331 0.0034 -0.2616 0.001 
Cell Wall 5.6425 1.68E-08 -0.4221 1.94E-07 
Cytoskeleton 5.2603 1.44E-07 -0.1812 4.79E-06 
Bud 3.0696 0.0021 -0.1976 2.01E-05 
Cytoplasm 1.1269 0.2598 0.0169 0.7412 
Nucleus 2.7344 0.0062 -0.0388 0.0329 
PM 9.2554 2.13E-20 0.4125 4.14E-27 
ER 14.2357 5.50E-46 0.3127 9.94E-42 
Golgi 8.0091 1.16E-15 0.2868 1.77E-11 
ER or Golgi Unique** 12.1017 1.04E-33 0.339 1.57E-30 
Integral/Endo Membranes 16.7279 8.21E-63 0.6476 1.63E-61 
Cell Periphery 3.0619 0.0022 0.219 4.43E-09 
Trans Vesicles 5.5631 2.65E-08 0.2486 6.98E-08 
Mitochondria 12.7576 2.83E-37 0.1906 1.99E-26 
Peroxisome 5.1641 2.42E-07 0.3945 1.27E-07 
Endosome 1.0502 0.2936 0.1283 0.2846 
Vacoule 9.8263 8.68E-23 0.334 2.17E-26 
Microsome 2.1375 0.0326 0.7372 0.0037 
Lipid Particles 4.769 1.85E-06 0.5112 7.58E-07 
Punctate Comp. 2.5557 0.0106 0.1258 0.0255 
Ambigious 3.7317 0.0002 0.1513 6.27E-05 
ER or Golgi Only*** 13.5775 5.45E-42 0.5142 4.10E-35 
Extracellular or Cell Wall 3.9124 9.14E-05 -0.2767 3.84E-05 
All* 17.3513 1.93E-67 0.1593 1.70E-53 
 
*      Duplicates removed or none present  
**    Duplicates, Cytoplasmic, Nuclear removed  









vs Cytoplasm T value 95% CI 99.9% CI Deg Free p value 
Extracellular 3.1178 2.0049 3.48 54 0.0029 
Cell Wall 5.7357 2.0154 3.5258 44 8.24E-07 
Cytoskeleton 5.6785 1.97 3.332 237 3.96E-08 
Bud 2.4981 1.975 3.3528 159 0.0135 
Nucleus 3.6015 1.9605 3.2926 4592 0.0003 
PM 7.982 1.972 3.3401 199 1.12E-13 
ER 12.8933 1.9636 3.3055 654 4.72E-34 
Golgi 7.9141 1.9741 3.349 169 3.13E-13 
ER or Golgi Unique** 11.3575 1.9666 3.3178 360 9.33E-26 
Integral/Endo Membranes 18.3235 1.9728 3.3436 186 1.59E-43 
Cell Periphery 2.0926 1.9702 3.333 232 0.0375 
Trans Vesicles 5.1461 1.9758 3.3561 151 8.16E-07 
Mitochondria 12.3166 1.9612 3.2958 1859 1.45E-33 
Peroxisome 5.4403 2.0057 3.4838 53 1.38E-06 
Endosome 1.2543 2.0017 3.4663 58 0.2148 
Vacoule 8.5034 1.9675 3.3218 314 7.60E-16 
Microsome 2.8618 2.7764 8.6103 4 0.0458 
Lipid Particles 4.9165 2.0555 3.7066 26 4.19E-05 
Punctate Comp. 2.36 1.9762 3.3579 147 0.0196 
Ambigious 3.6335 1.969 3.3279 263 0.0003 
ER or Golgi Only*** 13.7257 1.9747 3.3516 162 6.17E-29 
Extracellular or Cell Wall 4.0728 1.9939 3.4329 71 0.0001 
Cyto & Nuc* 1.1471 1.9603 3.2921 6186 0.2514 
All* 18.959 1.9603 3.2918 7445 2.55E-78 
 
†  Assumes unequal variance. Confidence Intervals are two tailed. 
*      Duplicates removed or none present  
**    Duplicates, Cytoplasmic, Nuclear removed  




Table 3.5C:  Statistics comparing ASC of proteins in different locations in M 
tuberculosis. 
 
  Mann Whitney U Kolmogorov–Smirnov 
vs Cytoplasm Z p value Max Dif p value 
Cytoplasmic Membrane 10.7167 8.49E-27 -0.229 6.74E-22 
Unknown 8.9557 3.37E-19 0.1446 1.93E-13 
Extracellular 12.371 3.75E-35 0.5584 8.58E-37 
Cell Wall 2.4495 0.0143 0.4744 0.0365 











Cytoplasm 2.0838 0.0372 -0.0488 0.0028 
Cytoplasmic Membrane 11.761 6.20E-32 -0.2285 3.28E-24 
Unknown 7.5395 4.72E-14 0.1152 3.32E-10 
Extracellular 11.8675 1.75E-32 0.5126 5.74E-32 
Cell Wall 2.2392 0.0251 0.4366 0.067 











Unknown 14.5359 7.18E-48 0.3347 3.10E-38 
Extracellular 13.4196 4.64E-41 0.6219 1.81E-39 
Cell Wall 2.9964 0.0027 0.4716 0.0397 
Extracellular and Cell Wall 13.6098 3.50E-42 0.6174 1.19E-40 
      
 
Student T Test* 
vs Cytoplasm T value 95% CI 99.9% CI Deg Free p value 
Cytoplasmic Membrane 10.5911 1.9631 3.3035 754 1.57E-24 
Unknown 8.9146 1.9613 3.2958 1841 1.15E-18 
Extracellular 12.2829 1.9768 3.3604 142 4.42E-24 
Cell Wall 2.0153 2.3646 5.4079 7 0.0837 
Extracellular and Cell Wall 12.3553 1.9759 3.3566 150 1.24E-24 
      * Assumes unequal variance. Confidence intervals are two tailed 
  Mann Whitney U test results used in text instead of student t test 
 Most locations fail normality 









Table 3.6:  Statistics comparing protein ASCs in different sublocations in E. coli. 
 
  Mann Whitney U Test Kolmogorov–Smirnov 
vs Cytoplasm Z p value Max Dif p value 
Integral Membrane Protein  27.6379 3.90E-168 -0.51 7.80E-140 
Membrane anchored  0.649 0.5164 -0.1178 0.0287 
Periplasmic w N-term mem anchor  0.3666 0.7139 -0.383 0.2696 
Inner Membrane Lipoprotein  4.1532 3.28E-05 0.5465 0.0002 
Membrane associated  1.7771 0.0756 0.287 0.3271 
Membrane Lipoprotein* 1.1243 0.2609 0.2708 0.6113 
OM ß-barrel protein  0.305 0.7604 -0.1226 0.3914 
OM Lipoprotein  4.892 9.98E-07 0.2395 3.51E-05 
Cell surface appendage  5.6057 2.07E-08 0.7376 1.40E-06 
Secreted and released  2.2686 0.0233 0.3138 0.7407 
Extracellular** 5.9832 2.19E-09 0.6739 3.57E-07 
  
 
      
vs All 
 
      
Integral Membrane Protein  24.0127 2.05E-127 -0.4287 1.32E-106 
Membrane anchored  2.1015 0.0356 0.1275 0.0127 
Periplasmic w N-term mem anchor  0.0509 0.9594 -0.3453 0.3899 
Inner Membrane Lipoprotein  4.2749 1.91E-05 0.5735 9.75E-05 
Membrane associated  2.1025 0.0355 0.3283 0.1873 
Membrane Lipoprotein* 1.3172 0.1878 0.273 0.6005 
OM ß-barrel protein  0.7611 0.4466 0.0973 0.6821 
OM Lipoprotein  5.89 3.86E-09 0.2483 1.36E-05 
Cell surface appendage  5.5665 2.60E-08 0.7417 1.17E-06 
Secreted and released  2.3687 0.0179 0.357 0.583488 
Extracellular** 6.0012 1.96E-09 0.663 5.70E-07 
  
 
      
vs Integral Membrane Protein 
 
      
Membrane anchored  10.8649 1.69E-27 0.4402 5.02E-23 
Periplasmic w N-term mem anchor  2.6038 0.0092 0.3674 0.3187 
Inner Membrane Lipoprotein  6.0709 1.27E-09 0.8172 4.64E-09 
Membrane associated  4.6997 2.61E-06 0.7301 1.85E-05 
Membrane Lipoprotein* 2.9816 0.0029 0.4839 0.0514 
Periplasmic 20.1056 6.59E-90 0.6431 2.86E-86 
OM ß-barrel protein  7.3597 1.84E-13 0.5222 1.24E-12 
OM Lipoprotein  12.4994 5.22E-37 0.6116 5.52E-29 
Cell surface appendage  5.9058 3.51E-09 0.8948 2.19E-09 
Secreted and released  3.2553 0.0011 0.6689 0.0296 













 vs OM Lipoprotein Z p value Max Dif p value 
Periplasmic 1.579 0.114 -0.125 0.183 
Inner Membrane Lipoprotein  1.695 0.090 0.347 0.082 
Membrane Lipoprotein* 0.197 0.844 -0.313 0.467 
  
  
    
vs Periplasmic 
  
    
Periplasmic w N-term mem anchor  1.171 0.242 -0.496 0.074 
Inner Membrane Lipoprotein  2.841 0.005 0.430 0.009 
Membrane Lipoprotein* 0.205 0.837 -0.286 0.551 
  
    
  
      Student T Test with Unequal Variance.  CI 2 tailed 
vs Cytoplasm T value 95% CI 99.9% CI 
Deg 
Free p value 
Integral Membrane Protein  28.897 1.962 3.300 1072 3.01E-136 
Membrane anchored  0.359 1.975 3.351 164 0.7198 
Periplasmic w N-term mem anchor  0.373 2.571 6.869 5 0.7244 
Inner Membrane Lipoprotein  5.652 2.160 4.221 13 7.91E-05 
Membrane associated  2.674 2.262 4.781 9 0.0255 
Membrane Lipoprotein* 0.548 2.447 5.959 6 0.6038 
OM ß-barrel protein  0.281 2.006 3.484 53 0.7799 
OM Lipoprotein  5.249 1.984 3.391 100 8.61E-07 
Cell surface appendage  9.614 2.201 4.437 11 1.09E-06 
Secreted and released  2.257 3.182 12.924 3 0.1092 
Extracellular** 8.461 2.132 4.073 15 4.29E-07 
    
  
    
vs OM Lipoprotein   
  
    
Periplasmic 1.839 1.977 3.360 143 0.068 
Inner Membrane Lipoprotein  2.109 2.064 3.745 24 0.0456 
Membrane Lipoprotein* 0.625 2.365 5.408 7 0.5516 
    
  
    
vs Periplasmic   
  
    
Periplasmic w N-term mem anchor  1.419 2.571 6.869 5 0.2152 
Inner Membrane Lipoprotein  3.550 2.132 4.073 15 0.0029 
Membrane Lipoprotein* 0.183 2.447 5.959 6 0.8612 
 
*Difficulty determining which membrane for seven “Membrane Lipoproteins” VisC, YfbK, YiaF, 
YifL, YihN, YjbH, and YraM. These proteins included in “Inner Membrane” for Fig. 3.1A, 3.3B, 
3.6,3.8, 3.12, 3.13 and Tables 3.3-6. 






Table 3.7:  Amino acid percent of proteins in different compartments of E. coli. 
 
Mean 
ASC %A %R %N %D %C %E %Q %G %H %I %L %K %M %F %P %S %T %W %Y %V Total aa Number 
Overall Mean 23.555 9.37 5.6 3.87 5.03 1.29 5.83 4.42 7.12 2.33 6.1 10.6 4.7 2.96 3.91 4.3 5.81 5.36 1.52 2.79 7.09 312.46 4333 
Overall Median 23.398 9.23 5.45 3.68 5.15 1.08 5.9 4.24 7.06 2.17 5.87 10.4 4.27 2.78 3.62 4.24 5.61 5.18 1.32 2.61 6.99 275.00 4333 
Overall STDEVP 1.5038 2.9 2.43 1.79 2.04 1.24 2.59 2.06 2.5 1.5 2.27 3.2 2.44 1.33 2.06 1.75 2.07 1.95 1.2 1.47 2.28 209.22 4333 
  
                      
  
Extracellular* 20.652 12 2.5 6.9 5.81 0.6 3 6.5 8.04 0.7 4.83 8.45 4.43 1.7 2.6 2.7 9.1 9.9 0.6 2.42 7.09 280.44 16 
OM 22.852 9.04 4.59 5.5 5.66 1.14 4.2 5.16 8.2 1.4 4.97 8.64 4.88 2.79 3.23 4.16 7.4 6.8 1.51 4 6.69 334.95 149 
Periplasm 22.854 10.1 4.24 5.1 5.75 1.07 4.69 5.1 7.02 1.7 5.06 8.84 6.2 2.64 3.44 4.58 6.65 6.44 1.44 3.09 6.96 309.42 337 
IM 24.653 9.93 4.56 3.22 3.3 0.99 3.6 3.54 7.8 1.7 7.48 13.2 3.56 3.53 5.3 4.13 6.04 5.25 2.2 2.72 8.04 357.55 972 
Cytoplasm 23.317 9.1 6.18 3.86 5.5 1.44 6.82 4.59 6.84 2.68 5.82 10 4.9 2.82 3.54 4.34 5.53 5.17 1.32 2.72 6.8 296.50 2859 
  
                      
  
Sublocations 
                      
  
Cell surface 
appendage  20.474 12 2.2 8 5.26 0.5 2.3 6.3 9.3 0.7 4.91 8.2 3.5 1.6 2.7 2.2 9.4 11 0.6 2.67 7.11 299.17 12 
Secreted and released  21.187 12 3.5 3.78 7.4 0.8 5.27 6.9 4.4 0.8 4.61 9.19 7.2 2 2.1 4.43 8.4 7.9 0.9 1.7 7.01 224.25 4 
OM Lipoprotein  22.564 9.58 4.63 4.78 5.07 1.58 4.1 5.6 7.47 1.4 5.2 9.26 5.3 3.26 2.8 4.62 7.3 6.65 1.2 3.08 7.11 216.46 96 
OM ß-barrel protein  23.374 8.05 4.52 6.9 6.7 0.4 4.3 4.34 9.5 1.5 4.6 7.5 4.12 2 4.09 3.31 7.5 7.1 2.1 5.6 5.94 549.57 53 
Integral Membrane 
Protein  25.01 9.98 4.29 3 2.8 0.99 3.1 3.1 8.04 1.6 7.9 14 3.1 3.7 5.8 4.05 6.09 5.19 2.3 2.74 8.21 369.58 777 
Membrane anchored  23.374 9.69 5.9 3.98 4.95 0.9 5.45 5.09 6.77 1.79 5.88 10.8 5.23 2.82 3.56 4.28 5.81 5.49 1.67 2.52 7.39 284.58 158 
Peri. w N-term anchor 23.48 9.06 5.22 4.06 5.74 1.8 6.53 5.48 7 3.2 5.23 8.29 6.3 3.21 2.95 5.8 5.05 4.2 1.73 3.07 6.06 271.33 6 
IM Lipoprotein  21.987 9.47 4 4.76 6.4 0.8 6.14 6 7.11 1.2 4.4 9.65 6.6 1.9 2.6 4.38 6.44 6.32 0.8 3.09 7.85 485.50 14 
Membrane associated  22.708 11.1 5.65 4.17 5.03 1.02 6.13 5.22 7.08 2.19 4.92 9.79 5.17 3.25 2.7 4.6 5.65 5.06 1.46 2.46 7.36 390.50 10 
Membrane 
Lipoprotein 22.97 9.77 3.9 4.62 5.27 0.9 3.7 6.8 7.54 1.2 4.3 10.2 5.31 2.4 4.46 5.9 6.24 6.28 1.27 3.35 6.64 439.29 7 















   
Notes:    Bold indicates >25% change in amino acid composition from the overall mean. 
Underlined indicates >50% change in amino acid composition from the overall mean. 
 
Amino acid percents are on a per protein basis. The percent amino acid composition of each protein in that location were averaged; they are 
unweighted for chain length. See Table 3.22A for weighted percents (% of all amino acids) of proteins in nonmembrane locations of E. coli. 
*  We also looked at Extracellular proteins cost removing the SEC signal peptide when present (except FlgD for which a SEC signal is  






Table 3.8:  Percent of amino acids in curli specific genes. 
      
Standard Competition Ranking 
    
 
% Gly Rank Gly % Ser Rank Ser %GS Rank GS % Asn Rank Asn % Gln 
Rank 










































 CsgA 19.21 6 9.27* 227 28.48 6 10.60 22 7.28** 354 17.89 18 46.36 2 
CsgB 9.93 492 8.61 361 18.54 165 8.61 87 9.93 55 18.54 12 37.08 8 
CsgC 3.64 4028 14.55 12 18.18 198 3.64 2218 10.91 33 14.55 102 32.73 47 
CsgD 4.17 3884 8.33 420 12.50 2377 8.80 75 4.17 2214 12.96 223 25.46 438 
CsgE 4.65 3693 5.43 2358 10.08 3669 4.65 1160 3.88 2483 8.53 1907 18.61 3415 
CsgF 8.70 1077 7.97 536 16.67 419 11.59 13 7.97 218 19.57 7 36.23 13 




























   
* 94.7th Percentile 
    
** 91.8th Percentile 




Rank G Rank S Rank GS Rank N Rank Q Rank NQ Rank GSNQ 
CsgA 6 227 6 22 354 18 2 
CsgB 492 361 165 87 55 12 8 
CsgC 4029.5(4) 12 201.5(8) 2223(11) 34(3) 102 47 
CsgD 3889.5(12) 427.5(16) 2392(31) 75.5(2) 2224(21) 224(3) 438 
CsgE 3694.5(4) 2359.5(4) 3669.5(2) 1168.5(18) 2484.5(4) 1909.5(6) 3417.5(6) 
CsgF 1080.5(8) 536 423.5(10) 13 218 7 13 
CsgG 2323 847(3) 1405.5(2) 531 940 460 411 
 




Table 3.9:  Percentiles of flagella, curli, and Type 1 pili proteins. 
 
Percentile 99.9999 99.999 99.99 99.9 99 95 90 80 70 
Avg E 18.017 18.036 18.227 18.916 20.430 21.427 21.894 22.404 22.785 
Savings 5.538 5.519 5.328 4.639 3.125 2.128 1.661 1.151 0.770 
 
Flagella 
Percentile Avg Cost Rank Name Length Location Role Savings per aa 
99.885 19.1548 6 FliC 498 Cell surface appendage  Structural  4.4001 
99.793 19.3949 10 FlgM 97 Secreted&released(68, 77) Regulatory  4.1601 
99.677 19.6541 15 FlgD 231 Cell surface appendage  Assembly  3.9008 
99.608 19.7397 18 FliK 375 Secreted&released(95)  Assembly  3.8152 
99.539 19.8705 21 FlgF 251 Periplasmic  Structural  3.6844 
99.493 19.9291 23 FliD 468 Cell surface appendage  Structural  3.6258 
99.308 20.1981 31 FlgI 365 Periplasmic  Structural  3.3568 
98.985 20.4642 45 FlgC 134 Periplasmic  Structural  3.0907 
98.962 20.4713 46 FlgK 547 Cell surface appendage  Structural  3.0836 
98.846 20.5953 51 FlgE 402 Cell surface appendage  Structural  2.9596 
98.639 20.6565 60 FlgG 260 Periplasmic  Structural  2.8984 
98.5 20.6683 66 FliE 104 Cytoplasmic * Structural  2.8866 
98.015 20.8473 87 FlgL 317 Cell surface appendage  Structural  2.7076 
97.831 20.9435 95 FlgB 138 Periplasmic  Structural  2.6114 
96.03 21.2669 173 FliO 121 Membrane anchored  Export  2.2880 
95.868 21.2995 180 FliF 552 IM Protein  Structural  2.2555 
95.476 21.3480 197 FlgA 219 Periplasmic  Chaperone  2.2070 
95.407 21.3540 200 FliN 137 Cytoplasmic  Structural  2.2009 
95.361 21.3680 202 FliH 228 Cytoplasmic  Export  2.1869 
94.368 21.5162 245 FliS 136 Cytoplasmic  Chaperone  2.0387 
93.883 21.5544 266 FliG 331 Membrane associated  Structural  2.0005 
93.583 21.5961 279 FlgH 232 OM Lipoprotein  Structural  1.9588 
87.166 22.0514 557 FliI 457 Cytoplasmic  Export  1.5035 
83.796 22.2189 703 FlgJ 313 Periplasmic(102) Assembly  1.3361 
82.018 22.3130 780 MotB 308 Membrane anchored  Structural  1.2419 
81.072 22.3541 821 FliY 266 Periplasmic  ?  1.2008 
79.225 22.4391 901 FlgN 138 Cytoplasmic  Chaperone  1.1158 
78.048 22.4958 952 FliA 239 Cytoplasmic  Regulatory  1.0591 
70.868 22.7515 1263 FlhE 130 Periplasmic  ?  0.8034 
66.898 22.8840 1435 FlhA 692 IM Protein  Export  0.6709 
66.205 22.9020 1465 FliJ 147 Cytoplasmic  Export  0.6529 
59.65 23.0984 1749 FliT 121 Cytoplasmic  Chaperone  0.4566 
59.28 23.1126 1765 FliM 334 Cytoplasmic  Structural  0.4423 
57.11 23.1824 1859 MotA 295 IM Protein  Structural  0.3725 
53.948 23.2740 1996 FlhD 119 Cytoplasmic  Regulatory  0.2810 
45.568 23.5490 2359 FlhC 192 Cytoplasmic  Regulatory  0.0060 
41.736 23.6766 2525 FliL 154 OM Lipoprotein  ?  -0.1217 
40.859 23.7039 2563 FlhB 382 IM Protein  Export  -0.1490 
17.544 24.7843 3573 FliQ 89 IM Protein  Export  -1.2294 
17.314 24.8102 3583 FliP 245 IM Protein  Export  -1.2553 
13.805 25.0825 3735 FliZ 183 Cytoplasmic  Regulatory  -1.5276 
11.866 25.2406 3819 FliR 261 IM Protein  Export  -1.6857 






















Percentile Avg Cost Rank Name Length Location Role Savings per aa 
99.816 19.3887 9 CsgA 151 Cell surface appendage  Major 4.1662 
98.685 20.6517 58 CsgB 151 Cell surface appendage  Minor 2.9033 
96.538 21.2036 151 CsgC 110 Periplasmic  ? 2.3513 
24.146 24.3593 3287 CsgD 216 Cytoplasmic  Regulatory  -0.8044 
11.981 25.2326 3814 CsgE 129 Periplasmic  Chaperone  -1.6776 
88.874 21.9725 483 CsgF 138 Periplasmic**  Chaperone  1.5824 
68.006 22.8498 1387 CsgG 277 OM Lipoprotein  export 0.7051 



















Type 1 pili 
Percentile Avg Cost Rank Name Length Location Role Savings per aa 
99.77 19.5247 11 FimA 182 Cell surface appendage  Major 4.0302 
10.942 25.3265 3859 FimB 200 Cytoplasmic  regulatory -1.7716 
70.291 22.7739 1288 FimC 241 Periplasmic  Chaperone  0.7811 
72.115 22.7075 1209 FimD 878 OM ß-barrel protein  export 0.8474 
30.772 24.0742 3000 FimE 198 Cytoplasmic  Regulatory  -0.5193 
84.419 22.1852 676 FimF 176 Cell surface appendage  Adaptor 1.3697 
97.554 20.9916 107 FimG 167 Cell surface appendage  Adaptor 2.5633 
82.503 22.2920 759 FimH 300 Cell surface appendage  Tip 1.2629 
57.941 23.1536 1823 FimI 179 Periplasmic  ? 0.4013 
29.156 24.1405 3070 FimZ 210 Cytoplasmic  Regulatory  -0.5856 

















*FliE interacts with FlgB and is likely periplasmic (87, 96). 





     Table 3.10:  Cost savings and amino acid composition or extracellular proteins in E. coli. 
 
 
Cost vs Average aa 15.66 0.06 12.66 14.66 2.66 12.06 11.06 15.66 -10.9 -4.94 0.06 -2.94 -6.94 -24.6 7.06 15.66 8.66 -46.9 -22.6 4.06 
  
ATP/aa %A %R %N %D %C %E %Q %G %H %I %L %K %M %F %P %S %T %W %Y %V 
Overall MEAN 23.555 9.37 5.6 3.87 5.03 1.29 5.83 4.42 7.12 2.33 6.1 10.59 4.7 2.96 3.91 4.3 5.81 5.36 1.52 2.79 7.09 
 
MEDIAN 23.398 9.23 5.45 3.68 5.15 1.08 5.9 4.24 7.06 2.17 5.87 10.37 4.27 2.78 3.62 4.24 5.61 5.18 1.32 2.61 6.99 
 
STDEVP 1.504 2.9 2.43 1.79 2.04 1.24 2.59 2.06 2.5 1.5 2.27 3.2 2.44 1.33 2.06 1.75 2.07 1.95 1.2 1.47 2.28 
Extracellular MEAN 20.652 12.11 2.535 6.911 5.805 0.566 3.0305 6.474 8.0422 0.698 4.832 8.45 4.427 1.714 2.558 2.744 9.112 9.857 0.629 2.422 7.087 
                       
ATP savings per 
amino Acid 
 
ATP/aa A R N D C E Q G H I L K M F P S T W Y V 
FliC 19.155 11.85 2.21 9.64 7.83 0 2.81 5.42 8.84 0 5.62 7.43 5.02 0.8 1 1.2 8.63 13.05 0 2.01 6.63 
CsgA 19.389 10.6 1.32 10.6 5.3 0 1.32 7.28 19.21 1.99 3.31 5.96 2.65 1.32 2.65 1.32 9.27 5.96 0.66 2.65 6.62 
FimA 19.525 19.78 1.65 6.04 4.4 1.1 1.65 5.49 8.79 1.1 3.3 8.24 2.75 0.55 3.85 1.1 7.69 12.09 0 1.1 9.34 
 
FlgM 19.395 11.34 5.15 5.15 7.22 0 5.15 6.19 3.09 0 5.15 9.28 6.19 3.09 0 5.15 11.34 11.34 0 0 5.15 
 
FlgD 19.654 7.79 1.3 6.49 4.76 0 3.46 6.49 10.82 0.87 6.06 9.52 1.73 1.3 1.73 3.03 10.39 15.58 0.43 0.87 7.36 
 
FliK 19.74 12.53 1.87 2.4 6.93 0 5.07 9.6 4.53 1.87 3.73 11.2 3.2 1.07 1.87 8.8 8.27 10.67 0.27 0 6.13 
 
FliD 19.929 11.54 1.5 6.62 7.26 0 1.5 4.91 6.41 0.21 6.2 9.62 5.56 1.28 1.71 0.64 14.32 14.1 0.43 2.14 4.06 
 
FlgK 20.471 12.07 2.93 8.59 6.76 0 2.93 8.04 7.86 0.18 4.94 8.59 3.29 1.65 3.29 1.65 8.78 8.78 0.37 2.74 6.58 
 
FlgE 20.595 10.2 1.49 11.94 5.22 0 1.99 6.22 9.7 0.25 4.23 7.46 2.99 2.24 4.23 2.74 8.71 10.7 0.5 2.49 6.72 
 
CsgB 20.652 15.23 3.31 8.61 3.31 0 1.99 9.93 9.93 0 7.95 6.62 5.3 3.31 1.99 0.66 8.61 5.3 0 3.97 3.97 
 
FlgL 20.847 11.67 3.47 5.36 6.94 0 5.05 8.52 5.99 0.32 4.1 8.83 4.73 3.47 2.52 1.58 10.41 8.2 0.63 2.84 5.36 
 
FimG 20.992 13.77 1.8 4.79 5.39 1.8 1.2 5.99 7.78 1.2 4.19 7.78 3.59 1.2 1.8 1.8 9.58 12.57 1.2 3.59 8.98 
                       
Percent of total 
savings for each 
amino Acid 
 
Savings/aa A R N D C E Q G H I L K M F P S T W Y V 
FliC 4.4 8.8 -0.05 16.59 9.33 -0.78 -8.26 2.52 6.1 5.79 0.53 -0.04 -0.22 3.4 16.3 -4.97 10.06 15.14 16.22 4.02 -0.43 
CsgA 4.17 4.59 -0.06 20.43 0.94 -0.83 -13.03 7.61 45.42 0.9 3.3 -0.07 1.45 2.72 7.48 -5.04 13.02 1.25 9.67 0.76 -0.45 
FimA 4.03 40.43 -0.06 6.82 -2.31 -0.13 -12.5 2.95 6.49 3.34 3.43 -0.03 1.42 4.15 0.42 -5.61 7.32 14.46 17.71 9.49 2.27 
FlgM 4.16 7.4 -0.01 3.9 7.7 -0.83 -1.95 4.7 -15.17 6.13 1.12 -0.02 -1.05 -0.23 23.18 1.45 20.82 12.45 17.16 15.18 -1.89 
 
FlgD 3.9 -6.35 -0.07 8.5 -1.01 -0.88 -7.31 5.88 14.86 4.1 0.05 -0.02 2.24 2.95 13.79 -2.3 18.39 22.7 13.09 11.16 0.28 
 
FliK 3.82 12.96 -0.06 -4.89 7.31 -0.9 -2.4 15.02 -10.63 1.33 3.06 0.01 1.15 3.44 13.22 8.33 10.09 12.04 15.43 16.55 -1.02 
 
FliD 3.63 9.34 -0.07 9.6 9.03 -0.95 -14.41 1.51 -3.07 6.38 -0.13 -0.02 -0.7 3.21 14.98 -7.13 36.75 20.88 14.16 4.07 -3.39 
 
FlgK 3.08 13.67 -0.05 19.37 8.24 -1.12 -11.35 13 3.75 7.62 1.86 -0.04 1.34 2.95 4.98 -6.08 15.07 9.59 17.59 0.34 -0.67 
 
FlgE 2.96 4.36 -0.08 34.5 0.95 -1.16 -15.63 6.73 13.65 7.69 3.12 -0.06 1.7 1.69 -2.62 -3.73 15.34 15.61 16.23 2.3 -0.51 
 
CsgB 2.9 31.59 -0.05 20.65 -8.69 -1.19 -15.95 21.01 15.17 8.78 -3.15 -0.08 -0.61 -0.85 16.36 -8.85 15.11 -0.19 24.59 -9.24 -4.36 
 
FlgL 2.71 13.29 -0.05 6.96 10.33 -1.27 -3.47 16.74 -6.53 8.14 3.64 -0.04 -0.04 -1.31 12.65 -7.1 26.62 9.09 15.43 -0.42 -2.59 
 
FimG 2.56 26.87 -0.09 4.53 2.04 0.52 -21.78 6.77 4.05 4.83 3.67 -0.07 1.27 4.76 20.36 -6.9 23.05 24.37 5.92 -7.1 3 
   
                                        
 
Average >1.5ATPs 13.91 -0.06 12.25 3.65 -0.79 -10.67 8.7 6.17 5.42 1.71 -0.04 0.66 2.24 11.76 -3.99 17.64 13.12 15.27 3.92 -0.81 
  
ALL 17.6 -0.09 14.79 6.47 -0.57 -11.87 8.58 -1.23 9.3 2.78 -0.06 -1.79 4.54 10.88 -5.89 19.54 14.1 15.21 -3.3 1.1 
Bold:  Greater than 10% of total savings due to composition of that amino acid  
  
Percent of Total Cost Savings for E. coli  Major Extracellular Fiber Subunits 
 
Excluding Aromatics Aromatics 
 
Top 2 Savings >10% Savings Savings FW FYW FYWH 
CsgA GN 65.85 GNS 78.86 17.16 17.91 18.81 
FimA AT 54.89 AT 54.89 18.13 27.62 30.96 








Student T test (assuming heteroscedastic) Two tailed One tailed 
 






Variance P value 
Critical 
Value* P value 
Critical 
Value* 
vs Cytoplasm 13 22.532 1.364 
       IM 10 23.104 2.264 17 0.994 1.750 0.33405 2.110 0.16703 1.740 
Periplasm 9 21.201 1.059 19 2.821 1.242 0.01091 2.093 0.00546 1.729 
OM 2 22.636 2.164 1 0.096 1.426 0.93899 12.706 0.46949 6.314 
Extracellular 8 19.973 0.366 19 6.590 0.997 2.624E-06 2.093 1.312E-06 1.729 
           
           vs Cyto & IM 23 22.780 1.754 
       Cytoplasm 13 22.532 1.364 28 0.584 1.617 0.56359 2.048 0.28179 1.701 
IM 10 23.104 2.264 15 0.588 1.902 0.56529 2.131 0.28265 1.753 
Periplasm 9 21.201 1.059 19 3.587 1.569 0.00196 2.093 0.00098 1.729 
OM 2 22.636 2.164 1 0.134 1.772 0.91528 12.706 0.45764 6.314 
Extracellular 8 19.973 0.366 26 8.036 1.419 1.626E-08 2.056 8.128E-09 1.706 
           vs all flagella 42 21.900 2.556 
       Cytoplasm 13 22.532 1.364 27 1.550 2.286 0.13273 2.052 0.06636 1.703 
IM 10 23.104 2.264 14 2.246 2.504 0.04139 2.145 0.02069 1.761 
Periplasm 9 21.201 1.059 18 1.656 2.312 0.11504 2.101 0.05752 1.734 
OM 2 22.636 2.164 1 0.688 2.547 0.61616 12.706 0.30808 6.314 
Extracellular 8 19.973 0.366 29 5.902 2.237 2.085E-06 2.045 1.043E-06 1.699 
           BOLD = Statistically Significant.  P <0.05 
       * 5% Confidence Interval 




Table 3.12:  Flagella subunit ASC/economic rank versus stoichiometry & chain length. 
 
With FliC included (26 total) 
  
Without FliC (25 total) 
 Comparing Avg AA Cost & Number of Subunits 
 




 y = 17322 - 761.2x   R= 0.31913  
  
y = 84.851 - 2.8219x   R= 0.13516 
 Spearman R                        -0.25497 
 
Spearman R                        -0.16159 
Rank Difference Squares Sum       3662 
 
Rank Difference Squares Sum       3012 
t-test value for hypothesis r = 0 -1.29179 
 
t-test value for hypothesis r = 0 -0.78528 
p-level                           0.208733 
 
p-level                           0.440307 
Kendall Tau                       -0.12521 
 
Kendall Tau                       -0.05094 
Inversions Count                  177 
 
Inversions Count                  152 
Z                                 0.896972 
 
Z                                 0.356929 
p-level                           0.369734 
 
p-level                           0.721145 
Gamma                             -0.12739 
 
Gamma                             -0.0519 
Pearson Correlation Coefficient   -0.31913 
 
Pearson Correlation Coefficient   -0.13516 
Comparing Economic Rank & Number of Subunits 
 




 y = 1178.2 - 0.4517x   R= 0.14222  
  
y = 28.262 - 0.0055992x   R= 0.21034  
 Spearman R                        -0.25497 
 
Spearman R                        -0.16159 
Rank Difference Squares Sum       3662 
 
Rank Difference Squares Sum       3012 
t-test value for hypothesis r = 0 -1.29179 
 
t-test value for hypothesis r = 0 -0.78528 
p-level                           0.208733 
 
p-level                           0.440307 
Kendall Tau                       -0.12521 
 
Kendall Tau                       -0.05094 
Inversions Count                  177 
 
Inversions Count                  152 
Z                                 0.896972 
 
Z                                 0.356929 
p-level                           0.369734 
 
p-level                           0.721145 
Gamma                             -0.12739 
 
Gamma                             -0.0519 
Pearson Correlation Coefficient   -0.14222 
 
Pearson Correlation Coefficient   -0.21034 
 
 
Comparing Avg AA cost & Chain Length (all 42 proteins) 
Linear regression 
 Pearson Correlation Coefficient   -0.21355 
Spearman R                        -0.18857 
Rank Difference Squares Sum       14667 
t-test value for hypothesis r = 0 -1.21443 
p-level                           0.231703 
Kendall Tau                       -0.12674 
Inversions Count                  484 
Z                                 1.18265 
p-level                           0.236948 
Gamma                             -0.12689 






 Table 3.13:  Comparison of protein abundance and average synthetic cost (ASC) or mean amino acid mass in E. coli. 
    Avg. # per 
cell 
  Number per cell vs. Avg Cost Number per cell vs. Avg Mass 
   
  
  
Spearman Pearson Spearman Pearson 
  
Location Proteins Avg Cost Avg Mass R P value R P value R P value R P value 
Whole  Cell Lysates 
 
Overall 1270 1362.67 22.98 110.58 -0.1263 6.31E-06 -0.0717 0.0105 -0.0750 0.0075 -0.0512 0.0684 
 
Overall without Ribosomal Proteins 1217 529.21 22.98 110.55 -0.1349 2.33E-06 -0.0691 0.0159 -0.0995 0.0005 -0.0578 0.0437 
 
Cytoplasmic 1022 1625.28 22.95 110.81 -0.1078 0.0006 -0.0902 0.0039 -0.0773 0.0135 -0.0632 0.0435 
Masuda et al 2009 (89) 
 
Cytoplasmic without Ribosomal Proteins 969 592.86 22.95 110.78 -0.1187 0.0002 -0.0978 0.0023 -0.1019 0.0015 -0.0709 0.0273 
 
Inner membrane 134 348.65 23.51 109.80 0.0038 0.9656 0.1262 0.1461 -0.1584 0.0676 0.0066 0.9392 
 
          Integral Membrane Protein  81 371.32 24.27 109.84 0.1829 0.1022 0.2394 0.0313 -0.1156 0.3042 0.0061 0.9570 
  
          Inner membrane lipoprotein  3 162.75 21.25 107.65 - - -0.8752 0.3215 - - -0.8093 0.3997 
  
          Membrane anchored  43 337.14 22.44 110.14 -0.0854 0.5860 -0.0880 0.5747 -0.1093 0.4854 0.0015 0.9926 
  
          Membrane associated  3 213.32 22.65 108.07 - - 0.5438 0.6340 - - -0.0805 0.9487 
  
          Membrane Lipoprotein  3 328.33 21.77 107.64 - - 0.9649 0.1691 - - 0.4960 0.6696 
  
          Periplasmic w N-term memb anchor  1 32.03 22.16 111.15 - - - - - - - - 
  
Periplasmic  63 147.88 22.76 109.65 -0.3890 0.0016 -0.3009 0.0166 -0.4100 0.0008 -0.2913 0.0205 
  
Outer membrane 51 265.22 22.63 109.27 -0.2168 0.1264 0.0290 0.8397 -0.2627 0.0626 -0.0437 0.7609 
  
          Outer membrane Lipoprotein  31 140.62 22.11 108.35 -0.5761 0.0007 -0.4159 0.0200 -0.4994 0.0042 -0.3591 0.0472 
  
          Outer Membrane ß-barrel protein  20 458.36 23.43 110.68 0.1579 0.5061 -0.0841 0.7244 -0.0692 0.7720 -0.2258 0.3385 
   
  
   
  







Overall 961 1385.17 23.18 110.53 -0.2868 1.08E-19 -0.0741 0.0216 -0.0196 0.5440 -0.0506 0.1171 
 
Cytoplasmic 579 2265.89 22.95 110.87 -0.1250 0.0026 -0.1035 0.0127 -0.1381 0.0009 -0.0793 0.0566 
 
Inner membrane 294 7.47 23.80 110.22 -0.1115 0.0563 -0.1212 0.0378 -0.2400 3.20E-05 -0.0904 0.1221 
Masuda et al 2009 (89) 
 
          Integral Membrane Protein  208 1.54 24.30 110.23 0.1511 0.0293 0.1558 0.0246 -0.2283 0.0009 -0.1823 0.0084 
 
          Inner membrane lipoprotein  3 162.75 21.25 107.65 - - -0.8752 0.3215 - - -0.8093 0.3997 
 
          Membrane anchored  74 9.31 22.67 110.44 -0.1596 0.1744 0.0930 0.4305 -0.1601 0.1731 -0.0227 0.8478 
  
          Membrane associated  3 213.32 22.65 108.07 - - 0.5438 0.6340 - - -0.0805 0.9487 
  
          Membrane Lipoprotein  3 17.67 21.77 107.64 - - -0.9998 0.0138 - - -0.2296 0.8525 
  
          Periplasmic w N-term memb anchor  3 1.58 23.12 111.58 - - 0.7273 0.4816 - - 0.9170 0.2612 
  
Periplasmic  33 174.87 22.66 109.78 -0.4170 0.0158 -0.3849 0.0270 -0.3652 0.0367 -0.3454 0.0490 
  
Outer membrane 54 207.98 22.57 109.14 0.0094 0.9461 0.0632 0.6496 0.0271 0.8457 0.0328 0.8136 
  
          Outer membrane Lipoprotein  33 96.59 22.10 108.42 -0.2361 0.1860 -0.3545 0.0429 -0.1899 0.2898 -0.2224 0.2135 
  
          Outer Membrane ß-barrel protein  21 383.00 23.29 110.26 0.2519 0.2706 -0.0215 0.9262 0.2286 0.3190 -0.0383 0.8689 
  
Cell Surface Appendage 1 1.45 19.52 99.41 - - - - - - - - 
             
BOLD:  P < 0.05 
Notes:  Echobase sequence and location data were merged with abundance values of Masuda et al (89) using ECK numbers. GatA 
had two abundance values in whole cell lysates. InsH and yi81 have multiple Echobase number but only one ECK number; so ASC and 





 Table 3.13:  Comparison of protein abundance and average synthetic cost (ASC) or mean amino acid mass in E. coli (continued) 
 





Number per cell vs. Avg Cost Number per cell vs. Avg Mass 
   
  
  
Spearman Pearson Spearman Pearson 
  
Location Proteins Avg Cost Avg Mass R P value R P value R P value R P value 
  
Overall 1091 201883.19 22.95 110.54 -0.1606 9.69E-08 0.0653 0.0309 -0.0696 0.0215 0.0502 0.0973 
  




Cytoplasmic 874 251724.34 22.91 110.75 -0.1248 0.0002 0.0849 0.0120 -0.0663 0.0499 0.0530 0.1174 
 
Cytoplasmic without Ribosomal Proteins 821 4353.39 22.91 110.72 -0.1440 3.44E-05 -0.0980 0.0049 -0.0995 0.0043 -0.0494 0.1572 
 
Inner membrane 99 428.06 23.53 109.91 -0.0805 0.4285 -0.0532 0.6008 -0.2200 0.0287 -0.2605 0.0092 
Ishihama 
et al 2008 
(70) 
 
          Integral Membrane Protein  59 365.79 24.37 110.34 0.2052 0.1190 0.0922 0.4872 -0.0968 0.4657 -0.0782 0.5561 
 
          Inner membrane lipoprotein  4 507.25 21.60 107.92 - - -0.3656 0.6344 - - -0.5773 0.4227 
 
          Membrane anchored  29 457.27 22.29 109.69 -0.3169 0.0940 -0.1789 0.3532 -0.2479 0.1948 -0.2518 0.1876 
  
          Membrane associated  4 541.25 23.05 109.46 - - -0.2223 0.7777 - - -0.3074 0.6926 
  
          Membrane Lipoprotein  2 384.00 21.62 108.03 - - - - - - - - 
  
          Periplasmic w N-term mem anchor  1 147.00 23.44 111.77 - - - - - - - - 
  
Periplasmic  77 1322.96 22.84 109.59 0.0642 0.0505 -0.1758 0.1262 -0.2120 0.0642 -0.1067 0.3557 
  
Outer membrane 41 2616.32 22.61 109.27 -0.2947 0.0615 -0.0260 0.8719 -0.3497 0.0250 -0.1445 0.3675 
  
          Outer membrane Lipoprotein  21 1432.67 21.95 108.14 -0.5651 0.0076 -0.4722 0.0307 -0.4462 0.0426 -0.2605 0.2542 
  
          Outer Membrane ß-barrel protein  20 3859.16 23.30 110.47 0.1173 0.6224 -0.0602 0.8010 -0.2165 0.3591 -0.3991 0.0813 
  
Note:  12 proteins  exluded (plasmid origins:  P07676, P06717,Q00191,P22997,P62593,P27190,P02978,P00642,Q52280,Q57154 - Not in  K-12:  P15484,P11257) 
             
BOLD:  P < 0.05 
 
Notes:  Echobase sequence and location data were merged with the abundance values of Ishihama et al (70) using Uniprot numbers. 
We excluded 12 proteins that did not have Echobase information. Ten had plasmid origins:  P07676, P06717, Q00191, P22997, 





Table 3.14:  Comparison of protein chain length and average synthetic cost (ASC) or mean amino acid mass in E. coli. 
     
Length vs. Avg Cost Length vs. Avg Mass 
   
Resp. 
 
Pearson Spearman Pearson Spearman 
Location Number Avg Length Avg Cost Avg Mass R P value R P value R P value R P value 
Overall - E. coli 4333 312.46 23.55 111.01 -0.0992 5.92E-11 -0.0503 0.0009 -0.1225 6.00E-16 -0.1738 0, t=-11.62 
Cytoplasmic 2859 296.50 23.32 111.61 -0.1329 9.86E-13 -0.1263 1.23E-11 -0.1414 3.08E-14 -0.1949 0, t=-10.62 
Inner membrane 972 357.55 24.65 109.99 -0.3051 0, t=-9.98 -0.2850 1.08E-19 -0.1115 0.0005 -0.1469 4.22E-06 
          Integral Membrane Protein  777 369.58 25.01 109.78 -0.4555 0, t=-14.25 -0.4232 0, t=-13.00 -0.0961 0.0074 -0.1275 0.0004 
          Inner membrane lipoprotein  14 485.50 21.99 109.27 0.1662 0.5701 -0.2489 0.3908 0.0715 0.8080 -0.0419 0.8870 
          Membrane anchored  158 284.58 23.37 110.99 -0.2592 0.0010 -0.2887 0.0002 -0.1158 0.1472 -0.1588 0.0463 
          Membrane associated  10 390.50 22.71 109.97 0.5009 0.1403 0.4681 0.1725 0.0841 0.8172 0.0790 0.8282 
          Membrane Lipoprotein  7 439.29 22.97 109.51 0.0601 0.8982 0.2500 0.5887 0.5479 0.2030 0.6071 0.1482 
          Periplasmic w N-term memb anchor  6 271.33 23.48 111.99 -0.4745 0.3416 -0.2571 0.6228 -0.4790 0.3364 -0.3143 0.5441 
Periplasmic  337 309.42 22.85 109.72 0.1030 0.0590 0.1835 0.0007 0.1189 0.0291 0.1389 0.0107 
Outer membrane 149 334.95 22.85 109.62 -0.0217 0.7929 0.1089 0.1862 0.0678 0.4111 0.1858 0.0233 
          Outer membrane Lipoprotein  96 216.46 22.56 109.01 -0.0435 0.6739 0.0324 0.7543 0.0413 0.6892 0.1490 0.1474 
          Outer Membrane ß-barrel protein  53 549.57 23.37 110.73 -0.4286 0.0014 -0.3440 0.0117 -0.2493 0.0718 -0.1236 0.3779 




    




Yeast All 6732 449.90 26.59 113.20 -0.1853 0, t=-15.47 -0.2173 0, t=-18.26 -0.0428 0.0004 -0.0952 4.83E-15 
Yeast Cytoplasmic 2845 498.02 25.86 112.86 0.0164 0.3824 0.0119 0.5261 0.0247 0.1872 -0.0078 0.6783 
Yeast Extracellullar 54 479.54 24.88 107.16 -0.1672 0.2268 0.0081 0.9535 -0.0316 0.8203 0.0959 0.4905 




    




M. tuberculosis All 3927 339.23 22.15 107.14 -0.1116 2.36E-12 -0.0171 0.2848 -0.1952 0, t=-12.47 -0.1437 1.08E-19 
M. tuberculosis Cytoplasmic 2111 348.93 22.25 108.56 -0.0439 0.0438 -0.0154 0.4793 -0.1451 2.09E-11 -0.1841 1.53E-17 
M. tuberculosis Extracellullar 140 513.19 19.45 96.00 -0.4957 4.73E-10 -0.4958 4.72E-10 -0.5585 7.51E-13 -0.5670 2.81E-13 




    




P. syringae All 5608 329.66 23.05 110.08 -0.0967 3.98E-13 -0.0595 8.16E-06 -0.0867 7.67E-11 -0.1284 0, t=-9.69 
P. syringae Cytoplasmic 1973 317.70 22.96 110.98 -0.1083 1.42E-06 -0.0913 4.92E-05 -0.1407 3.41E-10 -0.1934 4.34E-18 
P. syringae Extracellular 84 433.73 21.58 107.30 -0.0855 0.4394 -0.1262 0.2525 -0.0902 0.4147 -0.1653 0.1330 
P. syringae HOPs & helpers 51 437.31 21.48 107.68 -0.0635 0.6577 -0.2346 0.0975 -0.0445 0.7567 -0.2175 0.1253 
           







Table 3.14:  Comparison of protein chain length and average synthetic cost (ASC) or mean amino acid mass in E. coli (continued). 
 
E. coli proteins 
   
  Length vs. Avg Cost Length vs. Avg Mass 
    
  Pearson Spearman Pearson Spearman 
Protein Length Number Avg Length Avg Cost Avg Mass R P value R P value R P value R P value 
All proteins 4333 312.46 23.55 111.01 -0.0992 5.92E-11 -0.0503 0.0009 -0.1225 6.00E-16 -0.1738 0, t=-11.62 
≤25 amino acids 7 17.57 30.50 121.29 -0.7388 0.0578 -0.8469 0.0162 -0.5140 0.2379 -0.3784 0.4026 
≤50 amino acids 65 37.82 25.61 113.55 -0.4416 2.31E-04 -0.2536 0.0416 -0.2284 0.0672 -0.1155 0.3595 
≤75 amino acids 240 57.76 24.46 113.03 -0.3644 6.01E-09 -0.2314 0.0003 -0.1140 0.0781 -0.0710 0.2732 
≤100 amino acids 478 72.91 23.95 112.32 -0.3524 2.01E-15 -0.2698 2.05E-09 -0.1645 3.04E-04 -0.1442 0.0016 
≤125 amino acids 718 86.09 23.88 112.20 -0.2215 2.00E-09 -0.1504 5.20E-05 -0.1172 0.001658 -0.1124 0.0026 
≤150 amino acids 954 98.88 23.81 112.07 -0.1888 4.17E-09 -0.1285 6.90E-05 -0.1104 6.37E-04 -0.1131 0.0005 
≤175 amino acids 1187 111.28 23.75 111.97 -0.1697 4.00E-09 -0.1150 7.15E-05 -0.1092 1.63E-04 -0.1129 9.68E-05 
≤200 amino acids 1438 124.62 23.71 111.82 -0.1574 1.95E-09 -0.1098 2.99E-05 -0.1296 8.24E-07 -0.1361 2.22E-07 
≤300 amino acids 2403 175.21 23.64 111.50 -0.1033 3.90E-07 -0.0549 0.0071 -0.1451 8.83E-13 -0.1504 1.26E-13 
≤500 amino acids 3759 251.50 23.59 111.01 -0.0674 3.53E-05 -0.0318 0.0513 -0.2223 0, t=-13.97 -0.2296 0, t=-14.46 




    
  
    
  
  
≥50 amino acids 4272 316.39 23.53 110.97 -0.0774 4.13E-07 -0.0331 0.0306 -0.1129 1.35E-13 -0.1648 0, t=-10.92 
≥100 amino acids 3861 341.79 23.50 110.84 -0.0706 1.13E-05 -0.0191 0.2360 -0.0830 2.42E-07 -0.1303 4.37E-16 
≥150 amino acids 3388 372.17 23.49 110.71 -0.0669 9.69E-05 -0.0157 0.3594 -0.0465 0.0068 -0.0937 4.65E-08 
≥200 amino acids 2902 405.27 23.48 110.61 -0.0767 3.50E-05 -0.0222 0.2311 -0.0132 0.4765 -0.0595 0.0013 
≥300 amino acids 1938 482.59 23.45 110.39 -0.0848 1.87E-04 0.0087 0.7017 0.0695 0.0022 0.0699 0.0021 
≥500 amino acids 581 709.12 23.35 110.97 -0.2317 1.60E-08 -0.1908 3.64E-06 -0.0355 0.3935 0.0479 0.2488 
≥1000 amino acids 57 1234.70 22.82 110.50 -0.3158 0.016716 -0.3325 0.0115 -0.1590 0.2375 -0.0148 0.9131 
           




Table 3.15:  Comparison of the ASCs of extracellular vs intracellular fiber and fiber-
associated proteins in E. coli. 
 
     Intracellular    
 Extracellular 
Fiber proteins:   RecA, MreB, ZapB (YiiU)  FliC, FlgE, FimA, CsgA 
RodZ (YfgA), FtsZ, MinD  PapA* (P04127), FlaK** 
 
Fiber-associated proteins‡: FtsA, ZipA, ZapA, FtsE  FliD, FlgK, FlgL, FlgD, FliK 
FtsX, FtsK, FtsQ, FtsL  CsgB, FimF, FimG, FimH, 
FtsB, FtsW, FtsI, FtsN  PapE(P08407)*, PapF (P08408)*  
MinC, MinE, DicB, MreC  PapG(P13720)*, PapK(P62532)* 
MreD 













U-Test   
P Value 
vs Intracellular Fibers 21.575 
      Extracellular Fibers 19.844 5.410 0.000428 9 1.731 2.8823 0.00395 
Extracellular Fibers without PapA 19.696 5.912 0.000357 8 1.879 2.7386 0.00617 
Extracellular Fibers without FlaK 19.850 4.713 0.002175 7 1.725 2.7386 0.00617 
Extracellular Fibers without PapA, FlaK 19.666 5.087 0.003811 5 1.909 2.5584 0.01052 
        vs Intracellular Fiber-associated 22.944 
      Extracelluar Fiber-associated 21.534 2.352 0.026514 26 1.410 2.532 0.01134 
Extracellular Fiber-associated without Pap Proteins 20.782 4.265 0.000269 24 2.162 3.4224 0.00062 
        vs Intracellular Direct Fiber-associated 22.031 
      Extracelluar Direct Fiber-associated 20.752 2.843 0.014807 12 1.280 1.8074 0.0707 
Extracelluar Direct Fiber-associated without PapK 20.536 3.512 0.004863 11 1.495 2.2857 0.02227 
        vs Cytoplasmic Proteins 23.555 
      Intracellular Fibers 21.575 9.952 0.000175 5 1.980 3.5948 0.00032 
Extracellular Fibers 19.844 14.685 2.65E-05 5 3.711 4.1923 2.76E-05 
Extracellular Fibers wihout PapA 19.696 15.435 0.000103 4 3.859 3.8367 0.00012 
Extracellular Fibers without FlaK 19.850 11.991 0.000277 4 3.705 3.8256 0.00013 
Extracellular Fibers wihout PapA, FlaK 19.666 12.157 0.001198 3 3.889 3.4321 0.0006 
Intracellular Fiber-associated 22.944 1.523 0.147252 16 0.611 2.4607 0.01387 
Extracellular Fiber-associated 21.534 4.523 0.000698 12 2.021 4.366 1.27E-05 
Intracellular Direct Fiber-associated 22.031 5.334 0.003104 5 1.524 2.9116 0.0036 
Extracelluar Direct Fiber-associated 20.752 8.025 8.93E-05 7 2.803 4.4242 9.68E-06 
        †    Student T test:  Assumes Unequal Variance. Confidence Intervals are 2 tailed 
  *    Not in K-12 
**  Average ASC of Flagellin phase 2 variable forms in Table 3.18D. Not in K-12 




Table 3.16:  Calculations of cost savings and fitness. 
 
Description                 Value calculated/used Literature values & Notes 
Average Doubling Time   30 minutes  30 minutes(2) 
Number of H+ per ATP   4  (143, 158)  4 (143, 158) 
Number of H+ per flagellar rotation  1240 (94)  800 (93, 99), ~1000 (37),  
1200 (38, 106), 1240±240 (94), 
1303 (162),1170-1270 (162), 
Flagella Rotation rates*.**  100Hz  (73, 106) 10-20 (134),13.4 (18), 
100 (73, 84, 93, 106), 170 (134), 
200(134), 250 (37),60-270 (94, 
134), 300 (20, 38, 101, 134) 
Number of H+/s (100Hz, 1flag.)  124,000   - 
Number of H+/s (100Hz, 5flag.)  620,000   - 
Growth disadvantage flagella  -   2% (106) 
Flagellar rotation cost**   -   0.1% total energy growth  
conditions (106) 
Growth of flagella   -   10000 aa/s 49, 50 
Respiratory chain total   20 million H+/s (106) 20 million H+/s (106) 
Total H+ per doubling (30 min.)  36 billion  or 9 billion ATPs if all  H+ are  
        converted to ATPs 
F0F1-ATPases H
+/s    -   3 million (106), 8 million(106)   
ATP molecules in cell   -   0.5 – 3 million (2),  
0.3-1.4 billion(58) 
ATP Cost per cell***   20 billion  6-11 billion (theoretical) (98), 
        12-20 billion (experimental) (98), 
        20-60 billion (3, 145), 55 billion(2) 
Cost per aa (% each aa is same)  27.36   - 
Average Cost per aa (MG1655)  23.555   - 
FliC Cost per aa    19.155   - 
FimA Cost per aa    19.525   - 
 
Flagella:  FliC 
Number of Flagella per cell  5   0-15 (8 typical) (105, 106), 5-10  
        (106),10 (2, 38), 9.9±2.9 log &  
        4.5±2.1 in stationary (78), 6.6±1.4 
         (74), 6±2 (124), 2.5 to 4.4 (69), 
 4 (73)  
Subunits FliC per flagella   20000 (73, 106)  20000 (29, 37, 73, 87, 106),  
        5340/helix turn (19, 60), 
        30000 (167), 33000 (3000x11) (2) 
Savings per aa vs average   4.4001   - 
Length of FliC    498 (97)   - 
Savings per FliC    2191.2 ATPs  - 




Table 3.16:  Calculations of cost savings and fitness (continued). 
 
Description                 Value calculated/used Literature values & Notes 
Flagella:  FliC (continued) 
One Gly to Trp substitution in FliC  0.0313%(10-4) of  using 5 flagella & 20x109 ATPs/cell 
total cellular cost    
Total savings per flagellum  43824894 ATP  20000 FliC subunits 
Saving for 5 flagella   219124470 ATP  - 
Saving for 5 flagella   876497883 H+  4H+/ATP 
Time Swimming (100Hz ,1 flag.)   1412 seconds   23.5 min:  1 flag. savings, 
constantly spinning 
% Savings Total Respiratory Chain  2.43%   using 30 minute doubling 
and 5 flagella 
% Savings ATP Cost per cell  1.096%   using 5 flagella & 20x109 ATPs/cell 
 
Type 1 Pili:  FimA 
Number of Pili per cell   300   200-500(21, 73),100-1000 (106),  
100-300(2, 105, 106), 100-200(85),  
171-200 (140), 100-500 (157) 
Number of FimA per pili   1000   1000 (21, 73), 3000 (73), 500 to  
        3000 (26, 59, 110), >>100(76),  
        ~2800 (59) (19.31nm*27 & 2um) 
Savings per aa vs average   4.0302   - 
Length of FimA    182 (97)   - 
Savings per FimA    733.5 ATPs  - 
Total savings for Type 1 pili  220048920 ATP  - 
Total savings for Type 1 pili  880548129 H+  4H+/ATP 
Time Swimming (100Hz ,5 flag.)  1420 seconds   23.7 min., all 5 flagella spinning 
% Savings Total Respiratory Chain  2.45%   30 minute doubling 
% Savings ATP Cost per cell  1.100%   using 300 fimbriae &  
20x109 ATPs/cell 
 
Typical Aerobic Gram Neg. Organism  
Extracellular protein aa cost (50% GC) 21.443 ATPs/aa  from eq. of line fitting Fig. 3.5B 
Total protein aa cost (50%GC)  23.492 ATPs/aa  from eq. of line fitting Fig. 3.5B 
Savings per Extracellular protein  2.0495 ATPs/aa  8.274% lower cost vs Total proteins  
Total proteins/cell   2.35x106(106)  3.6x106 (2) 
Extracellular proteins/cell   5.0x105   1x106(2); 100875 (5 flagella); 
300900 (300 Type I Pili);  
5x105 S-layer proteins per cell(133) 
Extracellular protein savings  1.537%   Assumes all amino acids are  
        recovered. 300aa/protein, 
2.0495ATPs/aa, 2x1010 ATPs/cell, 




Table 3.16:  Calculations of cost savings and fitness (continued). 
 
Description                 Value calculated/used Literature values & Notes 
Typical Aerobic Gram Neg. Organism (continued)  
Extracellular protein synthetic cost  16.08%   Assumes all amino acids are lost.  
300aa/protein, 21.443 ATPs/aa, 
2x1010 ATPs/cell, 5x105  
extracellular proteins per cell 
Extracellular protein synthetic cost  17.62%   Assumes all amino acids are lost. if 
if aa biases = cellular proteins      300aa/protein, 23.492 ATPs/aa,  
        2x1010 ATPs/cell, 5x105    
        extracellular proteins per cell  
   
Direct Competition     Assumes savings directly affect doubling times 
Generations Fold Increase % Cheaper Organism 
100 2.922 74.503 
200 8.539 89.516 
250 14.596 93.588 
500 213.043 99.533 
1000 45387.3 99.998 
 
Notes:  Most values are for E. coli K-12 or S. typhimurium except in a few instances (Streptococcus(84, 94)) 
 
*Many values are maximum rates and depend on temperature(20, 94) and other factors such as PMF(49) 
and pH(93, 99). Values can differ significantly depending on how they are measured (bundle, individual 
fiber, tethered cell, bead on polyhook, electrorotation of tethered cells)(141) (134). Above 100-175 Hz(28) 
torque decreases significantly (efficiency plummets) and approaches zero at ~300Hz (effect is greater at 
lower temperatures and lower pH)(17, 20, 49, 99). For free-swimming cells the motor saturation point is 
about 100Hz (MacNab in (107)). 
 
** Source of flagella power is PMF. Under aerobic respiration flagella rotation is saturation as it is a small 
percent of the total protons pumped. Under anaerobic glycolysis, ATP hydrolysis becomes the major 
source  of flagellar power and swimming speed is reduced(106). 
 
*** Values vary considerably and depend on conditions including growth rate, aerobic vs anaerobic 
conditions, availability and type of carbon source (glucose vs acetate), etc. Generally aerobic growth and 
richer media conditions require less ATPs/cell. A good discussion is listed in source (98) (references cited 
therein are (3, 11, 14, 45, 47, 64, 107, 115, 144-147, 156)). The calculation requires multiplying the cells 
per gram (dry cell weight) times YATPmax (Number of ATP per gram of cells). Cell weight used in (98) is 
0.28pg per cell (40 minutes growth on glucose(106) = 3.6 trillion cells per gram); however, cell weight 
varies with growth conditions (106) and changes would affect values listed in table. Theoretical values are 
smaller than experimental values because the former exclude some cell maintenance cost including 





Table 3.17A: Comparisons of the mean ASCs of proteins in locations of E. coli using 
different cost values. 
 
 
  Akashi & Gojobori Craig & Weber Molecular Mass 
 
Number Mean % of Overall Mean % of Overall Mean % of Overall 
Overall 4333 23.5549   20.3139   111.0052   
Cytoplasm 2859 23.3171 98.99 19.8168 97.55 111.6093 100.54 
Inner Membrane 972 24.6529 104.66 22.2954 109.75 109.9862 99.08 
Integral Membrane Protein  777 25.0102 106.18 22.9046 112.75 109.7845 98.90 
Membrane anchored  158 23.3743 99.23 20.0457 98.68 110.9876 99.98 
Periplasmic N-term mem anchor  6 23.4800 99.68 19.6510 96.74 111.9889 100.89 
Inner Membrane Lipoprotein  14 21.9869 93.34 18.3978 90.57 109.2690 98.44 
Membrane associated  10 22.7075 96.40 19.2283 94.66 109.9723 99.07 
Membrane Lipoprotein* 7 22.9700 97.52 19.8973 97.95 109.5073 98.65 
Periplasm 337 22.8538 97.02 19.3281 95.15 109.7200 98.84 
Outer Membrane 149 22.8521 97.02 19.4946 95.97 109.6250 98.76 
OM ß-barrel protein  53 23.3737 99.23 20.2872 99.87 110.7320 99.75 
OM Lipoprotein  96 22.5642 95.79 19.0570 93.81 109.0138 98.21 
Cell surface appendage  12 20.4738 86.92 17.1651 84.50 103.8034 93.51 
Secreted and released  4 21.1865 89.95 17.1547 84.45 108.1931 97.47 
Extracellular 16 20.6520 87.68 17.1625 84.49 104.9008 94.50 
 
 
  Cabons per aa Nitrogens per aa Sulfur per aa* Mean ∆G per aa 
 
Number Mean % Overall Mean % Overall Mean %Overall Mean % Overall 
Overall 4333 4.9663   1.3596   0.0425   206.0956   
Cytoplasm 2859 4.9530 99.73 1.3857 101.92 0.0425 100.00 207.2800 100.57 
Inner Membrane 972 5.0646 101.98 1.2950 95.25 0.0452 106.30 204.6274 99.29 
Periplasm 337 4.8686 98.03 1.3387 98.46 0.0371 87.33 202.4783 98.24 
Outer Membrane 149 4.8464 97.59 1.3373 98.36 0.0394 92.57 202.7336 98.37 
Extracellular 16 4.5437 91.49 1.2744 93.73 0.0228 53.63 191.1559 92.75 




cost Spearman Kendall   Pearson 
vs Akashi&Gojobori 23.555 R t-test p value Tau Z 
p 
value Gamma                             R t-test p value 
Craig&Weber 20.314 0.905 139.76 →0 190.58 18809.6 →0 0.73907 0.918 151.88 →0 
Molecular Mass 111.005 0.571 45.78 →0 89.06 8789.73 →0 0.42936 0.592 48.38 →0 
Carbons per Amino Acid 4.966 0.902 137.89 →0 279.17 27553.2 →0 0.91605 0.916 150.31 →0 
Nitrogens per Amino Acid 1.36 0.058 3.86 0.00012 
  
  0.05176 0.034 2.23 0.02573 
Seawater ∆G(kJ /mol) 18⁰C 206.096 0.622 52.26 →0 95.42 9417.33 →0 0.46002 0.636 54.24 →0 




    
  
  




    
  
  
Seawater ∆G(kJ/mol) 18⁰C 206.096 0.900 135.90 →0 
  
  0.733 0.903 138.71 →0 
Carbons per Amino Acid 4.966 0.784 83.12 →0 201.12 19850 →0 0.61254 0.802 88.29 →0 




Table 3.17A: Comparisons of the mean ASCs of proteins in locations of E. coli using 
different cost values (continued). 
 
Mann Whitney U Test Akashi & Gojobori Craig & Weber Molecular Mass 
 
Z p value Z p value Z p value 
vs Cytoplasm     
  
    
Inner Membrane 23.196 4.98E-119 29.497 3.18E-191 13.025 8.85E-39 
Integral Membrane Protein  27.638 3.90E-168 34.510 5.65E-261 13.352 1.16E-40 
Membrane anchored  0.649 0.5164 0.013 0.9897 2.258 0.0240 
Periplasmic w N-term mem anchor  0.367 0.7139 0.245 0.8068 0.277 0.7820 
Inner Membrane Lipoprotein  4.153 3.28E-05 3.795 0.0001 2.908 0.0036 
Membrane associated  1.777 0.0755 1.286 0.1985 1.831 0.0670 
Membrane Lipoprotein* 1.124 0.2609 0.470 0.6384 1.950 0.0512 
Periplasm 6.029 1.65E-09 5.698 1.21E-08 9.772 1.48E-22 
Outer Membrane 3.713 2.05E-04 2.510 0.0121 5.975 2.30E-09 
OM ß-barrel protein  0.305 0.7604 2.374 0.0176 1.843 0.0653 
OM Lipoprotein  4.892 9.98E-07 4.906 9.31E-07 6.151 7.72E-10 
Cell surface appendage  5.606 2.07E-08 4.883 1.05E-06 5.690 1.27E-08 
Secreted and released  2.269 0.0233 2.264 0.0236 1.980 0.0477 
Extracellular 5.983 2.19E-09 5.355 8.55E-08 5.912 3.38E-09 
 
    
  
    
vs All     
  
    
Cytoplasm 6.223 4.89E-10 8.631 6.09E-18 7.263 3.78E-13 
Inner Membrane 19.530 6.17E-85 24.304 1.77E-130 8.729 2.58E-18 
Integral Membrane Protein  24.013 2.05E-127 29.427 2.51E-190 9.405 5.20E-21 
Membrane anchored  2.102 0.0356 2.156 0.0311 0.204 0.8381 
Periplasmic w N-term mem anchor  0.051 0.9594 0.735 0.4621 0.807 0.4198 
Inner Membrane Lipoprotein  4.275 1.91E-05 4.034 5.49E-05 2.215 0.0268 
Membrane associated  2.103 0.0355 1.777 0.0756 1.181 0.2374 
Membrane Lipoprotein* 1.317 0.1878 0.836 0.4030 1.410 0.1587 
Periplasm 8.243 1.69E-16 8.648 5.25E-18 6.727 1.74E-11 
Outer Membrane 5.149 2.62E-07 4.599 4.25E-06 3.921 8.83E-05 
OM ß-barrel protein  0.761 0.4466 0.633 0.5269 0.479 0.6316 
OM Lipoprotein  5.890 3.86E-09 6.231 4.62E-10 4.559 5.14E-06 
Cell surface appendage  5.567 2.60E-08 4.958 7.12E-07 5.496 3.89E-08 
Secreted and released  2.369 0.0179 2.393 0.0167 1.643 0.1004 






Table 3.17B:  Comparisons of the mean ASCs of proteins in locations of S. cerevisiae using different cost values. 
 
  
Wagner Wagner Bragg & Wagner Bragg & Wagner Amino Acid 
Molecular Mass 
 













Overall 6732 26.59   6.61   25.14   5.81   113.20   
Cytoplasm 2845 25.86 97.25 6.46 97.68 24.32 96.73 5.61 96.51 112.86 99.70 
PM 186 27.05 101.70 6.54 98.99 25.94 103.17 5.94 102.11 111.66 98.64 
Integral/Endo Memb. 172 28.46 107.04 6.69 101.22 27.42 109.04 6.12 105.19 112.81 99.65 
Cell Wall 44 24.04 90.39 5.64 85.31 23.21 92.30 5.18 89.17 105.27 93.00 
Extracellular 54 24.88 93.54 5.92 89.56 24.00 95.46 5.44 93.57 107.16 94.66 
Extracellular & Cell Wall 98 24.50 92.13 5.79 87.65 23.65 94.04 5.32 91.59 106.31 93.92 
 
 
  Mean Spearman Kendall 
 
Linear (Pearson) 
vs Yeast respiratory (Wagner) 26.5937 R t-test p value Tau Z p value Gamma                             R t-test p value 
Yeast respiratory (Bragg&Wagner) 25.145 0.959 278.2 →0 772.5 95050 →0 0.83524 0.966 308.5 →0 
Yeast fermentative (Wagner) 6.61024 0.677 75.37 →0 380.3 46794 →0 0.49749 0.69 78.23 →0 
Yeast fermentative (Bragg&Wagner) 5.81345 0.693 78.9 →0 
   
0.51175 0.713 83.42 →0 
Molecular Mass 113.198 0.483 45.31 →0 
   









vs Yeast fermentative (Wagner)      
 
  




Yeast respiratory (Bragg&Wagner)      0.586 59.32 →0 237.7 29252 →0 0.42314 0.604 62.11 →0 
Yeast fermentative (Bragg&Wagner)      0.802 110.1 →0 520.4 64025 →0 0.62318 0.855 135.1 →0 






Table 3.17B:  Comparisons of the mean ASCs of protein in locations of S. cerevisiae using different cost values (continued). 
 
Mann Whitney U Test Wagner Wagner Bragg & Wagner Bragg & Wagner Amino Acid 
Molecular Mass 
 
 Respiratory Fermentative  Respiratory Fermentative 
vs Overall Z p value Z p value Z p value Z p value Z p value 
Cytoplasm 14.8616 5.85E-50 12.7545 2.94E-37 15.4240 1.13E-53 15.0629 2.84E-51 5.6203 1.91E-08 
PM 4.3898 1.13E-05 0.2869 0.7741849 6.0996 1.06E-09 4.9427 7.71E-07 7.0659 1.60E-12 
Integral/Endo Membranes 12.3372 5.71E-35 3.8335 0.0001263 13.2731 3.32E-40 9.4490 3.42E-21 2.2301 0.0257411 
Cell Wall 6.8980 5.27E-12 8.5229 1.56E-17 5.3273 9.97E-08 6.1732 6.69E-10 8.6931 3.53E-18 
Extracellular 4.8461 1.26E-06 7.1035 1.22E-12 3.1973 0.001387 12.6762 8.01E-37 7.6434 2.11E-14 
Extracellular & Cell Wall 8.1895 2.62E-16 10.9442 7.08E-28 5.9212 3.20E-09 10.1865 2.28E-24 11.4573 2.16E-30 
 
    
  
            
vs Cytoplasm     
  
            
PM 9.0114 2.04E-19 3.7753 0.0001598 10.9088 1.05E-27 9.9169 3.52E-23 5.6918 1.26E-08 
Integral/Endo Membranes 16.5602 1.35E-61 8.1420 3.89E-16 17.4758 2.19E-68 14.3009 2.16E-46 0.7752 0.4382106 
Cell Wall 5.7802 7.46E-09 7.9861 1.39E-15 3.7201 0.0001991 4.8510 1.23E-06 8.5915 8.59E-18 
Extracellular 3.0802 0.0020684 6.0747 1.24E-09 1.0085 0.3132149 1.8219 0.0684758 7.2476 4.24E-13 




Table 3.17C: Comparisons of the mean ASCs of proteins in locations of M. tuberculosis 
H37Rv using different cost values. 
 
 
  Akashi & Gojobori Craig & Weber Molecular Mass 
 
Number Mean % of Overall Mean % of Overall Mean % of Overall 
Overall 3927 22.1469   19.3088   107.1443   
Cytoplasm 2111 22.2479 100.46 19.1672 99.27 108.5627 101.32 
Cytoplasmic Membrane 598 22.9850 103.78 20.8788 108.13 106.1764 99.10 
Unknown 1070 21.8415 98.62 18.9533 98.16 106.3746 99.28 
Extracellular 140 19.4465 87.81 17.5376 90.83 95.9992 89.60 
Cell Wall 8 20.9739 94.70 17.8469 92.43 103.1890 96.31 





cost Spearman   Pearson 
vs Akashi & Gojobori 22.1456 R t-test p value Gamma                             R t-test p value 
Craig & Weber 19.3088 0.8744062 112.9059985 →0 0.697734461 0.8728684 112.0696964 →0 
Molecular Mass 107.1443 0.7032694 61.97531318 →0 0.532250842 0.7803322 78.17459575 →0 
 
 
Mann Whitney U Test Akashi & Gojobori Craig & Weber Molecular Mass 
 
Z p value Z p value Z p value 
vs Cytoplasm     
  
    
Cytoplasmic Membrane 10.7167 8.495E-27 19.0031 1.61E-80 14.4926 1.35E-47 
Unknown 8.9557 3.375E-19 5.1720 2.316E-07 15.0537 3.27E-51 
Extracellular 12.3710 3.752E-35 10.6110 2.65E-26 15.3676 2.70E-53 
Cell Wall 2.4495 0.0143057 2.0390 0.0414474 3.4030 0.0006665 
Extracellular and Cell Wall 12.5622 3.405E-36 10.7611 5.26E-27 15.6863 1.88E-55 
 
    
  
    
vs All     
  
    
Cytoplasm 2.0838 0.0371784 1.7299 0.0836427 11.3553 6.98E-30 
Cytoplasmic Membrane 11.7610 6.203E-32 17.8934 1.33E-71 7.8344 4.66E-15 
Unknown 7.5395 4.718E-14 6.4176 1.385E-10 7.3012 2.85E-13 
Extracellular 11.8675 1.747E-32 10.6696 1.41E-26 13.6224 2.95E-42 
Cell Wall 2.2392 0.025142 2.0735 0.0381271 2.7638 0.005713 




Table 3.18A: ASC of P. syringae HOPs and HOP Helpers 
Mean 
Mass ASC Percentile 
Total 
aa Description Note 
101.564 20.107 98.841 422 gi|28868125|PSPTO0905 glycosyl hydrolase family 5 HOP 
107.648 20.432 98.056 488 gi|28871892|PSPTO4776 type III effector HopPmaI(Pto) HOP 
105.695 20.432 98.038 416 gi|28870457|PSPTO3293 hypothetical protein HOP 
104.244 20.476 97.895 404 gi|28870456|PSPTO3292 hypothetical protein HOP 
107.477 20.486 97.860 553 gi|28870262|PSPTO3087 avirulence protein AvrPtoB HOP 
107.706 20.560 97.628 279 gi|28867704|PSPTO0474 hypothetical protein HOP 
104.303 20.566 97.592 486 gi|28868580|PSPTO1372 type III effector HopPtoA1 HOP 
103.549 20.625 97.432 404 gi|28872174|PSPTO5061 candidate type III effector Hop protein HOP 
108.166 20.629 97.396 287 gi|28867301|PSPTO0061 candidate type III helper HolPtoY HOP 
105.613 20.746 96.736 712 gi|28868583|PSPTO1375 type III effector HopPtoM HOP 
105.278 20.749 96.701 118 gi|28871729|PSPTO4597 candidate type III effector HolPtoZ HOP 
107.772 20.868 95.809 384 gi|29171488|type III effector HopX1|pDC3000A HOP 
104.950 21.013 94.650 487 gi|28871842|PSPTO4718 type III effector HopPtoA2 HOP 
108.109 21.103 93.990 338 gi|28867285|PSPTO0044 type III effector HopPtoK HOP 
106.294 21.176 93.508 705 gi|28868096|PSPTO0876 type III effector HopPtoD1 HOP 
107.385 21.217 93.223 83 gi|28871829|PSPTO4703 candidate type III effector HolPtoAA HOP 
105.429 21.302 92.367 177 gi|28871720|PSPTO4588 candidate type III effector Hop protein HOP 
107.500 21.337 91.849 1957 gi|28868103|PSPTO0883 candidate type III effector HolPtoR HOP 
108.709 21.614 87.837 1795 gi|28868585|PSPTO1377 avirulence protein AvrE(Pto) HOP 
109.748 21.700 86.374 468 gi|28871846|PSPTO4722 type III effector HopPtoD2 HOP 
108.056 21.739 85.536 168 gi|28871724|PSPTO4592 HopPtoO-related protein HOP 
108.020 21.811 84.038 466 gi|28868614|PSPTO1406 type III effector HopPtoB1 HOP 
111.655 21.947 80.917 164 gi|28871145|PSPTO4001 avirulence protein AvrPto(DC3000) HOP 
110.451 21.973 80.257 380 gi|28872465|PSPTO5354 type III effector HopPsyA(Pto) HOP 
109.687 22.003 79.597 204 gi|28867732|PSPTO0502 type III effector HopPtoF HOP 
108.953 22.115 76.743 284 gi|28868774|PSPTO1568 type III effector HopPtoJ HOP 
110.450 22.153 75.745 403 gi|28868127|PSPTO0907 hypothetical protein HOP 
109.548 22.190 74.835 632 gi|28871821|PSPTO4691 type III effector HopPtoI HOP 
109.462 22.216 74.050 298 gi|28871726|PSPTO4594 type III effector HopPtoS3 HOP 
108.876 22.248 72.998 447 gi|28868097|PSPTO0877 candidate type III effector HolPtoQ HOP 
108.806 22.291 71.874 378 gi|29171494|type III effector HopT1-1|pDC3000A HOP 
108.140 22.306 71.518 389 gi|28871725|PSPTO4593 candidate type III effector HolPtoU2 HOP 
111.456 22.382 69.146 218 gi|28867816|PSPTO0588 type III effector HopPtoH HOP 
107.665 22.388 68.914 269 gi|28867817|PSPTO0589 type III effector HopPtoC HOP 
110.507 22.493 65.525 261 gi|28868126|PSPTO0906 virulence protein putative HOP 
110.799 22.545 63.831 283 gi|29171493|type III effector HopO1-1|pDC3000A HOP 
110.456 22.742 57.410 899 gi|28870054|PSPTO2872 type III effector HopPtoL HOP 
110.845 22.761 56.626 493 gi|28871849|PSPTO4727 type III effector HopPtoG HOP 
109.895 22.888 52.042 152 gi|28868121|PSPTO0901 candidate type III effector Hop protein HOP 
110.105 22.898 51.685 350 gi|28868578|PSPTO1370 type III effector HopPtoN HOP 
113.754 23.257 39.736 211 gi|28871468|PSPTO4331 type III effector HopPtoE HOP 
113.518 23.372 35.919 264 gi|28867731|PSPTO0501 type III effector HoptoS2 HOP 
110.529 23.382 35.581 390 gi|28871844|PSPTO4720 hypothetical protein |HopVI HOP 
113.349 24.055 19.547 276 gi|28868239|PSPTO1022 avirulence protein AvrPpiB1(Pto) HOP 
113.349 24.055 19.529 276 gi|29171482|type III effector HopAM1-1|pDC3000A HOP 
98.635 18.191 100.000 370 gi|28868590|PSPTO1382 type III helper protein HrpZ(Pto) helper 
99.849 18.886 99.839 324 gi|28869866|PSPTO2678 type III helper protein HopPtoP helper 
101.162 19.213 99.661 424 gi|28868581|PSPTO1373 type III helper protein HrpW(Pto) helper 
100.609 19.300 99.590 113 gi|28868589|PSPTO1381 type III helper protein HrpA(Pto) - HrpA helper 
103.797 20.130 98.752 780 gi|28868613|PSPTO1405 type III helper protein HrpK(Pto) helper 
106.065 20.681 97.075 555 gi|28871243|PSPTO4101 type III helper protein HopPmaH(Pto) helper 
109.359 21.812 84.002 495 gi|28868586|PSPTO1378 memb-bound lytic murein transglycosylase D putative helper 





Table 3.18B: ASC of plant and animal Type III effectors 
 ASC Akashi Craig & Weber Avg. Mass Total aa Set SwissProt Number Organism Protein Name Description 
20.903 18.068 104.882 219 A A6M3N5 Yersinia pestis CA88-4125 YopE Translocated host-GTPase-activating protein  
20.816 18.203 104.699 219 A Q7BRY7 Yersinia enterocolitica YopE Yop effector YopE  
21.066 17.544 108.657 468 A A9R9K8 Yersinia pestis bv. Antiqua (strain Angola) YopH Protein-tyrosine-phosphatase YopH  
21.116 17.572 108.807 468 A Q7BRY8 Yersinia enterocolitica YopH Yop effector YopH  
24.338 20.640 115.285 182 A B0A3S4 Yersinia pestis biovar Orientalis str. F1991016 YopK YopK protein  
24.349 20.657 115.279 182 A Q56935 Yersinia pseudotuberculosis YopK Yop targeting protein yopK, yopQ  
24.186 20.330 114.345 182 A Q7BS06 Yersinia enterocolitica YopQ YopQ  
23.655 19.168 112.741 288 A B0HNN9 Yersinia pestis biovar Antiqua str. B42003004 YopJ Effector protein YopJ  
23.583 19.066 112.500 288 A Q93KQ5 Yersinia enterocolitica YopP Yop effector YopP  
22.126 19.043 112.922 409 A A6M3U5 Yersinia pestis CA88-4125 YopM Leucine-rich 15-repeat translocated effector protein  
21.896 18.906 112.760 550 A Q663L9 Yersinia pseudotuberculosis YopM YopM; putative targeted effector protein  
21.880 18.725 112.590 367 A Q93KU8 Yersinia enterocolitica YopM Yop effector YopM  
24.494 21.363 112.702 322 A B0A3S3 Yersinia pestis biovar Orientalis str. F1991016 YopT Cysteine protease YopT  
24.498 21.321 112.883 322 A Q93RN4 Yersinia pseudotuberculosis YopT Cysteine protease yopT  
24.616 21.494 113.109 322 A P27475 Yersinia enterocolitica YopT Cysteine protease yopT  
24.266 21.144 112.369 322 A P0C2N1 Yersinia enterocolitica YopT1 Cysteine protease yopT1  
22.839 19.117 111.671 732 A A9ZFE7 Yersinia pestis biovar Orientalis str. IP275 YopO Protein kinase YopO  
22.830 19.126 111.630 732 A Q05608 Yersinia pseudotuberculosis YpkA Protein kinase ypkA  
22.810 19.130 111.381 728 A Q56921 Yersinia enterocolitica YpkA Protein kinase A  
23.583 19.066 112.500 288 A Q93KQ5 Yersinia enterocolitica YopP Yop effector YopP  
22.781 19.129 111.438 729 A O85239 Yersinia enterocolitica YopO Protein kinase YopO  
22.304 19.321 111.091 165 A A9ZER0 Yersinia pestis biovar Orientalis str. IP275 YscH Type III secretion protein YopR  
22.398 19.397 111.273 165 A Q663I2 Yersinia pseudotuberculosis YscH Yop proteins translocation protein H  
22.392 19.339 111.486 165 A Q7BRZ4 Yersinia enterocolitica YscH Secreted protein YopR  
21.351 17.877 108.502 397 A O34020 Chlamydophila caviae CopN CopN protein  
21.249 17.635 108.741 399 A Q9Z8L4 Chlamydophila pneumoniae LcrE CopN  
19.550 15.618 102.481 880 A Q824H6 Chlamydophila caviae TARP Putative uncharacterized protein  
19.198 15.473 101.606 1005 A O84462 Chlamydia trachomatis TARP Translocated actin-recruiting phosphoprotein  






Table 3.18B: ASC of plant and animal Type III effectors (continued) 
ASC Akashi Craig & Weber Avg.  Mass Total aa Set SwissProt Number Organism Protein Name Description 
21.423 17.632 109.251 355 A Q46210 Chlamydophila caviae IncA Inclusion membrane localised protein  
22.769 19.764 111.022 273 A Q3KMQ0 Chlamydia trachomatis (strain A/HAR-13 / ATCC VR-571B) IncA Inclusion membrane protein A  
20.893 16.872 108.947 390 A Q9Z8Z8 Chlamydophila pneumoniae IncA Inclusion membrane protein A  
21.423 17.632 109.251 355 A Q46210 Chlamydophila caviae IncA Inclusion membrane localised protein  
23.328 20.796 106.398 115 A O84235 Chlamydia trachomatis IncB Inclusion Membrane Protein B  
21.250 18.310 102.826 176 A Q9Z8P7 Chlamydophila pneumoniae IncB Inclusion Membrane Protein B  
22.060 18.675 105.129 186 A O30783 Chlamydophila caviae IncC Inclusion membrane protein C  
22.179 20.320 103.458 178 A O84236 Chlamydia trachomatis IncC Inclusion Membrane Protein C  
21.858 18.096 105.469 203 A Q9Z8P6 Chlamydophila pneumoniae IncC Inclusion Membrane Protein C  
21.689 19.667 105.749 141 A Q9RPQ1 Chlamydia trachomatis IncD Inclusion membrane protein D  
21.961 20.227 102.555 132 A O84118 Chlamydia trachomatis IncE Inclusion membrane protein E  
21.540 20.361 100.179 104 A O84119 Chlamydia trachomatis IncF Inclusion membrane protein F  
20.819 19.213 104.114 167 A Q3KMQ1 Chlamydia trachomatis (strain A/HAR-13 / ATCC VR-571B) IncG Inclusion membrane protein G  
23.027 18.720 110.704 288 A Q9Z9F5 Chlamydophila pneumoniae 
 
Putative uncharacterized protein  
22.585 18.683 116.207 651 A Q9Z7W9 Chlamydophila pneumoniae 
 
CPj0585 protein  
21.076 17.135 108.391 336 A P40613 Salmonella typhimurium SpaN Surface presentation of antigens protein spaN  
21.335 16.859 107.918 685 A Q56027 Salmonella typhimurium SipA Cell invasion protein sipA  
22.637 19.744 110.667 788 A Q9RPH0 Salmonella typhimurium SspH2 Leucine-rich repeat protein  
24.193 19.820 114.525 336 A Q56061 Salmonella typhimurium SifA acc:Q56061 Protein sifA  
23.209 19.708 110.953 782 A Q8ZNR3 Salmonella typhimurium SopA Secreted effector protein of Salmonella  
22.881 19.104 110.369 561 A Q57QR2 Salmonella choleraesuis SopB Outer protein  
24.126 20.126 113.954 317 A P40722 Salmonella typhimurium SopD Sop effector protein sopD  
22.878 18.523 110.906 240 A O52623 Salmonella typhimurium SopE Guanine nucleotide exchange factor sopE  
22.997 18.873 110.126 240 A Q7CQD4 Salmonella typhimurium SopE2 Guanine nucleotide exchange factor sopE2  
22.271 18.242 110.552 543 A P74873 Salmonella typhimurium SptP Effector protein sptP  
19.334 15.437 103.303 574 A Q58I88 Escherichia coli Tir Translocated intimin receptor  
20.532 16.174 106.515 192 A Q47184 Escherichia coli EspA EspA  
19.658 15.963 104.528 312 A Q8XC86 Escherichia coli O157:H7 EspB EspB  






Table 3.18B: ASC of plant and animal Type III effectors (continued) 
ASC Akashi Craig & Weber Avg.  Mass Total aa Set SwissProt Number Organism Protein Name Description 
20.291 17.663 101.753 248 A Q7DB85 Escherichia coli O157:H7 EspF EspF  
22.146 18.472 110.271 398 A O85646 Escherichia coli EspG EspG  
22.035 17.562 110.309 337 A Q8X2D5 Escherichia coli O157:H7 TccP EspF-like protein  
21.972 17.320 110.165 250 A A2A0X3 Escherichia coli O157:H- TccP2 Type III secreted effector protein  
24.522 20.954 114.361 329 A B2NN32 Escherichia coli O157:H7 str. EC4196 NleB  NleB  
24.774 20.313 116.249 224 A Q8XBX7 Escherichia coli St47 Putative uncharacterized protein  
22.746 19.514 112.119 321 P P13835 Pseudomonas syringae pv. glycinea AvrB Avirulence protein B  
20.746 17.572 105.613 712 P Q887D0 Pseudomonas syringae pv. tomato HopM1 Effector protein hopM1  
22.248 18.733 108.876 447 P Q888Y7 Pseudomonas syringae pv. tomato HopQ1-1 Type III effector HopQ1-1  
21.570 17.695 111.071 220 P Q7BE94 Pseudomonas syringae pv. maculicola AvrRpm1 Avr protein  
22.115 18.995 108.953 284 P Q886L1 Pseudomonas syringae pv. tomato HopAF1 Type III effector HopAF1  
20.629 16.300 108.166 287 P Q88BF6 Pseudomonas syringae pv. tomato HopY1 Type III effector HopY1  
22.748 19.508 109.567 413 P Q889A9 Pseudomonas syringae pv. tomato HopAJ1 Type III effector HopAJ1  
20.625 18.323 103.549 404 P Q87V79 Pseudomonas syringae pv. tomato HopAN1 Type III effector HopAN1  
18.886 15.792 99.849 324 P Q882F0 Pseudomonas syringae pv. tomato HopP1 Type III helper protein HopP1  
20.936 17.863 104.344 484 P Q8RP03 Pseudomonas syringae pv. maculicola HopPtoA1Pma Type III effector HopPtoA1Pma  
21.337 18.449 107.500 1957 P Q888Y1 Pseudomonas syringae pv. tomato HopR1 Type III effector HopR1  
20.432 15.798 107.648 488 P Q87W07 Pseudomonas syringae pv. tomato HopI1 Type III effector HopI1  
22.221 18.616 110.507 375 P Q08370 Pseudomonas syringae pv. syringae HrmA Protein hrmA  
22.306 19.222 108.140 389 P Q87WF7 Pseudomonas syringae pv. tomato HopT1-2 Type III effector HopT1-2  
23.257 18.988 113.754 211 P Q87X57 Pseudomonas syringae pv. tomato HopE1 HopPtoE  
22.761 19.051 110.845 493 P Q87W42 Pseudomonas syringae pv. tomato HopG1 HopPtoG  
22.382 18.289 111.456 218 P Q88A09 Pseudomonas syringae pv. tomato HopH1 Type III effector HopH1  
22.742 19.811 110.456 899 P Q881L7 Pseudomonas syringae pv. tomato HopL1 Type III effector HopL1  
21.276 18.272 107.266 204 P Q9K2L5 Pseudomonas syringae pv. phaseolicola 
 
ORF2  
23.382 19.896 110.529 390 P Q87W46 Pseudomonas syringae pv. tomato HopV1 Type III effector HopV1  
20.560 16.496 107.706 279 P Q88AB8 Pseudomonas syringae pv. tomato HopAS1 Type III effector HopAS1  
21.412 18.878 106.338 914 P Q7PC62 Pseudomonas syringae pv. syringae (strain B728a) HopAE1 Effector protein hopAE1  



















23.385 19.566 111.770 311 P Q52530 Pseudomonas syringae pv. phaseolicola AvrD Avirulence gene D (Fragment)  
21.811 18.605 108.020 466 P Q9L6W4 Pseudomonas syringae pv. tomato HopB1 Putative uncharacterized protein  
22.396 19.459 107.661 269 P Q9F3T4 Pseudomonas syringae pv. pisi AvrPpiC2 Probable cysteine protease avirulence protein avrPpiC2  
20.763 17.388 107.871 380 P Q52394 Pseudomonas syringae pv. phaseolicola AvrPphE AvrPphE protein  
20.924 17.284 110.495 539 P Q48B61 Pseudomonas syringae pv. phaseolicola (strain 1448A / Race 6) HopAB1 Effector protein hopAB1  
22.493 18.929 110.507 261 P Q888W0 Pseudomonas syringae pv. tomato HopAI1 Type III effector HopAI1  
22.891 19.421 110.412 716 P Q7PC45 Pseudomonas syringae pv. syringae (strain B728a) HopAG1 Type III effector HopAG1  
22.837 19.386 111.171 907 P P11437 Pseudomonas syringae pv. glycinea AvrA Avirulence protein A  
20.248 16.680 108.453 220 P Q52432 Pseudomonas syringae AvrRps4 Avirulence protein (Fragment)  
21.209 18.155 106.180 710 P Q48BE0 Pseudomonas syringae pv. phaseolicola (strain 1448A / Race 6) HopD1 Type III effector HopD1  
21.183 17.132 108.895 494 P Q52389 Pseudomonas syringae 
 
Putative uncharacterized protein  
22.898 20.353 110.105 350 P Q9JP32 Pseudomonas syringae pv. tomato HopN1 Type III effector HopN1  
22.190 18.750 109.548 632 P Q87W65 Pseudomonas syringae pv. tomato HopAD1 Effector protein hopAD1  
20.681 16.777 106.065 555 P Q87XS5 Pseudomonas syringae pv. tomato HopAK1 Type III effector HopAK1  
20.130 16.451 103.797 780 P Q9L6W3 Pseudomonas syringae pv. tomato HrpK HrpK  
22.398 19.397 111.273 165 T Q663I2 Yersinia pseudotuberculosis YscH Yop proteins translocation protein H  
21.853 18.000 111.435 221 T A6M3R1 Yersinia pestis CA88-4125 YscL Regulator of YscN ATPase  
21.300 16.348 114.370 210 T/C P94517 Bacillus subtilis YscB Uncharacterized protein yscB  
25.537 23.396 112.485 217 T B0HZP5 Yersinia pestis biovar Antiqua str. E1979001 YscR Type III secretion apparatus protein YscR  
24.656 22.194 114.704 209 T A6M3R2 Yersinia pestis CA88-4125 YscK Putative type III secretion protein  
22.285 19.206 108.845 439 T B0HZP9 Yersinia pestis biovar Antiqua str. E1979001 YscN Type III secretion apparatus H+-transporting two-sector ATPase YscN  
26.185 22.101 124.197 74 T P94518 Bacillus subtilis YscA Uncharacterized protein yscA  
23.313 20.360 114.903 114 T A6M3T7 Yersinia pestis CA88-4125 YscY Putative type III secretion protein  
24.047 21.816 109.519 226 T A9K514 Burkholderia mallei ATCC 10399 BsaW Type III secretion system protein BsaW  
22.304 19.321 111.091 165 T A9R9K1 Yersinia pestis bv. Antiqua (strain Angola) YscH Type III secretion protein YopR  
25.009 23.730 108.941 261 T B0HZP3 Yersinia pestis biovar Antiqua str. E1979001 YscT Type III secretion apparatus protein YscT  
24.292 21.738 109.688 216 T A9K4S2 Burkholderia mallei ATCC 10399 SctR Type III secretion inner membrane protein SctR  
25.582 23.305 111.982 215 T B4TH61 Salmonella enterica subsp. enterica serovar Heidelberg str. SL476 EpaP Type III secretion apparatus protein, YscR/HrcR family  






Table 3.18B: ASC of plant and animal Type III effectors (continued) 
ASC Akashi Craig & Weber Avg.  Mass Total aa Set SwissProt Number Organism Protein Name Description 
24.737 20.926 112.202 360 T Q1MQX2 Lawsonia intracellularis (strain PHE/MN1-00) YscU Translocation protein in type III secretion  
22.895 19.674 110.756 244 T B0HZN2 Yersinia pestis biovar Antiqua str. E1979001 YscJ Type III secretion apparatus lipoprotein YscJ  
26.951 25.885 112.116 262 T Q2SC30 Hahella chejuensis (strain KCTC 2396) YscT Type III secretory pathway, component EscT  
24.800 21.288 114.022 354 T B0HNK1 Yersinia pestis biovar Antiqua str. B42003004 YscU Type III secretion appartus protein YscU  
21.199 17.197 114.500 157 T Q2SC35 Hahella chejuensis (strain KCTC 2396) YscO Putative type III secretion protein YscO  
23.524 21.406 112.054 307 T B0HZP6 Yersinia pestis biovar Antiqua str. E1979001 YscQ Type III secretion apparatus protein YscQ  
21.164 18.476 106.859 318 T Q2SC33 Hahella chejuensis (strain KCTC 2396) YscQ Putative type III secretion protein YscQ  
21.567 17.859 110.771 455 T B0HZP7 Yersinia pestis biovar Antiqua str. E1979001 YscP Type III secretion system needle length determinant YscP  
24.256 21.250 109.410 90 T Q2SC31 Hahella chejuensis (strain KCTC 2396) YscS Type III secretory pathway, component EscS  
23.313 20.360 114.903 114 T A6M3T7 Yersinia pestis CA88-4125 YscY Putative type III secretion protein  
21.853 18.000 111.435 221 T A6M3R1 Yersinia pestis CA88-4125 YscL Regulator of YscN ATPase  
24.186 21.875 109.465 216 T A3NKX4 Burkholderia pseudomallei (strain 668) YscR Type III secretion apparatus protein, YscR/HrcR family  
23.176 20.201 112.344 137 T/C B0HZP0 Yersinia pestis biovar Antiqua str. E1979001 YscB YopN-specific chaperone YscB  
21.825 16.696 110.013 115 T B0HNJ2 Yersinia pestis biovar Antiqua str. B42003004 YscI Type III secretion apparatus protein YscI  
26.638 24.934 112.527 271 T Q1MQX3 Lawsonia intracellularis (strain PHE/MN1-00) YscT Type III secretion component protein SctT  
24.255 21.801 108.506 88 T B0HZP4 Yersinia pestis biovar Antiqua str. E1979001 YscS Type III secretion apparatus protein YscS  
26.114 24.110 112.648 86 T Q1MQX4 Lawsonia intracellularis (strain PHE/MN1-00) YscS Probable translocation protein in type III secretion  
24.866 21.158 112.733 360 T Q254G9 Chlamydophila felis (strain Fe/C-56) YscU Type III secretory flagellar biosynthesis Yop translocation protein U  
24.255 21.801 108.506 88 T B0HZP4 Yersinia pestis biovar Antiqua str. E1979001 YscS Type III secretion apparatus protein YscS  
22.252 18.163 111.146 89 T Q2T727 Burkholderia thailandensis  YscF Type III secretion system needle protein  
23.422 19.651 110.529 700 T Q1MQX5 Lawsonia intracellularis (strain PHE/MN1-00) YscV Putative type III secretion pore protein  
21.825 16.696 110.013 115 T B0HNJ2 Yersinia pestis biovar Antiqua str. B42003004 YscI Type III secretion apparatus protein YscI  
24.308 20.499 113.148 351 T Q2SC29 Hahella chejuensis (strain KCTC 2396) YscU Type III secretory pathway, component EscU  
20.598 16.591 107.774 115 T A9R9K6 Yersinia pestis bv. Antiqua (strain Angola) YscM Type III secretion apparatus protein YscM  
21.567 17.859 110.771 455 T B0HZP7 Yersinia pestis biovar Antiqua str. E1979001 YscP Type III secretion system needle length determinant YscP  
22.294 18.393 109.614 908 T Q252Q1 Chlamydophila felis (strain Fe/C-56) YscC Type III secretion general secretion pathway protein D  
23.524 21.406 112.054 307 T B0HZP6 Yersinia pestis biovar Antiqua str. E1979001 YscQ Type III secretion apparatus protein YscQ  
25.009 23.730 108.941 261 T B0HZP3 Yersinia pestis biovar Antiqua str. E1979001 YscT Type III secretion apparatus protein YscT  






Table 3.18B: ASC of plant and animal Type III effectors (continued) 
ASC Akashi Craig & Weber Avg.  Mass Total aa Set SwissProt Number Organism Protein Name Description 
24.800 21.288 114.022 354 T B0HNK1 Yersinia pestis biovar Antiqua str. B42003004 YscU Type III secretion appartus protein YscU  
24.800 21.288 114.022 354 T B0HNK1 Yersinia pestis biovar Antiqua str. B42003004 YscU Type III secretion appartus protein YscU  
22.895 19.674 110.756 244 T B0HZN2 Yersinia pestis biovar Antiqua str. E1979001 YscJ Type III secretion apparatus lipoprotein YscJ  
23.655 18.971 123.230 154 T B0HNK7 Yersinia pestis biovar Antiqua str. B42003004 YscO Type III secretion protein YscO  
25.537 23.396 112.485 217 T B0HZP5 Yersinia pestis biovar Antiqua str. E1979001 YscR Type III secretion apparatus protein YscR  
20.598 16.591 107.774 115 T A9R9K6 Yersinia pestis bv. Antiqua (strain Angola) YscM Type III secretion apparatus protein YscM  
22.895 19.674 110.756 244 T B0HZN2 Yersinia pestis biovar Antiqua str. E1979001 YscJ Type III secretion apparatus lipoprotein YscJ  
24.890 22.733 110.423 227 T B0HZP5 Yersinia pestis biovar Antiqua str. E1979001 YscR Type III secretion apparatus protein YscR  
21.634 18.026 110.591 435 T P68587 Yersinia pestis.  P68587 was used instead of P40295(obsolete) YscP* Yop proteins translocation protein P  
23.054 20.119 112.604 122 T B0HZQ3 Yersinia pestis biovar Antiqua str. E1979001 YscX Type III secretion protein YscX  
24.850 22.316 110.742 215 T Q2SC32 Hahella chejuensis (strain KCTC 2396) YscR Type III secretory pathway, component EscR  
21.853 18.000 111.435 221 T A6M3R1 Yersinia pestis CA88-4125 YscL Regulator of YscN ATPase  
24.656 22.194 114.704 209 T A6M3R2 Yersinia pestis CA88-4125 YscK Putative type III secretion protein  
22.304 19.321 111.091 165 T A9R9K1 Yersinia pestis bv. Antiqua (strain Angola) YscH Type III secretion protein YopR  
25.009 23.730 108.941 261 T B0HZP3 Yersinia pestis biovar Antiqua str. E1979001 YscT Type III secretion apparatus protein YscT  
24.255 21.801 108.506 88 T B0HZP4 Yersinia pestis biovar Antiqua str. E1979001 YscS Type III secretion apparatus protein YscS  
23.524 21.406 112.054 307 T B0HZP6 Yersinia pestis biovar Antiqua str. E1979001 YscQ Type III secretion apparatus protein YscQ  
21.825 16.696 110.013 115 T B0HNJ2 Yersinia pestis biovar Antiqua str. B42003004 YscI Type III secretion apparatus protein YscI  
21.856 18.549 107.370 439 T Q2SC36 Hahella chejuensis (strain KCTC 2396) YscN Putative Yops secretion ATP synthase YscN  
23.280 21.455 110.495 123 C P61380 Yersinia pestis SycN Chaperone protein sycN  
25.028 21.492 116.655 132 C Q9ZGW6 Yersinia pestis SycT Chaperone protein sycT  
23.323 20.688 110.675 146 C O34021 Chlamydophila caviae SycE Scc1 protein  
 
Code: A = Animal Pathogens Set 
 P  = Plant Symbiont Set 
 T  = Type III Secretion System 







Table 3.18C: ASC of various Autotransporters 
          
% Savings α vs β  
Total 




(65) Uniprot (Domain) Description 
Amino 
acids Description &  Notes Organism ASC Mass/aa 
1045 21.898 107.490 P09489  Ssp P09489  All 1-1045 Extracellular serine protease Serratia marcescens 




Extracellular serine protease 28-645 
  
2.12 1.84 





    1036 21.377 103.842 Q54483 SSP-h1 BAA33455 All 1-1036 SSP-h1 Serratia marcescens 
  1034 21.385 104.205 Q54484 SSP-h2 BAA11383 All 1-1034 SSP-h2 Serratia marcescens 
  985 21.069 104.230 Q9ZNI6 PspA BAA36466 All 1-985 Serine protease homologue Pseudomonas fluorescens 
  1036 21.242 103.061 Q9ZNI5 PspB BAA36467 All 1-1036 Serine protease homologue Pseudomonas fluorescens 
  934 22.900 110.886 Q51846 Ssa1 AAA80490 All 1-934 Serotype-1-specific antigen Pasteurella haemolytica  
  1039 21.479 105.663 Q93L97 SphB1 CAC44081 All 1-1039 Autotransporter subtilisin-like protease Bordetella pertussis  
  1083 21.429 104.915 Q8GKS5 NaiP AAN71715 All 1-1083 NalP Neisseria meningitidis 
  1296 22.143 107.826 Q48247 VacA Q48247 All 1-1296 Vacuolating cytotoxin autotransporter Helicobacter pylori 




Vacuolating cytotoxin 34-1022 
  
4.39 0.67 





    1286 20.626 102.841 Q03155 AIDA-1 Q03155 All 1-1286 AIDA-I autotransporter Escherichia coli 




Adhesin AIDA-I 50-846 
  
12.88 7.51 




AIDA-I translocator 847-1286 
    1102 21.757 105.469 Q7BCK4 IcsA AAA26547 All 1-1102 OM protein icsA autotransporter  Shigella flexneri 




Outer membrane protein icsA 53-758 
  
13.13 7.77 




Outer membrane protein icsA translocator 759-1102 
    955 21.523 105.967 Q9Z625 MisL AAD16954 All 1-955 MisL 
   989 20.535 102.218 Q9XD84 TibA AAD41751 All 1-989 Adhesin/invasin tibA Escherichia coli 




Adhesin/invasin tibA 55-677 
  
13.30 8.45 




Adhesin/invasin tibA translocator 677-989 
    1039 20.340 102.798 P39180 Ag43 P39180 All 1-1039 Antigen 43 Escherichia coli (strain K12 




Antigen 43 alpha chain 53-551 
  
9.13 5.48 




Antigen 43 beta chain 552-1039 
    2035 19.832 101.727 Q9XCJ4 ShdA AAD25110 All 1-2035 ShdA Salmonella typhimurium 
  619 22.999 110.449 Q9JPL5 AutA CAB89117 All 1-619 Autotransporter A Neisseria meningitidis 
  1377 22.183 107.632 Q47692 Tsh I54632 All 1-1377 Temp-sens hemagglutinin tsh autotransporter Escherichia coli 




Temperature-sensitive hemagglutinin tsh 53-1100 
  
7.09 3.32 




Temperature-sensitive hemagglutinin tsh translocator 1101-1377 
    1364 22.067 107.038 Q8VSL2 SepA CAC05786 All 1-1364 Serine protease sepA autotransporter Shigella flexneri 




Serine protease sepA 57-1089 
  
7.57 3.93 




Serine protease sepA translocator 1090-1386 
    1305 22.281 107.865 Q9EZE7 EspC AAC44731 All 1-1305 Serine protease espC Escherichia coli O127:H6 




Secreted autotransporter protein espC 54-1018 
  
6.53 2.87 




Autotransporter protein espC translocator 1019-1305 





Table 3.18C: ASC of various Autotransporters (continued) 
          
% Savings α vs β  
Total 




(65) Uniprot (Domain) Description 
Amino 
acids Description &  Notes Organism ASC Mass/aa 
1300 22.726 109.031 Q7BSW5 EspP CAA66144 All 1-1300 Serine protease espP Escherichia coli O157:H7 




Secreted autotransporter protein espP 56-1023 
  
3.91 0.46 




Autotransporter protein espP translocator 1024-1300 
    1295 22.258 107.916 O68900 Pet AAC26634 All 1-1295 Serine protease pet autotransporter Escherichia coli O44:H18 




Serine protease pet 53-1018 
  
6.29 1.51 




Serine protease pet translocator 1019-1295 
    1372 22.209 106.732 Q7BS42 Pic AAD23953 All 1-1372 Serine protease pic autotransporter Escherichia coli O44:H18 




Serine protease pic 56-1095 
  
8.37 4.49 




Serine protease pic translocator 1096-1372 
    1285 22.634 108.683 Q9L8L1 SigA AAF67320 All 1-1285 Exported serine protease SigA Shigella flexneri 
  1295 22.495 108.127 Q8FDW4 SatA AAG30168 All 1-1295 Serine protease sat autotransporter Escherichia coli  




Serine protease sat 50-1018 
  
4.45 1.13 




Serine protease sat translocator 1019-1295 
    1377 22.298 107.678 Q6YGS9 Vat AAO21903 All 1-1377 Vacuolating autotransporter toxin Escherichia coli 
  1359 22.521 108.404 Q79JW1 EpeA AAL18821 All 1-1359  Autotransporter protease Escherichia coli 
  1364 22.514 108.269 Q84GK0 EatA AAO17297 All 1-1364 Serine protease eatA Escherichia coli 




Secreted autotransporter protein eatA 57-1098 
  
6.95 2.97 




Autotransporter protein eatA translocator 1099-1364 
    1363 22.239 107.199 Q93SE3 EspI CAC39286 All 1-1363 Putative uncharacterized protein Escherichia coli 
  1335 21.984 106.112 Q9LA58 EaaA AAF63237 All 1-1335 EaaA Enterobacterial phage P-EibA 
  1335 22.005 106.109 Q9LA54 EaaC AAF63038 All 1-1335 EaaC Enterobacterial phage P-EibA 
  910 20.844 102.676 P14283 Pertactin P14283 All 1-910 Pertactin autotransporter Bordetella pertussis 




Outer membrane protein P.69 35-711 
  
12.50 5.72 




Pertactin translocator 712-910 
    1010 20.537 102.336 Q45340 BrkA AAA51646 All 1-1010 BrkA Bordetella pertussis 
  642 20.547 102.566 Q6U948 Tef AAQ82668 All 1-644 Tracheal colonization factor protein Bordetella pertussis 
  915 20.942 103.707 O66044 Vag8 AAC31247 All 1-915 Vag8 Bordetella pertussis 
  1531 21.467 104.984 O84818 PmpD O84818 All 1-1531 Probable outer membrane protein pmpD Chlamydia trachomatis 




Probable outer membrane protein pmpD 21-1243 
  
12.75 4.85 





    1723 21.299 104.223 Q9Z812 Pmp20 Q9Z812 All 1-1723 Probable outer membrane protein pmp20 Chlamydia pneumoniae 




Probable outer membrane protein pmp20 22-1433 
  
17.03 9.55 





    1609 21.775 106.183 Q9Z6U5 Pmp21 Q9Z6U5 All 1-1609 Probable outer membrane protein pmp21 Chlamydia pneumoniae 




Probable outer membrane protein pmp21 31-1327 
  
16.22 6.35 










Table 3.18C: ASC of various Autotransporters (continued) 
          
% Savings α vs β 
Total 




(65) Uniprot (Domain) Description 
Amino 
acids Description &  Notes Organism ASC Mass/aa 
1552 21.875 110.301 Q9AIU6 Iga1 NP_283693 All 1-1552 IgA1 protease Neisseria meningitidis 
  
1449 22.479 109.768 Q9F3Z5 App CAC14670 All 1-1449 Adhesion penetration protein Neisseria meningitidis 
  
1849 21.342 109.756 P45386 Iga1 P45386 All 1-1849 
Immunoglobulin A1 protease 
autotransporter Haemophilus influenzae 
  




Immunoglobulin A1 protease 26-1021 
  
-13.93 -1.79 




Immunoglobulin A1 protease translocator 1022-1849 
    
1394 22.758 111.494 P45387 Hap P45387 All 1-1394 
Adhesion & penetration protein 
autotransporter Haemophilus influenzae 
  




Adhesion and penetration protein 26-1139 
  
6.96 2.80 





    
2249 19.884 99.740 P15921 rOmpA P15921 All 1-2249 Outer membrane protein A Rickettsia rickettsii 
  




Outer Membrane Protein A 29-1961 
  
17.72 11.25 





    
1654 20.530 101.673 Q53047 rOmpB Q53047 All 1-1654 Outer membrane protein B  Rickettsia rickettsii 
  




120 kDa surface-exposed protein 1-1333 
  
12.19 7.36 




32 kDa beta peptide 1362-1654 
    
656 21.781 106.469 O52756 ApeE AAC38796 All 1-656 
OM N-acetyl Phe β-naphthyl ester-
cleaving esterase Salmonella typhimurium 
  
646 22.076 107.726 O33407 EstA AAB61674 All 1-646 Esterase estA - Not cleaved Pseudomonas aeruginosa  
  





    





    
645 23.098 109.610 P40601 Lip-1 P40601 All 1-645 Lipase 1 Photorhabdus luminescens 
  




Lipase I 25-382 
  
13.13 6.13 





    
650 22.532 109.947 Q7WVT7 McaP AAP97134 All 1-650 McaP Moraxella catarrhalis 
  
741 22.395 108.403 O52269 BabA AAC38081 All 1-741 
Adhesin binding fucosylated histo-blood 
group antigen Helicobacter pylori 
  
651 22.998 110.831 Q9ZLB8 SabA AAD06240 All 1-651 
 
Helicobacter pylori J99 
  
518 22.573 108.314 O32641 AlpA CAB05386 All 1-518 Adhesin Helicobacter pylori 
  




1070 23.659 111.937 Q9EZV7 NanB AAG35309 All 1-1070 Sialidase NanB 
   
         





Table 3.18D: ASC of various extracellular proteins of interest 
Total 
aa 
Avg Cost of 
Amino Acid 
Economic 





185 20.58595 51 / 4333 MG1655 P04127 Escherichia coli PapA Pap fimbrial major pilin protein 
182 19.52473 11 / 4333 same P04128 Escherichia coli K-12 FimA Type I pili major pilin protein 
498 19.15482 6 / 4333 same P04949 Escherichia coli K-12 FliC Flagellum subunit 
368 19.5663 13 / 4333 MG1655 B3SGP3 Escherichia coli FlkA Flagellum subunit - phase variable form 
502 19.91474 23 / 4333 MG1655 B3SGN1 Escherichia coli FlkA Flagellum subunit - phase variable form 
556 19.71115 16 / 4333 MG1655 B3SGN7 Escherichia coli FlkA Flagellum subunit - phase variable form 
423 19.91773 23 / 4333 MG1655 Q75SX7 Escherichia coli FlkA Flagellum subunit - phase variable form 
529 19.97108 25 / 4333 MG1655 Q75SY3 Escherichia coli FlkA Flagellum subunit - phase variable form 
495 19.55818 13 / 4333 MG1655 P06179 Salmonella typhimurium FliC Flagellum subunit 
507 19.46193 11 / 4333 MG1655 P52616 Salmonella typhimurium FljB Flagellum subunit - phase variable form 
638 22.27445 1764 / 5567 P. aeruginosa PAO1 P11439 Pseudomonas aeruginosa ToxA Exotoxin A 
453 20.61148 158 / 5567 P. aeruginosa PAO1 Q51451 Pseudomonas aeruginosa ExoS Exoenzyme S - Ranked 155 in PSORTDB 
378 22.45503 2111 / 5567 P. aeruginosa PAO1 Q9I1S4 Pseudomonas aeruginosa ExoY Adenylate cyclase 
687 21.24309 463 / 5567 P. aeruginosa PAO1 O34208 Pseudomonas aeruginosa ExoU not in PSORTDB 
457 20.49256 135 / 5567 P. aeruginosa PAO1 Q9I788 Pseudomonas aeruginosa ExoT Exoenzyme T 
479 21.67724 854 / 5567 P. aeruginosa PAO1 Q03023 Pseudomonas aeruginosa AprA Alkaline metalloproteinase 
429 21.30256 501 / 5567 P. aeruginosa PAO1 Q9HXZ5 Pseudomonas aeruginosa Eno Enolase 
311 21.71383 891 / 5567 P. aeruginosa PAO1 P26876 Pseudomonas aeruginosa Lip Lactonizing lipase 
462 21.67619 852 / 5567 P. aeruginosa PAO1 Q9HWK6 Pseudomonas aeruginosa PrpL Lysyl endopeptidase 
85 21.39882 588 / 5567 P. aeruginosa PAO1 P95434 Pseudomonas aeruginosa PscF Major component Type III needle structure 
1072 21.17603 135 / 3885 Yersinia pestis CO92 Q9F288 Yersinia pestis  YapE Type V secretion 
170 21.20765 140 / 3885 Yersinia pestis CO92 P26948 Yersinia pestis  Caf1 F1 capsule antigen 
147 19.37347 23 / 3737 same B8H0U8 Caulobacter crescentus CB15N HfaA Holdfast attachment protein HfaA 
415 18.4106 3 / 3737 same B8H0V0 Caulobacter crescentus CB15N HfaD Holdfast attachment protein HfaD-not in PSORTDB 
1073 19.15443 14 / 3737 same B8H2X0 Caulobacter crescentus CB15N RsaA  S-layer protein 
1026 18.81969 24 / 3737 CB15N P35828 Caulobacter crescentus (Caulobacter vibrioides) RsaA  S-layer protein 
862 21.58898 147 / 4112 B. Subtilus 168 P94217 Bacillus anthracis Eag  S-layer protein EA1 






Table 3.19:  Comparison of the ASC of Type III secretion effectors with cytoplasmic proteins. 
 
   
E. coli K-12* E. coli K-12* P. syringae pv. tomato** P. syringae pv. tomato** 
   
Cytoplasm Overall Cytoplasm Overall 
 
ASC Num. Z P value Z P value Savings Z P value Z P value Savings 
Animal Type III Effectors† 22.233 64 5.835 5.39E-09 6.456 1.08E-10 1.32 4.064 4.81E-05 4.225 2.39E-05 0.81 
Plant Type III Effectors† 21.74 38 7.181 6.90E-13 7.375 1.64E-13 1.81 5.878 4.16E-09 5.766 8.11E-09 1.31 
Animal and Plant Type III Effectors† 22.049 102 8.928 4.35E-19 9.561 1.17E-21 1.51 6.722 1.79E-11 6.835 8.19E-12 1 
Type III Secretion System, Chaperones† 23.468 65 0.957 0.3385 0.163 0.8703 0.09 2.764 5.71E-03 2.257 0.024037 -0.42 
  
           
  
E. coli  Type III Effectors† 21.564 10 3.1 1.94E-03 3.254 1.14E-03 1.99 2.77 5.60E-03 2.743 6.09E-03 1.48 
E. coli&Salmonella  Type III Effectors† 22.162 20 3.171 1.52E-03 3.539 4.02E-04 1.39 2.197 0.028041415 2.318 0.02046 0.88 
P. syringae sp. Type III Effectors† 21.74 38 7.181 6.90E-13 7.375 1.64E-13 1.81 5.878 4.16E-09 5.766 8.11E-09 1.31 
P. syringae pv tomato HOPs 21.757 44 7.966 1.67E-15 8.123 4.54E-16 1.8 6.679 2.40E-11 6.489 8.61E-11 1.29 
P. syringae pv tomato HOP Helpers 19.745 7 4.45 8.59E-06 4.424 9.67E-06 3.81 4.387 1.15E-05 4.303 1.69E-05 3.3 







Table 3.19:  Comparison of the ASC of Type III secretion effectors with cytoplasmic proteins (continued). 
 
   
E. coli K-12* E. coli K-12* P. syringae pv. tomato** P. syringae pv. tomato** 
   
Cytoplasm Overall Cytoplasm Overall 
 
Mean Mass Num. Z P value Z P value Z P value Z P value 
Animal Type III Effectors† 109.29 64 4.062 4.87E-05 2.817 4.84E-03 2.661 7.80E-03 0.789 0.429864 
Plant Type III Effectors† 108.6 38 5.529 3.21E-08 4.43 9.43E-06 4.509 6.50E-06 2.695 7.03E-03 
Animal and Plant Type III Effectors† 109.033 102 6.535 6.36E-11 4.906 9.28E-07 4.798 1.60E-06 2.259 0.0239 
Type III Secretion System, Chaperone† 111.579 65 0.787 0.431 0.827 0.408218 1.088 0.2765355 3.525 4.23E-04 
  
         
  
E. coli  Type III Effectors† 108.191 10 2.366 0.018 2 0.0455 2.041 0.0412 1.447 0.148 
E. coli&Salmonella  Type III Effectors† 109.513 20 2.339 0.0193 1.609 0.1076 1.596 0.1106 0.434 0.664 
Pseudomonas Type III Effectors† 108.6 38 5.529 3.21E-08 4.43 9.43E-06 4.509 6.50E-06 2.695 7.03E-03 
P. syringae pv tomato HOPs 108.457 44 6.281 3.36E-10 5.165 2.40E-07 5.261 1.43E-07 3.423 6.20E-04 
P. syringae pv tomatoHOP Helpers 102.782 7 4.192 2.77E-05 4.043 5.28E-05 4.108 3.98E-05 3.863 1.12E-04 
P. syringae pv tomato HOP w Helpers 107.678 51 7.368 1.73E-13 6.284 3.29E-10 6.384 1.73E-10 4.603 4.17E-06 




Num. ASC Mean Mass 
      
E. coli K-12*  Cytoplasm 2859 23.317 111.609 
  
BOLD ITALIC = Not significant, P > 0.05 
  
E. coli K-12*  Overall 4333 23.555 111.005 
  
Sequences and locations: Echobase (67, 97) 
 
P. syringae pv. tomato**  Cytoplasm 1973 22.961 110.982 
  
** Sequences and locations: PSORTDB (122) 
 
P. syringae pv. tomato**  Overall 5608 23.047 110.075 
  










per aa %A %R %N %D %C %E %Q %G %H %I %L %K %M %F %P %S %T %W %Y %V 
Total Amino 
Acids Number 
Overall Mean 23.05 10.55 6.45 3.09 5.36 1.13 5.66 4.48 7.47 2.33 5.03 11.20 4.00 2.58 3.67 4.75 6.14 5.07 1.41 2.49 7.13 329.67 5607 
Overall Median 22.94 10.37 6.36 2.96 5.44 0.91 5.67 4.36 7.39 2.23 4.92 10.97 3.54 2.37 3.51 4.63 5.93 4.95 1.23 2.41 7.06 282.00 
 
Overall STDEVP 1.37 3.01 2.48 1.48 1.98 1.09 2.30 1.99 2.43 1.38 1.98 3.28 2.40 1.25 1.74 1.96 2.09 1.89 1.11 1.33 2.19 276.48 
 
                        
Extracellular all 21.58 10.90 4.93 4.89 6.06 0.60 4.52 4.86 8.26 2.40 4.13 8.59 4.76 2.22 3.04 4.95 9.12 6.61 0.85 2.30 6.00 433.73 84 
Extracellular - HOP 21.74 11.08 4.00 4.85 6.76 0.69 4.03 4.56 8.82 1.71 4.52 8.44 4.16 1.88 3.28 4.44 8.26 7.75 1.22 2.77 6.80 428.18 33 
HOPs w Helpers 21.48 10.79 5.54 4.91 5.60 0.55 4.84 5.06 7.90 2.85 3.87 8.69 5.16 2.44 2.89 5.29 9.67 5.87 0.61 2.00 5.48 437.31 51 
Outer Membrane 22.25 10.09 5.86 4.96 6.43 0.34 4.69 5.04 8.99 1.35 3.72 9.56 3.67 1.55 3.47 4.22 7.84 6.45 1.42 3.84 6.52 649.23 115 
Periplasm 22.65 11.41 4.18 3.85 6.27 0.63 5.08 4.55 7.74 1.50 4.56 9.37 6.54 2.40 3.71 5.19 6.17 5.43 1.38 2.77 7.26 414.95 110 
Inner Membrane 23.83 11.36 5.38 2.66 3.63 0.81 3.90 3.72 8.18 1.76 6.18 13.93 2.80 3.05 4.59 4.43 6.17 5.09 1.90 2.41 8.05 412.61 961 
Unknown 22.91 10.73 6.46 3.21 5.42 1.20 5.43 4.85 7.28 2.32 4.55 10.56 4.28 2.59 3.50 5.03 6.51 5.31 1.46 2.56 6.74 282.73 2364 
Cytoplasm 22.96 9.91 7.19 2.92 5.99 1.29 6.93 4.36 7.20 2.72 5.19 10.96 4.10 2.43 3.48 4.56 5.44 4.63 1.13 2.35 7.21 317.70 1973 
Cost Savings (ATP) 
 
15.66 0.06 12.66 14.66 2.66 12.06 11.06 15.66 -10.9 -4.94 0.06 -2.94 -6.94 -24.6 7.06 15.66 8.66 -46.9 -22.6 4.06 
  
 
Notes:  Bold indicates >25% change in amino acid composition from the overall mean. 
Underlined indicates >50% change in amino acid composition from the overall mean. 
Amino acid percents are on a per protein basis.  The percent amino acid composition of each protein in that location were averaged; they are 
unweighted for chain length.  See Table 3.22B for weighted percents (% of all amino acids) of proteins in nonmembrane locations of P. syringae. 
 
 
Savings A R N D C E Q G H I L K M F P S T W Y V Count 
Extracellular-HOPs >1.5 ATPs 13.34 -0.08 13.86 8.64 -0.95 -9.75 0.79 8.47 6.45 1.01 -0.08 -0.49 2.28 5.39 -5.29 25.09 12.51 16.96 2.07 -0.23 14 
Extracellular-HOPs >0 ATPs 17.00 -0.10 13.25 12.36 -0.48 -11.11 -3.07 18.47 2.37 1.13 -0.06 -0.35 3.52 7.54 -4.09 21.40 9.43 9.25 5.36 -1.82 23 
HOPS and Helpers >1.5 ATPs 11.61 -0.03 10.16 0.00 -0.93 -6.04 3.22 7.12 1.22 3.18 -0.06 -1.13 1.17 11.20 2.36 25.68 4.94 18.70 10.16 -2.53 24 
HOPS and Helpers >0 ATPs -3.64 -0.05 17.69 1.88 -1.29 -5.84 6.24 0.45 -12.90 5.33 -0.12 -4.00 1.75 4.86 2.20 53.36 1.16 38.54 2.77 -8.39 47 
Extraceullar All >1.5 ATPs 12.25 -0.05 11.53 3.19 -0.94 -7.41 2.33 7.62 3.15 2.38 -0.07 -0.90 1.58 9.06 -0.46 25.46 7.73 18.06 7.18 -1.68 38 





Table 3.21:  Comparison of the ASC of cellular and extracellular serine proteases. 
 
     
U-Test Student T-test Savings (ATP) 
 
ASC Mass Number Length Z P value T Deg. Free P value per aa per protein 
vs Cellular Serine proteases 22.547 109.500 5592 494.01               
All Extracelluar Serine proteases 22.157 107.408 191 737.93 4.700 2.60E-06 5.872 206 1.71E-08 0.390 287.97 
Extracelluar Serine proteases† 21.827 106.596 82 897.34 6.474 9.52E-11 6.657 84 2.70E-09 0.720 646.09 
 
  
   
              
vs Bacillus sp. Cellular Serine proteases 22.454 108.502 447 502.75               
Bacillus sp. Extracellular Serine proteases 21.210 103.899 23 455.61 5.185 2.16E-07 6.558 25 7.19E-07 1.245 567.08 
Bacillus sp. Extracellular Serine proteases† 21.273 104.409 18 485.87 4.305 1.67E-05 5.244 19 4.62E-05 1.181 573.85 
 
  
   
              
vs E. coli Cellular Serine proteases 23.126 110.089 192 401.68               
E. coli Extracellular Serine proteases 22.381 107.912 10 1335.56 3.856 1.15E-04 6.581 64 1.01E-08 0.745 995.41 
E. coli Extracellular Serine proteases † 22.319 107.914 8 1335.60 3.822 1.33E-04 6.729 49 1.74E-08 0.807 1077.88 
E. coli Extracellular Serine proteases ‡ 21.994 107.306 10 1005.30 4.639 3.51E-06 8.443 30 2.02E-09 1.133 1138.73 
E. coli Extracellular Serine proteases †,‡ 21.973 107.316 8 1005.69 4.302 1.69E-05 8.461 23 1.62E-08 1.154 1160.14 
 
  
   
              
vs E. coli K-12 Cytoplasm 23.555 111.005 4333 312.46               
E. coli Cellular Serine proteases 23.126 110.089 192 401.68 6.214 5.16E-10 4.546 216 9.09E-06 0.429 172.14 
E. coli Cellular Serine proteases †  23.142 110.393 26 387.65 2.151 3.15E-02 1.478 25 0.152 0.412 159.88 
E. coli Extracellular Serine proteases 22.381 107.912 10 1335.56 3.299 9.70E-04 16.626 11 3.84E-09 1.174 1567.75 
E. coli Extracellular Serine proteases† 22.319 107.914 8 1335.60 3.005 2.66E-03 16.631 9 4.59E-08 1.236 1650.24 
E. coli Extracellular Serine proteases ‡ 21.994 107.306 10 1005.30 4.108 3.99E-05 15.490 10 2.57E-08 1.561 1569.54 
E. coli Extracellular Serine proteases †,‡ 21.973 107.316 8 1005.69 3.720 1.99E-04 15.259 8 3.37E-07 1.582 1591.13 
            Note:  Cellular serine proteases are serine proteases from Uniprot that are not secreted. 
 † Homologs (Genes with same name and similar ASC, lengths, sequences) were averaged. 
‡ All the E. coli secreted serine proteases were autotransporters.  Just the secreted domain was analyzed here. 





Table 3.22A:  Effects of protein structure on ASC in E. coli. 
     
Mean values based on per protein amounts (unweighted for length) 
     
  
Mean Filtered Database Neural Networks only Unfiltered Database† 
     
 
Count Mass/aa ATPs/aa Length %H %E %C %H %E %C %H %E %C 
     Overall 3212 111.38 23.26 297.75 39.82 17.54 42.64 41.41 17.80 40.79 33.91 21.14 44.95 
     Cytoplasmic 2859 111.61 23.32 296.47 40.58 17.08 42.33 42.40 17.27 40.33 ND ND ND 
     Periplasmic 337 109.72 22.85 309.42 33.85 20.96 45.18 33.47 22.00 44.53 34.13 20.88 45.00 
     Extracellular 16 104.90 20.65 280.44 29.29 26.64 44.07 31.14 24.82 44.04 29.38 26.72 43.90 
     




  Neural Netwoks only Unfiltered Database† 
vs ASC (ATPs/aa) %H %E %C %H %E %C %H %E %C 
 
R P value R P value R P value R P value R P value R P value R P value R P value R P value 
Overall 0.0408 0.0208 -0.0291 0.0996 -0.0360 0.0412 -0.0010 0.9527 0.0164 0.3514 -0.0174 0.3249 0.0167 0.3440 -0.0172 0.3290 -0.0072 0.6815 
Cytoplasmic 0.0219 0.2408 0.0011 0.9552 -0.0379 0.0427 -0.0311 0.0964 0.0501 0.0073 -0.0023 0.9003 ND ND ND ND ND ND 
Periplasmic -0.0102 0.8518 -0.0622 0.2547 0.0939 0.0852 -0.0300 0.5826 -0.0184 0.7359 0.0798 0.1439 -0.0121 0.8255 -0.0619 0.2572 0.0963 0.0776 
Extracellular 0.2177 0.4179 0.0324 0.9053 -0.4340 0.0931 0.3288 0.2138 -0.0063 0.9816 -0.5458 0.0287 0.2022 0.4528 0.0599 0.8255 -0.4339 0.0931 
 
Notes:  ND - Not Done    BOLD: P < 0.01 † Overall contains only data from Periplasmic and Extracellular proteins 
       




Neural Networks Only 
 
Student T* Mann Whitney Student T* Mann Whitney 
vs Cytoplasmic T value P value Z P value T value P value Z P value 
%H Periplasmic 6.622 1.16E-10 7.199 6.05E-13 9.639 1.08E-19 10.347 4.32E-25 
%E Periplasmic 5.317 1.79E-07 4.551 5.33E-06 7.341 1.21E-12 7.734 1.04E-14 
%C Periplasmic 4.768 2.62E-06 5.507 3.65E-08 8.383 8.15E-16 9.792 1.22E-22 
%H Extracellular 2.023 0.061 2.487 0.013 2.695 0.017 3.058 0.002 
%E Extracellular 2.212 0.043 2.108 0.035 2.305 0.036 2.628 0.009 
%C Extracellular 0.557 0.586 0.656 0.512 1.498 0.155 1.348 0.178 
Notes:  Comparisons are versus same % secondary structure in cytoplasmic proteins  





Table 3.22A:  Effects of protein structure on ASC in E. coli (continued). 
  
Filtered Database (Percent of all amino acids in the Secondary Structure of each location) 
  
%A %C %D %E %F %G %H %I %K %L %M %N %P %Q %R %S %T %V %W %Y 
Overall Helix 12.77 1.06 4.77 8.46 3.47 3.06 2.23 5.71 13.09 5.21 2.92 3.02 2.24 6.03 7.11 4.63 4.14 5.79 1.51 2.76 
 
Coil 7.37 1.32 7.75 5.68 2.74 12.23 2.91 3.24 6.23 4.86 2.40 5.73 7.80 4.07 5.20 6.97 5.91 4.29 1.01 2.29 
 
Strand 6.72 1.70 2.57 4.31 5.42 3.58 2.32 11.40 12.37 3.31 2.60 2.01 1.38 2.96 5.06 4.26 6.51 15.38 1.82 4.31 
                      Cytoplasm Helix 12.63 1.09 4.76 8.74 3.45 3.02 2.33 5.78 13.13 5.09 2.92 2.95 2.23 5.97 7.33 4.52 4.06 5.79 1.50 2.74 
 
Coil 7.25 1.38 7.69 5.86 2.79 12.33 3.04 3.29 6.38 4.68 2.43 5.51 7.79 3.99 5.40 6.86 5.79 4.30 0.98 2.26 
 
Strand 6.68 1.86 2.53 4.46 5.43 3.53 2.43 11.71 12.58 3.20 2.63 1.84 1.37 2.81 5.18 4.07 6.27 15.54 1.76 4.13 
                      Extracellular Helix 12.79 0.33 5.53 3.73 3.00 3.26 0.40 5.93 13.32 5.53 1.73 6.53 0.60 9.13 2.93 9.46 7.79 4.86 0.67 2.47 
 
Coil 12.01 0.46 7.90 2.98 1.74 13.44 0.46 2.46 4.41 4.05 1.64 9.65 4.82 3.85 1.64 10.83 11.29 4.82 0.31 1.23 
 
Strand 9.74 0.29 3.47 2.22 3.66 4.05 1.06 8.20 9.74 3.09 1.25 3.66 1.54 7.62 2.60 6.17 12.54 13.60 0.77 4.73 
                      Periplasm Helix 14.22 0.86 4.75 5.94 3.74 3.41 1.24 5.04 12.76 6.48 3.01 3.49 2.45 6.52 5.18 5.53 4.83 5.82 1.72 3.01 
 
Coil 8.08 0.90 8.20 4.50 2.37 11.47 2.05 2.85 5.17 6.28 2.21 7.17 8.03 4.64 3.82 7.67 6.61 4.16 1.26 2.56 
 






Table 3.22A:  Effects of protein structure on ASC in E. coli (continued). 
 
Average Cost Filtered Database Neural Networks Unfiltered Database† 
 
Percent Cost of vs Cytoplasmic vs Overall 
  
ATPs/aa % total ATPs/aa % total ATPs/aa % total 
   
Filtered NN Filtered NN 
Overall Helix 23.904 39.37 24.017 41.21 23.608 32.90 
 
Extracellular Helix 91.06 90.40 91.19 90.55 
 
Coil 21.420 43.41 20.871 41.63 20.902 46.59 
  
Coil 84.94 85.33 85.22 85.64 
 
Strand 26.792 17.23 27.607 17.16 26.463 20.50 
  
Strand 88.00 88.03 88.17 88.09 
               
Cytoplasm Helix 23.936 40.22 24.055 42.30 ND ND 
 
Periplasm Helix 98.93 98.56 99.06 98.71 
 
Coil 21.490 42.98 20.949 41.08 ND ND 
  
Coil 97.81 97.50 98.13 97.87 
 
Strand 26.844 16.80 27.627 16.63 ND ND 
  
Strand 99.09 100.04 99.28 100.11 
               
Extracellular Helix 21.797 33.45 21.746 32.81 21.831 33.41 
       
 
Coil 18.255 43.44 17.875 43.37 18.188 43.10 
 
Notes:  Values on this page are based on the total amino acids in all of that 
secondary structure of every protein in that location.  Values in the table on the 
page above are from averaging % secondary structure in each protein. 
ND – not done.   NN – Neural Networks.  
Strand 23.623 23.11 24.320 23.82 23.616 23.49 
 
         
Periplasm Helix 23.679 32.67 23.708 32.68 23.685 32.68 
 
† Overall contains only data from Periplasmic and Extracellular proteins 
 
Coil 21.019 46.88 20.426 46.09 21.009 46.09 
       
 
Strand 26.599 20.45 27.638 21.22 26.604 21.22 





Table 3.22B:  Effects of protein structure on ASC in P. syringae. 
     
Mean values based on per protein amounts (unweighted for length) 
     
  
Mean Filtered Database Neural Networks only Unfiltered Database† 
     
 
Count Mass/aa ATPs/aa Length %H %E %C %H %E %C %H %E %C 
     
Overall 2167 110.72 22.89 327.13 40.80 16.50 42.70 43.41 15.98 40.61 36.02 15.88 48.10 
     
Cytoplasmic 1973 110.98 22.96 317.70 41.28 16.56 42.16 44.13 15.90 39.97 ND ND ND 
     
Periplasmic 110 108.72 22.65 414.95 36.86 18.37 44.78 37.22 17.86 44.92 36.88 18.36 44.75 
     
Extracellular 84 107.30 21.58 433.73 34.68 12.64 52.67 34.60 15.37 50.04 34.88 12.62 52.49 
     
HOPS&Helpers 51 107.68 21.48 437.31 41.31 8.03 50.65 38.23 10.89 50.88 41.57 8.03 50.40 
     
Extracelluar-HOPS 33 106.70 21.74 428.18 24.43 19.77 55.80 28.98 22.28 48.74 24.54 19.73 55.73 
     




  Neural Netwoks only Unfiltered Database† 
vs. ASC (ATPs/aa) %H %E %C %H %E %C %H %E %C 
 
R P value R P value R P value R P value R P value R P value R P value R P value R P value 
Overall -0.1329 5.21E-10 0.1340 3.84E-10 0.0825 0.0001 -0.1055 8.57E-07 0.1363 1.90E-10 0.0376 7.98E-02 0.0196 0.3616 0.0071 0.7421 -0.0331 0.1239 
Cytoplasmic -0.1717 1.60E-14 0.1259 2.04E-08 0.1605 7.33E-13 -0.1484 3.45E-11 0.1432 1.64E-10 0.1069 1.96E-06 ND ND ND ND ND ND 
Periplasmic 0.0346 0.7196 -0.1271 0.1858 0.0619 0.5205 -0.0466 0.6290 -0.0256 0.7909 0.1126 0.2416 0.0275 0.7758 -0.1280 0.1828 0.0707 0.4628 
Extracellular -0.0908 0.4116 0.1980 0.0710 -0.0434 0.6949 -0.1792 0.1029 0.1871 0.0884 0.0705 0.5238 -0.1008 0.3615 0.2057 0.0605 -0.0362 0.7435 
HOPS&Helpers 0.1766 0.2152 0.2297 0.1049 -0.3477 0.0124 0.0621 0.6650 0.1996 0.1603 -0.2331 0.0998 0.1668 0.2420 0.2245 0.1132 -0.3377 0.0154 
Extracelluar-HOPS -0.2626 0.1398 0.1538 0.3929 0.2212 0.2161 -0.3455 0.0489 0.1440 0.4241 0.4587 0.0073 -0.2704 0.1280 0.1713 0.3405 0.2178 0.2235 
 
Notes:  ND - Not Done    BOLD: P < 0.01 † Overall contains only data from Periplasmic and Extracellular proteins 
       




Neural Networks Only 
 
Student T* Mann Whitney Student T* Mann Whitney 
vs Cytoplasmic T value P value Z P value T value P value Z P value 
H Periplasmic 3.510 6.21E-04 2.538 1.12E-02 6.302 4.22E-09 5.249 1.53E-07 
E Periplasmic 2.356 0.020 2.126 0.034 2.682 8.29E-03 2.705 0.007 
C Periplasmic 3.046 0.003 2.243 0.025 7.983 6.56E-13 6.670 2.55E-11 
H Extracellular 3.410 0.001 2.721 0.007 6.154 2.00E-08 5.509 3.60E-08 
E Extracellular 3.328 0.001 4.377 1.20E-05 0.478 0.634 1.436 0.151 
C Extracellular 8.029 4.32E-12 8.232 2.22E-16 10.689 1.23E-17 9.724 2.37E-22 
H HOPs 0.017 0.987 0.547 0.584 3.629 6.31E-04 3.075 0.002 
E HOPs 6.334 2.93E-10 6.580 4.70E-11 5.447 1.23E-06 4.499 6.83E-06 
C HOPs 5.469 1.31E-06 5.495 3.92E-08 9.032 3.10E-12 8.055 7.93E-16 
H Extracellular - HOPs 5.417 5.38E-06 5.079 3.80E-07 5.528 3.88E-06 5.061 4.18E-07 
E Extracellular - HOPs 1.508 0.141 1.146 0.252 3.337 0.002 5.652 1.59E-08 
C Extracellular - HOPs 8.648 1.05E-17 6.438 1.21E-10 5.988 1.00E-06 3.297 0.001 





Table 3.22B:  Effects of protein structure on ASC in P. syringae (continued). 
  
Filtered Database (Percent of all amino acids in the Secondary Structure of each location) 
  
%A %C %D %E %F %G %H %I %K %L %M %N %P %Q %R %S %T %V %W %Y 
Overall Helix 13.61 0.95 4.98 8.44 3.35 3.57 2.34 5.04 13.96 4.51 2.45 2.31 2.33 5.65 8.14 4.68 3.83 6.17 1.26 2.45 
 
Coil 8.36 1.13 8.12 5.61 2.72 12.52 2.87 2.96 6.79 4.11 2.22 4.40 8.32 3.92 5.91 7.25 5.46 4.57 0.84 1.95 
 
Strand 6.76 1.67 2.75 4.47 5.59 3.61 2.54 10.66 13.58 3.02 2.25 1.64 1.47 3.09 5.83 4.17 5.41 16.19 1.56 3.75 
                      Cytoplasm Helix 13.46 1.00 4.96 8.67 3.35 3.54 2.41 5.10 14.11 4.29 2.43 2.23 2.31 5.60 8.42 4.51 3.73 6.19 1.25 2.45 
 
Coil 8.11 1.23 8.10 5.82 2.76 12.57 3.01 3.02 6.96 3.95 2.28 4.17 8.30 3.85 6.19 7.02 5.33 4.57 0.83 1.94 
 
Strand 6.70 1.78 2.76 4.58 5.46 3.57 2.61 10.82 13.78 2.90 2.21 1.54 1.46 3.04 6.00 4.07 5.17 16.36 1.52 3.67 
                      Periplasm Helix 15.45 0.50 5.28 6.46 3.52 3.89 1.33 4.58 12.51 7.11 2.53 2.78 2.85 5.73 5.35 5.41 4.38 5.97 1.66 2.72 
 
Coil 9.84 0.51 8.53 4.59 2.79 11.77 1.80 2.57 5.69 6.08 2.10 5.25 8.97 4.45 3.90 7.46 5.70 4.62 1.03 2.36 
 
Strand 7.52 0.83 2.39 3.93 6.49 4.25 1.57 9.12 11.48 4.38 2.69 2.28 1.86 3.37 4.40 4.79 6.78 15.60 2.15 4.12 
                      Extracellular Helix 14.37 0.51 4.89 6.24 3.03 3.83 2.30 4.38 12.64 5.71 2.76 3.30 1.96 6.49 6.03 7.31 5.20 5.99 0.94 2.09 
 
Coil 10.06 0.42 7.90 3.87 2.10 12.70 2.18 2.54 5.69 4.17 1.57 6.47 7.86 4.16 4.31 10.18 6.95 4.45 0.70 1.72 
 
Strand 6.75 0.78 3.09 3.05 6.84 3.38 2.51 9.74 12.70 3.40 2.40 2.73 0.93 3.59 4.59 5.37 8.31 13.46 1.43 4.96 
                      HOPS Helix 13.97 0.49 4.97 6.52 2.98 3.65 2.62 4.07 12.63 6.12 3.02 2.98 2.13 6.50 6.49 7.27 4.77 6.00 0.80 2.04 
 
Coil 9.60 0.35 7.01 4.08 1.98 12.14 2.63 2.72 5.70 4.48 1.66 6.44 8.84 4.36 4.78 10.92 6.31 4.14 0.53 1.33 
 
Strand 7.20 0.93 2.24 3.27 7.14 3.22 3.65 9.05 13.30 3.65 2.34 2.45 0.93 3.71 6.27 4.85 6.54 14.50 0.98 3.76 
                      Extracellular - HOPs Helix 15.60 0.56 4.66 5.42 3.17 4.40 1.35 5.32 12.69 4.49 1.98 4.23 1.45 6.48 4.66 7.44 6.48 5.98 1.39 2.25 
 
Coil 10.69 0.52 9.13 3.58 2.27 13.48 1.56 2.28 5.66 3.75 1.44 6.52 6.52 3.88 3.66 9.17 7.82 4.87 0.94 2.26 
 







Table 3.22B:  Effects of protein structure on ASC in P. syringae (continued). 
 




Percent Cost of vs Cytoplasmic vs Overall 
  
ATPs/aa % total ATPs/aa % total ATPs/aa % total 
   
Filtered NN Filtered NN 
Overall Helix 23.549 40.58 23.691 43.08 22.993 34.90 
 
Periplasm Helix 98.61 98.94 98.87 99.19 
 
Coil 21.138 43.49 20.640 41.58 20.359 50.03 
  
Coil 98.09 98.18 98.65 98.71 
 
Strand 26.629 15.93 27.397 15.34 26.658 15.07 
  
Strand 99.87 100.21 99.85 100.33 
               Cytoplasm Helix 23.610 41.35 23.752 44.02 ND ND 
 
Extracellular Helix 95.73 95.26 95.97 95.50 
 
Coil 21.258 42.62 20.751 40.72 ND ND 
  
Coil 93.24 93.53 93.77 94.03 
 
Strand 26.625 16.03 27.429 15.26 ND ND 
  
Strand 100.60 97.39 100.59 97.50 
               Periplasm Helix 23.282 35.95 23.500 36.97 23.287 35.98 
 
HOPS Helix 95.99 95.08 96.24 95.32 
 
Coil 20.852 46.93 20.373 46.46 20.859 46.96 
  
Coil 93.23 94.73 93.76 95.24 
 
Strand 26.590 17.12 27.487 16.57 26.577 17.06 
  
Strand 100.46 97.22 100.45 97.34 
               Extracellular Helix 22.601 33.15 22.626 34.584 22.597 33.55 
 
Extracellular - HOPs Helix 94.93 95.67 95.18 95.92 
 
Coil 19.821 54.17 19.409 50.295 19.813 53.87 
  
Coil 93.25 91.65 93.78 92.14 
 
Strand 26.785 12.68 26.713 15.121 26.796 12.58 
  
Strand 100.69 97.51 100.68 97.62 
               HOPS Helix 22.664 40.58 22.583 39.21 22.662 41.20 
 
Notes:  Values on this page are based on the total amino acids in all of that 
secondary structure of every protein in that location.  Values in the table on 
the page above are from averaging % secondary structure in each protein. 
ND – not done.   NN – Neural Networks.                                                                            
† Overall contains only data from Periplasmic and Extracellular proteins 
 
Coil 19.819 51.19 19.657 50.25 19.809 50.68 
 
 
Strand 26.748 8.22 26.667 10.54 26.691 8.12 
 
         Extracellular - HOPs Helix 22.413 21.42 22.724 27.28 22.402 21.48 
 
 
Coil 19.824 58.86 19.018 50.37 19.819 58.90 
 
 






Table 3.23:  Disorder prediction and ASC in nonmembrane proteins of E. coli and P. syringae. 
 
E. coli Mean values vased on per protein amounts (unweighted for length)  E. coli Linear Correlation of ASC (ATPs/aa) and… 
 




Disordered   
% Ordered % Disordered 
Overall 3212 111.38 23.26 297.75 94.25 5.75 
  
R P value R P value 
Cytoplasmic 2859 111.61 23.32 296.47 94.50 5.50 
 
Overall 0.1122 1.81E-10 -0.1122 1.81E-10 
Periplasmic 337 109.72 22.85 309.42 92.39 7.61 
 
Cytoplasmic 0.0719 1.20E-04 -0.0719 1.20E-04 
Extracellular 16 104.90 20.65 280.44 88.81 11.19 
 
Periplasmic 0.2597 1.35E-06 -0.2597 1.35E-06 
        
Extracellular 0.3342 0.2058 -0.3342 0.2058 
             
        
P. syringae Linear Correlation of ASC (ATPs/aa) and… 
P. syringae Mean values vased on per protein amounts (unweighted for length)   % Ordered % Disordered 
 




Disordered   
R P value R P value 
Overall 2167 110.72 22.89 327.13 93.70 6.30 
 
Overall 0.1762 1.43E-16 -0.1762 1.43E-16 
Cytoplasmic 1973 110.98 22.96 317.70 94.07 5.93 
 
Cytoplasmic 0.0648 0.0040 -0.0648 0.0040 
Periplasmic 110 108.72 22.65 414.95 95.62 4.38 
 
Periplasmic 0.4273 3.23E-06 -0.4273 3.23E-06 
Extracellular 84 107.30 21.58 433.73 82.63 17.37 
 
Extracellular 0.4987 1.38E-06 -0.4987 1.38E-06 
HOPS&Helpers† 51 107.68 21.48 437.31 77.13 22.87 
 
HOPS&Helpers† 0.5896 5.29E-06 -0.5896 5.29E-06 
Extracellular-HOPS 33 106.70 21.74 428.18 91.14 8.86 
 







Table 3.23:  Disorder prediction and ASC in nonmembrane proteins of E. coli and P. syringae (continued). 
 
      
P. syringae Comparing composition (Filtered database) 
       
Student T* Mann Whitney 
      
vs Cytoplasmic T value P value Z P value 
E. coli Comparing composition (Filtered Database) 
 
Periplasmic         
 
Student T* Mann Whitney 
 
% Ordered 1.865 0.0647 3.989 6.62E-05 
vs Cytoplasmic T value P value Z P value 
 
% Disordered 1.865 0.0647 3.990 6.62E-05 
Periplasmic         
 
Extracellular     
 
  
% Ordered 3.518 4.87E-04 4.337 1.44E-05 
 
% Ordered 5.814 1.07E-07 6.836 8.15E-12 
% Disordered 3.518 4.87E-04 4.337 1.45E-05 
 
% Disordered 5.814 1.07E-07 6.836 8.16E-12 




HOPS†     
 
  
% Ordered 1.020 0.324 0.099 0.921 
 
% Ordered 8.029 1.31E-10 9.615 6.93E-22 
% Disordered 1.020 0.324 0.099 0.921 
 
% Disordered 8.029 1.31E-10 9.615 6.93E-22 
      
Extracellular - HOPS     
 
  
      
% Ordered 0.884 0.3832 0.962 0.3360 
      
% Disordered 0.884 0.3832 0.962 0.3358 
 
Notes:  BOLD – P > 0.01 * Assumes unequal variance, two tailed.   
 
†  The N terminus (non cleaved signal sequence) of Type III effectors is typically disordered(50); 
    HOPS have higher % disorder in the rest of their proteins. 





Table 3.23:  Disorder prediction and ASC in nonmembrane proteins of E. coli and P. syringae (continued). 
 
Filtered Database (Percent of all amino acids in the (dis)ordered region of each location) 
E. coli  
%A %C %D %E %F %G %H %I %K %L %M %N %P %Q %R %S %T %V %W %Y ASC 
% 
total 
Overall Disordered 9.82 0.44 4.96 7.93 1.42 5.54 2.43 2.71 5.29 8.16 6.98 4.77 5.78 6.87 7.14 8.17 5.95 4.17 0.35 1.12 21.326 4.29 
 
Ordered 9.36 1.32 5.71 6.48 3.58 7.20 2.55 5.75 10.20 4.58 2.45 3.99 4.45 4.55 5.87 5.47 5.29 6.91 1.39 2.90 23.413 95.71 
Cytoplasm Disordered 9.72 0.47 4.97 8.35 1.37 5.46 2.49 2.75 5.23 7.93 6.95 4.65 5.77 6.77 7.53 8.08 5.81 4.20 0.35 1.14 21.344 4.07 
 
Ordered 9.30 1.38 5.67 6.71 3.59 7.18 2.66 5.83 10.34 4.45 2.48 3.83 4.42 4.50 6.08 5.34 5.15 6.90 1.36 2.83 23.459 95.93 
Periplasm Disordered 10.23 0.32 4.82 5.75 1.74 6.11 2.21 2.44 5.41 9.71 7.39 5.48 5.70 7.34 5.30 8.42 6.23 3.95 0.35 1.11 21.338 5.78 
 
Ordered 9.81 0.88 6.03 4.69 3.54 7.35 1.68 5.07 9.08 5.66 2.22 5.11 4.82 4.93 4.32 6.40 6.28 6.97 1.69 3.45 23.133 94.22 
Extracellular Disordered 11.31 0.23 6.11 4.52 1.36 3.62 0.45 2.49 8.14 5.20 4.07 4.30 7.92 7.47 2.26 11.76 12.90 5.20 0.45 0.23 19.763 9.85 
 
Ordered 11.79 0.40 6.08 2.89 2.74 8.33 0.59 5.22 8.68 4.23 1.31 7.54 2.08 6.38 2.30 9.02 10.14 7.05 0.54 2.69 20.780 90.15 
                        
P. syringae                        
Overall Disordered 11.95 0.40 5.91 7.22 1.39 6.17 2.21 2.42 5.93 5.39 5.23 3.58 8.27 5.83 7.63 9.08 5.47 4.84 0.26 0.82 20.540 5.73 
 
Ordered 10.13 1.18 5.99 6.54 3.56 7.55 2.63 5.19 11.07 4.02 2.14 3.08 4.58 4.41 6.75 5.51 4.75 7.20 1.18 2.54 23.140 94.27 
Cytoplasm Disordered 11.47 0.48 6.00 7.78 1.40 5.96 2.30 2.39 6.11 5.31 5.92 3.39 7.91 5.51 8.25 8.49 5.37 4.92 0.27 0.78 20.811 5.00 
 
Ordered 10.02 1.26 5.94 6.75 3.55 7.47 2.72 5.27 11.27 3.85 2.14 2.93 4.56 4.39 7.02 5.35 4.60 7.25 1.16 2.52 23.211 95.00 
Periplasm Disordered 15.14 0.12 6.11 6.35 1.72 6.17 1.17 2.56 5.39 6.98 3.94 2.83 10.90 7.34 4.85 7.28 4.73 5.18 0.21 1.02 20.090 7.28 
 
Ordered 11.17 0.60 6.33 5.06 3.84 7.77 1.62 4.56 9.43 6.09 2.23 3.93 5.13 4.52 4.48 6.19 5.46 7.12 1.55 2.93 22.914 92.72 
Extracellular Disordered 12.71 0.13 5.33 4.78 1.14 7.30 2.30 2.52 5.28 4.91 2.32 5.05 8.69 6.66 5.89 13.17 6.44 4.24 0.24 0.89 19.364 16.32 
 
Ordered 10.75 0.56 6.48 4.51 3.38 8.83 2.25 4.36 9.58 4.52 2.02 4.92 4.31 4.51 4.72 7.73 6.56 6.47 1.00 2.52 22.067 83.68 
HOPS Disordered 12.03 0.14 4.85 4.94 1.12 7.76 2.52 2.62 5.24 4.90 2.03 4.96 9.04 6.82 6.24 13.35 6.40 3.90 0.28 0.85 19.417 22.76 
 
Ordered 10.92 0.55 6.07 5.02 3.31 8.02 2.76 4.13 10.29 5.13 2.33 4.63 4.41 4.69 5.40 7.64 5.50 6.29 0.80 2.11 22.170 77.24 
Extracellular - HOPs Disordered 16.69 0.12 8.17 3.80 1.27 4.60 1.04 1.96 5.52 4.95 4.03 5.52 6.67 5.75 3.80 12.08 6.67 6.21 0.00 1.15 19.057 6.15 
 
Ordered 10.53 0.59 7.02 3.85 3.46 9.89 1.59 4.66 8.67 3.73 1.61 5.30 4.18 4.28 3.84 7.86 7.93 6.70 1.27 3.06 21.933 93.85 
 
Percent Cost of E. coli 
 
Percent Cost of P. syringae 
  
vs Cytoplasmic vs Overall 
  
 
vs Cytoplasmic vs Overall 
Periplasm Disordered 99.98 100.06 
 
Periplasm Disordered 96.54 97.81 
 
Ordered 98.61 98.81 
  
Ordered 98.72 99.02 
Extracellular Disordered 92.59 92.67 
 
Extracellular Disordered 93.05 94.27 
 
Ordered 88.58 88.76 
  
Ordered 95.07 95.36 
     
HOPS Disordered 93.30 94.53 
      
Ordered 95.52 95.81 
    
Extracellular - HOPs Disordered 91.57 92.78 
      
Ordered 94.49 94.78 
Notes:  Values on this page are based on the total amino acids in all the (dis)ordered region of every protein in that location.  Values in the table on the pages 





Table 3.24:  Amino acid composition of extracellular flagellar subunits in endosymbionts & other Gammaproteobacteria. 
 
   
Protein 
Sequence 
Insect Host Presence of Amino Acid Pathway – Source (153, 169) 
 
Symbiont Name Nutrition A R N D C E Q G H I L K M F P S T W Y V 
Wigglesworthia glossinidia (5) PSORTDB Glossina brevipalpis blood 
   
P 
 
Y Y Y 
   
P 
    
P 
   Sodalis glossinidius str. 'morsitans' (153) NCBI Glossina morsitans morsitans blood 
 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 


























            
P=Some genes in pathway are present 
 
   
Mean Protein Values   
 
Proteins %GC Length Mass/aa ATPs/aa %A %R %N %D %C %E %Q %G %H %I %L %K %M %F %P %S %T %W %Y %V 
W. glossinidia 611 22.5 330.1 114.979 25.585 3.6 3.3 8.4 3.8 1.3 5 2.3 5 1.6 13.3 9.5 12.1 2.1 5.5 2.7 7.6 3.7 0.8 3.9 4.2 
S. glossinidius 2515 54.51 287.1 110.743 23.261 10.1 6.6 3.4 5.3 1.3 5.4 4.7 7.2 2.4 5.6 10.9 4.2 2.8 3.6 4.5 5.8 5.3 1.3 2.8 6.9 
B. aphidicola APS 574 26.35 328 114.303 25.027 4.5 4 7.1 4.1 1.2 5.4 3.2 5.4 2.1 11.7 9.8 10.3 2.3 5 2.9 7.2 4.6 0.9 3.5 4.9 
B. aphidicola SG 545 25 326.2 114.531 25.192 4.4 3.9 7.2 4 1.2 5.4 3 5.3 2 11.8 9.8 11 2.2 5.3 2.9 7 4.4 0.8 3.5 4.8 
E. coli K-12 4333 50.8 312.5 111.005 23.555 9.4 5.6 3.9 5 1.3 5.8 4.4 7.1 2.3 6.1 10.6 4.7 3 3.9 4.3 5.8 5.4 1.5 2.8 7.1 
 





Table 3.24:  Amino acid composition of extracellular flagellar subunits in endosymbionts & other Gammaproteobacteria (continued). 
 
Amino Acids A R N D C E Q G H I L K M F P S T W Y V 










↓† ↑† ↓ ↓ ↑ 
                       Source of insect host nutrition 
                    
BOLD 
Vicia faba phloem (molar %)(165) 3 0.6 68.7 3.4 
 
3.7 6.7 0.8 3.3 0.5 0.6 1 0.2 0.4 
 
4.4 1 0.2 0.5 1 >3% 













 Triticum aestivum (>10mM)(127) 










   
Y 
 Human whole blood (μM)(117) 325 nd 48 129 nd 208 528 234 58 51 114 79 19 47 184 118 124 nd 63 213 >200μM 
Human plasma (μM)(117) 208 nd 15 7 nd 35 344 105 40 37 80 69 15 34 130 64 82 nd 41 146 >100μM 
Human serum (μM)(118) 351 91 59 11 10 99 748 325 88 89 135 187 8 63 254 155 186 73 70 274 >100μM 
Mature human serum albumin (%aa) 10.6 4.1 2.9 6.2 6.0 10.6 3.4 2.1 2.7 1.4 10.4 10.1 1.0 5.3 4.1 4.1 4.8 0.2 3.1 7.0 >10% 
                      %aa in ext. flagellar prot. ** 






↓ ↑ ↑ 
 
↑ 























↑ ↓ ↓ ↑ ↑ 
 







Notes: Selected papers related to amino acid composition in phloem sap – (4, 40, 126, 127, 165), in human blood – (103, 104, 117, 118). 
Legend:  nd – not done 
 † only in W. glossinidia;  
* Histidine in stylus from B. aphidicola str. Sg feeding on T. aestiviumis is ~4.9mM (Adobe Photoshop used to measure graph in (127)) 
 ** Trend in amino acid composition in at least 3 of 4 (Buchnera) or 4 of 7 (Wigglesworthia) in flagellar proteins compared to other 






Table 3.24:  Amino acid composition of extracellular flagellar subunits in endosymbionts & other Gammaproteobacteria (continued). 
 
  
Homologs Mean Values Economic Rank ** 
                    
  
Total Size* Mass/aa ATPs/aa Organism Homologs %A %R %N %D %C %E %Q %G %H %I %L %K %M %F %P %S %T %W %Y %V 
FliC γ Proteobacteria 544 516 104.682 19.662 
  








106.962 20.633 48/2515 489/516 10.7 3.3 6.9 6.7 0.0 6.9 5.7 8.1 0.0 9.1 7.2 7.4 1.0 1.9 1.4 7.9 8.1 0.0 2.6 5.0 
                            FliD γ Proteobacteria 284 277 104.682 19.662 
  








108.020 20.970 92/2515 224/277 9.1 3.1 5.6 6.0 0.0 7.6 5.1 7.2 1.0 6.2 9.9 8.6 2.5 1.4 2.3 9.7 8.6 0.4 1.9 3.9 
                            FliK γ Proteobacteria 208 160 104.442 19.734 
  








105.888 20.726 57/2515 151/160 14.2 5.4 2.4 5.6 0.5 3.8 8.6 7.5 4.3 3.5 11.8 1.9 1.1 1.3 7.3 5.9 7.8 0.5 1.3 5.1 
 
B. aphidicola APS 
  
118.654 26.538 479/574 160/160 0.9 0.4 11.9 4.3 0.4 4.7 1.3 0.9 3.0 14.0 7.7 20.4 2.1 4.7 2.1 9.8 3.4 0.9 4.7 2.6 
 
B. aphidicola SG 
  
119.464 26.081 408/545 158/160 1.3 2.4 15.5 4.2 1.0 4.7 3.1 1.3 2.4 10.8 7.1 17.6 1.8 8.4 1.3 7.3 3.9 0.3 3.1 2.4 
                            FlgD γ Proteobacteria 232 232 104.719 20.362 
  








107.147 21.125 15/2515 213/232 11.5 2.6 7.8 6.3 0.4 4.8 5.6 7.1 0.7 3.0 9.3 6.3 4.1 2.6 4.1 7.8 5.6 0.4 2.6 7.4 
 
B. aphidicola APS 
  
110.889 22.048 8/574 230/232 3.4 1.3 14.0 5.9 0.0 3.4 7.2 4.2 1.3 12.3 8.5 8.5 2.1 2.5 4.7 8.9 5.9 0.4 0.8 4.7 
 
B. aphidicola SG 
  
109.811 22.002 8/545 228/232 3.5 1.3 12.4 4.4 0.0 4.0 6.2 4.9 2.2 14.2 8.0 8.4 2.2 0.9 2.2 9.7 8.0 0.4 0.9 6.2 
                            FlgE γ Proteobacteria 260 253 105.108 20.884 
  








107.360 22.062 446/2515 249/253 7.9 1.5 7.7 5.4 0.5 4.5 6.2 11.1 0.2 5.2 6.7 6.4 3.2 4.5 4.2 7.7 7.4 0.7 4.0 5.0 
 
B. aphidicola APS 
  
112.277 22.797 24/574 252/253 2.9 1.7 12.5 6.4 0.5 6.1 4.4 6.1 0.7 9.1 7.6 8.1 2.5 4.4 1.7 10.5 7.1 0.7 3.4 3.4 
 
B. aphidicola SG 
  
112.295 23.113 43/545 253/253 2.9 1.5 12.2 6.6 0.2 5.6 5.1 6.1 1.7 12.0 9.3 7.6 1.2 5.1 2.0 10.3 4.4 0.5 2.7 2.9 
                            FlgK γ Proteobacteria 292 275 106.450 20.722 
  








108.524 20.891 76/2515 202/275 8.5 5.0 9.5 6.8 0.0 5.6 6.1 9.0 1.1 4.7 10.4 4.1 0.9 2.5 2.0 7.9 6.7 0.2 3.4 5.6 
 
B. aphidicola APS 
  
115.122 23.590 88/574 272/275 4.2 2.9 11.4 7.2 0.9 7.9 3.5 2.8 1.7 11.0 8.8 9.8 1.8 3.7 2.0 6.6 4.2 0.2 3.7 5.5 
 
B. aphidicola SG 
  
116.360 24.132 140/545 274/275 2.8 2.6 11.0 8.3 0.9 7.7 3.5 2.8 1.7 11.6 8.6 10.1 1.7 4.2 1.5 6.8 5.0 0.4 4.4 4.6 
                            FlgL γ Proteobacteria 264 238 108.528 21.057 
  








107.083 21.309 146/2515 176/238 11.2 3.8 4.8 8.0 0.0 3.5 7.3 9.6 1.3 5.1 9.3 4.8 4.2 2.6 1.9 7.3 5.4 0.3 2.9 6.7 
        
BOLD = Amino acid % is 2X or 1/2 that of same protein average in γ Proteobacteria 
 
Notes: * Homologs whose lengths were 50% (+/-) their respective E. coli counterpart were removed.  Comparisons were done on the remaining homologs. 
 ** Economic Rank in ATPs/aa (least expensive/total) amongst homologs and within each organism. 
Amino acid % in γproteobacteria are on a per protein basis. The amino acid compositions of each protein are averaged and unweighted for length.   

























Coverage Gram Negative (PSORTDB) Group 
Mean 
(ASC) STDEV 
Solibacter usitatus Ellin6076 Acidobacteria 7826 23.016 1.232 109.493 20.055 383.0 61.9 9.966 0 90 90 
Aquifex aeolicus VF5† Aquificae 1529 24.763 1.306 114.079 21.361 316.0 43.5 1.551 1 92 94 
Aquifex aeolicus VF5 plasmid ece1 - 32 25.284 1.344 116.665 21.698 226.1 36.4 0.039 - 53 54 
Cytophaga hutchinsonii ATCC 33406 Bacteroidetes/Chlorobi 3785 24.530 1.555 112.817 20.964 350.8 38.8 4.433 0 89 90 
Flavobacterium johnsoniae UW101 Bacteroidetes/Chlorobi 5017 24.443 1.431 113.337 20.685 352.7 34.11 6.097 0 87 87 
Flavobacterium psychrophilum JIP02/86  Bacteroidetes/Chlorobi 2412 24.568 1.527 113.394 20.666 333.6 32.5 2.862 0 84 85 
Salinibacter ruber DSM 13855† Bacteroidetes/Chlorobi 2801 22.310 1.293 109.508 19.229 357.8 66.2 3.552 1 84 85 
Sulcia muelleri GWSS* Bacteroidetes/Chlorobi 227 26.031 1.822 115.710 21.522 331.1 22.4 0.246 0 91 92 
Chlamydia trachomatis D/UW-3/CX Chlamydiae 895 23.782 1.365 111.637 20.790 348.9 41.3 1.043 0 89 90 
Chlamydophila pneumoniae AR39 Chlamydiae 1112 24.133 1.591 112.374 21.033 327.4 40.6 1.230 0 80 89 
Roseiflexus sp. RS-1 Chloroflexi 4517 23.080 1.284 110.071 20.033 363.4 60.4 5.802 0 84 85 
Roseiflexus castenholzii DSM 13941 Chloroflexi 4330 23.072 1.285 109.936 20.060 361.4 60.7 5.723 0 82 82 
Prochlorococcus marinus AS9601 Cyanobacteria 1921 24.483 1.711 113.434 20.730 262.4 31.3 1.670 0 90 91 
Synechocystis sp. PCC 6803† Cyanobacteria 3167 23.552 1.444 111.340 20.405 326.3 47.7 3.573 4 86 87 
Synechocystis sp. PCC 6803 plasmids‡ - 397 23.832 1.386 112.835 20.450 260.6 44.0 0.374 - 82.7 83.3 
Thermosynechococcus elongatus BP-1 Cyanobacteria 2475 23.497 1.479 111.154 20.557 312.8 53.9 2.594 0 89 90 
Trichodesmium erythraeum IMS101 Cyanobacteria 4451 24.086 1.543 112.993 20.519 346.8 34.14 7.750 0 59 60 
Thermus thermophilus HB27† Deinococcus-Thermus 1982 23.235 1.263 110.119 21.162 303.6 69.4 1.895 1 94 96 
Mycoplasma genitalium G37 Firmicutes 484 24.767 1.347 114.243 21.019 363.5 31.7 0.580 0 90 91 
Mycoplasma pneumoniae M129 Firmicutes 690 24.348 1.482 113.420 20.788 348.0 40.0 0.816 0 87 88 
Fusobacterium nucleatum ATCC 25586 Fusobacteria 2067 24.807 1.826 114.196 20.757 311.5 27.2 2.175 0 88 89 
Rhodopirellula baltica SH 1 Planctomycetes 7325 23.011 1.366 110.750 19.720 314.9 55.4 7.146 0 94 97 
Caulobacter cresentus CB15 Alphaproteobacteria 3737 22.423 1.311 107.884 19.544 323.6 67.2 4.017 0 90 91 
Ehrlichia chaffeensis str. Arkansas Alphaproteobacteria 1105 24.899 2.069 113.623 21.198 281.5 30.1 1.176 0 79 80 
Hodgkinia cicadicola Dsem* Alphaproteobacteria 169 22.759 1.387 107.651 20.859 257.9 58.4* 0.144 0 90 90* 
Pelagibacter ubique HTCC1062 Alphaproteobacteria 1354 24.632 1.619 113.151 20.578 307.6 29.7 1.309 0 95 96 
Rhodobacter sphaeroides 2.4.1†‡ Alphaproteobacteria 3857 22.479 1.375 108.138 19.660 314.9 69.0 4.132 5 87.5 88.3 
Rhodobacter sphaeroides 2.4.1 plasmids‡ - 385 22.498 1.307 108.263 19.766 313.2 66.8 0.471 - 76.2 76.6 
Rickettsia prowazekii Madrid E Alphaproteobacteria 835 24.691 1.484 113.404 20.684 334.4 29.0 1.112 0 75 75 
Silicibacter sp. TM1040† Alphaproteobacteria 3030 22.720 1.370 109.057 19.642 312.5 60.4 3.201 2 88 89 
Silicibacter sp. TM1040 plasmids‡ - 835 22.875 1.315 109.040 19.902 326.9 58.9 0.953 - 85.8 85.9 
Wolbachia pipientis wMel  Alphaproteobacteria 1195 24.270 1.508 113.080 20.504 282.7 35.2 1.268 0 80 80 
Bordetella pertussis Tohama I Betaproteobacteria 3436 22.684 1.296 108.604 19.907 326.6 67.7 4.086 0 82 92 
Burkholderia xenovorans strain LB400‡ Betaproteobacteria 8702 22.762 1.347 108.813 19.900 320.1 62.6 9.731 0 85.3 86.2 
Neisseria gonorrhoeae FA 1090 Betaproteobacteria 2002 23.472 1.530 110.805 20.203 280.8 52.7 2.154 0 78 79 
Ralstonia eutropha JMP134†‡ Betaproteobacteria 5846 22.641 1.305 108.409 19.767 329.2 64.8 6.533 2 88 88.6 
Ralstonia eutropha JMP134 plasmids‡ - 600 22.725 1.191 108.703 19.786 315.6 64.1 0.723 - 77.8 78.8 
Anaeromyxobacter dehalogenans 2CP-C Deltaproteobacteria 4346 21.913 1.324 106.920 19.421 349.1 74.9 5.013 0 90 91 
Geobacter metallireducens GS-15† Deltaproteobacteria 3519 23.231 1.289 110.169 20.028 343.2 59.5 3.997 1 90 91 
Myxococcus xanthus DK 1622 Deltaproteobacteria 7331 22.396 1.253 108.633 22.396 378.2 68.9 9.140 0 90 92 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
  
Proteins 
















Coverage Gram Negative (PSORTDB) Group 
Mean 
(ASC) STDEV 
Arcobacter butzleri RM4018 Epsilonproteobacteria 2259 24.608 1.597 113.851 20.601 320.9 27.0 2.341 0 92 93 
Campylobacter jejuni RM1221 Epsilonproteobacteria 1838 24.738 1.820 113.963 21.105 293.1 30.3 1.778 0 90 91 
Helicobacter pylori J99 Epsilonproteobacteria 1491 24.380 1.408 113.285 20.977 331.4 39.2 1.644 0 90 90 
Wolinella succinogenes  DSM1740 Epsilonproteobacteria 2044 24.042 1.384 112.206 20.968 322.6 48.5 2.110 0 93 94 
Acinetobacter sp. ADP1 Gammaproteobacteria 3325 23.947 1.592 112.141 20.561 316.2 40.4 3.599 0 87 88 
Baumannia cicadellinicola Hc Gammaproteobacteria 595 24.344 1.312 112.730 20.530 327.7 33.2 0.686 0 85 86 
Blochmannia floridanus Gammaproteobacteria 583 25.084 1.480 114.095 21.083 334.6 27.4 0.706 0 83 84 
Buchnera aphidicola APS Tokyo† Gammaproteobacteria 564 25.033 1.485 114.324 20.793 328.3 26.3 0.641 2 86 87 
Buchnera aphidicola APS Tokyo plasmids‡ - 10 24.719 1.091 113.104 20.789 311.3 28.6 0.015 - 58.2 62.3 
Carsonella ruddii PV Gammaproteobacteria 182 28.037 2.246 118.846 23.710 274.3 16.6 0.160 0 93 94 
Colwellia psychrerythraea 34H  Gammaproteobacteria 4910 23.864 1.625 111.778 20.442 308.0 38.0 5.373 0 84 85 
Coxiella burnetii RSA 493† Gammaproteobacteria 2009 24.286 1.654 112.896 20.857 279.3 42.7 1.995 1 77 85 
Escherichia coli K-12 MG1655 Gammaproteobacteria 4333 23.555 1.504 111.005 20.314 312.5 50.8 4.640 0 85 88 
Klebsiella pneumoniae MGH 78578† Gammaproteobacteria 4776 23.360 1.410 110.348 20.338 318.3 57.5 5.315 5 85 86 
Legionella pneumophila Paris† Gammaproteobacteria 3027 24.213 1.451 112.633 20.756 335.4 38.4 3.504 1 87 88 
Marinobacter aquaeolei VT8† Gammaproteobacteria 3858 23.075 1.310 110.691 19.939 336.3 57.3 4.780 2 90 90 
Marinobacter aquaeolei VT8 plasmids‡ - 414 23.096 1.242 111.568 19.638 305.1 53.7 0.453 - 83.2 84.2 
Photorhabdus luminescens laumondii TTO1 Gammaproteobacteria 4683 23.863 1.462 112.161 20.397 327.4 42.8 5.689 0 80 84 
Pseudomonas aeruginosa PAO1 Gammaproteobacteria 5567 22.280 1.303 109.787 20.314 334.1 66.6 6.264 0 89 89 
Pseudomonas syringae pv. tomato DC3000† Gammaproteobacteria 5471 23.050 1.362 110.067 20.080 331.1 58.4 6.397 2 85 85 
Pseudomonas syringae pv. tomato DC3000 plasmids‡ - 137 22.901 1.473 110.400 19.734 273.3 55.6 0.141 - 80.6 81.6 
Psychromonas ingrahamii 37 Gammaproteobacteria 3545 23.783 1.392 111.555 20.382 332.0 40.1 4.560 0 77 78 
Psychrobacter arcticum 273-4 Gammaproteobacteria 2120 23.277 1.446 110.842 19.676 335.1 42.8 2.651 0 80 81 
Psychrobacter cryohalolentis K5† Gammaproteobacteria 2467 23.303 1.449 110.759 19.745 342.9 42.3 3.060 1 83 83 
Salmonella typhimurium LT2† Gammaproteobacteria 4425 23.533 1.502 110.880 20.325 315.3 52.2 4.857 1 86 87 
Salmonella typhimurium LT2 plasmid pSLT - 102 23.496 1.449 112.144 20.146 243.7 53.1 0.094 - 78 79 
Shewanella denitrificans OS217 Gammaproteobacteria 3754 23.406 1.361 110.823 20.210 340.1 45.1 4.546 0 84 85 
Shewanella oneidensis MR-1† Gammaproteobacteria 4323 23.526 1.391 111.100 20.328 318.6 46 4.970 1 83 83 
Shewanella oneidensis MR-1 plasmid pMR-1 - 148 23.950 1.558 112.853 20.393 259.1 43.7 0.162 - 69 73 
Vibrio cholerae O1 biovar eltor N16961‡ Gammaproteobacteria 3835 23.759 1.532 111.782 20.572 304.4 47.5 4.033 0 86.2 86.5 
Wigglesworthia glossinidia brevipalpis† Gammaproteobacteria 611 25.585 1.654 114.979 21.203 330.1 22.5 0.698 1 86 87 
Yersinia pestis CO92† Gammaproteobacteria 3885 23.605 1.523 111.211 20.382 319.4 47.6 4.654 3 80 84 
Yersinia pestis CO92 plasmids‡ - 182 23.466 1.419 112.518 19.834 245.3 47.8 0.176 - 75 83 
Magnetococcus MC-1  Proteobacteria:Other 3716 23.277 1.354 110.848 20.093 365.2 54.2 4.720 0 86 87 
Borrelia burgdorferi B31† Spirochaetes 851 25.282 1.765 114.786 21.518 333.3 28.6 0.911 21 93 94 
Treponema pallidum Nichols Spirochaetes 1036 23.484 1.277 110.842 20.774 339.3 52.8 1.138 0 92 93 
Fervidobacterium nodosum Rt17-B1 Thermotogae 1750 24.703 1.362 113.590 20.985 334.5 35.0 1.949 0 90 90 
Thermosipho melanesiensis BI429 Thermotogae 1879 25.129 1.545 114.336 21.347 309.9 31.4 1.915 0 91 92 
Thermotoga petrophilaRKU-1 Thermotogae 1785 24.521 1.318 113.555 21.131 321.6 46.1 1.824 0 94 95 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
  
Proteins 















Coverage Gram Positive (PSORTDB) Group 
Mean 
(ASC) STDEV 
Arthrobacter aurescens TC1† Actinobacteria 4041 22.312 1.323 107.435 19.480 333.6 62.3 4.598 2 88 88 
Corynebacterium diphtheriae NCTC 13129 Actinobacteria 2272 22.766 1.428 109.039 19.550 320.2 53.5 2.489 0 87 90 
Frankia sp. EAN1pec Actinobacteria 7191 21.871 1.266 106.890 19.081 347.2 71.2 8.982 0 83 84 
Kineococcus radiotolerans SRS30216† Actinobacteria 4480 21.587 1.285 106.114 19.103 320.5 74.4 4.761 2 90 91 
Kineococcus radiotolerans SRS30216 plasmids‡ - 201 21.517 1.311 106.690 18.606 268.9 69.6 0.195 - 82.5 83.4 
Mycobacterium leprae TN Actinobacteria 1605 22.472 1.276 108.125 19.503 335.684 57.8 3.268 0 49 77 
Mycobacterium tuberculosis H37Rv Actinobacteria 3927 22.147 1.454 107.144 19.309 339.2 65.6 4.412 0 90 91 
Nocardia farcinica IFM 10152† Actinobacteria 5683 22.098 1.276 107.375 19.249 318.4 70.8 6.021 2 90 90 
Nocardioides sp. JS614† Actinobacteria 4645 22.017 1.229 107.248 19.298 325.6 71.7 4.986 2 91 91 
Rubrobacter xylanophilus DSM 9941 Actinobacteria 3140 22.418 1.275 108.883 19.987 313.8 70.5 3.226 0 91 92 
Saccharopolyspora erythraea NRRL 2338 Actinobacteria 7197 22.070 1.330 107.635 19.384 322.1 71.1 8.213 0 84 85 
Salinispora tropica CNB-440 Actinobacteria 4536 22.045 1.260 107.328 19.311 335.2 69.5 5.183 0 88 88 
Streptomyces coelicolor A3(2)† Actinobacteria 7769 21.925 1.272 107.096 19.187 329.6 72.1 8.668 2 88 89 
Thermobifida fusca YX Actinobacteria 3110 22.291 1.242 108.327 19.432 331.4 67.5 3.642 0 85 85 
Tropheryma whipplei Twist Actinobacteria 808 23.488 1.457 110.222 20.536 328.6 46.3 0.927 0 85 86 
Dehalococcoides ethenogenes 195 Chloroflexi 1580 23.676 1.549 110.863 20.329 277.7 48.9 1.470 0 89 90 
Deinococcus radiodurans R1†‡ Deinococcus-Thermus  2997 22.360 1.303 108.243 19.709 307.6 67.0 3.061 2 89.4 88.1 
Bacillus anthracis Ames Firmicutes 5311 24.518 1.745 113.244 20.842 263.9 35.4 5.227 0 80 81 
Bacillus cereus ATCC 14579† Firmicutes 5234 24.461 1.682 113.206 20.769 277.3 35.3 5.412 1 80 81 
Bacillus subtilis 168 Firmicutes 4112 24.052 1.533 112.397 20.453 296.4 43.5 4.216 0 87 88 
Clostridium botulinum A ATCC 19397 Firmicutes 3553 24.558 1.584 113.599 20.294 293.4 28.2 3.863 0 81 81 
Clostridium difficile 630† Firmicutes 3742 24.306 1.469 113.174 20.166 313.0 29.1 4.290 1 82 83 
Lactobacillus gasseri ATCC 33323 Firmicutes 1755 24.193 1.584 112.942 20.315 317.4 35.3 1.894 0 88 88 
Lactococcus lactis subsp. lactis Il1403 Firmicutes 2321 24.138 1.643 112.694 20.490 288.6 35.3 2.366 0 85 88 
Listeria monocytogenes EGD-e Firmicutes 2846 23.931 1.532 112.117 20.183 306.0 38.0 2.945 0 88 89 
Oceanobacillus iheyensis strain HTE831 Firmicutes 3500 24.135 1.689 112.892 20.338 290.9 35.7 3.631 0 84 85 
Staphylococcus aureus Newman Firmicutes 2614 24.320 1.674 113.427 20.321 305.2 32.9 2.879 0 83 83 
Staphylococcus aureus RF122 Firmicutes 2515 24.381 1.751 113.398 20.441 292.6 32.8 2.743 0 80 84 
Streptococcus mutans UA159 Firmicutes 1960 24.238 1.673 112.788 20.682 295.8 36.8 2.031 0 85 86 
Streptococcus pneumoniae TIGR4 Firmicutes 2094 24.240 1.836 112.990 20.792 283.5 39.7 2.161 0 83 84 
Caldicellulosiruptor saccharolyticus DSM 8903 Other bacteria 2679 24.743 1.373 114.034 20.923 318.2 35.3 2.970 0 86 86 
             Yeast 
            Saccharomyces cerevisiae S288C Ascomycetes 6732 26.594 2.145 113.198 N/A 
 
38.3 12.16 0 
   
†  Chromosomal only 
‡  Weighted averages were used for multiple plasmids or chromosomes 
Bacterial Mean Amino Acid Cost calculated from Ahashi and Gojobori; sequences from PSORTDB except Escherichia coli from Echobase and *from  NCBI 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
      Oxygen Requirement  Temperature (optimal) Gram Negative (PSORTDB) Shape Arrangement Endospore Motile Salinity Habitat 
Solibacter usitatus Ellin6076 Rod Clusters - No Non-halophilic Aerobic Terrestrial Mesophilic(30C) 
Aquifex aeolicus VF5† Coccus - - YesL - Aerobic Specialized Hyperthermophile (96C) 
Aquifex aeolicus VF5 plasmid ece1 - - - - - - - - 
Cytophaga hutchinsonii ATCC 33406 Rod Singles - Yes - Aerobic Multiple Mesophilic(30C) 
Flavobacterium johnsoniae UW101 Rod - No Yes Non-halophilic Aerobic Multiple Mesophilic(20-30C) 
Flavobacterium psychrophilum JIP02/86  Rod - No Yes - Aerobic Aquatic Psychophilic 
Salinibacter ruber DSM 13855† Curved Rod - - Yes Extreme halophilic Aerobic Specialized Mesophilic (37-47C) 
Sulcia muelleri GWSS* tubularL - - - - - Host associatedL Mesophilic L 
Chlamydia trachomatis D/UW-3/CX Rod - - - - - Host-associated Mesophilic (37C) 
Chlamydophila pneumoniae AR39 Rod - - - - - Host-associated Mesophilic (37C) 
Roseiflexus sp. RS-1 Rod Filaments No Yes - Facultative Specialized Thermophilic 
Roseiflexus castenholzii DSM 13941 - Filament - Yes - Facultative,O2 resp
L Aquatic Thermophilic (50C) 
Prochlorococcus marinus AS9601 - - - - - - Aquatic Mesophilic 
Synechocystis sp. PCC 6803† Coccus Aggregates - - - - Aquatic Mesophilic 
Synechocystis sp. PCC 6803 plasmids‡ - - - - - - - - 
Thermosynechococcus elongatus BP-1 Rod Singles - - - - Specialized Thermophilic (55C) 
Trichodesmium erythraeum IMS101 Filament Filaments,Aggregates - Yes - Aerobic Aquatic Mesophilic L 
Thermus thermophilus HB27† - - - - halotolerant** Aerobic Specialized Themophilic (68C) 
Mycoplasma genitalium G37 Sphere Singles No Yes Non-halophilic Facultative Host-associated Mesophilic (37C) 
Mycoplasma pneumoniae M129 Sphere Singles No Yes Non-halophilic Facultative Host-associated Mesophilic (37C) 
Fusobacterium nucleatum ATCC 25586 Rod Singles No No - Anaerobic Host-associated Mesophilic (37C) 
Rhodopirellula baltica SH 1 Sphere Singles,Rosettes No Yes - Aerobic Aquatic Mesophilic (28C) 
Caulobacter cresentus CB15 Rod Singles - Yes - Aerobic Aquatic Mesophillic (35C) 
Ehrlichia chaffeensis str. Arkansas Rod Singles - - - - Host-associated Mesophilic ** 
Hodgkinia cicadicola Dsem* tubularL - - - - - Host associatedL Mesophilic L 
Pelagibacter ubique HTCC1062 Rod Singles - No - Aerobic Aquatic Mesophilic 
Rhodobacter sphaeroides 2.4.1†‡ Rod Chains -  Yes - Facultative Multiple Mesophilic(25-35C) 
Rhodobacter sphaeroides 2.4.1 plasmids‡ - - - - - - - - 
Rickettsia prowazekii Madrid E Rod - - - - Aerobic Host-associated Mesophilic 
Silicibacter sp. TM1040† Rod - - Yes - AerobicL Multiple Mesophilic L 
Silicibacter sp. TM1040 plasmids‡ - - - - - - - - 
Wolbachia pipientis wMel  Rod, Coccus - - - - - Host-associated Mesophilic 
Bordetella pertussis Tohama I Rod Singles,Pairs,Chains - - - Aerobic Host-associated Mesophilic (35-37C) 
Burkholderia xenovorans strain LB400‡ Rod Singles No Yes - Aerobic Multiple Mesophilic (35-37C) 
Neisseria gonorrhoeae FA 1090 Coccus Singles,Pairs - - - Aerobic Host-associated Mesophilic (35-37C) 
Ralstonia eutropha JMP134†‡ Rod, Coccus - - Yes Non-halophilic Facultative Multiple Mesophilic(30C) 
Ralstonia eutropha JMP134 plasmids‡ - - - - - - - - 
Anaeromyxobacter dehalogenans 2CP-C Rod - Yes Yes - Facultative Terrestrial Mesophilic(30C) 
Geobacter metallireducens GS-15† Rod - - Yes - Aerobic Aquatic Mesophilic(30C) 
Myxococcus xanthus DK 1622 Rod Singles,Aggregates Yes Yes - Aerobic Terrestrial Mesophilic(20-30C) 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
      Oxygen Requirement  Temperature (optimal) Gram Negative (PSORTDB) Shape Arrangement Endospore Motile Salinity Habitat 
Arcobacter butzleri RM4018 Spiral Singles, Chains No Yes - Aerobic Multiple Mesophilic 
Campylobacter jejuni RM1221 Spiral Singles, Chains No Yes - Microaerophilic Multiple Mesophilc 
Helicobacter pylori J99 Spiral Singles - Yes - Aerobic Host-associated Mesophilic (37C) 
Wolinella succinogenes  DSM1740 Spiral, Curved - - Yes - Microaerophilic Host-associated Mesophilic 
Acinetobacter sp. ADP1 Coccobacillus Pairs No No Non-halophilic Aerobic Multiple Mesophilic (37C) 
Baumannia cicadellinicola Hc Irregular Sphere - - - - - Host associated Mesophilic L 
Blochmannia floridanus Rod - - - - - Specialized, Host-associatedL Mesophilic 
Buchnera aphidicola APS Tokyo† - Singles - - - - Host associated Mesophilic 
Buchnera aphidicola APS Tokyo plasmids‡ - - - - - - - - 
Carsonella ruddii PV - - - - - - Specialized, Host-associatedL Mesophilic L 
Colwellia psychrerythraea 34H  Rod Singles - Yes - Facultative Specialized Psychophilic (8C,-1C**) 
Coxiella burnetii RSA 493† Coccobacillus Singles - - - Facultative Multiple, Host-associatedL Mesophilic (37C) 
Escherichia coli K-12 MG1655 Rod Singles,Pairs - Yes - Facultative Host-associated Mesophilic (37C) 
Klebsiella pneumoniae MGH 78578† Rod Singles,Pairs,Chains - Yes - Facultative Multiple Mesophilic (37C) 
Legionella pneumophila Paris† Rod Singles - Yes - Aerobic Host-associated Mesophilic 
Marinobacter aquaeolei VT8† Rod - - Yes Moderate halophilic Facultative Aquatic Mesophilic (30C) 
Marinobacter aquaeolei VT8 plasmids‡ - - - - - - - - 
Photorhabdus luminescens laumondii TTO1 Rod - - Yes - Facultative Host-associated Mesophilic 
Pseudomonas aeruginosa PAO1 Rod Singles -  Yes - Aerobic Multiple Mesophilic (25-30C) 
Pseudomonas syringae pv. tomato DC3000† Rod Singels - Yes - Aerobic Multiple Mesophilic 
Pseudomonas syringae pv. tomato DC3000 plasmids‡ - - - - - - - - 
Psychromonas ingrahamii 37 Rod - No No - Anaerobic Aquatic Psychrophilic 
Psychrobacter arcticum 273-4 Rod Pairs - No - - Specialized Psychrophilic (22C) 
Psychrobacter cryohalolentis K5† Rod Pairs - No Moderate halophilic - Multiple Psychrophilic 
Salmonella typhimurium LT2† Rod Singles,Pairs - Yes - Facultative Host-associated Mesophilic (37C) 
Salmonella typhimurium LT2 plasmid pSLT - - - - - - - - 
Shewanella denitrificans OS217 Rod Singles,Pairs - Yes - Facultative Aquatic Mesophilic(20-25C) 
Shewanella oneidensis MR-1† Rod - - Yes - Facultative Multiple Mesophilic 
Shewanella oneidensis MR-1 plasmid pMR-1 - - - - - - - - 
Vibrio cholerae O1 biovar eltor N16961‡ Curved Singles - Yes - Facultative Aquatic Mesophilic(20-30C) 
Wigglesworthia glossinidia brevipalpis† - - - - - - Host-associated Mesophilic 
Yersinia pestis CO92† Rod Singles - No** - Facultative Multiple Mesophilic (28-30C) 
Yersinia pestis CO92 plasmids‡ - - - - - - - - 
Magnetococcus MC-1  Coccus - - Yes - Facultative Aquatic Mesophilic L 
Borrelia burgdorferi B31† Spiral - No Yes - Microaerophilic Host-associated Mesophilic 
Treponema pallidum Nichols Spiral Singles No Yes - Anaerobic Host-associated Mesophilic 
Fervidobacterium nodosum Rt17-B1 Rod Singles,Pairs,Chains No Yes - Anaerobic Specialized Thermophilic (70C) 
Thermosipho melanesiensis BI429 Rod Singles,Pairs,Chains - - - Anaerobic Host-associated** Thermophilic (70C) 
Thermotoga petrophilaRKU-1 Rod - No Yes - Anaerobic Aquatic Hyperthermophile (80C) 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
 
      Oxygen Requirement  Temperature (optimal) Gram Positive (PSORTDB) Shape Arrangement Endospore Motile Salinity Habitat 
Arthrobacter aurescens TC1† Rod,Coccus - No Yes Non-halophilc Aerobic Terrestrial Mesophilic (30C) 
Corynebacterium diphtheriae NCTC 13129 Rod Singles, Pairs No No - Aerobic Multiple Mesophilic (37C) 
Frankia sp. EAN1pec Filaments - - - - Aerobic Multiple Mesophilic 
Kineococcus radiotolerans SRS30216† Coccus Singles,Clusters No Yes - Aerobic Multiple Mesophilic (32C) 
Kineococcus radiotolerans SRS30216 plasmids‡ - - - - - - - - 
Mycobacterium leprae TN Rod - No No Non-halophilc Aerobic Host-associated Mesophilic (37C) 
Mycobacterium tuberculosis H37Rv Rod Singles No No - Aerobic Host-associated Mesophilic (37C) 
Nocardia farcinica IFM 10152† Rod Filaments Yes No Non-halophilc Aerobic Multiple Mesophilic (37C) 
Nocardioides sp. JS614† Rod - No No Non-halophilc Aerobic Terrestrial Mesophilic (30C) 
Rubrobacter xylanophilus DSM 9941 Rod Singles No No - Aerobic Specialized Thermophilic (60C) 
Saccharopolyspora erythraea NRRL 2338 Branched filament Filaments Yes No - Aerobic Terrestrial Mesophilc (28C) 
Salinispora tropica CNB-440 - Singles,Clusters,Branched mycelium Yes No - Aerobic Aquatic Mesophilic (28C) 
Streptomyces coelicolor A3(2)† Branched filament Filaments Yes No - Aerobic Multiple Mesophilic (25-35C) 
Thermobifida fusca YX Rod Branched hyphae Yes No - Aerobic Multiple Thermophilic (50-55C) 
Tropheryma whipplei Twist Rod Singles No NO - Aerobic Host-associated Mesophilic (37C) 
Dehalococcoides ethenogenes 195 Irregular coccus Singles No Yes - Anaerobic Multiple Mesophilic (35C) 
Deinococcus radiodurans R1†‡ Coccus Pairs, Tetrads - - - Aerobic Terrestrial Mesophilic (30-37C) 
Bacillus anthracis Ames Rod Singles, Pairs, Chains Yes Yes - Facultative Multiple Mesophilic 
Bacillus cereus ATCC 14579† Rod Chains Yes Yes - Aerobic Terrestrial Mesophilic (25-35C) 
Bacillus subtilis 168 Rod Singles, Chains Yes Yes - Facultative Terrestrial Mesophilic (25-35C) 
Clostridium botulinum A ATCC 19397 Rod Singles, Pairs, Chains Yes Yes - Anaerobic Multiple Mesophilc (37C) 
Clostridium difficile 630† Rod Singles, Pairs, Chains Yes Yes Non-halophilc Anaerobic Multiple Mesophilc (37C) 
Lactobacillus gasseri ATCC 33323 Rod Singles - - - Facultative Host-associated Mesophilic (25-35C) 
Lactococcus lactis subsp. lactis Il1403 Coccus Pairs, Chains - - - Facultative Multiple Mesophilic (40C) 
Listeria monocytogenes EGD-e Rod Singles, Chains - Yes - Facultative Multiple Mesophilic (30-37C) 
Oceanobacillus iheyensis strain HTE831 Rod - Yes Yes halophilic Aerobic Multiple Mesophilic (30C) 
Staphylococcus aureus Newman Coccus Pairs, Clusters No NO - - Host-associated** Mesophilic (30-37C) 
Staphylococcus aureus RF122 Coccus Pairs, Clusters No No - Facultative Host-associated Mesophilic (30-37C) 
Streptococcus mutans UA159 Coccus Pairs, Chains No No - Facultative Host-associated Mesophilc (37C) 
Streptococcus pneumoniae TIGR4 Coccus Chains No NO - Facultative Multiple Mesophilic (30-35C) 
Caldicellulosiruptor saccharolyticus DSM 8903 Rod - - - - Anaerobic Specialized Thermophilic (70C)** 
 
†  Chromosomal only 
‡  Weighted averages were used for multiple plasmids or chromosomes 
Data from NCBI except for: **    from Integr8- http://www.ebi.ac.uk/integr8/    






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
 
Gram Negative (PSORTDB) Pathogenic - Disease Other notes *,** 
Solibacter usitatus Ellin6076 No secrete high MW proteins 
Aquifex aeolicus VF5† No deep branch microbe 
Aquifex aeolicus VF5 plasmid ece1 - - 
Cytophaga hutchinsonii ATCC 33406 No cellulose degradation, gliding motlity, no flagella 
Flavobacterium johnsoniae UW101 No can use chitin, cellulose, lignin 
Flavobacterium psychrophilum JIP02/86  Salmoid fish - Cold water disease, Trout Fry syndrome infection occurs 3 to 15C, secretes 13 proteases 
Salinibacter ruber DSM 13855† No proteins have adapted to high intracellular salt 
Sulcia muelleri GWSS* - Metabolically complements Baumaninia 
Chlamydia trachomatis D/UW-3/CX Human - Pharyngitis, bronchitis and pneumonitis Intracellular active, Extraceullar inactive phase 
Chlamydophila pneumoniae AR39 Human - Pharyngitis, bronchitis and pneumonitis Intracellular active, Extraceullar inactive phase 
Roseiflexus sp. RS-1 No anoxygenic phototroph 
Roseiflexus castenholzii DSM 13941 No growth in aerobic dark conditions 
Prochlorococcus marinus AS9601 No highly abundant ocean microbe 
Synechocystis sp. PCC 6803† No phototactic movement, oxygenic photosynthesis 
Synechocystis sp. PCC 6803 plasmids‡ - - 
Thermosynechococcus elongatus BP-1 No obligate photoautotroph, many type II introns 
Trichodesmium erythraeum IMS101 No Nitrogen fixation in diazocyte 
Thermus thermophilus HB27† No halotolerant, Type IV pilus 
Mycoplasma genitalium G37 Human, Animal, Insect - Urogenital or Respiratory Infections obligate parasite (intracellular) 
Mycoplasma pneumoniae M129  Human - Atypical pneumonia in older children & young adults attachment organelle, can be grown alone in rich media 
Fusobacterium nucleatum ATCC 25586 Human, Animal - Periodontal disease, inflamations obligate anaerobe - associates with other organisms 
Rhodopirellula baltica SH 1 No has pirellulosome, petidoglycan production lost 
Caulobacter cresentus CB15 No asymetric lifestyle, stalk and swarmer cells 
Ehrlichia chaffeensis str. Arkansas Human,animal - Monocytic ehrlichiosis obligate intracellular pathogen, monocyte vacuoles 
Hodgkinia cicadicola Dsem* No Small genome yet high %GC, recoded Stop UGA to Trp 
Pelagibacter ubique HTCC1062 No smallest genome of free living org.- no transposons, HT DNA 
Rhodobacter sphaeroides 2.4.1†‡ No N fixation; aerobic,anaerobic respiration; photsyntesis 
Rhodobacter sphaeroides 2.4.1 plasmids‡ - - 
Rickettsia prowazekii Madrid E Human - Typhus, Mediterranean spotted fever intracellular parasite in cytoplasm of macrophages 
Silicibacter sp. TM1040† No Ruegeria sp. TM1040; sybiosis with dinoflagellates 
Silicibacter sp. TM1040 plasmids‡ - - 
Wolbachia pipientis wMel  No obligate intracellular symbiont of fruit fly 
Bordetella pertussis Tohama I Human - Respiratory diseases Whopping cough 
Burkholderia xenovorans strain LB400‡ Human,Plants - Oppurtunistic infections v large genome, aerobic PCB degrader, N fixation 
Neisseria gonorrhoeae FA 1090 Human - Gonorrhea naturally competent 
Ralstonia eutropha JMP134†‡ - aerobic heterotroph bioremediation chorlianted aeromatics 
Ralstonia eutropha JMP134 plasmids‡ - - 
Anaeromyxobacter dehalogenans 2CP-C No - 
Geobacter metallireducens GS-15† No uses iron in environment as e- acceptor 
Myxococcus xanthus DK 1622 No 1500 gene duplications 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued).  
 
Gram Negative (PSORTDB) Pathogenic - Disease Other notes *,** 
Arcobacter butzleri RM4018 Human - Gastroenteritis and bacteremia growth at various oxygen concentrations 
Campylobacter jejuni RM1221 Human - Food poisoning unique LOS and capsule loci 
Helicobacter pylori J99 Human - Gastric inflamation, peptic ulcers produces urease to suvrive low pH 
Wolinella succinogenes  DSM1740 No non pathogenic but contains serveral virulence genes 
Acinetobacter sp. ADP1 Human - Nonsocomial infection in immunocompromised high natural competency 
Baumannia cicadellinicola Hc No Metabolically complements Sulcia 
Blochmannia floridanus No ant symbiont - provides sulfur and nitrogen 
Buchnera aphidicola APS Tokyo† No symbiont of aphid Acyrthosiphon pisum 
Buchnera aphidicola APS Tokyo plasmids‡ - - 
Carsonella ruddii PV No obligate endosymbion of psyllids 
Colwellia psychrerythraea 34H  No active down to -5C, extracellular proteases 
Coxiella burnetii RSA 493† Animal, Human - Q fever obligate intracellular, replicates in phagocyte 
Escherichia coli K-12 MG1655 No derived from W1485, cured of lambda and F plasmid 
Klebsiella pneumoniae MGH 78578† Human, Animal - Pneumonia and UTIs strain genetically unmalleable - multiple restriction systems 
Legionella pneumophila Paris† Animal - Legionnaire's diesease Protozoa act as reservoir.  Legionella sp. require Cys 
Marinobacter aquaeolei VT8† No degrades hydrocarbons, iron & carbon cycles 
Marinobacter aquaeolei VT8 plasmids‡ - - 
Photorhabdus luminescens laumondii TTO1 Insect - Toxemia and septicemia symbiosis with soil entomopathogenic nematodes 
Pseudomonas aeruginosa PAO1 Human - Opportunistic infections Highly motile - single polar flagella 
Pseudomonas syringae pv. tomato DC3000† Plant - Plant rot resistent to stresses - plant pathogen interactions 
Pseudomonas syringae pv. tomato DC3000 plasmids‡ - - 
Psychromonas ingrahamii 37 No Grows at -12C lowest to date 
Psychrobacter arcticum 273-4 No isolated from Siberian permafrost core 
Psychrobacter cryohalolentis K5† - Growth at -10C, siberian permafrost cryopeg 
Salmonella typhimurium LT2† Human - Gastroenteritis and food poisoning numerous prophages some with virulence genes 
Salmonella typhimurium LT2 plasmid pSLT - - 
Shewanella denitrificans OS217 No vigorous denitrifier 
Shewanella oneidensis MR-1† Human - Rare oppurtunisitic pathogen can use a variety of e- acceptors 
Shewanella oneidensis MR-1 plasmid pMR-1 - - 
Vibrio cholerae O1 biovar eltor N16961‡ Human, Primate - Cholera hemonlysin production 
Wigglesworthia glossinidia brevipalpis† No Obligate endosymbiont Tsetse fly 
Yersinia pestis CO92† Human, Rodent - Bubonic plague transferred amongst rodents by fleas 
Yersinia pestis CO92 plasmids‡ - - 
Magnetococcus MC-1  No Magnetosomes 
Borrelia burgdorferi B31† Human - Lyme Disease Midgut of Ixodes ticks 
Treponema pallidum Nichols Human - Syphilis Obligate human parasite 
Fervidobacterium nodosum Rt17-B1 No obligate anaerobe** 
Thermosipho melanesiensis BI429 - found on gills of deep sea mussel Bathymodiolus brevior 
Thermotoga petrophilaRKU-1 No anaerotic heterotroph, reduces sulfur to H2S 






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued). 
  
Gram Positive (PSORTDB) Pathogenic - Disease Other notes *,** 
Arthrobacter aurescens TC1† None atrazine as sole C,N, energy source 
Corynebacterium diphtheriae NCTC 13129 Human - Diptheria snapping division 
Frankia sp. EAN1pec No symbiotic relationship with plants, fix nitrogen, hyphal 
Kineococcus radiotolerans SRS30216† No thick extracellular polymer shell 
Kineococcus radiotolerans SRS30216 plasmids‡ - - 
Mycobacterium leprae TN Human - Leprosy massive genome reduction many pseudogenes 
Mycobacterium tuberculosis H37Rv Human - Tuberculosis obligate aerobe 
Nocardia farcinica IFM 10152† Human, Animal - Nocardiosis soil saprophyte 
Nocardioides sp. JS614† No degrades vinyl chloride 
Rubrobacter xylanophilus DSM 9941 No reistant to gamma radiation 
Saccharopolyspora erythraea NRRL 2338 No obligate aerobe, produces erythromycin A 
Salinispora tropica CNB-440 No requires sea water for growth, anticancer metabolites 
Streptomyces coelicolor A3(2)† No linear chromosome 
Thermobifida fusca YX Human - Mushroom worker's & farmer's lung disease 
 Tropheryma whipplei Twist Human - Whipple's disease slow growth - nonculturable 
Dehalococcoides ethenogenes 195 No degrade clorinated organics 
Deinococcus radiodurans R1†‡ No most radiation resistant organism 
Bacillus anthracis Ames Animal - Anthrax endospores germinate in alveolar macrophages 
Bacillus cereus ATCC 14579† Human - Food poisoning two illnesses from two sources 
Bacillus subtilis 168 No well studied spore forming bacteria 
Clostridium botulinum A ATCC 19397 Human - Botulism heat resistant spores 
Clostridium difficile 630† Human - diarrhea, pseudomembraneous colitis produces toxin A and B 
Lactobacillus gasseri ATCC 33323 No probiotic 
Lactococcus lactis subsp. lactis Il1403 No cheese production 
Listeria monocytogenes EGD-e Human - Listeriosis enteroinvasive 
Oceanobacillus iheyensis strain HTE831 No salt tolerant alkaliphile, many H,Na,K pumps 
Staphylococcus aureus Newman Human, Animal - Skin infections, pneumonia, endocarditis robust pathogen, four prophages, 2 PAIs 
Staphylococcus aureus RF122 Human, Animal - Mastitis bovine mastitis 
Streptococcus mutans UA159 Human - Dental caries cariogenic 
Streptococcus pneumoniae TIGR4 Human - Mutiple(Pneumonia, Meningitis, others) highly virulent capsular serotype 4 clinical isolate 
Caldicellulosiruptor saccharolyticus DSM 8903 No cellulytic, produces hydrogen, strict anaerobe 
 
†  Chromosomal only 
‡  Weighted averages were used for multiple plasmids or chromosomes 
Data from NCBI except for: **    from Integr8- http://www.ebi.ac.uk/integr8/    






Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued). 
 
Amino Acid Auxotrophies 
Gram Negative (PSORTDB) Number*** Number Source 
Solibacter usitatus Ellin6076 - 2 Ward et al AEM 2009 
Aquifex aeolicus VF5† - None Deckert et al Nature 1998 - growth in media with only inorganic components, autotroph - obtains all C by fixing from CO2 
Aquifex aeolicus VF5 plasmid ece1 - - - 
Cytophaga hutchinsonii ATCC 33406 - None Xie et al AEM 2007 - growth on minimal media plus  
Flavobacterium johnsoniae UW101 - None McBride et al AEM 2009 - growth on minimial media plus glucose, cellulose - genome has all enyzmes necessary 
Flavobacterium psychrophilum JIP02/86  - ? Bernadet & Kerouault 1989 - many carbohydate enzmes missing, inablity to utilize several carbon sources 
Salinibacter ruber DSM 13855† - likely Anton et al Int J Syst Evol Microbiol 2002 - difficulty in defining minimal media - No growth on simple sugars,organic acids 
Sulcia muelleri GWSS* - 12 McCutcheon&Moran PNAS 2007 
Chlamydia trachomatis D/UW-3/CX - 6 Heizer et al Mol Biol Evol 2006 
Chlamydophila pneumoniae AR39 10 6 Heizer et al Mol Biol Evol 2006 
Roseiflexus sp. RS-1 - 
  Roseiflexus castenholzii DSM 13941 - None Hanada et al Int J Syst Evol Microbiol 2002 - growth on minimal media + citrate,lactate, or glucose 
Prochlorococcus marinus AS9601 - None Kettler et al Plos Genetics 2007 
Synechocystis sp. PCC 6803† - None Heizer et al Mol Biol Evol 2006, grows in minimal media BG-11 Rippka et al J Gen Micro 1979 
Synechocystis sp. PCC 6803 plasmids‡ - - - 
Thermosynechococcus elongatus BP-1 - 
  Trichodesmium erythraeum IMS101 - None Chen et al J Phycol 1996 - grows in defined media (without amino acids) 
Thermus thermophilus HB27† - None Heizer et al Mol Biol Evol 2006 
Mycoplasma genitalium G37 - ~20 Fraser et al Science 1995 -  has glyA 
Mycoplasma pneumoniae M129 10 
  Fusobacterium nucleatum ATCC 25586 - 
  Rhodopirellula baltica SH 1 - None Glockner et al PNAS 2003 
Caulobacter cresentus CB15 - None Ferber & Ely Mol Gen Genet 1982 - grows on minimal + glucose + ammonia 
Ehrlichia chaffeensis str. Arkansas 9 
  Hodgkinia cicadicola Dsem* - 11 McCutcheon et al PLOS Genetics 2009 
Pelagibacter ubique HTCC1062 - None Giovannoni et al Science 2005 
Rhodobacter sphaeroides 2.4.1†‡ - None Gray and Escalante-Semerena JBac 2009 - growth in Sistroms minimal A - Asp&Glu and succinate as sole carbon source 
Rhodobacter sphaeroides 2.4.1 plasmids‡ - - - 
Rickettsia prowazekii Madrid E - 
  Silicibacter sp. TM1040† - None Miller&Belas Enviro Micro - minimal + glycerol; Miller et al AEM 2004 - minimal + glucose,glycerol,succinate 
Silicibacter sp. TM1040 plasmids‡ - - - 
Wolbachia pipientis wMel  - 
  Bordetella pertussis Tohama I 1 1 Parkhill et al Nature Genetics 2003 - cysteine biosynthesis and sulfur assimilation genes 
Burkholderia xenovorans strain LB400‡ - None Agullo et al FEMS Microbiol Lett 2007 - growth on minimal media + glucose 
Neisseria gonorrhoeae FA 1090 None likely none Dempsey et al JBact 1991 - requires Pro for growth, Biocyc  - Pro biosyn genes present 
Ralstonia eutropha JMP134†‡ - None Muller et al Appl Microbiol Biotechnol - growth in minimal media with pyruvate or phenol as sole carbon source 
Ralstonia eutropha JMP134 plasmids‡ - - - 
Anaeromyxobacter dehalogenans 2CP-C - likely none Treude et al FEMS 2003 - related strain grown on minimal media,  See Note 1  
Geobacter metallireducens GS-15† - 
  Myxococcus xanthus DK 1622 - 
  Desulfotalea psychrophila LSv54† - 





Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued). 
 
Amino Acid Auxotrophies 
Gram Negative (PSORTDB) Number*** Number Source 
Arcobacter butzleri RM4018 - None Miller et al PLOS One 2007 - 96.5% homologs aa synthesis, Houf et al IJSEM 2009 - growh on minimal media 
Campylobacter jejuni RM1221 2 likely Grown in defined media containing several amino acids, no growth on sugars as major carbon source including glucose 
Helicobacter pylori J99 7 9 Doig et al Micro & Mol Bio Review 1999 
Wolinella succinogenes  DSM1740 - None Baar et al PNAS 2003 - enzymes for all amino acids present, growth in minimal media + fumarate 
Acinetobacter sp. ADP1 - None Metzgar et al Nucleic Acid Res 2004 - grows on minimal MS media with glucose 
Baumannia cicadellinicola Hc - 18 McCutcheon&Moran PNAS 2007 
Blochmannia floridanus - 5 Zientz et al Micro & Mol Bio Review 2004 
Buchnera aphidicola APS Tokyo† - 9 Zientz et al Micro & Mol Bio Review 2004 
Buchnera aphidicola APS Tokyo plasmids‡ - - - 
Carsonella ruddii PV - 14-16 Tamames et al BMC Evol Bio, Nakabachi et al Science 2006 
Colwellia psychrerythraea 34H  - likely none Methe et al PNAS 2005, Biocyc-aa biosyn genes present, Jung et al IJSEM 2006-malate,acetate sole C source 
Coxiella burnetii RSA 493† 10 11 Seshadri et al PNAS 2003 
Escherichia coli K-12 MG1655 None None Heizer et al Mol Biol Evol 2006 
Klebsiella pneumoniae MGH 78578† - yes Bob Bender, personal communication - will not grow on minimal media requires rich media 
Legionella pneumophila Paris† 7 9 Keen & Hoffman Cur Micro 1984 
Marinobacter aquaeolei VT8† - None Huu et al Int J Syst Bacteriology 1999 - aerobic growth, growth on minimal media + citrate, others as sole C source 
Marinobacter aquaeolei VT8 plasmids‡ - - - 
Photorhabdus luminescens laumondii TTO1 - None Ciche et al AEM 2003,Fischer-Le Saux Inter J Syst Biol 1999 - minimal media various sole carbon sources, See Note 2 
Pseudomonas aeruginosa PAO1 None None Stover et al Nature 2000 - grows on minimal media 
Pseudomonas syringae pv. tomato DC3000† - None Roine et al PNAS 1997 - growth in minimal media such as M9 + manitol 
Pseudomonas syringae pv. tomato DC3000 plasmids‡ - - - 
Psychromonas ingrahamii 37 - 
  Psychrobacter arcticum 273-4 - 
  Psychrobacter cryohalolentis K5† - 
  Salmonella typhimurium LT2† None None Gutnick et al Jbac 1969 - growth on minimal media with a variety of single carbon sources 
Salmonella typhimurium LT2 plasmid pSLT - - - 
Shewanella denitrificans OS217 - ? Inconclusive - couldn’t find appropriate literature source 
Shewanella oneidensis MR-1† - None Tang et al Biotechnol Bioeng 2006 - growth aerobically with lactate as sole carbon source 
Shewanella oneidensis MR-1 plasmid pMR-1 - - - 
Vibrio cholerae O1 biovar eltor N16961‡ None None Yildiz & Shoolnik PNAS 1999 - aerobic growth on minimal media with glucose 
Wigglesworthia glossinidia brevipalpis† - 16 Zientz et al Micro & Mol Bio Review 2004 
Yersinia pestis CO92† None 5,3 Perry & Fertherston Clin Micro Review 1997 - some revert, Parkhill et al Nature 2003 
Yersinia pestis CO92 plasmids‡ - - - 
Magnetococcus MC-1  - None Meldrum et al Proc R Soc Lond B 1993 - grown in O or S,O gradient w acetate or bicarbonate as sole carbon source, resp.; Williams et al AEM,2006 - chemolithoautotroph 
Borrelia burgdorferi B31† 10 
  Treponema pallidum Nichols - 
  Fervidobacterium nodosum Rt17-B1 - 
  Thermosipho melanesiensis BI429 - 
  Thermotoga petrophilaRKU-1 - 
  Thermotoga maritima MSB8 - 





Table 3.25: Average synthetic cost, GC-content, descriptions, and auxotrophy of microbes used (continued). 
 
Amino Acid Auxotrophies 
Gram Positive (PSORTDB) Number*** Number Source 
Arthrobacter aurescens TC1† - 
  Corynebacterium diphtheriae NCTC 13129 2 None Cerdeno-Tarraga et al Nucleic Acid Research 2003 
Frankia sp. EAN1pec - 
  Kineococcus radiotolerans SRS30216† - 
  Kineococcus radiotolerans SRS30216 plasmids‡ - - 
 Mycobacterium leprae TN - 1 Cole et al Nature 2001 - metC pseudogene 
Mycobacterium tuberculosis H37Rv 1 None Cole et al Nature 1998, Yu et al says His lacks genes 
Nocardia farcinica IFM 10152† - 
  Nocardioides sp. JS614† - 
  Rubrobacter xylanophilus DSM 9941 - 
  Saccharopolyspora erythraea NRRL 2338 - 
  Salinispora tropica CNB-440 - 
  Streptomyces coelicolor A3(2)† - 
  Thermobifida fusca YX 
   Tropheryma whipplei Twist - 
  Dehalococcoides ethenogenes 195 - 
  Deinococcus radiodurans R1†‡ - 
  Bacillus anthracis Ames None 
  Bacillus cereus ATCC 14579† - 
  Bacillus subtilis 168 - None Heizer et al Mol Biol Evol 2006 
Clostridium botulinum A ATCC 19397 8 
  Clostridium difficile 630† - 
  Lactobacillus gasseri ATCC 33323 - 
  Lactococcus lactis subsp. lactis Il1403 - 
  Listeria monocytogenes EGD-e - 6 Premaratne et al AEM 1991 
Oceanobacillus iheyensis strain HTE831 - 
  Staphylococcus aureus Newman 2 
  Staphylococcus aureus RF122 2 
  Streptococcus mutans UA159 - 
  Streptococcus pneumoniae TIGR4 3 
  Caldicellulosiruptor saccharolyticus DSM 8903 - 
    
 
*** from Yu et al Infection,Genetics, and Evolution (2009) 9:514-517 
Note 1:  Biocyc shows all amino acid synthesis genes  present except:  PheA(Q2IISO in UniprotkB), SerB (many HAD hydrolase-
difficult to anotate SerB), and tyrB (shares activity with ilvE (Q2IF34) & aspC (Q2IIM4)) 





Table 3.26:  Comparison of the ASC of extracellular protein with total proteins in 26 Gram-negative bacteria.* 
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Arcobacter butzleri RM4018 Epsilonproteobacteria 27 2259 24.608 113.851 13 12 92.31 21.736 108.451 90 2.87 1.75E-07 1.12E-07 11.67 4.74 
Flavobacterium johnsoniae UW101 Bacteroidetes/Chlorobi 34.11 5017 24.443 113.337 35 29 82.86 23.245 109.862 74.5 1.2 3.27E-05 5.72E-07 4.9 3.07 
Trichodesmium erythraeum IMS101 Cyanobacteria 34.14 4451 24.086 112.993 46 46 100 21.195 106.929 93 2.89 1.75E-22 9.50E-24 12 5.37 
Colwellia psychrerythraea 34H  Gammaproteobacteria 38 4910 23.864 111.778 37 31 83.78 21.894 107.82 80.3 1.97 1.14E-07 2.17E-10 8.26 3.54 
Cytophaga hutchinsonii ATCC 33406 Bacteroidetes/Chlorobi 38.8 3785 24.53 112.817 40 39 97.50 22.602 106.967 85.2 1.93 2.28E-12 1.67E-14 7.86 5.19 
Acinetobacter sp. ADP1 Gammaproteobacteria 40.4 3325 23.947 112.141 11 10 90.91 22.095 106.614 81 1.85 1.35E-03 3.80E-04 7.73 4.93 
Photorhabdus luminescens laumondii TTO1 Gammaproteobacteria 42.8 4683 23.863 112.161 33 31 93.94 22.02 108.192 83.5 1.84 2.23E-10 3.11E-11 7.72 3.54 
Aquifex aeolicus VF51 Aquificae 43.3 1560 24.774 114.13 11 10 90.91 23.214 111.694 81.8 1.56 7.80E-04 2.78E-04 6.3 2.13 
Shewanella oneidensis MR-1 Gammaproteobacteria 45.9 4471 23.54 111.158 36 34 94.44 21.357 106.088 89.1 2.18 4.85E-16 6.09E-16 9.27 4.56 
Synechocystis sp. PCC 6803 Cyanobacteria 47.3 3564 23.583 111.507 12 10 83.33 22.151 107.61 77.7 1.43 2.50E-03 9.17E-04 6.07 3.49 
Vibrio cholerae O1 biovar eltor N16961 Gammaproteobacteria 47.5 3835 23.759 111.782 50 45 90.00 22.278 108.608 77.3 1.48 8.97E-09 2.96E-11 6.23 2.84 
Wolinella succinogenes DSM 1740 Epsilonproteobacteria 48.5 2044 24.042 112.206 13 13 100 21.439 107.44 93.7 2.6 3.40E-08 5.48E-08 10.83 4.25 
Escherichia coli K-12 MG1655 Gammaproteobacteria 50.8 4333 23.555 111.005 16 16 100 20.652 104.9 93.4 2.9 2.19E-09 1.96E-09 12.32 5.5 
Salmonella typhimurium LT2 Gammaproteobacteria 52.2 4527 23.532 110.908 58 51 87.93 21.676 107.196 81.4 1.86 1.43E-14 2.22E-16 7.89 3.35 
Magnetococcus MC-1  Other 54.2 3716 23.277 110.848 37 37 100 20.261 105.888 94.2 3.02 1.08E-20 2.00E-20 12.96 4.47 
Rhodopirellula baltica SH 1 Plantomycetes 55.4 7325 23.011 110.75 24 21 87.50 20.872 106.693 85.9 2.14 1.54E-09 1.15E-09 9.3 3.66 
Marinobacter aquaeolei VT8 Gammaproteobacteria 57 4272 23.077 110.776 19 19 100 20.671 106.006 93.2 2.41 1.95E-11 7.50E-11 10.43 4.31 
Pseudomonas syringae pv. tomato DC3000 Gammaproteobacteria 58.3 5608 23.047 110.075 84 70 83.33 21.581 107.296 77.1 1.47 9.94E-18 1.25E-17 6.36 2.52 
Silicibacter sp. TM1040 Alphaproteobacteria 60.1 3864 22.754 109.053 29 29 100 20.397 104.447 92.7 2.36 4.34E-16 2.22E-15 10.36 4.22 
Roseiflexus castenholzii DSM 13941 Chloroflexi 60.7 4330 23.072 109.936 22 22 100 21.316 105.67 89.3 1.76 1.13E-10 2.02E-10 7.61 3.88 
Burkholderia xenovorans LB400  Betaproteobacteria 62.6 8702 22.762 108.813 45 39 86.67 21.063 103.631 79.1 1.7 5.80E-12 1.45E-11 7.46 4.76 
Ralstonia eutropha JMP134 Betaproteobacteria 64.5 6446 22.648 108.437 30 27 90.00 20.62 104.01 86.3 2.03 2.17E-12 6.63E-12 8.95 4.08 
Pseudomonas aeruginosa PAO1 Gammaproteobacteria 66.6 5667 22.881 109.787 48 41 85.42 21.392 105.903 79.2 1.49 2.89E-12 3.56E-12 6.51 3.54 
Caulobacter cresentus CB15 Alphaproteobacteria 67.2 3737 22.423 107.884 27 22 81.48 20.955 103.973 79 1.47 2.95E-07 1.95E-07 6.55 3.63 
Rhodobacter sphaeroides 2.4.1 Alphaproteobacteria 68.8 4242 22.481 108.15 29 29 100 20.251 102.962 90.1 2.23 7.22E-15 9.25E-14 9.92 4.8 
Anaeromyxobacter dehalogenans 2CP-C Deltaproteobacteria 74.9 4346 21.913 106.92 28 27 96.43 20.249 102.949 84.4 1.66 2.54E-12 2.00E-10 7.59 3.71 
 
*  Each is capable of aerobic growth and has the capacity to synthesis all 20 amino acids (See notes in Table 3.25). 
†  The number and % of extracellular proteins that have ASC that are less than the mean organismal ASC. 
1   Not graphed in Fig. 3.5B or used in later analysis.  Hyperthermophile (96C) - does not follow %GC cost trends of other organisms (See Fig. 3.5A) possibly due 
to different amino acid biases needed for protein folding at higher temperatures.  Many thermophiles had weak cost selection relative to Mesophiles (149); 
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Examining the Kinetics and Conditions Favoring the in Vitro Polymerization 
of the Functional Amyloid Protein CsgA1 
 
Abstract 
Amyloids form when soluble proteins convert into biochemically and structurally distinct 
fibers. Although amyloid formation is traditionally associated with diseases like 
Alzheimer’s disease, a number of biologically functional amyloids have recently been 
described. Curli are amyloid fibers produced by Escherichia coli that contribute to 
biofilm formation and other important physiological processes. We characterized the 
polymerization properties of the major curli subunit protein CsgA. CsgA polymerizes into 
an amyloid fiber in a sigmoidal kinetic fashion with a distinct lag, growth, and stationary 
phase. Adding sonicated, preformed CsgA fibers to the polymerization reaction 
significantly shortened the duration of the lag phase. This conversion of soluble CsgA 
into an insoluble fiber involves the transient formation of an intermediate similar to that 
characterized for several disease-associated amyloids. The CsgA core amyloid domain 
can be divided into 5 repeating units that share sequence and structural hallmarks. 
Peptides representing three of these repeating units are amyloidogenic in vitro. 
Although the defining aspects of CsgA polymerization appear conserved with disease-
associated amyloids, these proteins evolved in diverse systems and for different 
purposes. Therefore, amyloidogenesis appears to be an innate protein folding pathway 
that can be capitalized on to fulfill normal physiological tasks. 
1 Portions of this chapter, mainly Figures 4.1-4.4 and the associated text, were published in JBC (123) with 




Amyloid formation is the hallmark of clinical disorders such as Alzheimer’s disease, 
Huntington’s disease, Parkinson’s disease, and the transmissible spongiform 
encephalopathies (25). The root of these diseases is the uncontrolled conversion of 
seemingly unrelated soluble proteins into biochemically and structurally related fibers 
known as amyloids. Despite their diversity in size and amino acid content, all amyloid 
proteins assemble into 4-12nm wide fibers that are β-sheet rich and exhibit conserved 
tinctorial properties. Soluble pre-amyloid species also share common pore-like epitopes, 
and these globular species may induce cytotoxicity (51, 57, 91).  
Numerous studies have revealed that amyloidogenic proteins are mostly 
unstructured or contain mixtures of β-sheets and α-helices in their native state, but 
when polymerized into fibers they invariably adopt a characteristic cross β-sheet 
structure (7, 8, 52). This cross β-sheet structure is common to all amyloids and is 
characterized by β-strands that orient perpendicular to the fiber axis. In vitro, disease-
associated amyloids polymerize into fibers with nucleation-dependent kinetics with 
characteristic lag, growth and stationary phase. The lag phase is proposed to contain 
folding intermediates that are key to the toxicity associated with certain amyloidogenic 
proteins (61, 63). During the lag phase, amyloidogenic proteins adopt a transiently 
folded species that disrupts membrane integrity (16, 57, 61). Loss of membrane integrity 
is proposed to underlie the cell death and disease associated with many amyloids (16, 
57). A conformational-specific antibody has been generated that recognizes a transient 
intermediate formed during amyloidogenesis of several disease-associated proteins 
(57). 
A new class of amyloids has recently been found that play important physiological 
roles for the cell. These so-called ‘functional’ amyloids are found in bacteria (12, 19, 33), 
fungi (29, 113) and mammals (37). The first example of a functional amyloid in bacteria 
was curli (19). Curli compose part of the complex extracellular matrix that is required for 
biofilm formation (2, 135, 136), host cell adhesion (53), and invasion (44, 45), and they 
are proposed to be important stimulants of the host inflammatory response (10, 11, 
250 
 
114, 115). An intriguing question is whether these functional amyloid proteins 
polymerize in a manner similar to disease-associated amyloids.  
Curli formation is the result of an elegant biosynthetic pathway directed by the Csg 
proteins in E. coli. The major curli subunit, CsgA, can be secreted to the cell surface as a 
soluble, unstructured protein (5, 19). CsgA is efficiently nucleated into an insoluble 
amyloid fiber in the presence of the outer membrane-associated protein, CsgB (48, 49). 
After nucleation, the fibers are predicted to grow by subsequent CsgA addition to the 
amyloid fiber’s tip (5). 
Both CsgA and CsgB display a remarkable five-fold internal symmetry characterized 
by conserved polar residues. These five ‘repeating units’ consist of 19-24 amino acids 
and align along serine, glutamine and asparagine residues (5, 28). Each repeating unit is 
predicted to form a strand-loop-strand motif that closely resembles the cross β-spine 
structure described for many disease-associated amyloids (28, 79, 80).  
Here I characterize the folding of purified CsgA and show that its polymerization is 
similar to that of disease-associated amyloids. CsgA polymerization involves a transient 
structurally conserved intermediate that implies a common polymerization pathway 
between functional and disease-associated amyloids. I found that the conserved folding 
intermediate for CsgA is a monomer or low molecular weight multimer. We 
demonstrate that at least three of five repeating units of CsgA are amyloidogenic. These 




CsgA-His polymerization kinetics 
 To determine the polymerization kinetics of CsgA-His, an in vitro polymerization assay 
was developed. The transition of freshly purified, soluble CsgA-His to amyloid fibers was 
monitored using thioflavin T (ThT), an amyloid-specific dye commonly used to assay 
amyloid formation (64, 65). The ThT fluorescence of CsgA-His samples followed a 
sigmoidal curve with distinguishable lag, growth and stationary phases (Fig. 4.1A). While 
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the polymerization rate was concentration dependent (Fig. 4.1A and 4.24B), the lag 
phase and half time (t½) were not (Fig. 4.24A,C). However below 4 µM, the lag phase 
was concentration dependent, consistent with nucleation dependent kinetics; however, 
above 4 µM, the lag phase was concentration independent (Fig. 4.24A). Concentration-
independent lag phases have been reported for other amyloidogenic proteins including 
IAPP (71, 84, 93, 94, 103). ThT fluorescence signal did not change appreciably after 8 
hours, remaining at approximately the same level for over 30 days (data not shown).  
 The structural changes that occurred during CsgA-His amyloidogenesis were 
measured by circular dichroism spectroscopy and transmission electron microscopy 
(TEM). Circular dichroism spectrum indicated that immediately after purification CsgA-
His was largely unstructured (Fig 4.1B). However, CsgA-His adopted a β-sheet-rich 
structure after 2 days of incubation at room temperature (Fig 4.1B). Immediately after 
purification there was no apparent fiber formation or aggregation by TEM (Fig 4.1C). 
Two hours after purification regular, unbranched fibers were readily observed (Fig. 
4.1D). Dense fiber aggregates were also observed 7 days post purification (Fig. 4.1E). 
Therefore, the appearance of fibers observed by TEM was approximately coincident 
with an increase in ThT fluorescence.  
 
The A11 antibody recognizes a transient CsgA-His folding species. 
 The polymerization of several amyloids found in eukaryotes involves the formation of 
an intermediate folding species proposed to cause amyloid-associated toxicity to host 
cells (51, 57). The A11 antibody recognizes an Aβ transient intermediate (57). 
Remarkably, this antibody also recognizes a transient intermediate formed by the 
amyloids IAPP, poly Q, PrP, and Sup35p, among others (57, 104). The A11 antibody 
recognizes only a transient intermediate species, not soluble monomers or mature 
amyloid fibers derived from these proteins. 
 We utilized the A11 antibody to determine if CsgA-His shared a common 
polymerization intermediate with other amyloids. I found that immediately after 
purification CsgA-His was recognized by the A11 antibody (Fig. 4.2A). As fiber formation 
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proceeded, evidenced by increased ThT fluorescence and the appearance of fiber 
aggregates by TEM, the A11 antibody lost no longer bound CsgA-His (Fig.2A). A 
polyclonal antibody generated against CsgA recognized purified CsgA-His independently 
of its polymerization status (Fig. 4.2A).  
  The observation that the A11 antibody recognized CsgA-His suggested that 
intermediates during CsgA-His polymerization might be structurally similar to those 
formed by disease-associated amyloid proteins. It also suggested that, immediately after 
purification, CsgA-His had already begun its transition to an amyloid fiber. To prevent 
CsgA-His from folding during purification, the CsgA-containing fractions were amended 
with 8 M Guanidine hydrochloride (GdHCl). Under these strongly denaturing conditions, 
the A11 antibody did not recognize CsgA-His; however, 8M GdHCl denatured CsgA-His 
was readily recognized by the CsgA antibody (Fig. 4.2B). Immediately after GdHCl 
removal with a desalting column, CsgA-His was recognized by the A11 antibody (Fig. 
4.2B and Fig. 4.19).  
 To determine the minimum size of the CsgA-His transient intermediate, freshly 
purified protein was passed through Amicon Ultra centrifugal membranes with different 
molecular weight cutoffs. The retentate and filtrate were probed with the A11 antibody 
(Fig. 4.2C). The A11 antibody recognized a species in the filtrate of the 30 kD membrane, 
suggesting that the smallest reactive species of CsgA-His is 30 kD or less. Because CsgA-
His has a predicted molecular mass of 13.9 kD, the species recognized by the A11 
antibody is likely either a monomer or dimer. 
 
CsgA-His fibers can catalyze self-polymerization 
 The approximately sigmoidal ThT fluorescence curve suggests that CsgA-His 
polymerizes by a nucleation-dependent mechanism. Therefore, the growing fiber would 
be expected to direct the polymerization of new CsgA molecules. We tested the 
hypothesis that preformed CsgA-His fibers could catalyze CsgA-His polymerization. 
Addition of 2.5% (w/w) sonicated CsgA-His fibers to freshly purified, soluble CsgA-His 
resulted in a significantly reduced lag phase (Fig. 4.3A). Coincident with the dramatically 
253 
 
shorter lag phase in seeded reactions, CsgA-His was recognized by the A11 antibody for 
a significantly shorter period of time compared to unseeded reactions (Fig. 4.3B).  
 
CsgA-His is composed of several amyloid-forming units 
 The observation that CsgA-His was recognized by the A11 antibody immediately after 
passing through a 30 kD cutoff filter (Fig. 4.2C) was unexpected since the A11 antibody 
is thought to recognize an oligomeric form of amyloidogenic proteins (57, 63, 104). The 
number of molecules present in the oligomeric state recognized by A11 varies among 
amyloidogenic proteins, but Aβ oligomers have been estimated to be larger than 
tetramers (57, 63). However, CsgA-His is likely recognized by A11 as a monomer or at 
most a dimer as estimated by cutoff filtration. We postulate that thee multiple 
amyloidogenic domains of a single CsgA molecule collectively contribute to it folding 
into a state that interacts with the A11 antibody. The primary sequence of CsgA can be 
divided into three parts: the Sec-dependent signal sequence, the N-terminal 22 amino 
acids of the mature protein, and a repeat domain that contains five 19-22 amino acid 
repeating units (Fig. 4.4A). The five repeating units form a protease resistant structure 
that is proposed to be the amyloid core of CsgA (5, 28). Each repeat has four conserved 
polar amino acids: serine, glutamine, asparagine and glutamine (Fig. 4.4A). The regular 
arrangement of glutamine and asparagine residues also occurs in CsgA homologs from 
different Enterobacteriaceae (Wang and Chapman unpublished observation). 
 We hypothesized that these repeating units might represent single amyloid forming 
units. Accordingly, peptides corresponding to each repeating unit were chemically 
synthesized and tested for their ability to form amyloid fibers. Two independently 
derived preparations of each peptide were assayed. Peptides corresponding to 
repeating unit 1, 3 or 5 (R1, R3 or R5) produced a ThT-positive signal and self-assembled 
into fibers as evidenced by TEM when incubated at 0.2 mg/ml (Fig. 4.4B-E). Neither R2 
nor R4 showed evidence of amyloidogenesis when resuspended at a concentration of 
0.2 mg/ml, although fibers were observed by TEM when R2 or R4 were incubated at 2 
mg/ml (Fig. 4.4B and data not shown). The morphology of R1 fibers was similar to those 
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formed by purified CsgA-His, being generally longer than 1000nm (compare Fig. 4.4C to 
Fig. 4.1D and 4.1E). R3 fibers were consistently shorter (ranging from 200nm-1000nm) 
than those formed by CsgA-His (compare Fig. 4.4D to Fig. 4.1D and E). R5 fibers 
appeared more rigid and aggregated than CsgA-His fibers (Fig. 4.4E). The morphologies 
of the fibers did not appreciably change over the course of a ten-day incubation. This 
analysis suggests that CsgA contains at least three highly amyloidogenic domains, R1, R3 
and R5, that likely drive fiber formation in vivo.  
 
CsgA-His is not non-enzymatically glycated 
 In both purificaiton protocols, CsgA-His that eluted from the NiNTA column was often 
quite brown in color, indicative of glycated proteins (Fig. 4.5B). Non-enzymatic glycation 
contributes to fibrilization and toxicity of several disease-associated amyloids (100, 118). 
The Gel filtration column used in the denaturing protocol efficiently separated from 
CsgA-His the source of this brown color, which was also detectable by fluorescence (Fig. 
4.5E-G). The brown color is likely a small peptide present in LB that also binds to the 
NiNTA column with some affinity (Fig. 4.5H). Lag phases were more consistent upon gel 
filtration and were typically shorter than less pure preparations (data not shown) 
indicating the possibility that some of these small peptides may have an inhibitory role. 
 
Effects of pH, various salts, and ionic strength CsgA-His polymerization 
 The effects of pH, various salts, and ionic strength on amyloid formation has proved 
useful in studying the fiber formation pathway of amyloids because certain conditions 
stabilize or destabilize transient folding intermediates that are often correlated with 
cellular toxicity (23, 56, 75, 76, 78, 92, 96, 107, 110, 116, 125, 132-134). Coupling the 
knowledge of these effects with a protein sequence can also reveal which regions or 
types of interactions are important for efficient amyloid fiber formation. Consequently, 





Effects of pH on CsgA-His polymerization. 
 In a multiple buffer system consisting of 20 mM each of potassium borate, citrate, 
and phosphate (KBCP), CsgA-His had increased polymerization rates and reduced lag 
phases at around pH 3 and pH 8 with the latter having higher overall ThT fluorescence 
and relative rate of polymerization (See Fig. 4.6). Similar results were also obtained in 
other buffer systems including KAc (Potassium Acetate), 3M (MES, MOPS, and MOBS), 
and TSC (Tris, Sodium Succinate, and CAPS) (Fig. 4.7). Because ThT fluorescence of 
preformed CsgA-His fibers is affected by pH (58) (Fig. 4.8A), it is necessary to compare 
relative rates instead of slopes between pH values. Around pH 9, ThT fluorescence is 
maximal; whereas at pH 11 fibers start to breakdown (Fig. 4.8B,C).  
 Previously, different affects of pH on CsgA-observed. In earlier experiments CsgA-His 
was buffer exchanged using PD-10 columns, and CsgA-His polymerized better at lower 
pH values (Jonathon Jones, unpublished observations). However, those experiments 
used single component acetate or phosphate buffers. Different buffer ions can affect 
aggregation and amyloid formation in a pH independent fashion (56, 125, 134). For 
example, in potassium acetate at pH 4, CsgA-His has a much greater relative rate of fiber 
elongation than in any other buffer or pH assayed (Fig. 4.7A). The use of multiple buffer 
systems overcomes this to some degree, especially the 3M buffer which contains three 
compounds whose structure only differs by the number of carbons linking a morpholine 
to sulfonic acid. 
 The maximum polymerization rate of CsgA-His near pH 8 is unexpected. Most 
amyloids polymerize more readily near their isoelectric point (pI), where charges are 
balanced, thus allowing for efficient hydrophobic collapse and increased side chain 
interactions needed for amyloid nucleus formation (102). The theoretical pI of mature 
CsgA-His is 5.73 (88, 89); the pI for wild type (WT) CsgA is either 4.28 (88) or 4.51 (89). 
When graphing the pI versus the pHmax of other amyloids, CsgA-His appears to be quite 
the outlier (Fig. 4.9). To explore why this might be, I examined the theoretical titration 
curves of WT CsgA and CsgA-His (Fig. 4.10). The two curves are quite similar above pH 7, 
showing a shoulder that extends to pH 9, encompassing the pH range over which CsgA-
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His polymerizes the fastest. Below pH 7, CsgA-His becomes more positive, relative to WT 
CsgA, due to the 6X-His-tag on its C-terminus. CsgA-His is expected to be neutrally 
charged near pH 6, yet this is where CsgA-His polymerizes the slowest. Usually, lowering 
the net charge of amyloidogenic proteins increases their rate of aggregation (18, 24, 
112, 124).  
 Possible reasons for the discrepancy in the pHmax of CsgA-His include the proximity of 
the 6X-His-tag to R5, the presence of a His residue in the last beta strand of R5 (Fig. 
4.29B and 4.30), or the differences in the pI of the individual repeating units of CsgA 
(Fig. 4.30). R5 is an important region of CsgA-His and greatly increases the aggregation 
of CsgA-His (122). Like R1, it is relatively uncharged and may be one reason why both R1 
and R5 polymerize more efficiently than the other repeating units of CsgA (124). 
Perhaps the increased charge from the protonation of the 6X-His-tag or His149 (pKa ~ 
6.1) at lower pH inhibits important interactions in R5 needed for efficient curli fiber 
formation. Histidines appear to drive the slower polymerization of CsgA-His down to 
around pH 4. Near pH 3, CsgA-His polymerizes more quickly, possibly because Asp (pKa 
3.9) and Glu (pKa 4.1) residues become uncharged (Fig. 4.6). Wang et al 2010 (124) 
showed that replacing several Asp’s with neutral residues greatly increased CsgA 
polymerization. Alternatively, R1 and R5, the two most important repeating units of 
CsgA (122) (Fig. 4.4), have pI’s very near the two pH maximums of CsgA-His. Perhaps the 
increased polymerization of CsgA-His around pH 3 to 4 and around pH 8 reflects the 
collapse of R1 or R5, allowing them to form an amyloid nucleus that templates the other 
less efficient repeating units. 
 At both pH extremes CsgA-his polymerization is slowed down (Fig. 4.7). Below pH 3 
CsgA-His is more likely to be acid hydrolyzed; the pKa of α-COOH are between 1.8 and 
2.6. At pH >10, Tyr and Lys begin to be deprotonated leading to increased positive 
charge which should drive CsgA to a neutral charge. However, at high pH CsgA seems to 
polymerize more slowly and preformed fibers seem to depolymerize. Assuming high pH 
does not lead to increased degradation of CsgA-His (pKa of α-NH3 vary from 8.8 to 
10.6), one possible way to purify unfolded CsgA-His or CsgA would be to elute into a 
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buffer with a pH greater than 10 and then quickly adjusting to neutral pH to start 
polymerization. Further study of the pHmax of WT CsgA and mutants in charged residues 
may elucidate what regions and residues are important for CsgA polymerization. 
 
The pI’s of CsgA and CsgB appear complementary.  
 Intriguingly, the pI of mature CsgB is quite high (either 9.3 (89) or 9.7 (88)) due to the 
highly basic R1, R4, and R5 repeating units (Fig. 4.30). A comparison of the theoretical 
titration curves of both CsgA and CsgB (Fig. 4.10) shows both would be expected to have 
opposite charges near neutral pH. One possible role for this difference in pI’s is charge 
attraction. Charged amyloidogenic proteins have been shown to bind to opposite 
charged macromolecules resulting in increased aggregation (17). At physiological pH, 
the negative charge of CsgA is predicted to attract to the positive charge of CsgB, 
allowing heteronucleation to occur. Both R4 and R5 of CsgB are required for its proper 
function (Neal Hammer, Doctoral thesis and unpublished work). The importance of the 
charge of R4 and R5 of CsgB to attracting CsgA would be an interesting area of further 
study, perhaps by testing CsgA-His and WT CsgA seeding with CsgB at different pH 
values. 
  
Effects of various salts and ionic strength on CsgA-His polymerization. 
I also tested the effects of various salts on the polymerization of CsgA-His and 
found salts that are bound by His residues appear to inhibit CsgA-His polymerization. 
NiSO4 and ZnSO4 were both able to completely inhibit the polymerization of CsgA-His at 
1mM (Fig. 4.11A,C). AlCl3, CaCl2, MgCl2, and MgSO4 had no effect on csgA polymerization 
(Fig 4.11B). Sodium salts also do not have an effect, as phosphate buffered saline and 
sodium phosphate buffers have both been used for CsgA-His polymerization. Addition of 
EDTA rescued the inhibition from NiSO4 but not ZnSO4 (Fig. 4.11A,C); however, EDTA 
itself had no apparent effect on CsgA-His polymerization (Fig. 4.11D). Many amyloids 
respond to salts on the Hofmeister series, with more chaotropic ions either inhibiting or 
promoting amyloid formation depending on the amyloidogenic protein (78, 92, 96, 107, 
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132); however, there are exceptions to this rule, especially at different pH values (15, 
78, 92). Here, CsgA-His responded only to Zn+2 and Ni+2, both of which are known to 
bind to imidazole, the functional group of histidine. A similar result was seen with 
human IAPP, where Zn and Cu but not Ca, Mg, Na, or NH4 affected polymerization due 
to their binding to His18 (15). Thus, the effect of Zn and Ni ions could be due to their 
binding the 6X-His-tag or one of the three histidines in mature CsgA, one of which is in 
R5. Further study with WT CsgA and His mutants will hopefully elucidate which region of 
CsgA Zn and Ni bind. 
 To test the effects of ionic strength, I added different concentration of KCl to 
CsgA-His. Very low ionic strength resulted in increased lag phases and slower elongation 
rates, suggesting ionic interactions are crucial but not necessary for CsgA-His 
polymerization (Fig. 4.12A). Increasing ionic strength up to 100 mM resulted in 
decreased lag phases and increased polymerization rates. However, concentrations of 
KCl above 200 mM slowed polymerization rates, suggesting that fibril formation is 
inhibited by increasing ionic interactions (Fig. 4.12C,D). Similar results were seen for β2-
microglobulin above 200 mM NaCl (92). Strangely, addition of 200 and 400 mM KCl 
resulted in much longer lag phases for CsgA-His than those observed with KCl 
concentrations greater than 600 mM. Finally, I verified that high concentrations of did 
not interfere with binding or quench ThT fluorescence of preformed CsgA-his fibers (Fig 
4.12B-D). 
 
Effects of temperature on CsgA-His polymerization and A11 antibody binding 
I tested the effects of temperature on CsgA-His polymerization, solubility, and 
A11 antibody binding. Higher temperatures resulted in increased polymerization rates 
and decreased lag phases (Fig. 4.13A and 4.14A). At lower temperatures, CsgA-His 
polymerized more slowly; at 4⁰C the lag phase was greater than 12 hours. Temperatures 
greater than 43⁰C resulted in a slow breakdown of CsgA-His over time (Fig. 4.14B, 4.17, 
and 4.31B). At each temperature tested, A11 binding occurred during the lag phase and 
into the early stationary phase of CsgA-His, suggesting A11 binds to a monomer or a 
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multimer that is stable at multiple temperatures, including very high ones (Fig. 4.16 and 
4.31C). In many cases A11 antibody binding was seen up to the point where CsgA-His 
was completely degraded from its apparent monomeric form on native gels (Compare 
Fig. 4.14A and 4.14B, See Fig. 4.17C and 4.34A,C). Previous papers have suggested that 
formation of fibers at different temperatures results in different morphologies which 
can display seeding specificity (111). Preliminary data suggested the fibers formed at 
16⁰C, 24⁰C, 37⁰C, and 53⁰C all displayed the ability to seed unpolymerized CsgA at 25⁰C 
(data not shown, DS52). 
 
CsgA-His and A11 antibody binding 
 Amyloid formation typically involves a conversion from monomers into a 
multimeric nucleus; subsequently, monomer addition results in growing amyloid fibers 
(See Fig. 4.25). To determine if freshly purified CsgA-His was a mixture of multimeric 
species, I tested the mobility of CsgA-His in native gels. At multiple acrylamide 
percentages, CsgA-His ran as a single species on native gels (Fig 4.14C, 4.15, 4.17B, and 
4.31C). Preincubation of CsgA-His at multiple temperatures up to 95⁰C before mixing 
with Native Sample Buffer (30% glycerol 0.05% Bromophenol Blue) did not affect the gel 
mobility of CsgA-His. Furthermore, at concentrations of GdHCl that inhibited A11 
binding (2M in Fig. 4.31C), CsgA-His ran at the same location on a native gel as at 
multiple temperatures in the absence of GdHCl (Fig. 4.31A). Intriguingly, the 
degradation of the single species of CsgA-His into smaller fractions was concomitant 
with the loss of A11 binding in dot blot assays (Fig. 4.14, 4.15; 4.17B,C; and 4.313C). 
Close examination of the ThT fluorescence time course assays with native gel solubility 
(Fig. 4.14) shows the majority of CsgA-His appears to be in a single soluble form (Fig. 
4.14). As CsgA-polymerizes into curli fibers, this single species decreases in intensity (See 
43C in Fig. 4.14A and 4.14B at 3 hours). Perhaps another more sensitive technique, such 
as SDS agarose gel electrophoresis and immunoblotting (4, 119), would show additional 
species. I transferred these native gels onto nitrocellulose membranes and probed them 
with the A11 oligomer antibody. Intriguingly, the A11 bound to a single band of CsgA-His 
260 
 
(Fig. 4.14); however, no A11 binding was seen in control lanes containing either bovine 
serum albumin (BSA) or the proteins found in Benchmark Prestained Protein Ladder 
(data not shown). These data suggest the A11 oligomer antibody may be binding to a 
single monomeric species of CsgA-His. 
 Assays with the A11 antibody did generate some unexpected results. I filtered 
CsgA-His in 8M GdHCl through a cellulose acetate membrane and then transferred it to 
nitrocellulose. When probing this membrane with the A11 antibody, I saw A11 binding 
was restored (Fig. 4.20), even if the sample was boiled in 8M GdHCl; however, similar 
results were not seen for other types of filters including nylon (data not shown) and 
Anotop γ-alumina based filters (Fig. 4.20). Like curli, cellulose is an important 
component of the extracellular matrix in biofilms that are produced by many 
Enterobacteriaceae; cellulose is regulated by the master curli regulator CsgD via AdrA 
(13, 46, 54, 99, 108, 127, 135, 136). Therefore, cellulose may accelerate the 
polymerization of curli. However, addition of cellulose did not affect CsgA-His fiber 
formation in a ThT fluorescence time course assay (data not shown, Xuan Wang 
unpublished results). Another unexpected result was seen when sonication of 
preformed fibers of CsgA-His or the R1 repeating unit resulted in A11 oligomer binding 
(Fig. 4.28A). This restoration of A11 binding was observed for these samples for several 
days (Fig. 4.28B). Whether A11 is recognizing the seed species that accelerates CsgA-His 
seeding reactions will require further experimentation. 
 
The A11 oligomer antibody does not inhibit CsgA-His polymerization. 
The A11 oligomer antibody recognizes an on pathway intermediate in the yeast 
prions Sup35 (104) and RnqPD (119). Consequently, I determined the ability of A11 
antibody to inhibit CsgA-His polymerization and the concentration at which CsgA-His 
was no longer bound by the A11 antibody. Molar ratios up to 1:22.5 of the A11 antibody 
to CsgA-His had no affect the lag phase, polymerization rate, or fluorescent yield of 
CsgA-His. In Sup35 NM, partial inhibition was shown at molar ratios as low as 1:200, 
with nearly complete inhibition occurring at a 1:100 molar ratio (104). For RnqPD, a 
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molar ratio of 1:62 was sufficient to inhibit unseeded reactions (119). Furthermore, I 
tested the ability of the A11 antibody to inhibit CsgA-His below 4 μM, where the lag 
phase begins to increase in a concentration dependant manner (Fig. 4.1A and 4.24). A 
1:45 molar ratio of A11 antibody to CsgA-his failed to inhibit polymerization of 3.6 μM of 
CsgA-His (Fig. 4.18C). In multiple experiments, the A11 antibody was failed to bind to 
CsgA-His concentrations below 4 μM (Fig. 4.21). It is possible that 4 µM CsgA-His is the 
detection limit of the A11 antibody, or this limit may elucidate some aspect of the 
mechanism of CsgA-His polymerization. 
 
Effects of GdHCl on A11 binding and polymerization of CsgA-His  
I tested the effects of GdHCl to determine the concentration at which CsgA-His 
polymerization was inhibited and to see if that concentration was concomitant with the 
loss of A11 binding. GdHCl appears to block CsgA-polymerization and ThT binding above 
3.5 M (Fig. 4.23A,B); however, addition of GdHCl does affect ThT fluorescence of 
preformed fibers (Fig. 4.23C), complicating interpretation of this result. Concentrations 
of 0.8 and 1M GdHCl accelerated the half time (t½) of CsgA-His polymerization while 
concentrations greater than 2M had increased lag phases and slower rates of 
polymerization (Fig. 4.23A,B). To test which concentration of GdHCl blocked A11 
binding, I diluted NiNTA elutes (8M GdHCl and higher [CsgA-His]) in H20 or added GdHCl 
to gel filtered elutes (desalted into 50mM KPi pH 7.2). Diluted NiNTA elutes bound A11 
in the presence of 1.6M GdHCl 30 minutes after mixing; roughly an hour later, A11 
binding to CsgA-His was present in 3.2M GdHCl (Fig. 4.22A). When GdHCl was added 
back to gel filtered elutes, A11 antibody binding to CsgA-His was present in 2M (Fig. 
4.22B) and 3M (Fig. 4.22C) GdHCl samples; however, in Fig. 4.31C, 2M GdHCl was 
sufficient to prevent A11 binding. There was not an apparent link between the GdHCl 
concentration needed to inhibit CsgA-His polymerization and A11 antibody binding. 
Another complicating factor in this analysis is that high GdHCl concentrations appears to 




Tryptophan fluorescence of CsgA-His 
 CsgA contains a single Trp residue in the loop between R3 and R4 (Fig. 4.4A and 
4.29D); therefore, I exploited the intrinsic fluorescence and iodine quenching of this 
residue to analyze curli fiber formation. As little as 2.5 μM of unpolymerized CsgA-His 
gave a high amount of Trp 84 fluorescence with a maximum indicative of a Trp residue 
exposed to a polar solvent (Fig. 4.26A). When KI was added, I saw strong quenching of 
this residue suggesting solvent accessibility. Addition of 4 M GdHCl did not appreciably 
change the Trp84 fluorescence of unpolymerized CsgA-His; however, it did inhibit iodine 
quenching (Fig. 4.26B,C). In contrast to soluble CsgA-His, preformed CsgA-His fibers (2.5 
μM) had much lower Trp 84 fluorescence and was not as accessible to iodine quenching 
(Fig. 4.26D-F). These results are consistent with partial burial of the Trp 84 residue in 
mature CsgA-His fibers.  
Because the M2 plate reader can analyze multiple wavelengths nearly 
simultaneously, I also directly compared tryptophan fluorescence and Thioflavin T 
fluorescence. Strangely, tryptophan fluorescence increased in the plate reader and 
seemed to mimic the increasing ThT fluorescence (Fig. 4.27). This result opposes those 
found in a 90⁰ fluorometer  above. Perhaps this result is due to difference in geometry 
between the two machines. The plate reader may be reading increased light scattering 
from more turbid CsgA-His as its geometry is more sensitive to stray light. Alternatively, 
CsgA-His fibers may change over time with the Trp 84 later becoming buried as fibers 
mature. Consistent with this possibility, CD spectra analysis showed increasing β-sheet 
propensity over seven days (Fig. 4.1B). Either way, tryptophan fluorescence or light 
scattering may facilitate studying CsgA-His polymerization at low concentrations (below 
4μM) where polymerization is concentration dependent yet ThT fluorescence lacks the 






 Amyloid formation is traditionally associated with uncontrolled protein misfolding 
and aggregation that results in many systemic and neurodegenerative disorders (25, 
105). However, there are a growing number of functional amyloids that suggest 
amyloidogenesis is also a general tenet of normal cellular physiology (1, 3, 12, 19, 26, 
27, 29-31, 34, 37, 38, 50, 73, 74, 81, 83, 95, 106, 120, 128-130). In fact, amyloid 
formation may be a common property of most proteins (36, 47).  
 The work presented here, as well as that published previously, demonstrates that 
both disease-associated and functional amyloids share a common amyloid formation 
pathway (43). CsgA polymerizes with nucleation-dependent kinetics, and fiber formation 
is ameliorated by the addition of pre-formed CsgA fibers. We also found that CsgA 
polymerization involves the formation of a transient species similar to that produced by 
other amyloidogenic proteins such as Aβ, synuclein, IAPP, insulin, lysozyme and 
polyglutamine (57).  
 The transient species that the A11 antibody recognizes during CsgA polymerization is 
a monomer or low-molecular weight multimer (Fig. 4.2C). The A11-recognized species of 
Aβ and Sup35p are thought to be large molecular weight oligomers (57, 104). Unlike Aβ 
and Sup35p (57, 104), CsgA was immediately recognized by the A11 antibody upon 
removal of strong denaturants like GdHCl or after its passage through a 30 kD Amicon 
filter. I also found that freshly purified CsgA heated to 99°C for 5 minutes (Fig. 4.16) or 
longer (Fig. 4.14) was also recognized by the A11. At least two hypotheses can be 
proposed to explain CsgA’s ability to be recognized by A11 immediately after 
denaturation or passage through a 30 kD cutoff filter. First, CsgA may adopt an 
oligomeric conformation so quickly that our ability to measure this transition is lost in 
the time that it takes to immobilize CsgA on the blotting paper. Another possibility is 
that the CsgA species recognized by A11 is not an oligomer, but a monomer that 
contains multiple amyloidogenic units. In support of this hypothesis, CsgA does indeed 
contain at least three amyloidogenic domains (Fig. 4.4). Nonetheless, these two 
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hypotheses are not mutually exclusive, and there may be other plausible 
interpretations. 
 In any case, CsgA contains multiple amyloidogenic domains that may contribute to its 
ability to efficiently transition from a soluble protein to an amyloid fiber. Many studies 
have led to the proposal that amyloid fibers themselves are not toxic to cells; instead, 
toxicity is proposed to be caused by transient folding intermediates (32, 42, 51). 
Therefore, one mechanism that might be used by functional amyloids to prevent toxicity 
is to minimize the duration of toxic folding intermediates. This is apparently how 
Pmel17, an extremely rapidly forming functional amyloid found in mammalian cells, is 
able to assemble within the cell without eliciting a toxicity cascade (37).  
CsgA has a striking primary sequence arrangement (Fig. 4.4A). The five imperfect 
repeats of CsgA share greater than 30% sequence identity. Each repeating unit is 
potentially a single amyloid domain, and R1, R3 and R5 are highly amyloidogenic in vitro 
(Fig. 4.4B-E). The covalent linkage of multiple amyloid domains may facilitate amyloid 
fiber formation by increasing the number of amyloidogenic building blocks, and may 
also result in rapid formation of the intermediate recognized by the A11 antibody. Other 
amyloidogenic proteins contain repeat sequences that have been postulated to 
facilitate fiber formation (97, 131). For instance, the N-terminal prion-determining 
domain of Sup35p has five imperfect oligopeptide repeats and certain deletions of the 
repeats are defective in propagation of Sup35p fibrils. Moreover, in vitro, repeat-
expansion peptides (with 2 extra repeats) are more amyloidogenic than wild-type 
peptides (69). The most amyloidogenic domains of CsgA were reported to be contained 
in the hexapeptides GHGGGN and QFGGGN, which are present in R2 and R4 respectively 
(22). However, our analysis suggests that R1, R3 and R5 contain the more highly 
amyloidogenic sequences. A more thorough examination of was performed in our lab, 
confirming the importance of R1, R3, and R5 (121, 122, 124). 
 The amyloidogenic peptides R1 and R5 contain sequences that contribute 
significantly to CsgA’s ability to bind human proteins such as fibronectin, plasminogen, 
tissue plasminogen activator, and β2-microglobulin (82). This correlation suggests 
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amyloidogenicity of CsgA may be directly linked to these biological activities. In fact, 
Gebbink et al suggested that curli contribute to colonization in animal hosts by 
activating host proteases that are involved in haemostasis (41).  
 Curli can also enhance amyloid protein A amyloidosis in mice (72). It is proposed that 
cross-seeding may play a role in the development of amyloid diseases (59, 72). The in 
vitro system that we have established here provides an ideal vehicle to test the 
specificity of curli seeding with other amyloids. Understanding how functional amyloid 
proteins interact with other host proteins may lead to new ideas about cellular 
physiology and the processes that promote the toxicity associated with many amyloids. 
 Most amyloids are known to self-propagate in a process called seeding. In prion 
diseases such as Bovine Spongiform Encephalopathy, seeding underlies protein 
infectivity (90). Amyloid self-propagation is also critical to disease development in the 
non-transmissible amyloid diseases (59, 60). Our demonstration of CsgA seeding 
suggests that functional amyloids also utilize a controlled self-propagation process to 
fulfill their biological function. In vivo, CsgA polymerization is nucleated by the outer 
membrane associated protein CsgB, which shares nearly 49% sequence similarity with 
CsgA (48). One proposed model of nucleation is that CsgB provides an amyloid-like 
template that initiates CsgA polymerization (5, 48). The growing fiber tip could then act 
as a template to direct subsequent CsgA polymerization. 
Proteins that are not predicted to form stable globular folds may be prone to 
aggregation and amyloid formation. Indeed, most functional amyloid proteins have 
natively disordered segments (79, 117). Consistent with this, some proteins have been 
shown to form amyloid fibers only after the native, globular fold has been compromised 
by chemical denaturants or by mutations (14, 36, 47). Circular dichroism studies 
presented here suggest that CsgA is unstructured after secretion (Fig. 4.1B). Mature 
CsgA is also predicted to be natively unfolded (Fig. 4.29) by the algorithms of Uversky, 
Galzitskaya, and others (39, 117). The natively unfolded segments of CsgA may facilitate 
amyloidogenesis indirectly by preventing formation of stable globular structures that 
would be less likely to aggregate and precipitate into a fiber. Alternatively, the unfolded 
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regions of CsgA may actively direct amyloidogenesis by presenting specific aggregative 
surfaces to neighboring molecules. In this context, ‘natively unfolded’ would be a 
transition state during the formation of a stably-folded amyloid fiber. Importantly, in the 
case of functional amyloids, the amyloid fiber would not be the product of protein 
misfolding, but that of protein folding. Certainly, the growing number of functional 
amyloids suggests that the amyloid fiber is an evolutionarily conserved structure. The 
selective processes that have been employed by functional amyloids to limit cellular 
toxicity provide a unique context from which to investigate disease-associated 
amyloidogenesis.  
 
Proposed mechanism of CsgA-His polymerization and A11 binding. 
Based on published work and the evidence presented here, I propose the 
following mechanisms for CsgA-His polymerization. While fiber elongation is 
concentration independent (Fig. 4.24B), the lag phase and t½ were not (Fig. 4.24A,C), 
suggesting that CsgA-His fiber formation involves two lag phases. One lag phase is only 
present when CsgA-His is below approximately 4µM, is concentration dependent, and 
appears to follow nucleation dependent kinetics. This lag phase likely represents the 
time required to form an on-pathway multimeric nucleus (na) (Fig. 4.25). The second lag 
phase is concentration independent and is the same for all concentrations above 4µM 
(Fig. 4.24). This step likely represents a maturation of the on-pathway nucleus (na) into 
another nucleus (nb) of approximately the same stoichiometry (Fig. 4.25). While some 
amyloids follow nucleation dependent kinetics (9), many do not and instead display a 
concentration independent step (62, 71, 84, 94, 98, 103). Various explanations have 
been put forward for this concentration independent step, including the formation of 
micelles (62, 70, 71, 93, 94, 98, 103, 109), the presence of off-pathway detergent soluble 
oligomers (101), phase partitioning (84), and supercritical concentration (86). Following 
the formation of the nb nucleus, CsgA-His monomers polymerize on the template 
provided by the nucleus to form long fibers which associate into curli fibers.  
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While the intermediate recognized by the A11 antibody is observed during the 
polymerization of many amyloid proteins, the A11 antibody binding experiments 
discussed above indicate distinct differences regarding this common intermediate in 
CsgA-His polymerization. The A11 antibody may bind to any number of potential CsgA-
His intermediates including an off pathway monomer, an off-pathway multimer, or an 
on-pathway multimer. Alternatively, the A11 antibody may recognize a micelle-like form 
of CsgA-His that is present in concentrations above 4 µM, explaining both the lack of 
binding of A11 to unpolymerized CsgA-His below this concentration (Fig. 4.21) and the 
concentration independence of CsgA-His polymerization above this concentration (Fig 
4.1A and 4.24). Collectively, I believe our data suggest the A11 antibody binds to an off-
pathway monomer. Consistent with this idea, the A11 oligomer antibody reacts with 
CsgA-His in a monomeric state (See Fig. 4.2C and 4.15). Also, the A11 antibody does not 
inhibit CsgA-His polymerization (Fig. 4.18A) even at concentrations below 4 µM (Fig 
4.18B), consistent with an off-pathway interaction. Whatever the case, the multiple 
repeating units of CsgA may allow it to quickly adopt a form recognized by the A11 
antibody. This quick adoption of an intermediate should speed up CsgA-His amyloid 
formation thus lowering host toxicity. Fast cross linking of CsgA-His and the A11 anti 
body using PICUP (35) may aid in elucidating the stoichiometry and importance of the 
A11 bound intermediate in CsgA-His polymerization. Future work should aim to 
characterize this and other intermediate species in CsgA-His fiber formation which may 
differ from disease-associated amyloids due to either the evolved nature of the 
functional amyloid fold of CsgA or the requirement of an in vivo interaction of CsgA with 





Portions of this chapter, mainly Figures 4.1 through 4.4 and the associated text, 
were published in JBC (123). Wang et al 2007 (123) was a collaboration between Xuan 
Wang, Jonathon Jones, and I. Xuan Wang provided the largest portion of the manuscript 
and figures sent to JBC. The authorship of that paper properly reflects his role; however, 
much of the original manuscript was unpublished and is presented here for posterity. 
Xuan provided the work and design for Fig 4.1C-E, 4.3, and 4.4 provided here. Jonathon 
Jones provided the data for Fig. 4.1B; I designed the figure. The experiments leading to 
Fig. 4.2A were collectively performed several times by both Xuan and I. The non 
denaturing purification scheme used was developed by Jonathon Jones, Xuan Wang, 
and I. The denaturing purification scheme for CsgA-His was my development. I 
introduced the peptide purification scheme using TFA/HFIP (20) and did early fiber 
formation, cross seeding, and TEM work with the repeating units R1 and R3 of CsgA; 
Xuan followed up on and greatly extended this work. All the work and design for the 
remainder of the figures in the Wang et al 2007 (123), the work and design of Figs. 4.5 
through 4.30, and the unpublished portions of this Chapter are solely my work. 
Additionally, I have used different pronouns in this chapter when appropriate. Work 
done collectively or by others uses the pronoun we. My contributions are indicated 





 CsgG and CsgA-His were over expressed in LSR12 (C600::∆csg) as previously described 
(19). Following centrifugation for 15 minutes at 10,000g, the supernatant was clarified 
by filtration though a 0.22 µm PES bottle-top filter (Corning, Acton, MA). Filtrates 
containing CsgA-His were passed over a HIS-Select™ HF NiNTA (Sigma Aldrich, Atlanta, 
GA) column, washed with 10 volumes of 10 mM potassium phosphate buffer (KPi) pH 
7.2, and eluted with 10 mM KPi 100 mM imidazole pH 7.2. CsgA-containing fractions 
were combined and passed through a 0.02 µm Anotop 10 filter (Whatman, Maidstone, 
England). A modified protocol using guanidine hydrochloride (GdHCl) was employed to 
fully denature CsgA-His (Fig. 4.5). Following the first wash, the column was equilibrated 
with 5 volumes 10 mM KPi 8 M GdHCl pH 7.2 and eluted with 50 mM KPi 8 M GdHCl pH 
2. Sephadex G25 was used for desalting/buffer exchange. To create CsgA-His seeds, two 
week old fibers were sonicated using a Sonic Dismembrator (Fisher Model 100, Fisher, 
Pittsburg, PA) for three 15-second bursts on ice. Where indicated, CsgA-His samples 
were filtered through a prewashed Amicon Ultra-4 (Millipore, Bedford, MA) centrifugal 
filter devices. Samples were centrifuged at 4,000g for 2 minutes and the retentate and 
filtrate fractions were collected. A plasmid encoding CsgA-His can complement ∆csgA 
cells in vivo and purified CsgA-His polymerizes into an amyloid fiber with similar kinetics 
as Wt CsgA (19).  
 
Thioflavin T (ThT) assay 
 Following desalting to remove imidazole or GdHCl, CsgA-His was incubated at room 
temperature. At different time intervals, CsgA-His samples were mixed with 20 µM ThT 
and fluorescence was measured using a Spectramax M2 plate reader (Molecular 
Devices, Sunnyvale, CA) set to 438nm excitation and 495nm emission with a 475nm 
cutoff. Alternatively, samples amended with 25 µM ThT were assayed directly in the 
Spectramax M2 plate reader every 10 minutes after shaking for 5 seconds. Graphs were 
made in Kaleidagraph 4.0 and 4.1. ThT assays graphs were smoothed for images. Lag 
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phase, relative rates, and t½ were determined using Origin 6 and 7 using raw 
unsmoothed data. 
 
Circular Dichroism (CD) Spectroscopy 
  CsgA-His samples (10 µM CsgA-His in 50 mM KPi, pH 7.2) were assayed in a Jasco J-
810 spectropolarimeter from 190 to 250nm in a quartz cell with 1-mm path length at 
25°C.  
 
Blot assay with A11 and anti-CsgA 
 CsgA-His samples were dripped onto 0.2µm Transblot Nitrocellulose membranes 
(Bio-Rad, Hercules, CA) as described (57) and allowed to dry for 5 minutes. The 
membrane was blocked in 5% milk in TBS-T (0.01% Tween-20) for at least 1 hour. The 
dot blots were washed 3 times in TBS-T before and after incubating with 1:10000 
dilutions of A11 primary antibody (BioSource, Camarillo, California) and goat anti-rabbit-
HRP (Sigma-Aldrich) in 3%BSA/TBS-T. The blots were developed using the SuperSignal® 
West Dura system (Pierce, Rockford, IL). Blots were stripped and reprobed with a 
1:10000 dilution of rabbit anti-CsgA antibody (6).  
 
Electron microscopy 
 Philips CM12 Scanning Transmission Electron Microscope was used to visualize the 
fiber aggregates. Samples (10 µl) were placed on formvar coated copper grids (Ernest F. 
Fullam, Inc, Latham, NY) for 2 min, washed with deionized water, and negatively stained 
with 2% uranyl acetate for 90 seconds. 
 
Peptide preparation 
 Peptides were chemically synthesized by Proteintech Group Inc., Chicago. Purity was 
greater than 90% by HPLC and size was confirmed by mass spectroscopy. To equilibrate 
the pH of each sample and to remove any potential seed in the peptide preparations, 
the peptides were denatured using a modified protocol described previously (20). 
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Briefly, peptides were dissolved to 0.5 mg/ml in TFA/HFIP (1:1 v/v) and sonicated for 10 
min. The suspensions were incubated at room temperature until they visibly cleared. 
The solvent was then removed by vacuum. Peptides were then dissolved in cold 2 mM 
HCl and centrifuged at 100,000 X g in a TLA-55 (Beckman, Fullerton, CA) for 1 hour at 
4°C. The supernatants were equilibrated to 50mM K-Pi pH7.2 by 200mM K-Pi pH7.2 on 
ice. When the samples were shifted to room temperature, the polymerization was 
measured by ThT.  
 
CsgA-His polymerization in different pH buffers  
CsgA-His was purified using the alternative GdHCl method described above. Two 
Sephadex G-25 columns were used in tandem to desalting CsgA-His into MilliQ H20 after 
first equilibrating with 10mM potassium phosphate pH 7.2 and then 3 column volumes 
of MilliQ H20. The resulting desalted protein was added to black 96 well plates 
containing 5X concentration of different buffer at the given pHs. The 5X concentrated 
buffers tested:  KBCP is 100mM each of potassium borate, citrate, and phosphate; KAc is 
100mM potassium acetate; and 3M is 100mM each of MES, MOBS, and MOPS. 
Thioflavin T (ThioT) was present at a final concentration of 20 µM and timecourse 
measurements of ThioT fluorescent were taken as described above. Relative rates were 
calculated from the ThioT curve by taking the maximum rate divided by the total change 
in fluorescence and multiplying the result by 1000. Half time or t½ was determined to be 
the time at which half of the growth phase of CsgA-His polymerization was completed. 
 
Native Gels and Native Western blots 
 CsgA-His samples were mixed with 1:2 with 3X Native Sample buffer (30% glycerol 
0.05% Bromophenol Blue) and loaded onto 8 or 12% Native PAGE gels (3 or 4% PAGE 
stacking) and ran at 20mA each for 40 minutes at 4°C in Native Running buffer (25mM 
Tris 187.5mM Glycine pH 8.6 at 25°C; stored at 4°C). For Native Western blots gels were 
incubated in Native Transfer Buffer (0.8X Native Running Buffer) for 10 minutes and 
then transferred onto Nitrocellulose membranes (BioRad 162-0147 0.2µM) in using a 
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semidry apparatus at 10V for 30 minutes at 4°C. The Western blot stack consisted of 3 
Whatman papers, gel, Nitrocellulose membrane, three Whatman papers. The Whatman 
papers and Nitrocellulose gels were soaked in Native Transfer Buffer for more than 10 
minutes at 4°C. Following transfer the membrane was blocked at 4°C overnight in 5% 
Milk in TBST (0.01% Tween-20). The membranes were probed with 1:10000 dilution of 
A11 Oligomer antibody and 1:10000 Goat Anti Rabbit IgG HRP antibody both in 3% 
BSA/TBST (0.01% Tween-20) as described above for A11 Dot blots. TBST with 0.01% 
Tween-20 was used for the three 5 minute washes between before and after each 






Fig. 4.1. In vitro polymerization of CsgA-His measured by ThT fluorescence, CD and 
TEM. (A) The fluorescence of freshly purified CsgA-His mixed with 25 µM ThT was 
measured in 10-minute intervals at 495nm after excitation at 438nm. (B) Circular 
dichroism analysis of 10 µM CsgA-His immediately after purification, 2 days post-
purification, 7 days post-purification and 15 days post-purification. CsgA-His was 
incubated at room temperature without shaking after purification. (C-E) Transmission 
Electron Microscopy (TEM) micrographs of 30 µM CsgA-His after incubation at room 
temperature for the indicated times. (Scale bar: 500nm)  
 
Fig. 4.2. Detection of transient conserved intermediate species during CsgA-His 
polymerization. (A) ThT fluorescence (top) and immunoblotting (bottom) of 80 µM 
CsgA-His incubated for the indicated time post-purification. At the indicated times, 
samples were removed, ThT was added to a final concentration of 20 µM, and 
fluorescence was measured. Samples were blotted onto nitrocellulose membrane and 
probed with the A11 antibody, and after stripping, with the anti-CsgA antibody. (B) 
CsgA-His denatured with 8 M GdHCl was blotted onto nitrocellulose and probed with 
the A11 and anti-CsgA antibodies (left). GdHCl was removed using a Sephadex G25 
column (final buffer: 50 mM KPi pH 7.2) and then immediately blotted onto 
nitrocellulose and probed with the A11 and anti-CsgA antibodies (right). (C) Amicon 
ultra filters were used to separate CsgA-His solutions prior to probing with the A11 and 
anti-CsgA antibodies. The molecular weight cutoff of the filters is indicated. Retentates 
and filtrates were immediately blotted onto nitrocellulose and probed with the A11 
antibody, and after stripping, with the anti-CsgA antibody. 
 
Fig. 4.3. CsgA-His fibers can catalyze self-polymerization. (A) CsgA-His (40 µM) 
fluorescence in the absence (solid line) or presence of 2.5% by weight of sonicated CsgA-
His fibers (dashed line). Samples were incubated at room temperature, collected at the 
indicated times, and amended with 20 µM ThT prior to excitation at 438nm and 
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measurement at 495nm. (B) Samples were removed at the indicated times and 
immediately blotted to nitrocellulose. Blots were probed with the A11 antibody and 
after stripping with an anti-CsgA antibody. 
 
Fig. 4.4. Three CsgA intramolecular peptide repeats can assemble into amyloid fibers.  
(A) Alignment of internally conserved residues. CsgA primary sequence shows the 
repeated consensus sequences. The identical amino acid residues of five repeats are in 
gray color and the conserved polar amino acid residues are enclosed in 4 boxes.  
(B) Oligopeptides of R1, R2, R3, R4 and R5 at 0.2 mg/ml in KPi were incubated at room 
temperature for 5 days before ThT fluorescence measurements were taken. Error bar 
indicates the standard error mean for at least three separate experiments. CsgA-His 
fibers were diluted to 0.2 mg/ml and assayed for ThT fluorescence. (C-E) Transmission 
Electron Microscopy (TEM). 0.5 mg/ml of R1, R3 and R5 in pH7.2 KPi were incubated at 
room temperature for 5 days. Samples of different peptide solutions were directly 
applied on formvar-coated grids and visualized with negative staining electron 
microscopy. Scale bar is equal to 500nm. 
 
Fig. 4.5. Denatured CsgA-His purification. (A) Overview of denatured CsgA-His 
purification protocol. (B-G) DS47 was one such denaturing preparation of CsgA-His. (B-
D) NiNTA column and elutes:  After binding and washing the CsgA-His on 7.5mL NiNTA, 
the column was equilibrated in 8M GdHCl (Wash 2) and then eluted with 50mM KPi 8M 
GdHCl pH 2. Twenty five ~1.2 mL elutes were collected and tested for their (B) color; (C) 
absorbance at 280nM (green), pH (red), glycated protein fluorescence (blue), 
concentration (BCA Assay); and (D) anti-CsgA and A11 Oligomer antibody binding. (D) 
Abbreviations:  Sup = supernatant from pelleted CsgA-His expressing cells, FT = 
Flowthrough, W1 = Wash 1, 40mL of 10mM KPi pH 7.2, W2 = Wash 2, 20mL of 10mM 
KPi 8M GdHCl pH 7.2, E = Elutes; Suffixes for Flowthroughs and Washes = collected at 
the Beginning, Middle, or End. (B-C) Collectively, the NiNTA elutions shows early brown 
elutes which come off the column with high concentrations and may indicated glycated 
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proteins are present Further elution results in even lower pH changes bumping off 
additional brown elutes which peak around Elute 15. These later elutes also have high 
absorbance at 280nm and fluorescence similar to glycated proteins; however, according 
to the BCA Assay their concentrations are quite low. The browning of proteins is 
indicative of non-enzymatic protein glycation, which has a characteristic fluorescence 
emission around 450 nm when excited at 360 nm (55) and has been shown to affect the 
formation of many disease related amyloids (100, 118). Glycation fluorescence was 
measured on the M2 plate reader as the average of two reads at 360nm excitation, 
440nm emission, and 420nm cutoff. (E-G) Gel filtration of a combination of elutes E6 
though E11 of the NiNTA column (4.7mLs) after passage though a 0.1μm Anotop filter 
(Whatman). The Gel filtration column was 6 grams of swelled Sephadex G-25 Fine; it 
was equilibrated in and eluted with 50mM KPi pH 7.2. Five ~1.3mL flowthrough fractions 
and forty ~1.3mL elute fractions were collected. Each fraction was tested for (E) 
absorbance at 280nM (green), pH (red), glycated protein fluorescence (blue), and 
concentration (BCA Assay) as well as dot blotting (F) onto Nitrocellulose membranes to 
test for CsgA and A11 binding. (E) Abbreviations:  FT = Flowthrough, E = Elutes. (G) 
Flowthroughs and elutes were also subjected to SDS-PAGE on 13% Acrylamide Gels. 
Elute 16 was the first elute that showed precipitation due to the presence of GdHCl. Just 
20mM GdHCl is sufficient to precipitate Sample Buffer with 2% SDS (85). Collectively, 
the Gel filtration shows most of CsgA-His elutes quickly through the G-25 column while 
GdHCl, low pH, and the source of the glycated protein fluorescence are all are small 
enough to enter the matrix and elute in later fractions. Note: The A11 antibody 
background signal was high and is not shown here; however, none of the NiNTA elutes 
had any signal due to the presence of 8M GdHCl. Elutes 5-9 of the gel filtration column 
had high A11 binding; Elutes 10-13 had weak A11 binding. (H) In a non-denaturing 
preparation of CsgA-His, passage through a PD-10 gel filtration column separated the 
small peptide seen in the NINTA elutes on a 13% SDS-PAGE gel stained with Coomassie 
Blue. The brown color and glycated protein fluorescence in CsgA-His preparations may 
be due to a small peptide (less than 3kD, the cutoff range for Sephadex G-25) present in 
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Lysis Broth (LB). This peptide did not readily dialyze away even after two 1000X dialysis 
dilutions (data not shown) and may associate with CsgA-His and inhibit polymerization:  
gel filtration columns always removed this brown peptide, but also resulted in 
decreased lag phases (data not shown). 
 
Fig. 4.6. Effects of pH on CsgA-His polymerization. (A) Effects of pH on CsgA-His 
polymerization in KBCP buffer as measured by ThT fluorescence. Quantification of CsgA-
His polymerization in KPCP buffer:  (B) Lag phase (blue) and Half time (t½, orange) = 
when half of the CsgA-His is polymerized. (C) Delta fluorescence (purple) = change in 
ThT Fluorescence from beginning of the lag phase to the average fluorescence of 
stationary phase. (D) Rates of polymerization:  Slope (red) = ∆ThT fluorescence/min and 
Relative rate (green) = Slope /Delta fluorescence. CsgA-His was denatured in GdHCl and 
desalted into Milli-Q H20 before addition of KBCP buffer to a final concentration of the 
20mM each potassium borate, citrate, and phosphate.  
 
Fig. 4.7. Effects of pH on relative rates of CsgA-His polymerization in different buffer 
systems. (A) Relative rates of CsgA-His polymerization in different buffers as measured 
with ThioT fluorescence. CsgA-His (final concentration 40µM) was denatured in GdHCl 
and desalted into Milli-Q H20 before adding to a final concentration the following 
buffers: KBCP (20mM each potassium borate, citrate, and phosphate), KAc (20mM 
potassium acetate), or 3M (20mM each MES, MOPS, MOBS) buffers. (B) Lag phase and 
half time (t½) of CsgA-His polymerization in different buffers. Similar results were seen 
in TSC buffer (25mM each of Tris, sodium succinate, and CAPS – data not shown, 2:115-
8). 
 
Fig 4.8. Effects of pH on the ThT fluorescence and stability of preformed CsgA-His 
fibers. (A) ThT fluorescence is lower in more acidic pHs. Preformed fibers were from 
previous preparations dialyzed in 100 µM KPi pH 7.2 and then mixed with KBCP (here 
final concentration of potassium borate, citrate, and phosphate is 25mM). Similar 
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results were seen in TSC buffer (25mM each of Tris, Sodium succinate, and CAPS – data 
not shown, 2:115-8). (B) Preformed fibers incubated in KBPC pH 11 rapidly lost ThT 
fluorescence. (C) Absorbance of preformed fibers (green line) incubated in KBPC pH 11 
was identical to soluble CsgA-His that was allowed to ‘polymerize’ in KBPC pH 11 (blue 
line). Unlike soluble CsgA-His that polymerized in KBPC pH 7 (red line), the pH 11 fibers 
appear to have very little absorbance near 400nm where absorbance from amyloid fiber 
aggregates is typically found. 
 
Fig. 4.9. The pH of maximum amyloid formation (pHmax) typically occurs near a 
protein’s pI; not so in CsgA-His. Many proteins form amyloids more readily near the pH 
of their pI (102). At the pI the resulting net charge is nearly zero, solubility decreases, 
and hydrophobic collapse occurs more readily, thus increasing backbone interactions 
needed for efficient amyloid nucleus formation. Other amyloids (102) are indicated 
(black closed circles). Both HEWL and RNase Sa 5Kg (black open circles) have pHmax 
greater than 10 and were not be determined with the ThT method (102). Above pH 10 
ThT is either unable to efficiently bind to amyloid fibers or leads to their degradation 
(See Fig. 4.7 and 4.8). Unlike other amyloids, CsgA-His measured pHmax of 8.0 (red closed 
circle) is far from its pI of 5.73 (red X) (See Fig. 4.6 and Fig. 4.7). The theoretical pHmax 
and pI of mature WT CsgA are indicated (red open circle) for comparison. 
 
Fig. 4.10. Theoretical titration curves of mature CsgA-His, WT CsgA, and CsgB. Titration 
curves from http://www.iut-arles.up.univ-mrs.fr/w3bb/d_abim/compo-p.html (A) CsgA-
His (red) and wild type CsgA (blue). The 6X Histidine tag on the C-terminus of CsgA-His 
shifts the protein charge towards neutral and then positive, relative to wild type CsgA, 
at more acidic pH values. (B) CsgB (green) is relatively positively charged at near neutral 
pH values. 
 
Fig. 4.11. Effects of various salts on CsgA-His polymerization. (A) NiS04 (blue lines) is a 
potent inhibitor of CsgA-His polymerization at 1mM. However, addition of 1mM EDTA 
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restores CsgA-His polymerization (red lines). (B) AlCl3 (blue line) does not inhibit CsgA-
His polymerization, neither did CaCl2, MgCl2, or MgS04 (data not shown, DS7-8). (C) 
ZnS04 is also a potent inhibitor of CsgA-His polymerization at 0.1mM. Addition of 0.1 
mM EDTA did not rescue CsgA-His polymerization. ZnCl2 also inhibited CsgA-His 
polymerization but not as effectively as ZnS04 (data not shown, DS7-8). (D) Addition of 
EDTA alone does not seem to affect CsgA-His polymerization. 
 
Fig. 4.12. Effects of ionic strength on CsgA-His polymerization and preformed CsgA-His 
fibers. (A-B) Soluble unfolded CsgA-His was dialyzed for 3½ hours at 4°C in 1mM KPi pH 
7.2 using a 3500 MWCO Dialysis membrane. Concentrated KCl was added to each well 
to the get final KCl concentrations indicated. (data not shown, 2:76-8). (C-D) CsgA-His 
fibers were dialyzed against 1mM KPi pH 7.2. Concentrated KCl was added to each well 
to the get final KCl concentrations indicated. 
 
Fig. 4.13. Effects of temperature on polymerization and solubility of non-denaturing 
preparations of CsgA-His. (A) ThT time course of polymerization of DS37 preparation of 
CsgA-His at different temperatures. (B) SDS solubility of CsgA-His preparation DS37 
before incubation at various temperatures. (C). SDS solubility off CsgA-His preparation 
DS37 after incubation at various temperatures. 2X SDS sample buffer was mixed equally 
and not boiled before loading onto 13% SDS-PAGE gels. RT = room temperature, 
approximately 24°C. DS37 was dialyzed against 50mM KPi pH 7.2. for 4 hours at 4°C 
after elution from NiNTA under non denaturing conditions and filtered through Anotop 
0.2 and 0.02 µm filter. 
 
Fig. 4.14. Effects of temperature on the polymerization, solubility, and A11 Oligomer 
binding of denaturing preparation of CsgA-His. (A) ThT fluorescence of CsgA-His 
polymerization incubated at different temperatures. Start of polymerization is 5 minutes 
after temperature shift. (B) Dot blot time course of CsgA-His incubated at different 
temperatures probed with A11 Oligomer antibody; following A11 signal detection the 
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dot blots were stripped and reprobed with Anti-CsgA antibody. Both antibodies were 
detected using an Alpha Innotech FluorChem imager with all the dotblots being imaged 
at the same time which allowed equal background. Both resulting images were auto 
leveled using Adobe Photoshop. (C) Effects of temperature on CsgA-His solubility 
assayed with Native gels over 3 hours. Each Native gel was auto leveled using Adobe 
Photoshop except 12% + 3 hours which was manually adjusted to show faint bands. 12% 
Native gels were ran for 1:25 hour at 25mA. 12% Native gels had 1.8cm of 4% stacking 
gel; 8% Native gels had 1.8cm of 3% stacking gel. 
 
Fig. 4.15. The A11 Oligomer antibody recognizes a single species of CsgA-His at 
multiple temperatures. CsgA-His runs as a single band on a native gel which is 
recognized by the A11 Oligomer antibody. A denaturing prep of CsgA-His was incubated 
at the different temperatures indicated for 5 minutes and then ran on a 12% Native gel 
and dot blotted onto Nitrocellulose membranes. The Native gels were natively 
transferred to Nitrocellulose membranes. Both the Native westerns and the dot blots 
were probed with the A11 Oligomer antibody and anti CsgA antibodies. Native transfer 
worked best on 12% Native gel (8% Native gel were unsuccessful and had only faint A11 
signal). The CsgA-His sample used for this figure is the same as the one used in Fig. 4.14.  
 
Fig. 4.16. The A11 Oligomer signal is seen even after 5 minutes incubation of CsgA-His 
at 99°C. A denaturing prep of CsgA-His was incubated at the different temperatures 
indicated and dot blotted onto Nitrocellulose membranes. Even at 99°C, some A11 
Oligomer binding is seen. However, after 1 hour no signal is seen possibly due to 
hydrolysis of CsgA-His (See Fig. 4.14C and Fig. 4.17). For each time point, the entire dot 
blot was adjusted to the same levels using Adobe Photoshop so each temperature’s 
signal was treated equally. 
 
Fig. 4.17. High temperatures lead to rapid hydrolysis of CsgA-His. (A) In a non 
denaturing preparation of CsgA-His, boiling the protein in SDS Sample buffer resulted in 
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higher MW bands appearing in 13% SDS-PAGE gels. CsgA-His also had more smearing on 
SDS-PAGE gels if it was preincubated at higher temperatures even if the samples were 
not boiled in SDS Sample Buffer. (B) For the Native Gels, CsgA-His was prepared by the 
denaturing protocol. Following shift to higher temperatures, CsgA-His was mixed with 
Native Gel Sample Buffer and ran on a 12% Native PAGE gel and stained with Coomassie 
Brilliant Blue. Within 5 minutes at 95⁰C multiple breakdown products of CsgA-His are 
present. Within 1 hour hydrolysis is also apparent at 54⁰C and 65⁰C. The CsgA-His 
sample used in the native gels shown is the same as the one used in Fig 4.15. For each 
time point the entire native gel was auto leveled in Adobe Photoshop. The break seen in 
each time points gel band represents a cropped control band of BSA that was used to 
distinguish between different gels. See Fig. 4.14C for more examples of CsgA-His 
hydrolysis at high temperatures. (C) Time course of denaturation and hydrolysis of a 
denaturing prep of CsgA-His (DS69) at 95⁰C. Multiple breakdown products are present 
on a Novex 4-12% Tris Glycine Gel (Invitrogen) ran with Native Running Buffer; however, 
A11 binding is present in all samples. Native Mark sizing is consistent with a 200kD 
protein; however, charge and conformation can have large affects on native gel 
migration especially if the protein is in an unfolded conformation as CsgA-His is 
following a denaturing prep. Lysozyme did not run into the native gel; it has a pI of 9.3. 
 
Fig. 4.18. The A11 Oligomer antibody does not inhibit CsgA-His polymerization. (A) 
When A11 antibody was added to a denaturing prep of CsgA-His, no inhibition was seen 
even at a molar ratio of 1:30 A11 Oligomer antibody:CsgA; similarly, Anti-His antibody 
did not inhibit CsgA-His polymerization. This result contrast with the following papers: 
unseeded but not seeded Sup35 NM showed partial inhibition (~50% less CR binding) at 
1:200 and nearly complete inhibition at a 1:100 ratio of A11 Oligomer antibody to Sup35 
NM (104); unseeded but not seeded RnqPD showed inhibition at a 1:62 ratio of A11 
Oligomer antibody to RnqPD (119). (B) Similar results were seen at lower concentrations 
of a denaturing prep of CsgA-His (here 3.6µM) where lag phases begin to increase and 
CsgA-His polymerization more closely follows Nucleation Dependent Polymerization 
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kinetics. (C) A non-denaturing prep of CsgA-His was also not affected by a 1:22.5 or 1:45 
ratios of A11 Oligomer antibody:CsgA-His. No change in polymerization of ThT 
fluorescence was seen when 1mM total DTT was added to a reaction with 1:25 A11 
antibody at the time indicated (black arrow). 
 
Fig. 4.19. The A11 oligomer antibody binds CsgA-His directly after coming off the 
Sephadex G-25 fine desalting column. (A) Absorbance at 280nm of ~1.3 mL fractions of 
a Sephadex G-25 fine desalting column (6.1g dry Sephadex). CsgA-His in 8M GdHcl 
50mM KPi pH ~5 was eluted using 50mM KPi pH 7.2. (B) Dot blots of elutes of CsgA-His 
as it directly comes off the Sephadex G-25 desalting column probed with A11 Oligomer 
antibody and CsgA antibody. 
 
Fig. 4.20. Effects of filtering CsgA-His in GdHCl through a 0.22 μm Cellulose Acetate 
filter and an Anotop 0.1 μm γ-Alumina based filter on A11 antibody signal. NiNTA 
elutes are CsgA-His eluted into 50mM KPi 8M GdHCl pH 2 (final pH 4 to 5). NiNTA diluted 
were diluted by 25% with MilliQ-H20. After filtration through a 0.22μm Cellulose 
Acetate (CA) membrane, CsgA-His bound A11 antibody in the presence of 8M GdHCl 
even after further boiling for 5 minutes at 99°C. Unlike the CA membrane the Anotop 
(Whatman) 0.1 μm γ-Alumina based filter had no effect on A11 binding to CsgA-His in 
8M GdHCl. 
 
Fig. 4.21. The A11 oligomer antibody does not bind CsgA-His below 4 µM. Denaturing 
preps of CsgA-His were diluted in 50mM KPi pH 7.2 and dot blotted onto Nitrocellulose 
membranes. No A11 antibody signal was seen for concentrations of CsgA-His below 4 
µM. (A) Prep DS64 (B) Prep DS65 (C) Prep DS68 
 
Fig. 4.22. Effects of different GdHCl concentrations on A11 antibody binding to CsgA-
His. (A) In prep. DS64. CsgA-His was eluted from NiNTA using 50mM KPi 8 M GdHCl pH 2 
(final pH was 4.86) and diluted 1:10 or 1:5 with water or 8 M GdHCl to reach the final 
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concentrations of GdHCl indicated. Afterward mixing 3 µL was dotted onto a 
nitrocellulose membrane. The mixtures were allowed to incubate for the times 
indicated at room temperature and again dotted blotted. All the dot blots were probed 
with A11 Oligomer antibody and an antibody raised against CsgA. Over time A11 is seen 
binding to CsgA-His in up to 3.2 M GdHCl. In (B) prep. DS65 (C) prep. DS69, a denaturing 
preparation of CsgA-His was desalted using a gel filtration column and GdHCl was added 
to the concentrations indicated. At each time point after mixing, a portion of each 
reaction was dot blotted onto a nitrocellulose membrane, allowed to dry, and probed 
with the indicated antibodies. A11 antibody is shown binding to CsgA-His with GdHCl 
concentrations up to 3 M. Higher concentrations of GdHCl does seem to affect CsgA-His 
binding to nitrocellulose. 
 
Fig. 4.23. Effects of GdHCl on CsgA-His polymerization. GdHCl concentrations above 2.5 
M inhibit CsgA-His polymerization resulting in longer lag phases. However, these results 
are complicated by high concentrations of GdHCl quenched ThT fluorescence of 
preformed CsgA-His fibers. (A) ThT fluorescence time course of a denaturing prep of 
CsgA-His (DS64) with GdHCl added to final concentrations indicated. Not shown:  1.6M 
GdHCl was able to block 6 µM CsgA-His; while 0.8 M GdHCl doubled the lag phase. (B) 
ThT fluorescence time course of a denaturing prep of CsgA-His (DS65) with GdHCl added 
to final concentrations indicated. (C) ThT fluorescence of preformed CsgA-His fibers with 
GdHCl added to the final concentrations indicated.  
 
Fig. 4.24. Effects of CsgA-His concentration on the half time (t½), relative rate, and lag 
phase of polymerization. (A) The polymerizations of various concentrations of a 
denaturing prep of CsgA-His (DS51) were monitored with ThT fluorescence. Half time 
(t½) is indicated with blue dots and is the point at which half of the CsgA-His is 
polymerized into fibers. (B) The rate of CsgA-His polymerization is linear with 
concentration. (C) The lag phase of CsgA-His is concentration independent above 4μm. 
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In multiple other preps, CsgA-His concentrations below ~4μm showed increasing lag 
phase and concentrations up to 150um showed concentration independent lag phases.  
 
Fig. 4.25. Proposed mechanism of CsgA-His polymerization and A11 Oligomer antibody 
binding. (A) There are two lag phases in CsgA-His polymerization (see Fig. 4.24). The first 
lag phase is present below 4µM where lag phase is concentration dependent and CsgA-
His appears to follow nucleation dependent kinetics. This lag phase likely represents the 
time required to form an on-pathway multimeric nucleus (na). The second lag phase is 
concentration independent and is the same for all concentrations above 4µM. This step 
is likely a maturation of the on-pathway nucleus (na) into another nucleus (nb) of 
approximately the same stoichiometry. Following nb formation or further nucleus 
maturation, CsgA-His monomer are templated to form long amyloid fibers. (B) The A11 
Oligomer antibody (purple Y shape) may bind in one of three ways:  (1) to an off-
pathway monomer; (2) to an off-pathway multimer; (3) to an on-pathway multimer. The 
A11 Oligomer antibody most likely binds to an off-pathway monomer (1). 
 
Fig. 4.26. Tryptophan fluorescence spectra and iodine quenching of CsgA-His and CsgA-
His fibers. (A-F) 2.5μM of a denaturing prep of CsgA-His in 50mM KPi pH 7.2 was tested 
for changes in Tryptophan fluorescence in a Hitachi F-4500 FL Spectrophotometer. A 
wavelength scan was done with an excitation wavelength of 295 nm sweeping at 
1200nm/min. Both excitation and emissions slit widths were set to 5nm. The GdHCl 
used was from Fluka Biochemika Ultra pure 99.5% Pure (50935); it is spectral quality, 
which has low light absorption at 260 and 280nM. (A) Unpolymerized CsgA-His shows 
typical tryptophan fluorescence from a tryptophan in a polar solvent (maximum 
emission around 350nM). The Trp 84 of unpolymerized CsgA-His also appears readily 
available for fluorescent quenching with potassium iodine in the solvent. Potassium 
chloride does not readily quench intrinsic fluorescence of tryptophan and was used as a 
control. (B) Unpolymerized CsgA-His in 4M GdHCl does not as readily quench with KI. (C) 
Comparison of tryptophan fluorescence of unpolymerized CsgA-His with and without 
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4M GdHCl:  GdHCl increases CsgA-His tryptophan fluorescence. 0.2M KI less readily 
quenches the tryptophan of CsgA-His in 4M GdHCl. (D) Comparison of tryptophan 
fluorescence of unpolymerized CsgA-His and CsgA-His fibers. CsgA-His fibers have lower 
intensity of tryptophan fluorescence, consistent with partial burying of Trp 84 or 
possible quenching from nearby residues (21). Addition of 4M GdHCl has the opposite 
effect on tryptophan fluorescent of CsgA-His fibers. CsgA-His fibers with (E) and without 
(F) 4M GdHCl showed some quenching with the addition of 0.2M KI consistent with 
Trp84 being partially solvent exposed. Like tryptophan fluorescence, light scattering at 
360nm could be used to assay low concentrations of CsgA-His polymerization. A few 
early experiments were done which appeared to show rapid polymerization of CsgA-His 
by the R1 subunit fibers within minutes of addition to the reaction; however, these early 
experiments need to be repeated with better controls. 
 
Fig. 4.27. CsgA-His polymerization time course assayed with tryptophan and ThT 
fluorescence in the Molecular Devices Spectramax M2 plate reader. The tryptophan 
fluorescence (excitation 295 nm and emission 360 nm) of CsgA-His appears to increase 
in a manner similar to ThT fluorescence but with a lower sensitivity. These results 
oppose those seen in Fig. 4.26 and may be due to the following. (1) The M2 plate reader 
does not read emission at a 90⁰ angle to the incident light and also lacks selectable slits 
to reduce stray light. The increased Trp fluorescence may therefore reflect the geometry 
of M2’s fluorometer:  increased light scattering from more turbid CsgA-His fibers results 
in increased scattering of incident light. (2) CsgA-His Trp Fluorescence originally 
increases with fiber formation but may decrease over time as the fibers mature (See the 
changes in CD spectra over 15 days in Fig. 4.1B). Attempts to read ThT and Trp 
fluorescence in the same sample failed. Addition of ThT interferes with Trp fluorescence 
and resulted in small non-reproducible changes. 
 
Fig. 4.28. Sonication of CsgA-His fibers results in A11 oligomer antibody binding. (A) 
Sonication of preformed fibers of CsgA-His and a peptide corresponding to the R1 
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repeating units resulted in A11 oligomer antibody binding. Sonication also resulted in 
A11 binding to CsgA-His that was rapidly concentrated in a 10 NMWL Amicon Ultra-4 
filtration device (Millipore) immediately following purification. The rapid concentration 
prevented amyloid fibers from forming, pushing CsgA-His down an amorphous 
polymerization pathway. (B) Once sonicated, these fiber preps appear to retain their 
A11 antibody signal for several days. 
 
Fig. 4.29. CsgA is a predicted to be a natively unfolded protein. (A) The Uversky et al 
2000 (117) algorithm was incorporated into Foldindex (87) which is available online at 
(http://bip.weizmann.ac.il/fldbin/findex#info). Foldindex settings were window size = 10 
step size = 1. Data from the “show windows’ verbose detail” setting were graphed in 
Kaleidagraph 4.1; Adobe Photoshop was used to fill in regions where Foldindex scores 
were positive (green) for folded regions and negative (red) for unfolded regions. The 
overall folding index score for mature CsgA (without the Sec secretion signal region) is -
0.027 (charge: 0.046, phobic: 0.420) suggesting CsgA is an unfolded protein (87). (B) At 
default settings, Globprot 2 (67) which is available at (http://globplot.embl.de/) 
predicted most of CsgA is disordered. (C) At default settings Disembl 1.5, which is 
available at (http://dis.embl.de/), also predicted CsgA is mostly disordered according to 
a “loops or coil” definition (blue line) (66). Linding et al 2004 (68) discusses the 
propensity of many natively unfolded and globular proteins to aggregate and form 
amyloids. ( D) Disopred (126) and Psipred (77) predictions of the disordered and 
secondary structure of CsgA, respectively. Disopred2 predictions were performed at 
(http://bioinf.cs.ucl.ac.uk/at) using false positive rate thresholds of 2% and 10%. (*) 
represent disorder predictions and (.) prediction of order. The confidence estimates 
(graphed linearly as bars from 0-9) give a rough indication of the probability that each 
residue is disordered. Disopred results were affected by the presence or absence of the 
Sec signal region of CsgA; the results of CsgA without the sec signal are indicated as “Dis-
Sec 2%” and “Dis-Sec 10%”. Psipred version 2.6 was performed using a filtered data set:  
See Chapter III and Appendix A for more details. For Psipred, removal of the Sec signal 
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sequence did not appreciably affect the predictions. Unlike the other disorder 
predictors, Disopred did not predict CsgA to be particularly disordered and may reflect 
the training set on which it was made (87). Note:  FoldUnfold (40) which is based on 
Galzitskaya & Garbuzynskiy 2006 (39) was originally used to show CsgA-His was 
predicted to be unstructured (123). However, as of this writing the site at 
(http://skuld.protres.ru/~mlobanov/ogu/) was not available. There are many other 
protein disorder predictors; Disprot.org lists 19 such predictors at 
(http://www.disprot.org/predictors.php). 
 
Fig. 4.30. Theoretical Isoelectric points (pI) of Repeating Units of CsgA and CsgB. 
Theoretical pI’s are from Proteine (88) and Protparam (89). Acidic residues are colored 
in Red, Basic in Blue, Tyrosine and Histidine (pka 10.07 and 6.10 respectively) in purple. 
Gray bars represent aligned stacks of residues found in at least four repeating units. 
 
Fig. 4.31. The effects of temperature and GdHCl on the mobility of CsgA-His in Native 
or SDS-PAGE gels and on A11 Oligomer antibody binding. A denaturing preparation of 
CsgA-His (DS65) was subjected to Native gels, SDS-PAGE gels, and A11 Oligomer 
antibody binding. (A) 13% Native gel showing CsgA-His runs primarily as a single species 
even at elevated temperatures. The addition of 2M GdHCl did not affect the mobility of 
CsgA-His. (B) 13% SDS-PAGE samples of the reaction above. The breakdown of CsgA-His 
is apparent at 95⁰C especially at 35 minutes. (C) Dot blots show A11 oligomer binding is 
present at multiple temperatures but is absent in 8M GdHCl just off the NiNTA column 
and when 2M GdHCl is added back to CsgA-His that has been desalted on a Sephadex G-
25 Fine column into 50mM KPi pH 7.2.  
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Figure 4.1.  In vitro polymerization of CsgA-His measured
by ThT fluorescence, CD and TEM.
288
Figure 4.2.  Detection of transient conserved intermediate 
species during CsgA-His polymerization. 
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Figure 4.3.  CsgA-His fibers can catalyze self-polymerization. 
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Figure 4.4.  Three CsgA intramolecular peptide repeats can 
















































Figure 4.5 (continued).  Denatured CsgA-His purification.
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Figure 4.5 (continued).  Denatured CsgA-His purification.
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Figure 4.7.  Effects of pH on relative rates of CsgA-His












































Figure 4.8.  Effects of pH on the ThT fluorescence and




















Figure 4.9. The pH of maximum amyloid formation (pHmax) typically 


























Figure 4.12.  Effects of ionic strength on CsgA-His 
polymerization and preformed CsgA-His fibers.
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Figure 4.13.  Effects of temperature on polymerization and












Figure 4.14.  Effects of temperature on the polymerization, solubility,
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Figure 4.14 (continued).  Effects of temperature on the polymerization, solubility,
and A11 Oligomer binding of denaturing preparation of CsgA-His. 
Native Gel
Coomassie 










Figure 4.15.  The A11 Oligomer antibody recognizes a single 
species of CsgA-His at multiple temperatures. 









Figure 4.16.  A11 Oligomer signal seen after 5 minutes 
incubation of CsgA-His at 99°C.
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Figure 4.17.  High temperatures lead to rapid hydrolysis of CsgA-His
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Figure 4.18 (continued).  The A11 Oligomer antibody does not
inhibit CsgA-His polymerization.
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Figure 4.19.  The A11 oligomer antibody binds CsgA-His directly after
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Figure 4.20.  Effects of filtering CsgA-His in GdHCl through a 0.22μm Cellulose Acetate 
filter and an Anotop 0.1 μm γ-Alumina based filter on A11 antibody signal.
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Figure 4.21.  The A11 oligomer antibody does not bind CsgA-His below 4µM.
A














Figure 4.22.  Effects of different GdHCl concentrations on 
A11 antibody binding to CsgA-His.
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Figure 4.22 (continued).  Effects of different GdHCl concentrations on 
A11 antibody binding to CsgA-His.
A11 antibody
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Figure 4.24.  Effects of CsgA-His concentration on the half time (t½),
relative rate, and lag phase of polymerization.  
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Figure 4.25.  Proposed mechanism of CsgA-His polymerization
and A11 Oligomer antibody binding.























Figure 4.26.  Tryptophan fluorescence spectra and 






Figure 4.26 (continued).  Tryptophan fluorescence spectra and 
iodine quenching of CsgA-His and CsgA-His fibers.
322
Figure 4.27. CsgA-His polymerization timecourse assayed with tryptophan and
ThT fluorescence in the Molecular Devices Spectramax M2 plate reader. 
* Unpolyerized CsgA-His was rapidly concentrated in Amicon Ultra filter.
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CsgA-His*
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Figure 4.29.  CsgA is predicted to be a natively unfolded protein.
325
Figure 4.29 (continued).  CsgA is predicted to be a natively unfolded protein.
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Figure 4.31.  The effects of temperature and GdHCl on the mobility of CsgA-His 
in Native or SDS-PAGE gels and on A11 Oligomer antibody binding.
B
Figure 4.31 (continued).  The effects of temperature and GdHCl on the mobility of
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Future Directions and Synopsis 
 
Future directions 
How does a gcvA mutant affect curli production? 
 The Congo Red (CR) defect of the gcvA mutant (Fig. 1.6B) led me in several 
directions including developing programs to predict functional amyloids (See Appendix 
A) and studying the relative economy of extracellular proteins (Chapter III). GcvA both 
activates and represses the glycine cleavage system, which is responsible for degrading 
glycine to ammonia and carbon dioxide (36, 43, 51, 98-101, 124-127). Originally, I 
believed the gcvA strain was defective for curli production because it lacked sufficient 
glycine due to derepression of the glycine cleavage system. Intriguingly, CsgD increase 
the levels of GlyA (23, 24), which interconverts glycine and serine (Fig. 1.6C) (53). 
Consequently, I tested a glyA mutant strain for CR binding. However, the glyA from the 
Keio collection was not defective for CR binding even on YESCA plates with 1/10th the 
regular amount of casamino acids (Fig 5.1A). As this was unexpected, I verified the glyA 
mutant by testing its growth in minimal media (52, 53); without addition of glycine there 
was no appreciable growth (Fig. 5.2). Intriguingly, addition of serine and glycine 
inhibited growth in multiple strains. Accumulation of serine has been shown to starve 
cells of S-adenosylmethionine and C1 unit resulting in defects in cell wall biosynthesis 
and division (129, 130). The Congo Red binding of gcvA, gcvR, gcvTHP and other glycine 
or serine metabolism mutants were also tested (Fig 5.1). Only the gcvA mutant was 
defective for curli production (Fig. 5.1C). Supplementing CR YESCA plates with glycine or 
serine was unable to rescue the gcvA mutant (Fig. 5.1C) even when 1% glycine was 
added (Fig. 5.1D). 
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Because replacement of glycine did not restore the gcvA strains CR phenotype 
and the other glycine metabolism mutants produced wild type levels of curli, I looked at 
what else GcvA regulates. GcvA is required to activate the transcription of the small RNA 
gcvB (66, 101, 114). Expression of gcvB in trans restored the gcvA strain’s CR binding 
(Fig. 5.3). I also obtained plasmids containing gcvA and gcvB from George Stauffer, each 
of which partially rescued the CR phenotype gcvA strain (Fig. 5.4). Since expression of 
gcvB over expression restored the gcvA strain, I also tested the phenotype of a gcvB 
mutation. The gcvB strain was more defective than a gcvA strain for CR binding. 
Collectively, these results suggest the curli defect in gcvA is due to lower amounts of 
gcvB transcript. 
Several amino acid transport systems including the periplasmic dipeptide (Dpp) 
and oligopeptide (Opp) transport systems are negatively regulated by gcvB (66, 81-84, 
101, 114). DppA and OppA, the periplasmic binding proteins of these systems, are up 
regulated in several csg mutants. Periplasmic extracts from these csg mutants have 
been shown to inhibit CsgA-His polymerization (Fei Li and Margery Evans, unpublished 
observations). One possible reason for the CR defect in the gcvA and gcvB strains is the 
increased production of DppA and OppA due to the lack of repression by gcvB. To test 
this hypothesis I generated double mutants of dppA and oppA in gcvA and gcvB mutant 
backgrounds. In both cases deletion of the periplasmic component of the peptide 
transport system resulted in restored CR binding (Fig. 5.5).  
Collectively, these data suggest the gcvA mutant produces less curli because it 
has lower transcription of gcvB which typically down regulates the dppABCDF and 
oppABCDF operons. Without this down regulation, higher levels of DppA and OppA 
accumulate in the periplasm. One possible reason for the curli defect is that CsgA or 
another curli specific protein interacts with DppA or OppA. Both DppA and OppA have 
been shown to have chaperone activity (64, 65, 85, 87). Alternatively, the deletion of 
either periplasmic binding protein prevents transport of small peptides that may have a 
regulatory effect on curli production. I am currently exploring these possibilities. I have 
cloned DppA-His for purification and have made double mutants in gcvA or gcvB and 
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other parts of the dpp and opp system such as the inner membrane components. 
Hopefully, I will be able to tease apart why higher levels of DppA or OppA result in less 
curli production. 
 
Do less expensive extracellular proteins give the cell a metabolic leg up? 
Ample evidence was presented in Chapter III regarding the economy of 
extracellular proteins; however, a clear in vivo example of the competitive fitness of 
having less expensive extracellular proteins is lacking. Excessive production of 
extracellular proteins has been shown to result in a competitive disadvantage (29, 57, 
67, 77). Most of these examples involve mutants in which overproduction of flagella 
results in reduced cellular growth rates or competitive fitness, particularly in cases 
where there is no clear functional advantage for extraneous flagella. For example, 
constitutive flagellar mutants such as flgM and fliD grow slower due to excess FliC 
production (57), and flagellar mutants quickly overtake wild type strains (67). 
Additionally, flgG mutants, but not motAB mutants, outcompete wild type bacteria on 
plates (29), which suggests flagella synthesis itself is what taxes the cell when function 
does not provide an advantage. Lack of FlgG inhibits late flagellar development and thus 
secretion of extracellular flagellar proteins because secretion of the anti sigma factor 
FlgM requires hook assembly (22); however, a motAB mutant does not affect flagella 
assembly (63). A better example of the competitive costs of excessive extracellular 
protein production involves toxin production in the yeast Pichia kluyveri. Toxin-
producing and toxin-deficient strains of P. kluyveri were grown in the presence of either 
toxin-sensitive Pichia angusta or toxin-resistant Metschnikowia pulcherrima. When 
grown with toxin-sensitive P. angusta, the toxin-producing strain of P. kluyveri was able 
to outcompete the toxin-deficient strain; however, the opposite result occurred when 
these P. kluyveri strains were grown with toxin-resistant M. pulcherrima (77). Thus it 
appears either overproduction of extracellular proteins or production in cases where 




However, the examples presented above do not directly compare the cost of 
producing a more expensive extracellular protein with a less expensive one. To establish 
such a comparison one needs secretion of a functionally irrelevant protein in which 
mutations are made to increase or decrease the relative cost of its production. I 
considered several secretions systems to identify the best system for such an 
experiment. The Type I secretion system (T1SS) appears to be the best candidate. Unlike 
Type II, V, and VII secretion systems, T1SS secretes the protein from the cytoplasm to 
the extracellular milieu in a single step; the secreted protein does not enter the 
periplasm where it may interact with chaperones or proteases and possibly be degraded 
(3, 105). Additionally, the T1SS does not require contact with host membranes for 
secretion unlike many Type III, IV, and VI secretion systems (2, 105). 
The T1SS also has the advantage of a known tag that can be added to another 
protein to allow for its secretion. Angkawidjaja et al 2006 (3) added the C-terminal tag of 
Pseudomonas sp. MIS38 lipase (PMLC) to Escherichia coli alkaline phosphatase (AP) to 
make AP-PMLC. This fusion protein is under the control of an IPTG inducible promoter 
and was efficiently secreted into the extracellular milieu while the untagged AP 
remained in the cytoplasm. Such a system would be excellent for testing the cost 
associated with more expensive extracellular proteins. Theoretically, one could mutate 
residues between the C-terminal tag and AP domain in the fusion protein to increase or 
decrease the metabolic cost of producing it. For example, addition of more tyrosine, 
tryptophan, and phenylalanine residues would increase the relative cost of the fusion 
protein, while addition of glycine, alanine, and serine residues would decrease the 
relative cost (1, 27, 44).  
Using a library of such fusion proteins one could test the growth rate and 
competitive fitness of strains secreting proteins with different metabolic cost. To test 
the competitive fitness between strains one could mutate the AP domain of a particular 
strain to be completely inactive. AP active strains are easily differentiated; they will 
produce a black precipitate on plates amended with BCIP (5-bromo-4-chloro-3;-
indoylphosphate p-Toluidine Salt) and NBT (Nitro-Blue Tetrazolium Chloride). If a 
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disadvantage for increased metabolic cost is found, increasing the levels of two proteins 
should exacerbate differences in growth or competitive fitness. By making similar sets of 
mutations in a cytoplasmically localized AP one could test whether the growth or 
competitive fitness defects are greater for more expensive proteins when they are 
secreted. Additionally, by adding amino acid media supplements, especially in E. coli 
single amino acid auxotrophs or strains lacking an amino acid transport systems, one 
could modulate and study the relative costs of secreting different proteins. 
 Experiments involving cellular costs and competitive fitness are not without 
difficulty and would require careful controls. The most important consideration in 
comparing strains expressing different fusion proteins is making sure they produce and 
secrete the same amount of protein. As long as mutations did not affect antibody 
binding, this could be accomplished by western blotting for AP-PMLC in the culture 
medium. Alternatively, one could test the enzymatic activity of the secreted proteins. 
However, the AP-PMLC used in Angkawidjaja et al 2006 did not fold particularly well 
unless it was purified in a glutathione redox buffer (3). This is likely due to the lack of 
disulfide bonds which are generally added to AP by the DsbA and DsbB system when AP 
is in the periplasm (97). There is a cold adapted alkaline phosphatase in Vibrio sp. (6) 
that does not require a disulfide bond for activity; however, it is not particularly stable 
at room temperature. Another enzyme particularly one with a colorimetric assay that 
can be adapted to plates could overcome these problems. 
 
Are there expensive extracellular proteins? 
 The examination of protein economy began out of a desire to quantify the 
relative richness of glycine in CsgA. Once the amino acid compositions of all the proteins 
in E. coli were calculated, only a small step was needed to calculate their relative 
synthetic costs. Using this data, I noted another intriguing aspect of CsgA, a lower cost 
relative to other proteins. In Chapter III, I found that most if not all of the extracellular 
proteins in other microbes were economical; however, there were outliers amongst 
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extracellular proteins. Two of these worth noting are alpha factor in yeast and the major 
subunit of the conjugative pilus in E. coli. 
 Initially, Matt and I enjoyed entertaining the idea this discrepancy reflected that 
sex was more expensive. Many higher animals such a birds incur a fitness cost through 
extravagant displays to attract a mate (80). However, such an anthropomorphic thought 
belied a simpler explanation. Tzvi Tzfira approached us concerning the economy of 
transformation by Agrobacterium tumefaciens, in which a system homologous to the 
conjugative pilus is used to transfer DNA into plants (2, 32, 109, 110). When I examined 
the protein cost in A. tumefaciens, I found similar results as in other microbes. 
Extracellular proteins were significantly less expensive (Fig. 5.7). When I focused on the 
expense of Type IV system proteins, I noticed that many of the trends were similar to 
Type III and Type I secretion systems. Membrane and regulatory elements were average 
or relatively expensive while secreted proteins were economical. 
 Intriguingly, the Type IV pilus subunit VirB2 was more expensive than an average 
protein when examined for protein cost (red circle, Fig. 5.7). However, when using 
amino acid mass instead of synthetic cost, VirB2 is one of the most economical in the 
cell (green circle, Fig. 5.7). Accordingly, VirB2 has a relatively low carbon and nitrogen 
content. Collectively, the economic rank for VirB2 is 2822, 55, 227 and 399 out of 5402 
proteins using synthetic costs, mass, carbon, and nitrogen content to calculate relative 
amino acid cost, respectively. Such a strange result made me reexamine why there was 
such a discrepancy. As noted in Chapter I, each of the different ways to cost biases for 
certain amino acids over others. Consequently, I examined the amino acid composition 
of VirB2 and noticed it had a very low percent of acidic residues; less than 1.7% of the 
residues in VirB2 were acidic.  
 I examined the composition of other proteins to see if any had low acidic residue 
contents. A histogram of the percentage of Glu and Asp residues results in a bimodal 
distribution (Fig. 5.8). A similar distribution is seen for basic residues (data not shown) of 
which VirB2 is also depleted. Intriguingly, this bimodal distribution has a biological basis. 
Many inner membrane proteins are among the proteins with the least amount of 
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charged amino acids. These proteins include aquaporin and transporters of sodium, 
benzoate, ammonia, and other charged molecules (Fig. 5.8B). Collectively, these results 
suggest VirB2 is under the same strong selection to reduce charged residues in its 
composition as proteins that transport charged molecules. Accordingly, the role of VirB2 
in the cell is to transport negatively charged DNA (2, 109, 110). Additionally, I found that 
many of the type IV effectors (2) including VirD2, VirD5, VirE2, VirE3, and VirF were 
quite rich in charged amino acids, all of which had greater than 26.5% EDRK. Thus it 
appears that the composition of VirB2 is the result of a delicate balancing act between 
economy of carbon atoms and a functional reduction of charged amino acids. 
 
Synopsis 
Curli are thin proteinaceous fibers produced by many Enterobacteriaceae (11, 16, 21, 
42, 89, 117, 118, 120, 121, 131), primarily as a structural component of biofilms (26, 54, 
93, 96, 116). The formation of curli is incredibly complex and includes regulation of and 
by CsgD (4, 5, 11, 17, 19, 31, 33-35, 40, 46-48, 69, 70, 74, 78, 90, 91, 115, 116, 128); the 
accessory proteins CsgE, CsgF, and CsgG (11, 21, 30, 37, 62, 68, 88); and the major and 
minor fiber subunits CsgA and CsgB (21, 41, 42, 117, 118, 120, 121). Curli have been 
implicated in a variety of other biological functions including environmental persistence 
(92, 111, 119, 122, 123); pathogenesis including host cell adherence, internalization, and 
invasion (38, 39, 50, 56, 58, 59, 61, 94, 102, 112, 113, 119), binding to host factors (13, 
25, 45, 71-74, 76, 95), and inducing the host inflammatory response (14, 15, 72, 106-
108, 119); and adherence to plant (9, 10, 18, 49, 55, 60, 104) and manmade surfaces (7, 
12, 16, 20, 26, 75, 79, 103, 111). 
In this work I focused on the development, evolution and amyloidogenesis of curli 
using genetic, in silico, and biochemical tools. To study the development of curli 
formation in Escherichia coli K-12, I screened the Keio collection, a near complete 
collection of deletion mutants. I found more than 300 genes that modulated curli 
production. For example, the regulator of glycine metabolism GcvA, the sodium 
antiporter NhaA, NADH dehydrogenase, and many other proteins involved in 
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fundamental cellular processes affect curli production. Many of these genes likely 
regulate curli either directly or indirectly through either two component systems or the 
alternative sigma factors RpoS and RpoE. Despite the many regulatory and metabolic 
genes found to affect curli, there is little overlap between genes affecting curli and 
motility suggesting curli production is a distinct cellular lifestyle. 
To study the evolution of curli, I examined the composition and cost of amino acids in 
CsgA and CsgB. Both proteins, as well as many other extracellular proteins in a wide 
variety of microbes, appear to have been selected for increased economy. In curli 
producing cells, curli production is one of the most highly expressed proteins made, yet 
because of the lack of import systems many of the cost associated with building the 
biofilm matrix are not recovered. Thus selection for less expensive amino acids in curli 
saves the cell needed resources during stationary phase, a time where carbon and other 
resources are imitated. 
Finally, to study the amyloidogenesis of curli, I examined the conditions that promote 
the in vitro polymerization of purified CsgA-His. Like disease-associated amyloids, CsgA-
His bound Thioflavin T upon polymerizing into fibers, reacted with the amyloid specific 
A11 antibody, self seeded, and displayed other aspects of amyloid fiber formation. 
However, CsgA also displayed some unique properties. The quick adoption of the 
species recognized by the A11 antibody suggests that the many repeating units in CsgA 
may limit some of the toxic intermediates in amyloidogenesis. Additionally, as an 
evolved amyloid with a separate nucleator, I find the complementary pI’s of CsgA and 
CsgB quite intriguing. 
As a model system, many aspects of curli formation have been explored in the 
literature including the complex regulation, secretion, assembly, biological function, and 
amyloidogenesis. Collectively, this investigation sheds new light on the biology of the 
functional amyloid curli and the evolutionary pressures on extracellular proteins. My 
study of curli has led me down branched paths too numerous to mention. There remain 
many questions, both unanswered and unasked. Hopefully, this work will beget exciting 




Fig. 5.1. Addition of glycine, serine, or both has little effect on the CR phenotype of 
several stains lacking glycine and serine metabolism genes. (A) Strains were grown on 
CR YESCA with 1/10th the normal amount of Casamino acids per liter. (B) Strains were 
grown on CR YESCA with half the normal amount of Casamino acids per liter. (C) Strains 
were grown on regular CR YESCA. (D) Even addition of 1% glycine did not rescue the CR 
binding of the gcvA mutant. In each case the strains were grown for 2 days at 26⁰C. 
 
Fig. 5.2. The glyA strain cannot grow in minimal media without the addition of glycine. 
W minimal media (pH 7.4) was amended 0.4% Glucose, 0.2% Glutamine, and 0.1ug/mL 
Thiamine. The final concentration of 1X glycine or serine if present was 0.01%. (A) After 
36 hours, there is no appreciable growth in glyA strain in the absence of glycine. Glycine 
or glycine and serine addition rescue the growth defect of glyA. (B). Absorbance 
readings of the BW25113, gcvA, and glyA strains at the times indicated. A glyA strain 
should requires glycine to grow in minimal media (52, 53); the Keio collection glyA strain 
does require glycine addition for growth. 
 
Fig. 5.3. A plasmid expressing gcvB rescues the CR binding defect of a gcvA mutant. 
The RNA gcvB was cloned into pQE-70 which is a IPTG inducible high copy number 
plasmid to create pGcvB. Transformation of pGcvB into gcvA strains partially rescued 
the strains CR binding defect, especially when IPTG was added. The different patches for 
each strain represent independent isolates. Strains were grown on CR YESCA plates for 2 
days at 26⁰C. 
 
Fig. 5.4. Plasmids expressing gcvB or gcvA rescue the CR binding defect of the gcvA 
mutant. The pGS plasmids were obtained from George Stauffer and were transformed 
into gcvA strains. Plasmids containing gcvA or gcvB were able to partially complement 





Fig. 5.5. A gcvB deletion binds less CR than the gcvA mutant. The gcvB strain bound 
less Congo Red than the gcvA strain. A gcvB deletion strain was made by replacing the 
gcvB gene with a kanamyacin cassette using red swap mutagenesis (28). The different 
patches for each strain represent independent isolates. The gcvA dppA strain was 
created by flipping out the Kan cassette from the Keio gcvA strain and moving the 
dppA::Kan region using P1 transduction (8, 28). Strains were grown on CR YESCA plates 
for 2 days at 26⁰C. 
 
Fig. 5.6. Deletion of dppA or oppA rescues the CR defect of the gcvA and gcvB strains. 
Although dppA and oppA mutants were wild type for curli production, double mutants 
of either with gcvA or gcvB resulted in increased CR binding. Double deletion mutants 
were made by flipping out the Kan cassette with pCP20 (8, 28). Strains were grown on 
CR YESCA plates for 2 days at 26⁰C. 
 
Fig. 5.7. Average synthetic cost and mass of proteins in different locations from 
Agrobacterium tumefaciens. Average synthetic cost was calculated using values for 
chemoheterotrophic bacteria (1, 44). Protein locations were from PSORTDB version 3.0 
(86); a few type IV effectors were amended to extracellular (2). VirD5 was not changed 
but is economical. (A) Average synthetic cost in ATPs of proteins in various locations (B) 
Average mass of amino acids of proteins in various locations.  
 
Fig. 5.8. Distribution of amino acid composition in proteins of Agrobacterium 
tumefaciens. (A) Histogram of the percent of glutamic acid and aspartic acid. (B) 
Histogram of percent of basic and acidic residues. Green (All proteins), Red (Inner 
Membrane proteins), and Purple (Transporters). Inner membrane proteins were 
predicted using PSORTDB version 3.0. Transporters include aquaporin, SecG, CCOI and 
inner membrane proteins that were annotated as ABC transport membrane spanning, 
antiporter, or symporter.  
WT       csgA       gcvA gcvP glyA
fimA fliC flgM pyrE pyrD
flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
WT       csgA       gcvA gcvP glyA
fimA fliC flgM pyrE pyrD
flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
WT       csgA       gcvA gcvP glyA
fimA fliC flgM pyrE pyrD
flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
With 0.02% Gly
With 0.02% Ser
With 0.02% Gly + 0.02 % Ser
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Figure 5.1.  Addition of glycine, serine, or both has little effect on the CR phenotype
 of several stains lacking glycine and serine metabolism genes.
A YESCA with 1/10 Casamino Acids
WT       csgA       gcvA gcvP glyA
fimA fliC flgM pyrE pyrD
flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
With 0.02% Gly
WT       csgA       gcvA gcvP glyA
fimA fliC flgM pyrE pyrD
flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
With 0.02% Ser
WT       csgA       gcvA gcvP glyA
fimA fliC flgM pyrE pyrD
flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
With 0.02% Gly + 0.02 % Ser
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Figure 5.1 (continued).  Addition of glycine, serine, or both has little effect on the 
CR phenotype of several stains lacking glycine and serine metabolism genes.
B YESCA with 1/2 Casamino Acids
WT       csgA       gcvA gcvP glyA
fimA fliC pyrE pyrD
flgM flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
WT       csgA       gcvA gcvP glyA
fimA fliC pyrE pyrD
flgM flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
WT       csgA       gcvA gcvP glyA
fimA fliC pyrE pyrD
flgM flgM
cycA csgD gcvA glyA nhaA
sstT serC sdaC sdaA sdaB
YESCAC
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Figure 5.1 (continued).  Addition of glycine, serine, or both has little effect on the 
CR phenotype of several stains lacking glycine and serine metabolism genes.
With 0.02% Gly
With 0.02% Ser
With 0.02% Gly + 0.02 % Ser
WT            csgA       gcvA gcvR gcvP
dppA csgD gcvA glyA pyrE
serA hfq serC cycA purD
sdaA sdaB sdaC sstT purR
With 1% glycine
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Figure 5.1 (continued).  Addition of glycine, serine, or both has little effect on the 





















Figure 5.2.  The glyA strain cannot grow in minimal media without
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pQE-70 pGcvB
pGS311 – low copy vector control
pGS341 – gcvA on pGS311
pGS571 – gcvB on high copy plasmid
pGS594 – gcvB on pGS311






Figure. 5.4.  Plasmids expressing gcvB or gcvA rescue the CR binding defect of








Figure. 5.5.  A gcvB deletion binds less CR than the gcvA mutant. 
356
BW             csgA      gcvA gcvA gcvA
dppA oppA
dppA oppA gcvB gcvB gcvB
dppA oppA
glyA gcvR gcvT gcvA gcvB
csgA      csgA
Figure. 5.6.  Deletion of dppA or oppA rescues the CR defect of the gcvA and gcvB strains.
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Figure 5.7. Average synthetic cost and mass of proteins in


















Figure 5.8  Distribution of amino acid composition in proteins
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my $source=$ARGV; $source=~s/\....//; 
open FILE, ">$source-50aa.txt" or die "failed to clear"; 
print FILE "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE; 
foreach (@SEQ) { 
 my @spl = split('\:,'); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
 my $place=0; 
 START: 
 open FILE, ">>$source-50aa.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=50){goto END; 
 }else{ 
  my @try=join('',@array[0..49]); 
   foreach (@try) { 
    $place++; 
    my $last=$place+49; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
close FILE; 
open FILE2, ">$source-20aa.txt" or die "failed to clear"; 
print FILE2 "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE2; 
 
foreach (@SEQ) { 
 my @spl = split('\:,'); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 






 open FILE2, ">>$source-20aa.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=20){goto END; 
 }else{ 
  my @try=join('',@array[0..19]); 
   foreach (@try) { 
    $place++; 
    my $last=$place+19; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE2 $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
 
Rationale:  Possible functional amyloid prediction. This program will take a file of  
multiple protein sequences and for each protein analyze the number of 
Q,N,P,D,E residues in 50 and 20 amino acid windows. There must be a colon (:) 
between descriptors and the sequence on each line. Each Q and N adds plus one, 
each beta breaker amino acid (PDE) is -1. 
 
 
Input:   Simple text file “Each line is ‘description, location,:, sequence ” 
 
Output:  Inputfilename-20aa.txt 20aa window 
    Inputfilename-50aa.txt 50aa window 
 
Notes:  Output files can be opened in Excel using comma (,) delimited data.  If not using 
location another descriptor could be used. This program will also work on a single 









my $source=$ARGV; $source=~s/\....//; 
open FILE, ">$source-50aa.txt" or die "failed to clear"; 
print FILE "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE; 
foreach (@SEQ) { 
 my @spl = split('\','); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
 my $place=0; 
 START: 
 open FILE, ">>$source-50aa.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=50){goto END; 
 }else{ 
  my @try=join('',@array[0..49]); 
   foreach (@try) { 
    $place++; 
    my $last=$place+49; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
close FILE; 
open FILE2, ">$source-20aa.txt" or die "failed to clear"; 
print FILE2 "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE2; 
foreach (@SEQ) { 
 my @spl = split('\','); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
 my $place=0; 
 START: 






 if ($stuff<=20){goto END; 
 }else{ 
  my @try=join('',@array[0..19]); 
   foreach (@try) { 
    $place++; 
    my $last=$place+19; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE2 $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
 
Rationale:  Same usage as QPDE5020.perl except ‘ is used as a divider.  However,  
depending on the source file the symbol (') is read incorrectly as( ‘) and the split 
function does not work. There must be a (') dividing descriptions and sequence. 
Each Q and N are plus one, each beta breaker amino acid (PDE) is -1. Originally 
used on simplepos.txt outputs from QNPDEpos50.perl, QNPDEpos20.perl, or 
QNPDEposPercent.perl. 
 
Input:   Simple text file “Each line is ‘description, location, ', sequence ” 
 
Output:  Inputfilename-20aa.txt 20aa window 
    Inputfilename-50aa.txt 50aa window 
 
Notes:  Output files can be opened in Excel using comma (,) delimited data.  If not using 
location another description could be used. This program will also work on a single 
protein as well. Preferably use QNPDE5020c.perl as (:) are rare in fasta file descriptions 















s/\|Cytoplasmic /\| Cytoplasmic/g; 
s/\|CytoplasmicMembrane/,CytoMembrane,,,/g; 
s/\|Cytoplasmic/,Cytoplasmic,,,/g; 
s/\|Unknown \(This protein may have multiple localization sites\.\)/,UnknowMultiple,,,/g; 
s/\|Unknown /\| Unknown /g; 
s/\|Unknown/,Unknown,,,/g; 
s/\|Cellwall /\| Cellwall /g; 
s/\|Cellwall/,Cellwall,,,/g; 





open FILE, ">simplepos.txt" or die "unable to open $file $!"; 
print FILE @before; 
close FILE; 




open FILE, ">simplepos.txt" or die "this didnt work"; 
print FILE @after; 
close FILE; 
open FILE, "<simplepos.txt" or die "this didnt work either"; 
my @c=<FILE>; 
close FILE; 
open FILE2, ">scoredpos.txt" or die "failed to open"; 
print FILE2 "Description,Location,Number Q,Number N,Number P,Number D,Number E,Total AA,Percent 
QN-P,Percent QN-PD,Percent QN-PE,Percent QN-PDE,Sequence\n"; 
foreach (@c) { 
open FILE2, ">>scoredpos.txt" or die "failed on open again"; 
my @spl = split(',,'); 
print FILE2 $spl[0]; 
















print FILE2 ",",$q,",",$n,",",$p,",",$d,",",$e,",",$s,",",$qnp,",",$qnpd,",",$qnpe,",",$qnpde,$spl[1];} 
} 
 
Rationale:  An older way of predicting functional amyloids.  This program will take a  
Gram-positive organismal.faa file from pSORTdb v3 and then output the %QN-P, 
%QN-PD, and % QN-PDE.  Several functional amyloids rank highly when adding 
the percent of Gln and Asn and subtracting the percent of beta breaker residues 
such as Pro, Asp, and Glu . 
 
Input:   An organism.faa file from pSORTdb v3 Not tested on new pSORTdb v4 
 
Output:  simplepos.txt comma delimited text file of description,location,sequence 
    scorepos.txt  simplepos.txt plus % of single amino acids & combinations 
 
Notes:  Must be a Gram-positive organism as the first part of the program converts the  
 organism.faa file to a comma delimited text file.  The output file is readable using  














 s/\|Cytoplasmic /\| Cytoplasmic/g; 
 s/\|CytoplasmicMembrane/,CytoMembrane,'\,/g; 
 s/\|Cytoplasmic/,Cytoplasmic,\',/g; 
 s/\|Unknown \(This protein may have multiple localization sites\.\)/,UnknowMultiple,\',/g; 
 s/\|Unknown /\| Unknown /g; 
 s/\|Unknown/,Unknown,\',/g; 
 s/\|Cellwall /\| Cellwall /g; 
 s/\|Cellwall/,Cellwall,\',/g; 





open FILE, ">simpleseq.txt" or die "unable to open $file $!"; 
print FILE @before; 
close FILE; 




open FILE, ">simpleseq.txt" or die "this didnt work"; 
print FILE @after; 
close FILE; 
open FILE, "<simpleseq.txt" or die "this didnt work either"; 
my @in=<FILE>; 
close FILE; 
open FILE2, ">rollingpos.txt" or die "failed to clear"; 
print FILE2 "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE2; 
foreach (@in) { 
 my @spl = split('\','); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
my $place=0; 
 START: 
 open FILE2, ">>rollingpos.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=50){goto END; 
 }else{ 
  my @try=join('',@array[0..49]); 





    $place++; 
    my $last=$place+49; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE2 $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
 
Rationale:  Same usage as QPDE5020c.perl but only outputs 50 aa window and must  
uses a Gram-positive organism.faa file from pSORTdb v3. Each Q and N are plus 
one, each beta breaker amino acid (PDE) is -1. 
 
Input:   An organism.faa file from pSORTdb v3 Not tested on new pSORTdb v4 
 
Output:  simplepos.txt comma delimited text file of description,location,sequence 
    rollingpos.txt Score for 50 aa window 
 
Notes:  Must be a Gram-positive organism as the first part of the program converts the  
 organism.faa file to a comma delimited text file.  The output file is readable using  














 s/\|Cytoplasmic /\| Cytoplasmic/g; 
 s/\|CytoplasmicMembrane/,CytoMembrane,'\,/g; 
 s/\|Cytoplasmic/,Cytoplasmic,\',/g; 
 s/\|Unknown \(This protein may have multiple localization sites\.\)/,UnknowMultiple,\',/g; 
 s/\|Unknown /\| Unknown /g; 
 s/\|Unknown/,Unknown,\',/g; 
 s/\|Cellwall /\| Cellwall /g; 
 s/\|Cellwall/,Cellwall,\',/g; 





open FILE, ">simpleseq.txt" or die "unable to open $file $!"; 
print FILE @before; 
close FILE; 




open FILE, ">simpleseq.txt" or die "this didnt work"; 
print FILE @after; 
close FILE; 
open FILE, "<simpleseq.txt" or die "this didnt work either"; 
my @in=<FILE>; 
close FILE; 
open FILE2, ">rollingpos.txt" or die "failed to clear"; 
print FILE2 "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE2; 
foreach (@in) { 
 my @spl = split('\','); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
my $place=0; 
 START: 
 open FILE2, ">>rollingpos.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=20){goto END; 
 }else{ 
  my @try=join('',@array[0..19]); 




    $place++; 
    my $last=$place+19; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE2 $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
 
Rationale:  Same usage as QPDE5020c.perl but only outputs 20 aa window and must  
uses a Gram-positive organism.faa file from pSORTdb v3. Each Q and N are plus 
one, each beta breaker amino acid (PDE) is -1. 
 
Input:   An organism.faa file from pSORTdb v3 Not tested on new pSORTdb v4 
 
Output:  simplepos.txt comma delimited text file of description,location,sequence 
    rollingpos.txt Score for 20 aa window 
 
Notes:  Must be a Gram-positive organism as the first part of the program converts the  
 organism.faa file to a comma delimited text file.  The output file is readable using  









my $source=$ARGV; $source=~s/\....//; 
open FILE, ">$source-QNPDE.txt" or die "failed to clear"; 
print FILE "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE; 
foreach (@before) { 
 my @spl = split('\','); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
 my $place=0; 
 START: 
 open FILE, ">>$source-QNPDE.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=20){goto END; 
 }else{ 
  my @try=join('',@array[0..19]); 
   foreach (@try) { 
    $place++; 
    my $last=$place+19; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:} 
 
Rationale: Possible functional amyloid prediction. Takes a single protein and counts the  
number of Q,N,P,D, and E residues in a 20 amino acid window. Each Q and N are 
plus one, each beta breaker amino acid (PDE) is -1. 
 
Input:   Simple text file “Each line is ‘description, location, ', sequence ” 
 
Output:   Inputfilename-QNPDE.txt 
 















s/\|Cytoplasmic /\| Cytoplasmic/g; 
s/\|CytoplasmicMembrane/,CytoMembrane,,,/g; 
s/\|Cytoplasmic/,Cytoplasmic,,,/g; 
s/\|Unknown \(This protein may have multiple localization sites\.\)/,UnknowMultiple,,,/g; 
s/\|Unknown /\| Unknown /g; 
s/\|Unknown/,Unknown,,,/g; 
s/\|OuterMembrane/,OuterMembrane,,,/g; 
s/\|Periplasmic /\| Periplasmic /g; 
s/\|Periplasmic/,Periplasmic,,,/g; 





open FILE, ">simpleneg.txt" or die "unable to open $file $!"; 
print FILE @before; 
close FILE; 




open FILE, ">simpleneg.txt" or die "this didnt work"; 
print FILE @after; 
close FILE; 
open FILE, "<simpleneg.txt" or die "this didnt work either"; 
my @c=<FILE>; 
close FILE; 
open FILE2, ">scoredneg.txt" or die "failed to open"; 
print FILE2 "Description,Location,Number Q,Number N,Number P,Number D,Number E,Total AA,Percent 
QN-P,Percent QN-PD,Percent QN-PE,Percent QN-PDE,Sequence\n"; 
foreach (@c) { 
open FILE2, ">>scoredneg.txt" or die "failed on open again"; 
my @spl = split(',,'); 
print FILE2 $spl[0]; 
















print FILE2 ",",$q,",",$n,",",$p,",",$d,",",$e,",",$s,",",$qnp,",",$qnpd,",",$qnpe,",",$qnpde,$spl[1];} 
} 
 
Rationale:  An older way of predicting functional amyloids.  This program will take a  
Gram-negative organismal.faa file from pSORTdb v3 and then output the %QN-P, 
%QN-PD, % QN-PDE.  Several functional amyloids rank highly when adding the 
percent of Gln and Asn and subtracting the percent of beta breaker residues 
such as Pro, Asp, and Glu . 
 
Input:   An organism.faa file from pSORTdb v3 Not tested on new pSORTdb v4 
 
Output:  simpleneg.txt comma delimited text file of description,location,sequence 
    scoreneg.txt  simpleneg.txt plus % of single amino acids & combinations 
 
Notes:  Must be a Gram-negative organism as the first part of the program converts the  
 organism.faa file to a comma delimited text file.  The output file is readable using  










my $source=$ARGV; $source=~s/\....//; 
open FILE, ">$source-50aa.txt" or die "failed to clear"; 
print FILE "QN-PDE,Sequence,Amino Acids,Description,Location\n"; 
close FILE; 
foreach (@SEQ) { 
 my @spl = split('\','); 
 foreach ($spl[1]) { 
 my @array=split ''; 
 my $stuff=scalar(@array); 
 my $place=0; 
 START: 
 open FILE, ">>$source-50aa.txt" or die "failed to open"; 
 $stuff=scalar(@array); 
 if ($stuff<=50){goto END; 
 }else{ 
  my @try=join('',@array[0..49]); 
   foreach (@try) { 
    $place++; 
    my $last=$place+49; 
    my $q=0; 
    my $n=0;    
    my $p=0; 
    my $d=0; 
    my $e=0; 
    my $qnpde=0;   
    $q=(tr/Q//); 
    $n=(tr/N//); 
    $p=(tr/P//); 
    $d=(tr/D//); 
    $e=(tr/E//); 
    $qnpde=$q+$n-$p-$d-$e; 
    print FILE $qnpde,",",@try,",",$place," to ",$last,",",$spl[0],"\n"; 
    shift @array;} 
  goto START;}} 
END:}  
 
Rationale:  Same usage as QPDE5020.perl except ‘ is used as a divider and only 50 aa  
windows are used. 
 
Input:   Simple text file “Each line is ‘description, location, ', sequence ” 
 
Output:  Inputfilename-50aa.txt 50aa window 
 
Notes:  Output files can be opened in Excel using comma (,) delimited data.  If not using 









my @sorted=shift @sorting; 
@sorted=sort @sorting; 
open FILE, ">sortpos.txt"; 
print FILE @sorting 
 
Rationale:  Used to sort large output files from the QNPDE amino acid window programs  
which can result in several hundred thousand to over a million lines.  Program 
should also work on Gram-negative organisms too 
 
Input:   output file from 20 or 50 amino acid amyloid prediction program 
 








foreach (@file) { 
s/Staphylococcus aureus subsp\. aureus str\. Newman complete genome/Newman/g;} 
my $replace="short".$ARGV; 
open(FILE2,">$replace"); 
print FILE2 @file; 
 
Rationale: Used to remove extraneous description from large output files from  
programs that calculate the number of QNPDE over a 20 or 50 amino acid 
window.  File reduction allows easier manipulation in Excel or Word. 
 
Input:   Simple text file 
 
Output:  short.inputfilename 
 
Notes:  Much quicker than using Word or other search and replace programs and should 
not crash as easily.  Easily modified to search and replace other text items. Change bold 
text to what needs to be found and the italic text to the replacing text.  If either  text 
uses punctuation you must add a \ before.  For  example “subsp. aureus”  would be  













foreach (@before) { 
my @one=split/\t/; 
open FILE, ">sequence.txt" or die "Failed to open sequence.txt"; 
print FILE $one[0],"\n",$one[1]; close FILE; 
system("./rundisopred sequence.txt 2") == 0 or die "Failed on running DISOPRED"; 
open FILE, "sequence.horiz_d"; 
@result=<FILE>; close FILE; 
open FILE2, "$one[0].txt" or die "Failed to open EB file"; 
print FILE2 $one[0],"\n",@result; close FILE2; 
open FILE3, ">>Alldisopred.txt" or die "Failed to open Alldisopred.txt"; 
print FILE3 $one[0],"\n",@result; } 
 
 
Rationale:  Program to send multiple protein sequence files to Disopred2. 
 
Input:  Simple text file.    Each line is “>description[TAB]sequence”. 
 
Output:  An individual text file of each protein named after the protein description.   
   Alldisopred.txt - combines all the individual Disopred2 results. 
 
Notes:  I set up Disopred2 to run in Ubuntu.   The 2 above sets the false positive rate. 
  See Fixdisopred.perl.  Alldisopred.txt needs to be fixed. 
 
An alternative file is called Disopred2.perl which uses a second non redundant 
database and allows two large files to be worked on at once.  The nciblast which 
is part of the disopred prediction program only runs on one processor.  Utilizing 
a second program should roughly double output.  The outputs are the same for 
both programs; however, output files are named differently so that no file 









my $source=$ARGV; $source=~s/\....//; 
my $lines=join('',@before); 
open FILE, ">$source.old"; 
print FILE @before; close FILE; 
$lines=~s/(conf: \npred: .{60}\n  AA: .{60}\n.{66})//g; 
$lines=~s/(conf: \t\npred: .{60}\n  AA: .{60}\n.{66})//g; 
open FILE2, ">$source.new"; 
print FILE2 $lines; close FILE2; 
 
 
Rationale:  I found a bug in Disopred2 vs 2.4.  Protein sequences that are a multiples of  
60 (60,120,180,240,etc.) amino acids have their last 60 amino acids duplicated in 
the Disopred2 results.  This program strips out the offending lines so they do not 
affect DIS.perl, DIScost.perl, and further analysis of multiple protein Disopred 
results.  I emailed Daniel Buchan (d.buchan@cs.ucl.ac.uk) about the bug which 
was corrected in version 2.42. 
 
Input:  Alldisopred.txt   From Disopred.perl 
 
Output:  Alldisopred.old  Alldisopred.txt file backup    








my @before=(<>); my $count=0; 
my $source=$ARGV; $source=~s/all\.txt//; 
foreach (@before) { 
 if($_=~/conf: \n/){ 
  $_ = "bad"; } 
 if($_=~/conf: \t\n/){ 
  $_ = "bad"; } }  
open FILE, ">temp.txt"; print FILE @before; close FILE; 
open FILE, "<temp.txt";  
my @after = <FILE>; close FILE; 
foreach (@after) { 
 if($_=~/badpred: /){ 
  $_ = "bad"; } } 
open FILE, ">temp2.txt"; print FILE @after; close FILE; 
open FILE, "<temp2.txt"; 
my @final = <FILE>; close FILE; 
foreach (@final) { 
 if($_=~/bad  AA: /){ 
  $count++; 
  $_ = ""; } } 
open FILE, ">$source.txt"; 
print FILE @final; close FILE; 
unlink "temp.txt"; 
unlink "temp2.txt"; 
print "Number of proteins with doubled last lines is ",$count; 
 
Rationale:  I found a bug in Disopred2 vs 2.4.  Protein sequences that are a multiples of  
60 (60,120,180,240,etc.) amino acids have their last 60 amino acids duplicated in 
the Disopred2 results.  This program found the number of bad sequences 
allowing me to figure out what was wrong with Disopred and allowed me to 
check Fixdisospred.perl to make sure it was correcting the problem. 
 
 
Input:  Alldisopred.txt   From Disopred.perl 
 









my @ss; my @seq; 
my @file; my @seqonly; my @final; 
my $source=$ARGV; $source=~s/\....//; 
foreach(@before) { 
 if ($_=~/\>/) {push(@ss,$_,",");} 
 if ($_=~s/pred\: //) {push(@ss,$_);} } 
foreach(@before) { 
 if ($_=~/\>/) {push(@seq,$_,",");} 
 if ($_=~s/  AA\: //) {push(@seq,$_);} } 
chomp (@ss); chomp (@seq); 
foreach (@ss) {s/\>/\n\>/g;}  
foreach (@seq) {s/\>/\n\>/g;} 
open FILE, ">$source-SEQ.txt" or die "unable to save Sequence file"; 
print FILE @seq; close FILE; 
open FILE, ">$source-DS.txt" or die "unable to save Structure (DS) file"; 
print FILE @ss; close FILE; 
open FILE, "<$source-SEQ.txt"; my @seqfile = <FILE>; close FILE; 
open FILE, "<$source-DS.txt"; my @ssonly = <FILE>; close FILE; 
foreach (@seqfile) { 
 if ($_=~s/\>EB\d\d\d\d//) { 
  push(@seqonly,$_);} #Modify this pattern if not >EB1245 
 if ($_=~s/\>gi\d\d\d\d\d\d\d\d//) { 
  push(@seqonly,$_);} #Or add your pattern as another if statement 
}  
foreach (@seqonly) { 
 push(@final,$ssonly[1],$_); 
 shift @ssonly;} 
chomp @final; 
foreach (@final) {s/\>/\n\>/g;} 
open FILE, ">$source-final.txt" or die "unable to open Final file"; 
print FILE @final; close FILE; 
 
Rationale:  Strips out sequences and Disopred2 results from multiple results in  
Alldisopred.txt result file and converts them into a comma delimited text file 
suitable for Excel and DIScost.perl. 
 
Input:  Name.txt    (Fixed Disopred.perl file using Fixdisopred.perl) 
 
Output:  Name-DS.txt    Each line is “Description,Disopred2 result”. 
    Name-SEQ.txt   Each line is “Description,sequence”. 
   Name-final.txt   Each line is “Description,Disopred2,sequence”. 
 
Notes:  See Fixdisopred.perl.  Alldisopred.txt needs to be fixed if using Disopred2  









my @all; my @smp; my @splA; my @splB; 
my @A; my @B; my @arrA; my @arrB; 
my @final; my $line; 
my $source=$ARGV; $source=~s/\-final\....//; 
foreach (@before) { 
 s/\>EB\d\d\d\d\,//; #Modify this pattern if not >EB1245 
 s/\>gi\d\d\d\d\d\d\d\d\,//; # or add your pattern as another substituion 
 @all=@before; } 
shift @all; 
chomp @all; 
foreach (@all) { 
 @smp=split ','; 
 push (@A,$smp[0]); #@A appears chomped 
 push (@B,$smp[1]); } 
foreach (@A) {@splA=split ''; 
 foreach (@splA) {push (@arrA,$_);} } 
foreach (@B) {@splB=split ''; 
 foreach (@splB) {push (@arrB,$_);} } 
foreach (@arrA) { 
 $line=join('',$_,$arrB[0]); 
 shift @arrB; 
 push (@final,$line,","); } 
open FILE, ">$source-DSaaRAW.txt" or die "failed to open DSaaRAW file"; 
print FILE @final; close FILE; 
my $DSA=my $DSC=my $DSD=my $DSE=my $DSF=my $DSG=my $DSH=my $DSI=my $DSK=my 
$DSL=my $DSM=my $DSN=my $DSP=my $DSQ=my $DSR=my $DSS=my $DST=my $DSV=my $DSW=my 
$DSY=0; 
my $ORA=my $ORC=my $ORD=my $ORE=my $ORF=my $ORG=my $ORH=my $ORI=my $ORK=my 
$ORL=my $ORM=my $ORN=my $ORP=my $ORQ=my $ORR=my $ORS=my $ORT=my $ORV=my $ORW=my 
$ORY=0; 
foreach (@final) { 
 if ($_=~/\*A/) {$DSA++;} if ($_=~/\*C/) {$DSC++;} if ($_=~/\*D/) {$DSD++;} 
 if ($_=~/\*E/) {$DSE++;} if ($_=~/\*F/) {$DSF++;} if ($_=~/\*G/) {$DSG++;} 
 if ($_=~/\*H/) {$DSH++;} if ($_=~/\*I/) {$DSI++;} if ($_=~/\*K/) {$DSK++;} 
 if ($_=~/\*L/) {$DSL++;} if ($_=~/\*M/) {$DSM++;} if ($_=~/\*N/) {$DSN++;} 
 if ($_=~/\*P/) {$DSP++;} if ($_=~/\*Q/) {$DSQ++;} if ($_=~/\*R/) {$DSR++;} 
 if ($_=~/\*S/) {$DSS++;} if ($_=~/\*T/) {$DST++;} if ($_=~/\*V/) {$DSV++;} 
 if ($_=~/\*W/) {$DSW++;} if ($_=~/\*Y/) {$DSY++;} if ($_=~/\.A/) {$ORA++;} 
 if ($_=~/\.C/) {$ORC++;} if ($_=~/\.D/) {$ORD++;} if ($_=~/\.E/) {$ORE++;} 
 if ($_=~/\.F/) {$ORF++;} if ($_=~/\.G/) {$ORG++;} if ($_=~/\.H/) {$ORH++;} 
 if ($_=~/\.I/) {$ORI++;} if ($_=~/\.K/) {$ORK++;} if ($_=~/\.L/) {$ORL++;} 
 if ($_=~/\.M/) {$ORM++;} if ($_=~/\.N/) {$ORN++;} if ($_=~/\.P/) {$ORP++;} 
 if ($_=~/\.Q/) {$ORQ++;} if ($_=~/\.R/) {$ORR++;} if ($_=~/\.S/) {$ORS++;} 
 if ($_=~/\.T/) {$ORT++;} if ($_=~/\.V/) {$ORV++;} if ($_=~/\.W/) {$ORW++;} 
 if ($_=~/\.Y/) {$ORY++;} } 
open FILE2, ">$source-DSaa.txt" or die "failed to open DSaa result file"; 













Rationale:  Allows one to count the number of each amino acid that is either disordered  
or ordered out of a large set of proteins analyzed by Disospred2.  Using this data 
one can see the bias of amino acid or their relative cost in disordered and 
ordered regions as predicted by Disopred.  First you must use Disopred.perl, 
Fixdisopred.perl (if using the Disopred 2.4 or lower), and Dis.perl. 
 
Input:  Name-final.txt from Dis.perl 
 
Output:  Inputfilename-DSaaRAW.txt Each aa and its predition divided by a (,) 
    Inpufilename-DSaa.txt  Comma delimited results (see below) 
 
Notes:  The DSaa file is a comma delimited file suitable for use by Excel.  The output list  
the number of each amino acid out of all the protein sequences in the input file 

















foreach (@before) { 
my @one=split/\t/; 
open FILE, ">sequence.txt" or die "Failed to open sequence.txt"; 
print FILE $one[0],"\n",$one[1]; 
close FILE; 
system("./runpsiprednr sequence.txt") == 0 or die "Failed on running PSIPRED"; 
open FILE, "sequence.horiz"; 
@result=<FILE>; 
close FILE; 
open FILE2, "$one[0].txt" or die "Failed to open EB file"; 
print FILE2 $one[0],"\n",@result; 
close FILE2; 
open FILE3, ">>all.txt" or die "Failed to open all.txt"; 
print FILE3 $one[0],"\n",@result; 
} 
 
Rationale:  Sends multiple sequences to Psipred - similar to Disospred.perl  except used  
Psipred predicts secondary structure as either helix, strand, or coil. 
 
Input:  Simple text file.    Each line is “>description[TAB]sequence”. 
 
Output:  An individual text file of each protein named after the protein description.   
   All.txt - combines all the individual Psipred results. 
 
Notes:  There are several other perl files that do similar things and include  
Shufflehome.perl, Shufflesingle.perl, and Shuffleunfil.perl.  Shufflehome.perl 
uses a second non redundant database to increase the number of sequences 
that can be processed at once.  The nciblast which is part of the psipred 
prediction program only runs on one processor.  Using a second program 
instance should double the output.  Shufflesingle.perl uses just neural networks 
(no blasting) and is much faster but not as accurate as when sequences are first 
blasted and a consensus sequence of sorts is used.  Shuffleunfil.perl uses an 
unfiltered database for blasting and gives slightly different results from a filtered 
database. The output are quite similar for each of the other perl files; however, 
output files are named differently so that no file overwriting or combining 
occurs. Care should be used in using two program instances as the individual 









my @ss; my @seq; 
my @file; my @seqonly; my @final; 
my $source=$ARGV; $source=~s/\.txt//; 
foreach(@before) { 
 if ($_=~/\>/) {push(@ss,$_,",");} 
 if ($_=~s/Pred\: //) {push(@ss,$_);} } 
foreach(@before) { 
 if ($_=~/\>/) {push(@seq,$_,",");} 
 if ($_=~s/  AA\: //) {push(@seq,$_);} } 
chomp (@ss); chomp (@seq); 
foreach (@ss) {s/\>/\n\>/g;}  
foreach (@seq) {s/\>/\n\>/g;} 
open FILE, ">$source-SEQ.txt" or die "unable to save Sequence file"; 
print FILE @seq; close FILE; 
open FILE, ">$source-HEC.txt" or die "unable to save Structure (HEC) file"; 
print FILE @ss; close FILE; 
open FILE, "<$source-SEQ.txt"; my @seqfile = <FILE>; close FILE; 
open FILE, "<$source-HEC.txt"; my @ssonly = <FILE>; close FILE; 
foreach (@seqfile) { 
 if ($_=~s/\>EB\d\d\d\d//) { 
  push(@seqonly,$_);} #Modify this pattern if not >EB1245 
 if ($_=~s/\>gi\d\d\d\d\d\d\d\d//) { 
  push(@seqonly,$_);} #Or add your pattern as another if statement 
}  
foreach (@seqonly) { 
 push(@final,$ssonly[1],$_); 
 shift @ssonly;} 
chomp @final; 
foreach (@final) {s/\>/\n\>/g;} 
open FILE, ">$source-final.txt" or die "unable to open Final file"; 
print FILE @final; close FILE 
 
Rationale:  Similar to Dis.perl except used for Psipred results.  Strips out sequences and  
Psipred from multiple results in the All.txt result file and converts them into a 
comma delimited text file suitable for Excel and HECcost.perl. 
 
Input:  Name.txt    Output file from Shuffle.perl or similar protein 
 
Output:  Name-HEC.txt    Each line is “Description,Psipred result”. 
    Name-SEQ.txt   Each line is “Description,sequence”. 








my @all; my @smp; my @splA; my @splB; 
my @A; my @B; my @arrA; my @arrB; 
my @final; my $line; 
my $source=$ARGV; $source=~s/\-final\.txt//; 
foreach (@before) { 
 s/\>EB\d\d\d\d\,//; #Modify this pattern if not >EB1245 
 s/\>gi\d\d\d\d\d\d\d\d\,//; # or add your pattern as another substituion 
 @all=@before; } 
shift @all; 
chomp @all; 
foreach (@all) { 
 @smp=split ','; 
 push (@A,$smp[0]); #@A appears chomped 
 push (@B,$smp[1]); } 
foreach (@A) {@splA=split ''; 
 foreach (@splA) {push (@arrA,$_);} } 
foreach (@B) {@splB=split ''; 
 foreach (@splB) {push (@arrB,$_);} } 
foreach (@arrA) { 
 $line=join('',$_,$arrB[0]); 
 shift @arrB; 
 push (@final,$line,","); } 
open FILE, ">$source-S2aaRAW.txt" or die "failed to open SSaaRAW file"; 
print FILE @final; close FILE; 
my $HA=my $HC=my $HD=my $HE=my $HF=my $HG=my $HH=my $HI=my $HK=my $HL=my $HM=my 
$HN=my $HP=my $HQ=my $HR=my $HS=my $HT=my $HV=my $HW=my $HY=0; 
my $CA=my $CC=my $CD=my $CE=my $CF=my $CG=my $CH=my $CI=my $CK=my $CL=my $CM=my 
$CN=my $CP=my $CQ=my $CR=my $CS=my $CT=my $CV=my $CW=my $CY=0; 
my $EA=my $EC=my $ED=my $EE=my $EF=my $EG=my $EH=my $EI=my $EK=my $EL=my $EM=my 
$EN=my $EP=my $EQ=my $ER=my $ES=my $ET=my $EV=my $EW=my $EY=0; 
foreach (@final) { 
 if ($_=~/HA/) {$HA++;} if ($_=~/HC/) {$HC++;} if ($_=~/HD/) {$HD++;} 
if ($_=~/HE/) {$HE++;} if ($_=~/HF/) {$HF++;} if ($_=~/HG/) {$HG++;} 
if ($_=~/HH/) {$HH++;} if ($_=~/HI/) {$HI++;} if ($_=~/HK/) {$HK++;} 
if ($_=~/HL/) {$HL++;} if ($_=~/HM/) {$HM++;} if ($_=~/HN/) {$HN++;} 
if ($_=~/HP/) {$HP++;} if ($_=~/HQ/) {$HQ++;} if ($_=~/HR/) {$HR++;} 
 if ($_=~/HS/) {$HS++;} if ($_=~/HT/) {$HT++;} if ($_=~/HV/) {$HV++;} 
if ($_=~/HW/) {$HW++;} if ($_=~/HY/) {$HY++;} if ($_=~/CA/) {$CA++;} 
if ($_=~/CC/) {$CC++;} if ($_=~/CD/) {$CD++;} if ($_=~/CE/) {$CE++;} 
if ($_=~/CF/) {$CF++;} if ($_=~/CG/) {$CG++;} if ($_=~/CH/) {$CH++;} 
if ($_=~/CI/) {$CI++;} if ($_=~/CK/) {$CK++;} if ($_=~/CL/) {$CL++;} 
 if ($_=~/CM/) {$CM++;} if ($_=~/CN/) {$CN++;} if ($_=~/CP/) {$CP++;} 
 if ($_=~/CQ/) {$CQ++;} if ($_=~/CR/) {$CR++;} if ($_=~/CS/) {$CS++;} 
 if ($_=~/CT/) {$CT++;} if ($_=~/CV/) {$CV++;} if ($_=~/CW/) {$CW++;} 
 if ($_=~/CY/) {$CY++;} if ($_=~/EA/) {$EA++;} if ($_=~/EC/) {$EC++;} 






if ($_=~/EG/) {$EG++;} if ($_=~/EH/) {$EH++;} if ($_=~/EI/) {$EI++;} 
if ($_=~/EK/) {$EK++;} if ($_=~/EL/) {$EL++;} if ($_=~/EM/) {$EM++;} 
if ($_=~/EN/) {$EN++;} if ($_=~/EP/) {$EP++;} if ($_=~/EQ/) {$EQ++;} 
if ($_=~/ER/) {$ER++;} if ($_=~/ES/) {$ES++;} if ($_=~/ET/) {$ET++;} 
if ($_=~/EV/) {$EV++;} if ($_=~/EW/) {$EW++;} if ($_=~/EY/) {$EY++;} } 
open FILE, ">$source-S2aa.txt" or die "failed to open S2aa result file"; 









Rationale:  Similar to DisCost.perl but for Psipred results.  Allows one to count the 
number of  
each amino acid that is either in a helix (H), strand (E), or coil (C) from a large set 
of proteins analyzed by Psipred using Shuffle.perl and Psipred.perl.  Using this 
data one can see the bias of amino acid or their relative cost in each secondary 
structure.   
 
Input:  Name-final.txt from Psipred.perl 
 
Output:  Inputfilename-SSaaRAW.txt Each aa and its prediction divided by a (,) 
    Inpufilename-SSaa.txt  Comma delimited results (see below) 
 
Notes:  The SSaa file is a comma delimited file suitable for use by Excel.  The output list  
the number of each amino acid out of all the protein sequences in the input file 
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Appendix B:  Seeding and Cross seeding with CsgA-His
IAPP used in the seeding of CsgA-His was from Andrew Miranker. See Koo and Miranker
(2005) for this method.  When IAPP was made by the Chen and Wetzel (2001) method by
Jenz no seeding occured; see Hammer et al PNAS (2007).  However, preformed fibers of
CsgA-His were able to seed unpolymerized IAPP prepared by the method used in 
Hammer et al PNAS (2007).
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Appendix C:  Downstream promoting and polar effects when  
using Keio collection strains
The Kan resistance cassettes in Keio collection strains promote downstream genes that
are usually off.  CsgG is present in cells grown in LB overnight or logarithmically only in
csgD, csgE, and csgF strains. Other Keio mutants had no effect. When the Kan cassette
was removed using pCP20, no CsgG is seen in LB; however this mutant (csgF’) may be 
polar on csgG. The csgF’ strain does not have polymerized CsgA in the agar of CR plates.
37C in LB
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Appendix D:  Effects of cold shock on CsgA-His yields
When purifying CsgA-His, addition of room temperature (RT) or colder LB to mid-log 
(OD600 0.4 to 0.8) cells increases the final yield on a per cell basis (cells are induced
at OD600 0.8 to 1.2). This effect appears to be due to a cold shock since LB of the same
temp (37oC) has not effect on the amounts of CsgA in the supernatant fraction. Yields
are increased two to four fold using 50% volume additions. The RT LB addtion lowered
the culture temperature to 32oC; the 4oC LB addition lowered the temperature to 27oC.
By the time of induction temperatures had returned to 37oC.
No Cutback 4 C RT 37 C





 This method can be used to make a lot of CsgA protein for later use and should 
result in a more consistent lag phase as you can always resuspend the same amount of
CsgA using the same protocol. 
 Other methods for precipitation and resuspension were also tried.
TCA, acetone, and EtOH did not appreciably precipitate CsgA-His. Ammonium sulfate did
work but was much slower than CH3Cl/MeOH which instantly precipitate CsgA-His.
Peptides of AB and CsgA repeating using (R1-R5) can be denatured and resuspended using
the Chen & Wetzel (2001) method. These methods denature any seeds with TFA or HFIP
which is then evaporated away. The resulting peptide film is resuspened in 2mM KOH
or 2mM HCl and then buffered appropriately.  CsgA-his treated in this manner did not
resuspend well in either 2mM HCl or 2mM KOH, in water, or in 50mM KPi. Additionally,


















1.  Elute CsgA-His in 8M GuHCl using NiNTA.
2.  Buffer exchange into H20 to remove all salts and filter though 0.02µm Filter
3.  Imediately precipitate using Chloroform Methanol to prevent amyloid formation
4.  Pellet, Decant, and Evaporate
5.  Store at -20°C or -80°C
Resuspension (approximately 1 to 2 hours)
1.  Add 8M GdHCl 1% TFA to CsgA-His (50µM).  Mix and bath sonicate 20 min.
2.  Centrifuge 20 minutes at >10,000xG.  Carefully remove and keep top 80%.
3.  Fitler through 0.02µm Anotop.
4.  Buffer exchange use G-25 column into 50mM KPi pH 7.2.  Use immediately.
Appendix E:  Method to purify and store CsgA-His for later use
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There are eight palindromic regions in the promoter region between csgD and csgB
which would allow for an inversion similar to the Type I pili sysytem.  Six sets of internal
primers were made to ensure that each segment between repeats were covered and 
that there were no large regions between either genes.  Using PCR one can then check
for inversion of DNA elements.





Primers that annealed to either csgB or csgD were mixed with one primer of a set of 
complementary primers. The position of these second primers are indicated on the
previous page. For each PCR reaction a product will only be generated if the second
primer anneals to the opposite strand of DNA from the csgB or csgD primer. For example,
a product is expected if the csgD primer is used with any of the second set of primers 
that anneal to the negative strand. Primers that anneal to the postive strand are 
indicated with a (+). If the second primer set anneals in the middle of an invertable DNA 
element and this element is present in both the default and inverted state, then a PCR 
product is expected for both primers in a comlementary set. When using the csgB primer,
none of the sets had products for both primers, indicating there are not invertible DNA
elements in BW25113 under the conditions tested. The csgD primer generated artifacts.
Cells grown on LB for 24 hoursCells grown on YESCA for 24 hours
csgB  primer csgB primer
csgD  primer csgD primer
P1      P1+     P2      P2+  AR1   AR1+    P3     P3+    P4     P4+   AR2   AR2+ P1      P1+     P2      P2+  AR1   AR1+    P3     P3+    P4     P4+   AR2   AR2+
